Vous êtes sur la page 1sur 71

page numbers in bold type relate to monograph titles Index V-A797

Index
Page numbers in bold type relate to monograph titles.

Pages Vol I: i xxxii, (Preliminaries and Introduction)


1 1280, (General Notices and Monographs)
Pages Vol II: i viii, (Preliminaries)
1 1220, (General Notices and Monographs)
Pages Vol III: i viii, (Preliminaries)
1 1238, (General Notices and Monographs)
Pages Vol IV: i viii, (Preliminaries)
1 754, (General Notices and Monographs)
Pages Vol V: i viii, (Preliminaries)
1 34, (General Notices)
S1 S144, (Spectra)
A1 A796, (Appendices; Supplementary Chapters)
page numbers in bold type relate to monograph titles Index V-A799

Acetate Buffer Solution pH 6.0, see N-Acetyltryptophan see Acetyltryptophan


A Acetate Buffer pH 6.0 Acetyltryptophan, I-63
Abacavir, V-S4 Acetate Buffer Solution pH 4.4, V-A152 Acetyltyrosine, I-65
Abacavir Oral Solution, III-85 Acetate Buffer Solution pH 4.5, V-A152 N-Acetyltyrosine see Acetyltyrosine
Abacavir Sulfate, I-39 Acetate Buffer Solution pH 4.7, V-A152 Acetyltyrosine Ethyl Ester, V-A21
Abacavir Tablets, III-86 Acetate Buffer Solution pH 5.0, V-A153 Acetyltyrosine Ethyl Ester, 0.2M, V-A21
Abbreviated, V-598 Acetate Buffer Solution pH 6.0, V-A153 Aciclovir, I-67
Adjectives, V-598 Acetateedetate Buffer Solution pH 5.5, Aciclovir Cream, III-93
Anions, V-598 V-A153 Aciclovir Eye Ointment, III-94
Cations, V-598 Acetates, Reactions of, V-266 Aciclovir Infusion, III-95
Preparations, V-598 Acetazolamide, I-54, V-S5 Aciclovir Intravenous Infusion, see
Titles of Monographs, V-598 Acetazolamide Oral Suspension, III-89 Aciclovir Infusion,
Abbreviated Titles, Status of, I-7, II-7, Acetazolamide Tablets, III-90 Aciclovir Oral Suspension, III-97
III-7, IV-7, V-7 Acetic Acid, V-A20 Aciclovir Sodium for Infusion, III-95
Abbreviations and symbols, I-30, II-30, Acetic Acid (6 per cent), I-56 Aciclovir Sodium for Intravenous
III-30, IV-30, V-30 Acetic Acid (33 per cent), I-56 Infusion, see Aciclovir Sodium for
Abnormal Toxicity, Test for, V-409 Acetic Acid, Anhydrous, V-A20 Infusion,
About, definition of, I-5, II-5, III-5, Acetic Acid, Deuterated, V-A50 Aciclovir Tablets, III-98
IV-5, V-5 Acetic Acid, Dilute, V-A20 Aciclovir Tablets, Dispersible, III-99
Absence of Mycoplasmas, Test for Acetic Acid, Dilute, see Acetic Acid Acid Blue 92, V-A21
V-487 (6 per cent) Acid Blue 92 Solution, V-A21
Absolute Ethanol, V-A61 Acetic Acid, Glacial, I-55, V-A20 Acid Blue 83, V-A21
Absolute Ethanol R1, V-A62 Acetic Acid in Synthetic Peptides, Acid Blue 93 Solution, V-A21
Absorbent Cotton, IV-743 Determination of, V-299 Acid Blue 90, V-A21
Absorbent Viscose Wadding, IV-744 Acetic Acid VS, V-A142 Acid Gentian Mixture, IV-197
Absorption spectrophotometry, infrared, Acetic Acid, see Acetic Acid (33 per cent) Acid Gentian Oral Solution, IV-197
V-162 Acetic Anhydride, V-A20 Acid Potassium Iodobismuthate
Absorption Spectrophotometry, Acetic Anhydride Solution R1, V-A20 Solution, V-A108
Ultraviolet and Visible, V-169 Acetic AnhydrideDioxan Solution, Acid Value, V-317
Acacia, I-41, V-A19 V-A20 Acid/base Indicators, V-789
Acacia Solution, V-A19 Acetic AnhydrideSulfuric Acid Solution, Acid-base titrations, V-788
Acacia Spray-dried, I-42 V-A20 Acidified Chloroform, V-A41
Acamprosate Calcium, I-43 Acetic AnhydrideSulphuric Acid Acidified Dichloromethane, V-A52
Acanthopanax Bark, IV-49 Solution, see Acetic AnhydrideSulfuric Acidified Methanol, V-A85
Acarbose, I-44 Acid Solution Acidified Methylene Chloride, see
Accuracy, V-674 Acetic Bromine Solution, V-A34 Acidified Dichloromethane
Acebutolol Capsules, III-87 Acetone, I-57, V-A20 Acid-insoluble Ash, Determination of,
Acebutolol Hydrochloride, I-46, V-S5, Acetone, Deuterated, V-A50 V-336
V-A19 Acetone Solution, Buffered, V-A153 Acid-washed Diatomaceous Support,
Acebutolol Tablets, III-88 Acetone-dried Ox Brain, V-A98 V-A51
Aceclofenac, I-48 Acetonitrile, V-A20 Acitretin, I-69
Acemetacin, I-50 Acetonitrile for Chromatography, V-A20 Acitretin Capsules, III-100
Acenocoumarol, I-52, V-S5 Acetonitrile R1, V-A20 Acknowledgements, I-xxvii
Acenocoumarol Tablets, III-88 Acetoxyvalerenic Acid, V-A20 Acrylamide, V-A21
Acesulfame Potassium, I-52 Acetyl Chloride, V-A20 Acrylamide/bisacrylamide (29:1)
Acetal, V-A19 Acetyl Groups, Reactions of, V-266 Solution, 30 per cent, V-A21
Acetaldehyde, V-A19 Acetyl Salicylic Acid see Aspirin Acrylamide/bisacrylamide (36.5:1)
Acetaldehyde Ammonia Trimer Acetyl Value, Determination of, V-317 Solution, 30 per cent, V-A21
Trihydrate, V-A20 Acetylacetamide, V-A20 Acrylic Acid, V-A21
Acetaldehyde Standard Solution Acetylacetone, V-A20 Actein, V-A21
(100 ppm C2H4O), V-A148 Acetylacetone Reagent R1, V-A20 Acteoside, V-A21
Acetaldehyde Standard Solution Acetylacetone Reagent R2, V-A20 Action and Use Statement, Status of,
(100 ppm C2H4O) R1, V-A148 4-Acetylbiphenyl, V-A20 I-17, II-17, III-17, IV-17, V-17
Acetamide, V-A20 O-Acetyl Groups in Polysaccharide Activated Acid Aluminium Oxide, V-A23
Acetate Buffer pH 2.8, V-A152 Vaccines, V-467 Activated Attapulgite, I-220
Acetate Buffer pH 2.45, V-A152 N-Acetyl-e-caprolactam, V-A20 Activated Charcoal, I-496, V-A40
Acetate Buffer pH 3.4, V-A152 Acetylcholine Chloride, I-58, V-A20 Activated Zinc, V-A140
Acetate Buffer pH 3.5, V-A152 Acetylcysteine, I-59, V-S6 Active Moiety, V-651
Acetate Buffer pH 3.7, V-A152 Acetylcysteine Eye Drops, III-90 Adamantane, V-A21
Acetate Buffer pH 4.4, V-A152 Acetylcysteine Injection, III-91 Adapalene, I-71
Acetate Buffer pH 4.6, V-A152 Acetyldigoxin, I-61 Adapalene Cream, III-101
Acetate Buffer pH 5.0, V-A152 b-Acetyldigoxin see Acetyldigoxin Adapalene Gel, III-103
Acetate Buffer pH 6.0, V-A152 Acetyleugenol, V-A20 Additions, List of, I-xxviii
Acetate Buffer Solution pH 4.7 R1, N-Acetylglucosamine, V-A21 Additions, List of Monographs, I-xxii
V-A153 Acetyl-11-keto-b-boswellic Acid, V-A21 Additives, Plastic, V-592
Acetate Buffer Solution pH 4.4, see N-Acetyl-L-cysteine, V-A20 Adenine, I-72, V-A21
Acetate Buffer pH 4.4 N-Acetylneuraminic Acid, V-A21 Adenosine, I-73, V-A21
Acetate Buffer Solution pH 4.6, see Acetylsalicylic Acid Tablets, see Aspirin Adipic Acid, I-75, V-A21
Acetate Buffer pH 4.6 Tablets Adrenaline, V-A21
N-Acetyltryptophan, V-A21 Adrenaline / Epinephrine, I-76
V-A800 Index

Adrenaline Acid Tartrate, V-A21 Agarose for Chromatography, Cross- Alendronic Acid Tablets, III-109
Adrenaline Acid Tartrate / Epinephrine linked, V-A22 Aleuritic Acid, V-A22
Acid Tartrate, I-77 Agarose for Chromatography R1, Cross- Alexandrian Senna Fruit, IV-362
Adrenaline and Cocaine Intranasal linked, V-A22 Alfacalcidol, I-87
Solution, III-107 Agarose for Electrophoresis, V-A22 Alfadex, I-88
Adrenaline (Epinephrine), V-S6 Agarose/Cross-linked Polyacrylamide, Alfentanil Hydrochloride, I-89
Adrenaline Eye Drops, Epinephrine Eye V-A22 Alfuzosin, V-S7
Drops, Neutral, III-104 Agarose-DEAE for Ion Exchange Alfuzosin Hydrochloride, I-91
Adrenaline Eye Drops/Epinephrine Eye Chromatography, V-A22 Alfuzosin Tablets, III-111
Drops, III-104 Agnus Castus Fruit, IV-50 Alfuzosin Tablets, Prolonged-release,
Adrenaline Injection, Bupivacaine and, Agrimony, IV-52 III-112
III-220 Air, Medical, I-78 Alginate Antacid Oral Suspension,
Adrenaline Injection, Dilute (1 in Air, Medicinal see Medical Air Compound, III-113
10,000), III-106 Air Permeability, Specific Surface Area Alginate Oral Suspension, Raft-forming,
Adrenaline Injection, Lidocaine and, by, V-505 III-114
III-751 Air, Synthetic, I-81 Alginate Raft-forming Oral Suspension,
Adrenaline Injection/Epinephrine Air, Synthetic Medicinal see Synthetic Air III-114
Injection, III-105 Alanine, I-83, V-A22 Alginic Acid, I-92
Adrenaline Solution/Epinephrine -Alanine, see 3-Aminopropionic Acid Alimemazine, V-S7
Solution, III-106 Albendazole, I-84 Alimemazine Oral Solution, Paediatric,
Adrenaline Tartrate see Adrenaline Acid Albumin, Bovine, V-A22 III-115
Tartrate Albumin, Bovine R1, V-A22 Alimemazine Tablets, III-116
Adrenaline Tartrate Albumin, Human, V-A22 Alimemazine Tartrate, I-93
Injection/Epinephrine Tartrate Albumin Solution, IV-467 Alizarin S, V-A22
Injection, III-105 Albumin Solution, Human, V-A22 Alizarin S Solution, V-A22
Adrenaline Tartrate Albumin Solution R1, Human, V-A22 Alkaline Corallin Solution, V-A46
Solution/Epinephrine Tartrate Alchemilla, IV-53 Alkaline Eye Drops, see Hypromellose Eye
Solution, III-106 Alcohol (20 per cent), I-900 Drops
Adrenalone Hydrochloride, V-A21 Alcohol (25 per cent), I-900 Alkaline Gentian Mixture, IV-198
Adsorbed Diphtheria and Tetanus Alcohol (45 per cent), I-900 Alkaline Gentian Oral Solution, IV-198
Vaccine, IV-537 Alcohol (50 per cent), I-900 Alkaline Hydroxylamine Solution, V-A74
Adsorbed Diphtheria and Tetanus Alcohol (60 per cent), I-900 Alkaline Hydroxylamine Solution R1,
Vaccine for Adults and Adolescents, Alcohol (70 per cent), I-900 V-A74
see Adsorbed Diphtheria and Tetanus Alcohol (80 per cent), I-900 Alkaline Potassium Mercuri-iodide
Vaccine (adsorbed, Reduced Antigen(s) Alcohol (90 per cent), I-900 Solution, V-A109
Content) Alcohol, Aldehyde-free, see Ethanol Alkaline Potassium Tetraiodomercurate
Adsorbed Diphtheria, Tetanus and (96%), Aldehyde-free Solution, V-A109
Pertussis (Acellular Component) Alcoholic Calcium Standard Solution Alkaline Pyrogallol Solution, V-A111
Vaccine, IV-541 (100 ppm Ca), V-A149 Alkaline Sodium Picrate Solution,
Adsorbed Diphtheria, Tetanus, Pertussis Alcoholic Dimethylaminobenzaldehyde V-A124
(Acellular Component) and Solution, V-A55 Alkaline Tetrazolium Blue Solution,
Haemophilus Type b Conjugate Alcoholic Hydroxylamine Solution, V-A132
Vaccine, IV-545 V-A74 Alkali-washed Diatomaceous Support,
Adsorbed Diphtheria, Tetanus, Pertussis Alcoholic Iodine Solution, III-696, V-A51
(Acellular Component) and Hepatitis V-A75 Alkaloids, Complete Extraction of,
B (rDNA) Vaccine, IV-547 Alcoholic Potassium Hydroxide, 2M, V-335
Adsorbed Diphtheria, Tetanus, Pertussis V-A108 Alkaloids, Reactions of, V-266
(Acellular Component) and Alcoholic Potassium Hydroxide, see all--Alpha-Tocopherol, II-1051
Inactivated Poliomyelitis Vaccine, Potassium Hydroxide VS, Ethanolic Allantoin, I-94, V-A23
IV-548 Alcoholic Potassium Hydroxide Solution, Allergen Products, I-95
Adsorbed Diphtheria Vaccine, IV-534 V-A108 Allium Sativum for Homoeopathic
Adsorbed Diphtheria Vaccine for Adults Alcoholic Potassium Hydroxide Solution Preparations, IV-427
and Adolescents, see Diphtheria Vaccine R1, V-A108 Allopurinol, I-98
(Adsorbed, Reduced Antigen Content) Alcoholic Solution of Sulfuric Acid, Allopurinol Oral Suspension, III-117
Adsorbed Pertussis Vaccine (Acellular V-A128 Allopurinol Tablets, III-118
Component), IV-604 Alcoholic Sulfuric Acid, 0.25M, V-A128 all-rac-Alpha-Tocopheryl Acetate,
Adsorbed Pertussis Vaccine (Acellular, Alcoholimetric Tables, V-687 II-1054
Co-purified), IV-605 Alcohol, see Ethanol (96%) all-rac-a-Tocopheryl see all-rac-Alpha-
Adsorbed Tetanus Vaccine, IV-633 Alcuronium Chloride, I-85 Tocopheryl
Adsorbed Vaccines, Aluminium in, Aldehyde Dehydrogenase, V-A22 all-rac-Tocopheryl Acetate see all-rac-
V-463 Aldehyde Dehydrogenase Solution, Alpha-Tocopheryl Acetate
Adsorbed Vaccines, Calcium in, V-464 V-A22 Almagate, I-100
Adsorption, Gas, Specific Surface Area Aldehyde-free alcohol, see Ethanol (96%), Almond Oil Ear Drops, III-119
By (2.9.26.) (5.8.), V-701 Aldehyde-free Almond Oil, Refined, I-100
Aescin, V-A22 Aldehyde-free Ethanol (96%), V-A62 Almond Oil, Virgin, I-99
Aflatoxin B1, V-A22 Aldehyde-free Methanol, V-A85 Almond Oil see Virgin Almond Oil
Aflatoxin B, in Herbal Drugs, Aldehydes, Determination of, V-321 Aloes, Barbados, IV-53
Determination of, V-341 Aldrin, V-A22 Aloes, Cape, IV-54
Agar, I-79, V-A22 Alendronate Sodium Tablets, see Alovudine, V-A23
Agarose for Chromatography, V-A22 Alendronic Acid Tablets Alovudine (18F) Injection, IV-669
page numbers in bold type relate to monograph titles Index V-A801

Aloxiprin, I-102 Aluminium Standard Solution (200 ppm Aminohydroxynaphthalenesulphonic


Aloxiprin Tablets, III-119 Al), V-A148 Acid Solution, Strong, see
Alpha Tocopheryl Acetate Concentrate Aluminium Stearate, I-123 Aminohydroxynaphthalenesulfonic Acid
(Powder Form), II-1057 Aluminium Sulfate, I-125, V-A23 Solution, Strong
Alpha Tocopheryl Hydrogen Succinate, Aluminium Sulphate, see Aluminium Aminohydroxynaphthalenesulphonic
II-1058 Sulfate Acid Solution, see
Alpha Tocopheryl Succinate Tablets, Alverine Capsules, III-122 Aminohydroxynaphthalenesulfonic Acid
III-1164 Alverine Citrate, I-126, V-S7 Solution
Alphacyclodextrin see Alfadex Amantadine Capsules, III-123 4-Amino-3-hydroxynaphthalene-1-
Alprazolam, I-103 Amantadine Hydrochloride, I-127 sulphonic Acid, see 4-Amino-3-
Alprenolol Hydrochloride, I-105 Amantadine Oral Solution, III-124 hydroxynaphthalene-1-sulfonic Acid
Alprostadil, I-107 Amantidine, V-S8 Aminohydroxynaphthalenesulphonic,
Alteplase for Injection, I-109 Amaranth S, V-A23 Acid, see Aminonaphthalenesulfonic Acid
Alternative methods, I-20, II-20, III-20, Amaranth Solution, V-A23 Solution
IV-20, V-20 Ambroxol Hydrochloride, I-128 5-Aminoimidazole-4-carboxamide
Alternative Methods for Control of Americium-243 Spiking Solution, V-A23 Hydrochloride, V-A24
Microbiological Quality, V-745 Amethocaine Eye Drops, see Tetracaine cis-Aminoindanol, V-A24
Altizide, I-113 Eye Drops Aminomethylalizarindiacetic Acid
Alum, I-114 Amfetamine Sulfate, I-130 Reagent, V-A24
Aluminium, V-A23 Amfetamine Sulphote, see Amfetamine Aminomethylalizarindiacetic Acid
Aluminium Acetate Ear Drops, III-120 Sulfate, I-130 Solution, V-A25
Aluminium Chloride, V-A23 Amido Black 10B Solution, V-A23 3-Aminomethylalizarin-N,N-diacetic
Aluminium Chloride Hexahydrate, I-114 Amidohexadecylsilyl Silica Gel for Acid, V-A24
Aluminium Chloride Reagent, V-A23 chromatography, V-A115 4-Aminomethylbenzoic acid, V-A25
Aluminium Chloride Solution, III-121, Amidotrizoic Acid Dihydrate, I-130 3-(Aminomethyl)pyridine, V-A25
V-A23 Amikacin, I-132 8-Aminonaphthalene-2-sulfonic Acid,
Aluminium Glycinate, I-115 Amikacin Injection, III-124 V-A25
Aluminium Hydroxide and Magnesium Amikacin Sulfate, I-135 Aminonaphthalenesulfonic Acid
Trisilicate Tablets, Chewable, III-776 Amiloride and Furosemide Tablets, see Solution, V-A25
Aluminium Hydroxide, Dried, I-115 Co-amilofruse Tablets Aminonaphthalenesulphonic Acid
Aluminium Hydroxide Gel, V-A23 Amiloride and Hydrochlorothiazide Oral Solution, see Aminonaphthalenesulfonic
Aluminium Hydroxide, Hydrated for Solution, see Co-amilozide Oral Solution Acid Solution
Adsorption, I-114 Amiloride and Hydrochlorothiazide 8-Aminonaphthalene-2-sulphonic Acid,
Aluminium Hydroxide Oral Suspension, Tablets, see Co-amilozide Tablets see 8-Aminonaphthalene-2-sulfonic Acid
III-121 Amiloride Hydrochloride, I-138 4-Amino-n-butyric Acid, V-A24
Aluminium Hydroxide Oral Suspension, Amiloride Tablets, III-125 2-Amino-5-nitrobenzophenone, V-A25
Magnesium Hydroxide and, III-401 Amines, Primary Aromatic, Reactions of, Aminonitrobenzophenone, see 2-Amino-5-
Aluminium Hydroxide Tablets, V-266 nitrobenzophenone
Chewable, III-122 Amino Acid Analysis, V-221 4-Aminophenazone, V-A25
Aluminium Hydroxide Tablets, Amino Acid Analysis (2.2.56.) (5.8.), Aminophenazone Solution, V-A25
Magnesium Hydroxide and, III-402 V-700 3-Aminophenol, V-A25
Aluminium Hydroxide Tablets see Amino Acids, Use of Codes for, I-8, 4-Aminophenol-free Paracetamol, V-A99
Chewable Aluminium Hydroxide II-8, III-8, IV-8, V-8 Aminophylline, I-143
Tablets, III-122 Aminoazobenzene, V-A23 Aminophylline Hydrate, I-145
Aluminium in Adsorbed Vaccines, V-463 Aminobenzoic Acid, I-139, V-A23, Aminophylline Injection, III-128
Aluminium Magnesium Silicate, I-118 V-A24 Aminophylline Tablets, III-128
Aluminium Nitrate, V-A23 4-Aminobenzoic Acid Solution, V-A24 Aminophylline Tablets, Prolonged-
Aluminium Oxide, Activated Acid, (4-Aminobenzoyl)-L-glutamic Acid, release, III-129
V-A23 V-A24 Aminopolyether, V-A25
Aluminium Oxide, Anhydrous, V-A23 4-Aminobutanoic acid, see 4-Amino-n- 3-Aminopropanol, V-A25
Aluminium Oxide, Basic, V-A23 butyric Acid 3-Aminopropionic Acid, V-A25
Aluminium Oxide, Deactivated, V-A23 2-Aminobutan-1-ol, V-A24 Aminopropylmethylsilyl Silica Gel for
Aluminium Oxide G, V-A23 Aminocaproic Acid, I-140 Chromatography, V-A115
Aluminium Oxide, Neutral, V-A23 2-Amino-5-chlorobenzophenone, V-A24 Aminopropylsilyl Silica Gel for
Aluminium Paste, Compound, III-120 Aminochlorobenzophenone, see 2-Amino- Chromatography, V-A115
Aluminium Phosphate Gel, I-120 5-chlorbenzophenone Aminopropylsilyl Silica Gel for
Aluminium Phosphate, Hydrated see 4-Aminofolic Acid, V-A24 Chromatography R1, V-A115
Dried Aluminium Phosphate Aminoglutethimide, I-141, V-S8 Aminopyrazolone, see 4-Aminophenazone
Aluminium Potassium Sulfate, V-A23 Aminoglutethimide Tablets, III-126 Aminopyrazolone Solution, see
Aluminium Potassium Sulphate, see Aminohexadecylsilyl Silica Gel for Aminophenazone Solution
Aluminium Potassium Sulfate Chromatography, V-A115 3-Aminosalicylic Acid, V-A25
Aluminium Powder, I-121 6-Aminohexanoic Acid, V-A24 Amiodarone, V-S8
Aluminium Salts, Reactions of, V-266 p-Aminohippuric Acid, V-A24 Amiodarone Concentrate, Sterile,
Aluminium Sodium Silicate, I-122 Aminohippuric Acid Reagent, V-A24 III-130
Aluminium Standard Solution (2 ppm 4-Amino-3-hydroxynaphthalene-1- Amiodarone Hydrochloride, I-147
Al), V-A148 sulfonic Acid, V-A24 Amiodarone Infusion, III-129
Aluminium Standard Solution (10 ppm Aminohydroxynaphthalenesulfonic Acid Amiodarone Intravenous Infusion, see
Al), V-A148 Solution, V-A24 Amiodarone Infusion,
Aluminium Standard Solution (100 ppm Aminohydroxynaphthalenesulfonic Acid Amiodarone Oral Suspension, III-131
Al), V-A148 Solution, Strong, V-A24 Amiodarone Sterile Concentrate, III-130
V-A802 Index

Amiodarone Tablets, III-132 Ammonium Cerium(IV) Nitrate, V-A26 Ammonium Iron(III) Sulphate, see
Amisulpride, I-149, V-S9 Ammonium Cerium(IV) Nitrate VS, Ammonium Iron(iii) Sulfate
Amisulpride Oral Solution, III-133 V-A142 Ammonium Mercaptoacetate Solution,
Amisulpride Tablets, III-134 Ammonium Cerium(IV) Sulfate, V-A26 V-A27
Amitriptyline Embonate, I-150 Ammonium Cerium(IV) Sulfate VS, Ammonium Mercurithiocyanate Reagent,
Amitriptyline Hydrochloride, I-151 V-A142 V-A27
Amitriptyline Tablets, III-135 Ammonium Cerium(IV) Sulphate VS, see Ammonium Metavanadate, V-A27
Amlodipine Besilate, I-153 Ammonium Cerium(IV) Sulfate VS Ammonium Metavanadate Solution,
Ammonia, V-A25 Ammonium Cerium(IV) Sulphate, see V-A27
Ammonia (13N) Injection, IV-672 Ammonium Cerium(iv) Sulfate Ammonium Molybdate, V-A27
Ammonia Buffer pH 9.5, see Ammonium Ammonium Chloride, I-159, V-A26 Ammonium Molybdate Reagent, V-A27
Chloride Buffer Solution pH 9.5 Ammonium Chloride Buffer Solution Ammonium Molybdate Reagent R1,
Ammonia Buffer pH 10.9, V-A153 pH 10.0, see Ammonia Buffer pH 10.0 V-A27
Ammonia Buffer pH 10.9, Dilute, Ammonium Chloride Buffer Solution Ammonium Molybdate Reagent R2,
V-A153 pH 10.4, V-A153 V-A27
Ammonia Buffer pH 10.0, V-A153 Ammonium Chloride Buffer Solution Ammonium Molybdate Solution, V-A27
Ammonia, Chloride-free, V-A25 pH 10.7, V-A153 Ammonium Molybdate Solution R2,
Ammonia, Concentrated, V-A25 Ammonium Chloride Buffer Solution V-A27
Ammonia, Lead-free, V-A25 pH 9.5, V-A153 Ammonium Molybdate Solution R3,
Ammonia, Methanolic, V-A25 Ammonium Chloride Buffer Solution V-A27
Ammonia R1, Concentrated, V-A26 pH 10.0, V-A153 Ammonium Molybdate Solution R4,
Ammonia R1, Dilute, V-A26 Ammonium Chloride Mixture, III-137 V-A27
Ammonia R2, Dilute, V-A26 Ammonium Chloride Oral Solution, Ammonium Molybdate Solution R5,
Ammonia R3, Dilute, V-A26 III-137 V-A27
Ammonia Solution, Aromatic, III-136 Ammonium Chloride Solution, V-A26 Ammonium Molybdate Solution R6,
Ammonia Solution, Concentrated see Ammonium Citrate, V-A26 V-A27
Strong Ammonia Solution Ammonium Citrate Solution, V-A26 Ammonium Molybdate-Sulfuric Acid
Ammonia Solution, Dilute, III-137 Ammonium Cobaltothiocyanate Solution, V-A27
Ammonia Spirit, Aromatic, III-137 Solution, V-A26 Ammonium Molybdate-Sulphuric Acid
Ammoniacal Copper Oxide Solution, Ammonium Dihydrogen Solution, see Ammonium Molybdate-
V-A46 Orthophosphate, V-A26 Sulfuric Acid Solution
Ammoniacal Silver Nitrate Solution, Ammonium Formate, V-A26 Ammonium Muriaticum, V-609
V-A120 Ammonium Glycyrrhizinate, I-160 Ammonium Nitrate, V-A27
Ammoniacal Solution of Copper Ammonium Hexafluorogermanate, Ammonium Nitrate R1, V-A27
Tetrammine, V-A46 V-A26 Ammonium Oxalate, V-A27
Ammonia-free Water, V-A139 Ammonium Hydrogen Carbonate, Ammonium Oxalate Solution, V-A27
Ammonio Methacrylate Copolymer V-A26 Ammonium Persulfate, V-A27
(Type A), I-155 Ammonium Hydrogen Carbonate see Ammonium Persulphate, see Ammonium
Ammonio Methacrylate Copolymer Ammonium Bicarbonate Persulfate
(Type B), I-156 Ammonium Ichthosulphonate see Ammonium Phosphate, see Diammonium
0.5M Ammonium acetate buffer solution Ichthammol Hydrogen Orthophosphate
pH 4.5, see Ammonium acetate buffer Ammonium Iron(II) Sulfate, V-A26 Ammonium Polysulfide Solution, V-A27
pH 4.5, 0.5M Ammonium Iron(II) Sulfate VS, V-A142 Ammonium Polysulphide Solution, see
0.01M Ammonium and Cerium Nitrate, Ammonium Iron(II) Sulphate VS, see Ammonium Polysulfide Solution
see Ammonium Cerium(IV) Nitrate VS Ammonium Iron(II) Sulfate VS Ammonium Pyrrolidinedithiocarbamate,
0.1M Ammonium and Cerium Sulfate, Ammonium Iron(II) Sulphate, see V-A27
see Ammonium Cerium(IV) Sulfate VS Ammonium Iron(ii) Sulfate Ammonium Pyrrolidinedithiocarbamate
Ammonium Acetate, V-A26 Ammonium Iron(III) Citrate, V-A26 Solution, V-A27
Ammonium acetate buffer pH 4.5, 0.5M, Ammonium Iron(III) Sulfate, V-A26 Ammonium Reineckate, V-A27
V-A153 Ammonium Iron(III) Sulfate Solution R1, Ammonium Reineckate Solution, V-A28
Ammonium Acetate Solution, V-A26 V-A26 Ammonium Salts and Salts of Volatile
Ammonium Acetate Solution, Strong, Ammonium Iron(III) Sulfate Solution R2, Bases, Reactions of, V-267
III-137 V-A26 Ammonium Salts Reactions of, V-266
Ammonium and Cerium Nitrate, see Ammonium Iron(III) Sulfate Solution R5, Ammonium Standard Solution (1 ppm
Ammonium Cerium(IV) Nitrate V-A26 NH4), V-A148
Ammonium and Cerium Sulfate, see Ammonium Iron(III) Sulfate Solution R6, Ammonium Standard Solution (2.5 ppm
Ammonium Cerium(IV) Sulfate V-A27 NH4), V-A148
Ammonium and Cerium Sulphate, see Ammonium Iron(III) Sulfate VS, V-A142 Ammonium Standard Solution (3 ppm
Ammonium and Cerium Sulfate Ammonium Iron(III) Sulphate Solution NH4), V-A148
Ammonium Bicarbonate, I-157 R1, see Ammonium Iron(iii) Sulfate Ammonium Standard Solution (100 ppm
Ammonium Bromide, I-158 Solution R1 NH4), V-A148
Ammonium Carbamate, V-A26 Ammonium Iron(III) Sulphate Solution Ammonium Sulfamate, V-A28
Ammonium Carbonate, V-A26 R2, see Ammonium Iron(iii) Sulfate Ammonium Sulfate, V-A28
Ammonium Carbonate Buffer Solution Solution R2 Ammonium Sulfide Solution, V-A28
pH 10.3, 0.1M, V-A153 Ammonium Iron(III) Sulphate Solution Ammonium Sulphamate, see Ammonium
Ammonium Carbonate Solution, V-A26 R5, see Ammonium Iron(iii) Sulfate Sulfamate
Ammonium Carbonate Solution, Dilute, Solution R5 Ammonium Sulphate, see Ammonium
V-A26 Ammonium Iron(III) Sulphate VS, see Sulfate
Ammonium carbonate solution R1, Ammonium Iron(III) Sulfate VS Ammonium Sulphide Solution, see
V-A26 Ammonium Sulfide Solution
page numbers in bold type relate to monograph titles Index V-A803

Ammonium Thiocyanate, V-A28 Anethum Graveolens L. Sowa Group, see Aniline Hydrochloride Solution, V-A28
Ammonium Thiocyanate Solution, Anethum Graveolens Sowa Fruit, Animal Spongiform Encephalopathy
V-A28 Anethum Graveolens Sowa Fruit, IV-58 Agents Via Human and Veterinary
Ammonium Thiocyanate VS, V-A142 Angelica Archangelica Root, IV-59 Medicinal Products, Minimising the
Ammonium Vanadate Solution, V-A28 Angelica Dahurica Root, IV-60 Risk of Transmitting, V-611
Ammonium Vanadate, see Ammonium Angelica Pubescens Root, IV-62 Animals, Use of, I-15, II-15, III-15,
Metavanadate Angelica Sinensis Root, IV-63 IV-15, V-15
Amobarbital, I-161 Angelica Sinensis Root, see Processed Anion Exchange Resin, V-A28
Amobarbital Sodium, I-162 Angelica Sinensis Root Anion Exchange Resin for
Amomum fruit, IV-56 Anhydrous Acetic Acid, V-A20 Chromatography, Strongly Basic,
Amorphous Organosilica Polymer, Anhydrous Aluminium Oxide, V-A23 V-A28
Octadecylsilyl, V-A98 Anhydrous Ampicilin see Ampicillin Anion Exchange Resin R1, V-A28
Amoxicillin and Potassium Clavulanate Anhydrous Azapropazone, V-S12 Anion Exchange Resin R2, V-A28
Injection, see Co-amoxiclav Injection Anhydrous Beclometasone Dipropionate, Anion exchange resin R3, V-A29
Amoxicillin and Potassium Clavulanate I-239 Anion Exchange Resin, Strongly Basic,
Oral Suspension, see Co-amoxiclav Oral Anhydrous Caffeine, see Caffeine V-A28
Suspension Anhydrous Calcipotriol, I-353 Anion Exchange Resin, Weak, V-A29
Amoxicillin and Potassium Clavulanate Anhydrous Calcium Acetate, see Calcium Anion-exchange Resin for
Tablets, Dispersible, see Dispersible Co- Acetate Chromatography, Strongly Basic R1,
amoxiclav Tablets Anhydrous Calcium Chloride, V-A37 V-A28
Amoxicillin and Potassium Clavulanate Anhydrous Calcium Gluconate, I-372 Anionic Emulsifying Wax, see Emulsifying
Tablets, see Co-amoxiclav Tablets Anhydrous Calcium Hydrogen Wax
Amoxicillin Capsules, III-138 Phosphate, I-377 Anisaldehyde, V-A29
Amoxicillin Injection, III-139 Anhydrous Calcium Lactate, I-378 Anisaldehyde Solution, V-A29
Amoxicillin Oral Suspension, III-141 Anhydrous Chlorobutanol, I-518 Anisaldehyde Solution R1, V-A29
Amoxicillin Sodium, I-163, V-S9 Anhydrous Citric Acid, I-569, V-A45 Anise Ketone, V-A29
Amoxicillin Sodium for Injection, Anhydrous Copper Sulfate, I-647 Anise Oil, IV-71
III-139 Anhydrous Disodium Hydrogen Anise Water, Concentrated, IV-73
Amoxicillin Trihydrate, I-165, V-S9, Orthophosphate, V-A59 Aniseed, IV-66
V-A28 Anhydrous Disodium Hydrogen Aniseed Oil, see Anise Oil
Ampere, Definition of, I-32, II-32, Phosphate, I-788 p-Anisidine, V-A29
III-32, IV-32, V-32 Anhydrous Docetaxel, I-796 Anisidine Value, V-326
Amperometric, Potentiometric and Anhydrous Ephedrine, I-849 Anolyte for Isoelectric Focusing pH 3 to
Voltametric Titrations, V-280 Anhydrous Formic Acid, V-A67 5, V-A29
Amperometric Titration, V-280 Anhydrous Glucose, I-1083 Antazoline Hydrochloride, I-181
Amphotericin, I-168 Anhydrous Iron(III) Chloride, V-A77 Anthracene, V-A29
Amphotericin B see Amphotericin Anhydrous Lactose, II-66 Anthranilic Acid, see 2-Aminobenzoic Acid
Amphotericin for Infusion, III-142 Anhydrous Lithium Metaborate, V-A81 Anthrax, see Anthrax Vaccine for Human
Amphotericin Lozenges, I-xxix Anhydrous Magnesium Citrate, II-166 Use (Adsorbed, Prepared from Culture
Amphotericin Oral Suspension, I-xxix Anhydrous Methanol, V-A85 Filtrates)
Ampicillin, I-170 Anhydrous Morphine, V-A91 Anthrax Vaccine for Human Use
Ampicillin Capsules, III-143 Anhydrous Nevirapine, II-358 (Adsorbed, Prepared from Culture
Ampicillin Capsules, Flucloxacillin and, Anhydrous Niclosamide, II-362 Filtrates), IV-527
see Co-fluampicil Capsules Anhydrous Paroxetine Hydrochloride, Anthrone, V-A29
Ampicillin Injection, III-144 II-504 Anthrone Reagent, V-A29
Ampicillin Oral Suspension, III-146 Anhydrous Phloroglucinol, II-566 Antibiotics, Microbiological Assay of,
Ampicillin Oral Suspension, Anhydrous Pyridine, V-A110 V-396, V-655
Flucloxacillin and, see Co-fluampicil Anhydrous Silica Gel, V-A114 Antibiotics, Potency of, I-14, II-14,
Oral Suspension Anhydrous Silica, Hydrophobic III-14, IV-14, V-14
Ampicillin Sodium, I-172, V-S10 Colloidal, II-807 Anticoagulant and Preservative Solutions
Ampicillin Sodium for Injection, III-144 Anhydrous Sodium Acetate, V-A120 for Blood, IV-461
Ampicillin Trihydrate, I-175, V-S10 Anhydrous Sodium Carbonate, II-830, Anti-D Immunoglobulin for Intravenous
Amyl Acetate, V-A28 V-A121, V-A141 Use, IV-497
Amyl Alcohol, see Isoamyl Alcohol Anhydrous Sodium Dihydrogen Anti-D (Rh0) Immunoglobulin, IV-496
a-Amylase, V-A28 Orthophosphate, V-A122 Antimicrobial Preservation, Efficacy of,
a-Amylase Solution, V-A28 Anhydrous Sodium Dihydrogen V-494, V-653
Amylmetacresol, I-178, V-S10 Phosphate, II-839, V-A122 Antithrombin III Concentrate
Amylose-derivative Silica Gel for Anhydrous Sodium Sulfate, II-872, Anticomplimentary activity of
Chromatography, V-A115 V-A124 immunoglobulin, Test for V-427
b-Amyrin, V-A28 Anhydrous Sodium Sulfite, II-873, Anti-D immunoglobulin, human, Assay
Anacardium for Homoeopathic V-A124 of V-429
Preparations, IV-428 Anhydrous Sodium Sulphate see Anti-D antibodies in human
Anaesthetic Ether, I-902 Anhydrous Sodium Sulfate immunoglobulin V-431
Analytical Procedures, Validation of, Anhydrous Sodium Sulphite see Anti-A and anti-B haemogglutinins
V-673 Anhydrous Sodium Sulfite V-432
Analytical Sieving, Particle-size Anhydrous Torasemide, II-1066 Antimicrobial Preservatives, Definition of
Distribution Estimation By, V-503 Anhydrous Valaciclovir Hydrochloride, Suitable, I-11, II-11, III-11, IV-11,
Anastrozole, I-179 II-1134 V-11
cis-Anethole, V-A28 Aniline, V-A28 Antimony Compounds, Reactions of,
Aniline Hydrochloride, V-A28 V-267
V-A804 Index

Antimony Potassium Tartrate, V-A29 Arginine Hydrochloride Infusion, III-148 Aspirin, I-204
Antimony Standard Solution (1 ppm Arginine Hydrochloride Intravenous Aspirin and Caffeine Tablets, III-154
Sb), V-A148 Infusion, III-148 Aspirin and Codeine Tablets,
Antimony Standard Solution (100 ppm Arginine Hydrochloride Oral Solution, Dispersible, see Co-codaprin Tablets,
Sb), V-A148 III-149 Dispersible
Antimony Trichloride, V-A29 Argon, I-193, V-A30 Aspirin and Codeine Tablets, see Co-
Antimony Trichloride in Dichloroethane Argon for Chromatography, V-A30 codaprin Tablets
Solution, V-A29 Argon R1, V-A30 Aspirin Tablets, III-151
Antimony Trichloride Solution, V-A29 Aristolochic Acids in Herbal Drugs, Aspirin Tablets, Dispersible, III-152
Antimony Trichloride Solution R1, V-339 Aspirin Tablets, Effervescent, III-152
V-A29 Aripiprazole, I-194 Aspirin Tablets, Gastro-resistant, III-153
Anti-T Lymphocyte Immunoglobulin for Aristolochic Acids I and II in Herbal Assay of 1,8-cineole in essential oils, see
Human Use, Animal, IV-514 Drugs, Test for, V-339, V-341 Determination of Cineole
Antithrombin III, V-A29 Arjuna Stem Bark, see Terminalia Arjuna Assay of Diphtheria Vaccine (Adsorbed)
Antithrombin III, human, Assay of Stem Bark (2.7.6.), V-436
V-424 Arnica Flower, IV-73 Assay of Interferons, V-456
Antithrombin III Concentrate, IV-469 Arnica Tincture, IV-75 Assay of Pancreatin, V-416
Antithrombin III Solution R1, V-A29 Aromadendrene, V-A30 Assay, Release and Check, V-657
Antithrombin III Solution R2, V-A29 Aromatic Ammonia Solution, III-136 Assays and Tests, I-12, II-12, III-12,
Antithrombin III Solution R3, V-A29 Aromatic Ammonia Spirit, III-137 IV-12, V-12
Antithrombin III Solution R4, V-A29 Aromatic Cardamom Tincture, IV-128 Astragaloside I CRS, V-A160
Apigenin, V-A29 Aromatic Magnesium Carbonate Astragaloside II CRS, V-A160
Apigenin-7-glucoside, V-A30 Mixture, III-771 Astragaloside IV, V-A31
Apiole, V-A30 Aromatic Magnesium Carbonate Oral Astragaloside IV CRS, V-A160
Apis for Homoeopathic Preparations, Suspension, III-771 Astragalus Mongholicus Root, IV-80
IV-429 Aromatic Waters, III-81 ATCC, V-628
Apomorphine Hydrochloride for Aromatic-free Petroleum Spirit, (boiling ATCC - American Type Culture
Homoeopathic Preparations, IV-430 range, 408 to 608), V-A101 Collection, address of, I-31, II-31,
Apomorphine Hydrochloride Arsenic Compounds, Reactions of, III-31, IV-31, V-31
Hemihydrate, I-182 V-267 Atenolol, I-205, V-S11, V-A31
Apomorphinum Muriaticum for Arsenic Standard Solution (0.1 ppm As), Atenolol and Chlortalidone Tablets,
Homoeopathic Preparations, see V-A148 III-405
Apomorphine Hydrochloride for Arsenic Standard Solution (1 ppm As), Atenolol Injection, III-155
Homoeopathic Preparations V-A148 Atenolol Oral Solution, III-156
Apparatus and procedures, I-23, II-23, Arsenic Standard Solution (10 ppm As), Atenolol Tablets, III-157
III-23, IV-23, V-23 V-A148 Atomic Absorption Spectrometry, V-177
Apparent Density, Determination of, Arsenic Trioxide, V-A141 Atomic Emission Spectrometry, V-174
V-246 Arsenious Trioxide, V-A30, V-A141 Atomic Spectrometry, Elementary
Apparent Dissolution V-368 Arsenious Trioxide for Homoeopathic Standard Solutions for, V-A149
Appendices, I-xxiii Preparations, IV-430 Atomic Spectrophotometry, Emission
Appendices, Contents of the, V-A3 Arsenite Solution, V-A30 and Absorption, V-174
Application of dissolution limits, V-649 Artemisia Cina for Homoeopathic Atomic Weights, I-6, II-6, III-6, IV-6,
Approved Synonyms, V-598 Preparations, IV-431 V-6
Approved Synonyms for Homoeopathic Articaine Hydrochloride, I-196 Atomic Weights of Elements, Names,
Use, V-609 Artichoke Leaf, IV-76 Symbols and, V-629
Aprotinin, I-183, V-A30 Artichoke Leaf Dry Extract, IV-78 Atomoxetine Hydrochloride, I-207
Aprotinin Concentrated Solution, I-186 Artificial Gastric Juice, V-A68 Atorvastatin Calcium Trihydrate, I-209
aP, see Adsorbed Pertussis Vaccine Artificial Tears, see Hypromellose Eye Atovaquone, I-212
(Acellular Component) Drops Atractylodes Lancea Rhizome, IV-82
aP, see Adsorbed Pertussis Vaccine Ascorbic Acid, I-198, V-A30 Atractylodes Rhizome, Largehead, see
(Acellular, Co-purified) Ascorbic Acid Injection, III-150 Largehead Atractylodes Rhizome
Aqueous Calamine Cream, III-227 Ascorbic Acid, see L-Ascorbic Acid Atracurium Besilate, I-213
Aqueous Cream, III-147 Ascorbic Acid Solution, V-A30 Atropine, I-215
Aqueous Cream, Menthol in, see Ascorbic Acid Tablets, III-150 Atropine Eye Drops, III-157
Levomenthol Cream Ascorbic Acid Tablets, Chewable, Atropine Eye Ointment, III-158
Aqueous Iodine Oral Solution, III-696 III-150, III-151 Atropine Injection, III-158
Aqueous Nile Blue A Solution, V-A93 Ascorbyl Palmitate, I-200 Atropine Injection, Morphine and,
Aqueous Phenol Injection, III-977 Ash, Determination of, V-335 III-865
L-Arabinose, V-A30 Ash, Determination of Acid-insoluble, Atropine Sulfate, I-217, V-A31
Arabinose, see L-Arabinose V-336 Atropine Sulphate, see Atropine Sulfate
Arachidic Alcohol, V-A30 Ash, Determination of Sulfated, V-306 Atropine Tablets, III-159
Arachis Oil, I-188 Ash Insoluble in Hydrochloric Acid, Atropinum Sulfuricum, V-609
Arachis Oil Enema, III-147 V-336 Attapulgite, I-219
Arbutin, V-A30 Ash Leaf, IV-79 Attapulgite, Activated, I-220
Argentum Nitricum, V-609 Ash, Sulfated (2.4.14.) (5.8.), V-700 Aucubin, V-A31
Arginine, I-189, V-A30 Asiaticoside, V-A30 Aurum Chloratum Natronatum for
Arginine Aspartate, I-191 Asparagine Monohydrate, I-200 Homoeopathic Preparations, see
Arginine Hydrochloride, I-192, V-S11 Aspartame, I-201 Sodium Tetrachloroaurate Dihydrate for
Arginine Hydrochloride Concentrate, Aspartic Acid, I-203, V-A30 Homoeopathic Preparations
Sterile, III-148 L-Aspartyl-L-phenylalanine, V-A30 Azadirachta Indica Leaf, IV-84
page numbers in bold type relate to monograph titles Index V-A805

Azadirachtin, V-A31 Barbituric Acid, V-A31 Beclometasone Pressurised Inhalation,


Azadirachtin A CRS, V-A160 Barium Acetate, V-A31 III-169
Azapropazone, I-220, V-S11 Barium Carbonate, V-A31 Belamcanda Chinensis Rhizome, IV-88
Azapropazone, Anhydrous, V-S12 Barium Chloride, V-A31 Belerica Fruit, see Terminalia Belerica
Azapropazone Capsules, III-160 Barium Chloride Dihydrate for Belladonna Herb, see Belladonna Leaf
Azapropazone Tablets, III-161 Homoeopathic Preparations, IV-432 Belladonna Herb, Prepared, see Prepared
Azathioprine, I-222 Barium Chloride Solution, V-A31 Belladonna
Azathioprine Oral Suspension, III-161 Barium Chloride Solution R1, V-A31 Belladonna Leaf, IV-89
Azathioprine Tablets, III-163 Barium Chloride Solution R2, V-A31 Belladonna Leaf Dry Extract,
Azelastine Hydrochloride, I-223, V-S12 Barium Chloride VS, V-A142 Standardised, see Standardised
Azithromycin, I-225 Barium Hydroxide, V-A31 Belladonna Leaf Dry Extract
Azobenzene, V-A31 Barium Hydroxide Solution, V-A31 Belladonna Leaf Tincture, Standardised,
Azomethine H, V-A31 Barium Nitrate, V-A31 see Standardised Belladonna Leaf Dry
Azomethine H Solution, V-A31 Barium Perchlorate VS, V-A142 Tincture
Barium Standard Solution (2 ppm Ba), Belladonna Prepared, see Prepared
V-A149 Belladonna
B Barium Standard Solution (50 ppm Ba),
V-A148
Belladonna Tincture, IV-93
Benazepril Hydrochloride, I-245
B1. Assay of Heparin in Coagulation
Barium Sulfate, I-238, V-A31 Bendrofluazide Tablets, see
Factors, V-424
Barium Sulfate for Suspension, I-238 Bendroflumethiazide Tablets
B2. Assay of Heparin, V-425
Barium Sulfate Oral Suspension, III-165 Bendroflumethiazide, I-247
B3. Assay of Human Antithrombin III,
Barium Sulphate for Suspension, see Bendroflumethiazide Tablets, III-172
V-426
Barium Sulfate for Suspension Benorilate, I-247, V-S13
B4. Assay of Human Protein C, V-426
Barium Sulphate Oral Suspension, see Benorilate Oral Suspension, III-172
B5. Assay of Human Protein S, V-427
Barium Sulfate Oral Suspension Benorilate Tablets, III-173
Bacampicillin Hydrochloride, I-227
Barium Sulphate, see Barium Sulfate Benperidol, I-248
Bacillus Calmette-Guerin Vaccine,
Base-deactivated End-capped Benserazide Hydrochloride, I-250
IV-528
Octadecylsilyl Silica Gel for Benserazide Hydrochloride and
Bacitracin, I-229
Chromatography, V-A116 Levodopa Capsules, see Co-beneldopa
Bacitracin Eye Ointment, Polymyxin
Base-deactivated End-capped Capsules
and, III-999
Octadecylsilyl Silica Gel for Benserazide Hydrochloride and
Bacitracin Ointment, Polymyxin and,
Chromatography R1, V-A118 Levodopa Tablets, Dispersible, see
III-1001
Base-deactivated End-capped Octylsilyl Dispersible Co-beneldopa Tablets
Bacitracin Zinc, I-232
Silica Gel for Chromatography, Bentonite, I-251
Back titrations, V-789
V-A117 Benzalacetone, V-A31
Baclofen, I-234
Base-deactivated Octadecylsilyl Silica Gel Benzaldehyde, I-252, V-A31
Baclofen Oral Solution, III-163
for Chromatography, V-A116 Benzalkonium Chloride, I-253, V-A31
Baclofen Tablets, III-164
Base-deactivated Octylsilyl Silica Gel for Benzalkonium Chloride Solution, I-255,
Bacopa Monnieri, IV-85
Chromatography, V-A117 V-A31
Bacopaside I CRS, V-A160
Basic Aluminium Oxide, V-A23 Benzathine Benzylpenicillin, I-257
Bacopaside II CRS, V-A160
Basic Butylated Methacrylate Benzatropine Injection, III-174
Bacoside A CRS, V-A160
Copolymer, II-231 Benzatropine Mesilate, I-259, V-S14
Bacterial Endotoxin Testing, V-640
Basic Fuchsin, V-A67 Benzatropine Tablets, III-175
Bacterial Endotoxin Testing,
Basic Fuchsin Solution, V-A67 Benzbromarone, I-260
Supplementary Information, V-640
Batch Release, I-9, II-9, III-9, IV-9, V-9 Benzene, V-A31
Bacterial Endotoxins, Guidelines for
BCG for Immunotherapy, IV-530 Benzene-1,2,4-triol, V-A31
Using the Test for (5.1.10.), V-641
BCG Vaccine, see Bacillus Calmette- Benzethonium Chloride, I-261, V-A31
Bacterial Endotoxins, Test for, V-404
Guerin Vaccine Benzethonium Chloride VS, 0.004M,
Baicalin, V-A31
BCG, see Bacillus Calmette-Guerin Vaccine V-A143
Baltimore Paste, III-120
Bearberry Leaf, IV-86 Benzhexol Tablets, see Trihexyphenidyl
Bambuterol Hydrochloride, I-236
Beclometasone Aqueous Nasal Spray, Tablets
BAN, V-659
III-170 Benzidine, V-A32
Barbados Aloes, IV-53
Beclometasone Cream, III-166 Benzil, V-A32
Barbaloin, V-A31
Beclometasone Dipropionate (1), V-S12 Benzoates, Reactions of, V-267
Barbital, I-237, V-A31
Beclometasone Dipropionate (2), V-S13 Benzocaine, I-262, V-A32
Barbital Buffer Solution pH 8.6 R1, see
Beclometasone Dipropionate Benzoic Acid, I-262, V-S14, V-A32,
Barbitone Buffer pH 8.6 R1
Monohydrate, I-241, V-S13 V-A141
Barbital Buffer Solution pH 7.4, see
Beclometasone Inhalation Powder, Benzoic Acid Ointment, Compound,
Barbitone Buffer pH 7.4
III-167 III-175
Barbital Buffer Solution pH 7.4, V-A153
Beclometasone Inhalation Powder, pre- Benzoic Acid Solution, III-176
Barbital Buffer Solution pH 8.6 R1,
dispensed, III-168 Benzoin, V-A32
V-A153
Beclometasone Nasal Spray, III-170 Benzoin, see Sumatra Benzoin
Barbital Sodium, V-A31
Beclometasone Ointment, III-171 Benzoin Inhalation, IV-98
Barbital Sodium, see Barbitone Sodium
Beclometasone Powder for Inhalation, Benzoin Inhalation, Menthol and,
Barbitone, V-A31
Metered dose Powder Inhaler, see IV-277
Barbitone Buffer pH 8.6 R1, V-A153
Beclometasone Inhalation Powder Benzoin Inhalation Vapour, IV-98
Barbitone Buffer pH 8.4, V-A153
Beclometasone Powder for Inhalation, Benzoin Inhalation Vapour, Menthol
Barbitone Sodium, V-A31
pre-metered units, see Beclometasone and, IV-277
Barbiturates, Non-nitrogen Substituted,
Inhalation Powder, pre-dispensed Benzoin Tincture, Compound, IV-98
Reactions of, V-267
Benzophenone, V-A32
V-A806 Index

1,4-Benzoquinone, V-A32 Betaxolol Eye Drops, Solution, III-193 Bismuth Standard Solution (100 ppm
Benzoyl Chloride, V-A32 Betaxolol Eye Drops, Suspension, Bi), V-A149
Benzoyl Peroxide, V-A32 III-195 Bismuth Subcarbonate, I-298, V-A33
Benzoyl Peroxide Cream, III-176 Betaxolol Hydrochloride, I-287 Bismuth Subcarbonate, see Bismuth
Benzoyl Peroxide Cream, Potassium Betulin, V-A33 Oxycarbonate
Hydroxyquinoline and, III-1008 Bezafibrate, I-289, V-S15 Bismuth Subgallate, I-299
Benzoyl Peroxide Cutaneous Suspension, Bezafibrate Tablets, III-195 Bismuth Subnitrate, V-A33
III-178 Bezafibrate Tablets, Prolonged-release, Bismuth Subnitrate R1, V-A33
Benzoyl Peroxide Gel, III-177 III-196 Bismuth Subnitrate Solution, V-A33
Benzoyl Peroxide Lotion, III-178 Bibenzyl, V-A33 Bismuth Subsalicylate, I-301
Benzoylarginine Ethyl Ester Biberry, Dried, see Dried Bilberry Bisoprolol Fumarate, I-302
Hydrochloride, V-A32 Bicalutamide, I-290, V-S16 Bisoprolol Tablets, III-201
Benzoylecgonine Hydrate, V-A32 Bicalutamide Tablets, III-197 Bistort Rhizome, IV-104
N-Benzoyl-L-prolyl-L-phenylalanyl-L- Bicarbonates, Reactions of, V-267 Bis(trimethylsilyl)trifluoroacetamide,
arginine 4-Nitroanilide Acetate, V-A32 Bifonazole, I-292 V-A33
3-Benzoylpropionic Acid, V-A32 Bilberry, Fresh, see Fresh Bilberry Bis-tris propane, V-A109
2-Benzoylpyridine, V-A32 Bilberry Fruit, Dried, see Dried Bilberry Bitter Fennel, IV-180
Benzydamine Cream, III-179 Bilberry Fruit, Dry Extract, Refined and Bitter-Fennel Fruit Oil, IV-181
Benzydamine Hydrochloride, I-265, Standardised Fresh, see Refined and Bitter-Fennel Herb Oil, IV-183
V-S14 Standardised Fresh Bilberry Fruit Dry Bitterness Value, Determination of,
Benzydamine Mouthwash, III-180 Extract V-338
Benzydamine Oromucosal Spray, III-181 Bilberry Fruit, Fresh, see Fresh Bilberry Bitter-Orange Flower, IV-301
Benzyl Alcohol, I-266, V-A32 Bioavailability, V-649 Biuret, V-A33
Benzyl Benzoate, I-268, V-A32 Bioequivalence, V-649 Biuret Reagent, V-A33
Benzyl Benzoate Application, III-182 Bioequivalence of Oral Liquids, V-784 Black Cohosh, IV-105
Benzyl Cinnamate, V-A32 Biological Assays and Tests, V-396 Black Currant, IV-109
Benzyl Cyanide, V-A32 Biological Assays and Tests, V-652 Black Currant Syrup, IV-109
Benzyl Ether, V-A32 Biological Assays and Tests, Black Horehound, IV-111
Benzyl Hydroxybenzoate, I-268, V-S15 Supplementary Information, V-652 Blackcurrant Leaf, IV-109
Benzylparaben, see Benzyl Biological Medicinal Products, Similar, Bleomycin Injection, III-203
Hydroxybenzoate V-795 Bleomycin Sulfate, I-304, V-S16
Benzylpenicillin for Injection, III-182 Biological Products, Terminology used in Bleomycin Sulfate for Injection, III-203
Benzylpenicillin Injection, III-182 Monographs on, V-463 Bleomycin Sulphate, see Bleomycin Sulfate
Benzylpenicillin Potassium, I-269 Biological Reference Materials, see Bleomycin Sulphate for Injection, see
Benzylpenicillin Sodium, I-271, V-A32 Reference Materials Bleomycin Sulfate for Injection
2-Benzylpyridine, V-A32 Biological Reference Preparations, I-15, Blocking Solution, V-A33
Benzyltrimethylammonium Chloride, II-15, III-15, IV-15, V-15 Blood, Components,
V-A32 Biological Tests, V-396 Containers for, V-555
Berberine Chloride, V-A32 Biosimilar, see Similar Biological Medicinal Containers for, V-555
Berberis Aristata, IV-98 Products Blood and Blood Components, Human,
Bergapten, V-A32 Biotin, I-293 Materials for Containers for, V-563
Betacarotene, I-273 Biperiden Hydrochloride, I-295 Blood and Related Products, V-418
Betacyclodextrin see Betadex Biphasic Insulin, see Biphasic Insulin Blue Dextran 2000, V-A33
Betadex, I-273 Injection Blue Litmus Paper, V-A81
Betahistine Dihydrochloride, I-275 Biphasic Insulin Injection, III-688 Bogbean Leaf, IV-112
Betahistine Dihydrochloride Tablets, Biphasic Isophane Insulin Injection, Boiling Point, Determination of, V-243
III-183 III-689 Boldine, V-A33
Betahistine Mesilate, I-276 Biphasic Isophane Insulin, see Biphasic Boldo Leaf, IV-113
Betamethasone, I-278, V-S15, V-A33 Isophane Insulin Injection Boldo Leaf Dry Extract, IV-114
Betamethasone Acetate, I-280 Biphenyl, V-A33 Borage Oil, Refined I-305
Betamethasone and Clioquinol Cream, Biphenyl-4-ol, V-A33 Borate Buffer pH 7.5, V-A153
III-188 Birch Leaf, IV-103 Borate Buffer pH 9.6, V-A153
Betamethasone and Clioquinol (-)-a-Bisabolol, V-A33 Borate Buffer pH 8.0, V-A153
Ointment, III-189 Bisacodyl, I-296 Borate Buffer pH 9.0, V-A153
Betamethasone Dipropionate, I-281 Bisacodyl Suppositories, III-199 Borate Buffer Solution pH 8.0, 0.0015M,
Betamethasone Eye Drops, III-184 Bisacodyl Tablets, Gastro-resistant, see V-A153
Betamethasone Injection, III-186 Gastro-resistant Bisacodyl Tablets Borate Buffer Solution pH 7.5, see Borate
Betamethasone Sodium Phosphate, I-284 Bisbenzimide, V-A33 Buffer pH 7.5
Betamethasone Sodium Phosphate Bisbenzimide Stock Solution, V-A33 Borate Buffer Solution pH 10.4, V-A154
Tablets, III-190 Bisbenzimide Working Solution, V-A33 Borate Buffer Solution pH 7.5, V-A153
Betamethasone Tablets, III-187 Bismuth and Bismuth Compounds, Borate Solution, V-A33
Betamethasone Valerate, I-285 Reactions of, V-267 Borax, I-306
Betamethasone Valerate Cream, III-191 Bismuth Carbonate see Bismuth Boric Acid, I-306, V-A33
Betamethasone Valerate Cutaneous Subcarbonate Boric Acid Solution, V-A34
Solution, III-192 Bismuth Nitrate Pentahydrate, V-A33 Boric Acid Solution, Cold Saturated,
Betamethasone Valerate Lotion, III-192 Bismuth Oxycarbonate, V-A33 V-A34
Betamethasone Valerate Ointment, Bismuth Oxynitrate, V-A33 Boric Buffer pH 9.0, V-A154
III-193 Bismuth Oxynitrate R1, V-A33 Borneol, V-A34
Betamethasone Valerate Scalp Bismuth Oxynitrate Solution, V-A33 D-Bornyl Acetate, V-A34
Application, III-191 Boron Trichloride, V-A34
page numbers in bold type relate to monograph titles Index V-A807

Boron Trichloride-Methanol Solution, Bromothymol Blue Solution R4, V-A35 Buffer Solutions, V-A152
V-A34 Bromperidol, I-319 Buffered Acetone Solution, V-A153
Boron Trifluoride, V-A34 Bromperidol Decanoate, I-321 Buffered Copper Sulfate Solution
Boron Trifluoride Solution, V-A34 Brompheniramine Maleate, I-323 pH 5.2, V-A155
Boron Trifluoride-Methanol Solution, Brompheniramine Tablets, III-207 Buffered Copper Sulfate Solution
V-A34 Bronopol, I-324, V-S17 pH 4.0, V-A155
Bot/Ser, see Botulinum Antitoxin Brotizolam, I-325 Buffered Copper Sulphate Solution
Botulinum Antitoxin, IV-517 BRP, I-15, II-15, III-15, IV-15, V-628, pH 5.2, see Buffered Copper Sulfate
Botulinum Toxin Type B for Injection, V-15 Solution pH 5.2
I-309 BRP Indicator Solution, V-A35 Buffered Copper Sulphate Solution
Botulinum Toxin Type A for Injection, Brucine, V-A35 pH 4.0, see Buffered Copper Sulfate
I-307 BS, V-628 Solution pH 4.0
Bovine Albumin, V-A22 Buccal Tablets and Sublingual Tablets, Buffered Cream, III-213
Bovine Coagulation Factor Xa, V-A34 III-63 Buffered Salt Solution pH 7.2, V-A154
Bovine Euglobulins, V-A64 Buckwheat Herb, IV-115 Buffered Sodium Acetate Solution
Bovine Factor Xa Solution, V-A34 Buclizine Hydrochloride, I-326, V-S17 pH 6.0, V-A158
Bovine Factor Xa Solution R1, V-A34 Budesonide, I-327 Buflomedil Hydrochloride, I-331
Bovine Insulin, I-1211 Budesonide Aqueous Nasal Spray, Bulk Density and Tapped Density of
Bovine Serum, I-310 III-207 Powders, V-534
Bovine Thrombin, V-A132 Budesonide Inhalation Powder, III-210 Bumetanide, I-332, V-S17
BP, I-3, II-3, III-3, IV-3, V-3 Budesonide Inhalation Powder, pre- Bumetanide and Prolonged-release
BPCRS, I-15, II-15, III-15, IV-15, dispensed, III-211 Potassium Tablets, III-216
V-628, V-15 Budesonide Nebuliser Suspension, Bumetanide Injection, III-214
BPCRS, see British Pharmacopoeia III-208 Bumetanide Oral Solution, III-215
Chemical Reference Substances Budesonide Powder for Inhalation, Bumetanide Tablets, III-215
Bretylium Injection, III-204 metered dose powder inhaler, see Bupivacaine, V-S18
Bretylium Tosilate, I-312, V-S16 Budesonide Inhalation Powder Bupivacaine and Adrenaline Injection,
Brilliant Blue, see Acid Blue 83 Budesonide Powder for Inhalation, pre- III-220
Brilliant Green, V-A34 metered units, see Budesonide Inhalation Bupivacaine and Dextrose Injection,
Brimonidine Tartrate, I-313 Powder, pre-dispensed III-218
British Approved Names, V-659 Budesonide Pressurised Inhalation, Bupivacaine and Diamorphine Injection,
British Pharmacopoeia Chemical III-212 III-221
Reference Substances, V-673 Bufexamac, I-330 Bupivacaine and Epinephrine Injection,
British Pharmacopoeia Commission, I-xi Buffer (Acetate) Solution pH 5.0, see Bupivacaine and Adrenaline Injection
Bromazepam, I-314 V-A154 Bupivacaine and Fentanyl Injection,
Bromelains, V-A34 Buffer (HEPES) Solution pH 7.5, III-221
Bromelains Solution, V-A34 V-A154 Bupivacaine and Glucose Injection,
Bromhexine Hydrochloride, I-315 Buffer (Phosphate) Solution pH 9.0, III-218
0.0167M Bromide-bromate, see Bromine V-A154 Bupivacaine Heavy Injection, III-218
VS Buffer Solution pH 9.0 R1, see Boric Bupivacaine Hydrochloride, I-333
Bromides, Reactions of, V-267 Buffer pH 9.0 Bupivacaine Injection, III-218
Brominated Hydrochloric Acid, V-A72 Buffer Solution pH 2.5 R1, V-A154 Buprenorphine, I-336
Bromine, V-A34 Buffer Solution pH 10.9, see Ammonia Buprenorphine Hydrochloride, I-337
Bromine Solution, V-A34 Buffer pH 10.9 Buprenorphine Injection, III-222
Bromine Solution, Acetic, V-A34 Buffer solution pH 9.0, see Borate Buffer Buprenorphine Sublingual Tablets,
Bromine VS, V-A143 pH 9.0 III-224
Bromine Water, V-A34 Buffer Solution pH 2.0, see Chloride Buprenorphine Transdermal Patches,
Bromine Water R1, V-A34 Buffer pH 2.0, 0.1M III-223
Bromobenzene, V-A34 Buffer Solution pH 3.6, see Phthalate Burnet Root, Greater, IV-117
Bromocresol Green, V-A34 Buffer pH 3.6 Buserelin, I-339
Bromocresol Green Solution, V-A34 Buffer Solution pH 10.9, V-A154 Buspirone Hydrochloride, I-341
Bromocresol Green-Methyl Red Buffer Solution pH 7.2, V-A154 Busulfan, I-343, V-S18
Solution, V-A34 Buffer Solution pH 2.0, V-A154 Busulfan Tablets, III-225
Bromocresol Purple, V-A35 Buffer Solution pH 2.2, V-A154 Butanal, V-A35
Bromocresol Purple Solution, V-A35 Buffer Solution pH 2.5, V-A154 Butane-1,3-diol, V-A35
Bromocriptine Capsules, III-205 Buffer Solution pH 3.0, V-A154 Butanol, V-A35, V-A36
Bromocriptine Mesilate, I-317 Buffer Solution pH 3.5, V-A154 2-Butanol R1, V-A35, V-A36
Bromocriptine Tablets, III-206 Buffer Solution pH 3.6, V-A154 Butan-2-one, V-A36
5-Bromo-2-deoxyuridine, V-A35 Buffer Solution pH 3.7, V-A154 Butchers Broom, IV-118
Bromomethoxynaphthalene, V-A35 Buffer Solution pH 7.4, V-A154 Butyl Acetate, V-A36
Bromophenol Blue, V-A35 Buffer Solution pH 6.5, V-A154 Butyl Acetate R1, V-A36
Bromophenol Blue Solution, V-A35 Buffer Solution pH 5.5, V-A154 Butyl Chloride, see 1-Chlorobutane
Bromophenol Blue Solution R1, V-A35 Buffer Solution pH 6.6, V-A154 Butyl Hydroxybenzoate, I-344, V-S18,
Bromophenol Blue Solution R2, V-A35 Buffer Solution pH 7.0, V-A154 V-A36
Bromophos, V-A35 Buffer Solution pH 8.0, V-A154 Butyl Methacrylate, V-A36
Bromophos-ethyl, V-A35 Buffer Solution pH 9.0, V-A154 Butyl Parahydroxybenzoate, V-A36
Bromothymol Blue, V-A35 Buffer Solution pH 11, V-A154 Butyl Parahydroxybenzoate, see Butyl
Bromothymol Blue Solution R1, V-A35 Buffer Solution pH 9.0 R1, V-A154 Hydroxybenzoate
Bromothymol Blue Solution R2, V-A35 Buffer Solution pH 3.5, see Acetate Buffer n-Butylamine, V-A36
Bromothymol Blue Solution R3, V-A35 pH 3.5 Butylated Hydroxyanisole, I-345, V-A36
V-A808 Index

Butylated Hydroxytoluene, I-346, V-A36 Calcium and Colecalciferol Tablets, Calcium Phosphate for Homoeopathic
Butylboronic Acid, V-A36 III-234 Preparations, IV-434
Butylhydroxyanisole, see Butylated Calcium and Colecalciferol Tablets, Calcium Phosphate Monobasic
Hydroxyanisole Chewable, III-235 Monohydrate, V-A37
Butylhydroxytoluene, see Butylated Calcium and Ergocalciferol Tablets, Calcium Phosphoricum for
Hydroxytoluene III-236 Homoeopathic Preparations, see
Butylparaben, see Butyl Hydroxybenzoate Calcium and Ergocalciferol Tablets, Calcium Phosphate for Homoeopathic
Butylsilyl Silica Gel for Chromatography, Chewable, III-237 Preparations
V-A115 Calcium Ascorbate, I-363 Calcium Polystyrene Sulfonate, I-387,
Butyric Acid, V-A36 Calcium Carbonate, I-364, V-A36 V-S19
Butyrolactone, V-A36 Calcium Carbonate and Heavy Calcium Polystyrene Sulphonate, see
Magnesium Carbonate Tablets, Calcium Polystyrene Sulfonate
Chewable, III-238 Calcium Standard Solution
C Calcium Carbonate R1, V-A37
Calcium Carbonate Tablets, Chewable,
(10 ppm Ca), V-A149
Calcium Standard Solution
Cabergoline, I-347
III-238 (100 ppm Ca), V-A149
Cadmium, V-A36
Calcium Chloride, V-A37 Calcium Standard Solution
Cadmium Acetate, V-A36
Calcium Chloride, Anhydrous, V-A37 (100 ppm Ca), Alcoholic, V-A149
Cadmium- and Lead-free Nitric Acid,
Calcium Chloride Dihydrate, I-365 Calcium Standard Solution
V-A94
Calcium Chloride Hexahydrate, I-366 (100 ppm Ca) R1, V-A149
Cadmium and Ninhydrin Solution,
Calcium Chloride Injection, III-239 Calcium Standard Solution
V-A36
Calcium Chloride Intravenous Infusion, (400 ppm Ca), V-A149
Cadmium Iodide, V-A36
see Calcium Chloride Injection Calcium Standard Solution
Cadmium Iodide Solution, V-A36
Calcium Chloride R1, V-A37 (1000 ppm Ca), V-A149
Cadmium Nitrate Tetrahydrate, V-A36
Calcium Chloride Solution, V-A37 Calcium Stearate, I-388
Cadmium Standard Solution (0.1% Cd),
Calcium chloride solution, 0.025m, Calcium Sulfate, V-A37
V-A149
V-A37 Calcium Sulfate Dihydrate, I-390
Cadmium Standard Solution (10 ppm
Calcium Chloride Solution, 0.02M, Calcium Sulfate, Dried, I-389
Cd), V-A149
V-A37 Calcium Sulfate Solution, V-A37
Cadmium Sulfate Hydrate for
Calcium Dobesilate Monohydrate, I-367 Calcium Sulphate, Dihydrate, see
Homoeopathic Preparations, IV-433
Calcium Folinate, I-368, V-S19 Calcium Sulfate Dihydrate
Caesium Chloride, V-A36
Calcium Folinate for Injection, III-240 Calcium Sulphate Solution, see Calcium
Caffeic Acid, V-A36
Calcium Folinate Injection, III-239 Sulfate Solution
Caffeine, I-348, V-A36
Calcium Folinate Tablets, III-240 Calcium Sulphate, see Calcium Sulfate
Caffeine Citrate Injection, III-226
Calcium Glucoheptonate, I-370 Calconcarboxylic Acid, V-A37
Caffeine Citrate Oral Solution, III-227
Calcium Gluconate, I-371 Calconcarboxylic Acid Triturate, V-A37
Caffeine Hydrate, I-350
Calcium Glucanate, Anhydrous I-372 Calculations, Pharmacopoeial, V-786
Caffeine Monohydrate, see Caffeine
Calcium Gluconate for Injection, I-373 Calendula Flower, IV-119
Hydrate
Calcium Gluconate Injection, III-241 Camphene, V-A37
Caffeine Tablets, Aspirin and, III-154
Calcium Gluconate Tablets, III-242 Camphor, V-A37
Caffeine Tablets, Paracetamol and, see
Calcium Gluconate Tablets, Chewable, Camphor, Racemic I-392
Paracetamol and Caffeine Tablets
III-242 Camphor Water, Concentrated, III-243
Calamine, I-351
Calcium Gluconate Tablets, D-Camphor, see Natural Camphor
Calamine and Coal Tar Ointment,
Effervescent, III-243 Camphorated Opium Tincture, IV-300
III-228
Calcium Glycerophosphate, I-375 Camphorated Opium Tincture,
Calamine Cream, Aqueous, III-227
Calcium Hydrogen Phosphate, I-375 Concentrated, IV-300
Calamine Lotion, III-227
Calcium Hydrogen Phosphate, Candela, Definition of, I-32, II-32,
Calamine Ointment, III-228
Anhydrous I-377 III-32, IV-32, V-32
Calamine Ointment, Compound, III-228
Calcium Hydrogen Phosphate Dihydrate, Candesartan Cilexetil, I-393
Calamine, Prepared, I-351
see Calcium Hydrogen Phosphate Cape Aloes, IV-54
Calcifediol, I-352
Calcium Hydroxide, I-378, V-A37 Capecitabine, I-395
Calciferol, V-A36
Calcium Hydroxide Solution, III-243, Capillary Electrophoresis, V-210
Calciferol Tablets, see Colecalciferol
V-A37 Capillary Viscometer Method, V-247
Tablets or Ergocalciferol Tablets
Calcium in Adsorbed Vaccines, V-464 Capital Initial Letters, Significance of,
Calcipotriol, Anhydrous I-353
Calcium Iodide Tetrahydrate for I-8, II-8, III-8, IV-8, V-8
Calcipotriol Cream, III-228
Homoeopathic Preparations, IV-433 Capric Acid, V-A37
Calcipotriol Monohydrate, I-356
Calcium Lactate, V-A37 Capric Alcohol, see Decan-1-ol
Calcipotriol Ointment, III-230
Calcium Lactate, Anhydrous I-378 Caproic Acid, V-A37
Calcipotriol Scalp Application, III-231
Calcium Lactate Monohydrate, I-379 e-Caprolactam, V-A37
Calcitonin (Salmon), I-358
Calcium Lactate Pentahydrate, I-380 Caprylic Acid, V-A37
Calcitonin (Salmon) Injection, III-232
Calcium Lactate Tablets, III-243 Caprylocaproyl Macrogolglycerides,
Calcitriol, I-361
Calcium Lactate Trihydrate, I-381 I-397
Calcitriol Capsules, III-233
Calcium Lactate, see Calcium Lactate Capsaicin, V-A38
Calcium Acetate, I-362
Pentahydrate Capsicum, IV-121
Calcium Acetate, Anhydrous, see Calcium
Calcium Levofolinate Pentahydrate, Capsicum Oleoresin, Refined and
Acetate
I-381 Standardised, see Refined and
Calcium Acetate, Dried, V-A36
Calcium Levulinate Dihydrate, I-384 Standardised Capsicum Oleoresin
Calcium and Calcium Salts, Reactions
Calcium Pantothenate, I-385 Capsicum Soft Extract, Standardised,
of, V-267
Calcium Phosphate, I-386 IV-123
page numbers in bold type relate to monograph titles Index V-A809

Capsicum Tincture, Standardised, see Carmellose, I-417 Cefadroxil Oral Suspension, III-255
Standardised Capsicum Tincture Carmellose Calcium, I-418 Cefalexin, V-S21
Capsules, III-40 Carmellose Sodium, I-418 Cefalexin Capsules, III-257
Capsules and Tablets, Disintegration of, Carmellose Sodium Eye Drops, III-249 Cefalexin Monohydrate, I-434
V-346 Carmellose Sodium, Low-substituted Cefalexin Oral Suspension, III-258
Capsules, Disintegration Test for, V-346 I-419 Cefalexin Tablets, III-259
Capsules of the BP, III-41 Carminic Acid, V-A38 Cefalotin Sodium, I-436
Capsules, Oromucosal, III-63 Carmustine, I-421 Cefamandole Nafate, I-438
Capsules, Rectal, III-69 Carnauba Wax, I-421 Cefapirin Sodium, I-439
Capsules, Vaginal, III-80 Carob Bean Gum, V-A38 Cefatrizine Propylene Glycol, I-441
Captopril, I-398, V-S19 Carrageenan, I-422 Cefazolin Injection, III-260
Captopril Oral Solution, III-244 Carteolol Eye Drops, III-250 Cefazolin Sodium, I-442
Captopril Powder for Oral Solution, Carteolol Hydrochloride, I-423 Cefazolin Sodium for Injection, III-260
III-244 Carum Carvi, V-609 Cefepime Hydrochloride Monohydrate,
Captopril Tablets, III-245 Carvacrol, V-A38 I-445
Caraway, IV-125 Carvedilol, I-424 Cefepime Dihydrochloride Monohydrate,
Caraway Fruit, see Caraway Carveol, V-A38 see Cefepime Hydrochloride Monohydrate
Caraway Oil, IV-126 Carvone, V-A38, V-A39 Cefixime, I-447
Carbachol, I-400 Carvone R1, V-A39 Cefoperazone Sodium, I-448
Carbamazepine, I-401, V-S20 b-Caryophyllene, V-A39 Cefotaxime Injection, III-262
Carbamazepine Tablets, III-246 Caryophyllene Oxide, V-A39 Cefotaxime Sodium, I-450, V-S21
Carbaryl, I-403, V-S20 Cascara, IV-129 Cefotaxime Sodium for Injection,
Carbaryl Cutaneous Solution, III-247 Cascara Dry Extract, Standardised, see III-262
Carbaryl Lotion, III-247 Standardised Cascara Dry Extract Cefoxitin Injection, III-263
Carbasalate Calcium, I-404 Cascara Sagrada, V-609 Cefoxitin Sodium, I-452, V-S22
Carbazole, V-A38 Cascara Tablets, IV-132 Cefoxitin Sodium for Injection, III-263
Carbenoxolone, V-S20 Casein, V-A39 Cefpodoxime Proxetil, I-454
Carbenoxolone Sodium, I-405 Casein Substrate, Concentrated, V-A39 Cefprozil Monohydrate, I-457
Carbidopa, I-406 Cassava Starch, II-916 Cefradine, I-459, V-S22
Carbidopa Tablets, Levodopa and, Cassia Oil, IV-133 Cefradine Capsules, III-265
III-376 Casticin, V-A39 Cefradine for Injection, III-267
Carbimazole, I-407, V-S21 Castor Oil Cream, Zinc and, III-1229 Cefradine Injection, III-267
Carbimazole Tablets, III-247 Castor Oil, Hydrogenated Polyoxyl I-428 Cefradine Oral Suspension, III-269
Carbocisteine, I-408 Castor Oil Ointment, Zinc and, III-1229 Ceftazidime for Injection, III-270
Carbomer, V-A38 Castor Oil, Polyoxyethylated, V-A106 Ceftazidime Injection, III-270
Carbomer Eye Drops, III-248 Castor Oil, Polyoxyl I-427 Ceftazidime Pentahydrate, I-461
Carbomers, I-409 Castor Oil, Refined I-429 Ceftazidime Pentahydrate with Sodium
Carbon, Determination of Total Organic, Castor Oil, Virgin, I-430 Carbonate for Injection, I-464
V-257 Castor Oil, see Virgin Castor Oil Ceftazidime, see Ceftazidime Pentahydrate
Carbon Dioxide, I-411, V-A38 Catalpol, V-A39 Ceftriaxone Injection, III-272
Carbon Dioxide R1, V-A38 Catechin, V-A39 Ceftriaxone Sodium, I-466, V-S22
Carbon Dioxide R2, V-A38 Catechol, V-A39 Ceftriaxone Sodium for Injection,
Carbon Dioxide-free Water, V-A139 Catgut, Sterile, see Sterile Catgut III-272
Carbon Disulfide, V-A38 Catholyte for Isoelectric Focusing Cefuroxime Axetil, I-468, V-S23
Carbon Disulphide, see Carbon Disulfide, pH 3 to 5, V-A39 Cefuroxime Axetil Oral Suspension,
Carbon for Chromatography, Cation Exchange Resin, V-A39 III-277
Graphitised, V-A38 Cation Exchange Resin (Calcium Form), Cefuroxime Axetil Tablets, III-278
Carbon Monoxide, I-412, V-A38 Strong, V-A39 Cefuroxime Eye Drops, III-273
Carbon Monoxide (15O), IV-672 Cation Exchange Resin R1, V-A39 Cefuroxime Injection, III-274
Carbon Monoxide in Medicinal Gases, Cation-exchange resin (sodium form), Cefuroxime Injection, Intracameral,
Limit Test for, V-309 strong, V-A39 III-275
Carbon Monoxide, R1, V-A38 Cation-Exchange Resin, Strong, V-A39 Cefuroxime Intracameral Injection,
Carbon Tetrachloride, V-A38 Cationic Resin, Weak, V-A39 III-275
Carbonate Buffer pH 9.7, V-A154 Caustic Soda, see Sodium Hydroxide Cefuroxime Sodium, I-469, V-S23
Carbonate-free Sodium Hydroxide Caustic Potash, see Potassium Hydroxide Cefuroxime Sodium for Injection,
Solution, V-A123 Caution Statements, I-7, II-7, III-7, III-274
Carbonates and Bicarbonates, Reactions IV-7, V-7 Celandine, Greater, IV-134
of, V-268 CCID50, Definition of, I-30, II-30, Celecoxib, I-471
Carbonates, Reactions of, V-268 III-30, IV-30, V-30 Celiprolol Hydrochloride, I-472, V-S23
Carbophenothion, V-A38 CCID50, V-628 Celiprolol Tablets, III-279
Carboplatin, I-413 CD34/CD45 Cells in Haematopoietic Cell Substrates for the Production of
Carboplatin Injection, III-248 Products, Numeration of, V-458 Vaccines for Human Use, V-471
Carboprost Trometamol, I-415 Cedarwood Oil, V-A39 Cellacefate, I-473
Cardamom Fruit, IV-127 Cefaclor, I-431 Cellular Products, Microbiological
Cardamom Oil, IV-128 Cefaclor Capsules, III-251 Control of, V-496
Cardamom Tincture, Aromatic, IV-128 Cefaclor Oral Suspension, III-252 Cellulose Acetate, I-483
Cardamom Tincture, Compound, Cefaclor Tablets, Prolonged-release, Cellulose Acetate Butyrate, I-484
IV-128 III-253 Cellulose Acetate Phthalate, see
Car-3-ene, V-A38 Cefadroxil Capsules, III-254 Cellacefate
Carisoprodol, I-416 Cefadroxil Monohydrate, I-433
V-A810 Index

Cellulose, Dihydrochloride see Cellulose Ceylon Cinnamon, see Cinnamon Chewable Magnesium Trisilicate
Hydrochloride Ceylon Cinnamon Bark Oil, IV-142 Tablets, Aluminium Hydroxide and,
Cellulose, Dispersible, I-475 Ceylon Cinnamon Leaf Oil, IV-144 III-776
Cellulose for Chromatography, V-A40 Chalk, I-496 Chewable Magnesium Trisilicate
Cellulose for Chromatography F254, Chalk, Prepared, I-496 Tablets, Compound, III-776
V-A40 Chamazulene, V-A40 Chewable Montelukast Tablets, III-860
Cellulose for Chromatography R1, Chamomile Flowers, IV-137 Chewable Piperazine Phosphate Tablets,
V-A40 Changes in Monograph Titles, V-659 III-996
Cellulose F254, see Cellulose for Changes in Title of Monographs, I-xxxii Chewable Tablets, III-75
Chromatography F254 Characterisation of Crystalline and Chewable Vitamin C Tablets see
Cellulose, Microcrystalline, see Cellulose Partially Crystalline Solids by X-ray Chewable Ascorbic Acid Tablets,
for Chromatography R1 Powder Diffraction (XRPD), V-526 III-151
Cellulose Nitrate, see Pyroxylin Characterisation of Crystalline Solids by Chewing Gums, Medicated, Dissolution
Cellulose Powdered, I-473 Microcalorimetry and Solution Test for, V-363
Cellulose, see Cellulose for Chromatography Calorimetry, V-541 Chicken Flocks Free from Specified
Celsius, Definition of, I-32, II-32, Characteristics, Status of, I-11, II-11, Pathogens for the Production and
III-32, IV-32, V-32 III-11, IV-11, V-11 Quality Control of Vaccines, V-469
Centaury, IV-135 Characters, I-26, II-26, III-26, IV-26, China, V-609
Centella, IV-136 V-26 Chininum Sulfuricum, V-609
Centigrade, Definition of, I-32, II-32, Characters Section in Monographs, Chitosan Hydrochloride, I-499
III-32, IV-32, V-32 V-745 Chloral Hydrate, I-500, V-A40
Centrifugation, Definition of, I-32, II-32, Charcoal, Activated, V-A40 Chloral Hydrate Oral Solution, III-286
III-32, IV-32, V-32 Charcoal, Activated see Activated Chloral Hydrate Solution, V-A40
Cephalin Regent, V-A40 Charcoal Chlorambucil, I-500
Cephaeline Dihydrochloride, V-A40 Chebula Fruit, see Terminalia Chebula Chlorambucil Tablets, III-287
Cerium (iv) Sulfate, see Cerium Sulfate Fruit Chloramine Solution, V-A40
Cerium Sulfate, see Cerium Sulfate Check Assay, V-657 Chloramine Solution R1, V-A40
Cerium Sulphate, see Cerium Sulfate Chemical Abstracts Service (CAS) Chloramine Solution R2, V-A40
Cerium(III) Nitrate, V-A40 Registry Number, I-25, II-25, III-25, Chloramine T, V-A40
Cerium(III) Nitrate Solution, V-A40 IV-25, V-25 Chloramine, see Chloramine T
Cerium(iv) Sulfate, V-A40 Chemical Abstracts Service Registry Chloramphenicol, I-502
Cerium(IV) Sulfate VS, V-A143 Number, Status, I-4, II-4, III-4, IV-4, Chloramphenicol Capsules, III-287
Cerium(IV) Sulphate VS, see Cerium(IV) V-4 Chloramphenicol Ear Drops, III-288
Sulfate VS Chemical and Biological Reference Chloramphenicol Eye Drops, III-289
Cerium(iv) Sulphate, see Cerium Sulfate Materials, see Reference Materials Chloramphenicol Eye Ointment, III-290
Cerous Nitrate, see Cerium(III) Nitrate Chemical Formulae, I-8, II-8, III-8, Chloramphenicol Palmitate, I-503
Certification Scheme, European IV-8, V-8 Chloramphenicol Sodium Succinate,
Pharmacopoeia, V-677 Chemical Reference Materials, see I-504
Cetirizine Capsules, III-281 Reference Materials Chloramphenicol Sodium Succinate for
Cetirizine Hydrochloride, I-485, V-S24 Chemical Reference Substances, I-15, Injection, III-291
Cetirizine Oral Solution, III-282 II-15, III-15, IV-15, V-15 Chloramphenicol Sodium Succinate
Cetirizine Tablets, III-283 Chenodeoxycholic Acid, I-497 Injection, III-291
Cetomacrogol Emulsifying Ointment, Chewable Aluminium Hydroxide and Chlorcyclizine Hydrochloride, I-506
III-285 Magnesium Trisilicate Tablets, III-776 Chlordane, V-A40
Cetomacrogol Emulsifying Wax, III-285 Chewable Aluminium Hydroxide Chlordiazepoxide, I-507, V-A40
Cetostearyl Alcohol, I-487, V-A40 Tablets, III-122 Chlordiazepoxide Capsules, III-292
Cetostearyl Alcohol, Emulsifying Chewable Ascorbic Acid Tablets, III-151 Chlordiazepoxide Hydrochloride, I-508
(Type A) see Emulsifying Cetostearyl Chewable Calcium and Colecalciferol Chlordiazepoxide Hydrochloride Tablets,
Alcohol (Type A) Tablets, III-235 III-293
Cetostearyl Alcohol, Emulsifying Chewable Calcium and Ergocalciferol Chlorfenvinphos, V-A41
(Type B) see Emulsifying Cetostearyl Tablets, III-237 Chlorhexidine V-S24
Alcohol (Type B) Chewable Calcium and Ergocalciferol Chlorhexidine Acetate, I-509, V-A41
Cetostearyl Isononanoate, I-491 Tablets, Chewable Calcium and, Chlorhexidine Diacetate, see
Cetrimide, I-491, V-A40 III-237 Chlorhexidine Acetate
Cetrimide Cream, III-285 Chewable Calcium Carbonate and Heavy Chlorhexidine Dihydrochloride, see
Cetrimide Cutaneous Solution, III-286 Magnesium Carbonate Tablets, Chlorhexidine Hydrochloride
Cetrimide Cutaneous Solution, Sterile, III-238 Chlorhexidine Digluconate Eye Drops,
III-286 Chewable Calcium Carbonate Tablets, see Chlorhexidine Gluconate Eye Drops
Cetrimide Emulsifying Ointment, III-286 III-238 Chlorhexidine Digluconate Solution, see
Cetrimide Solution, III-286 Chewable Calcium Gluconate Tablets, Chlorhexidine Gluconate Solution
Cetrimide Solution, Sterile, III-286 III-242 Chlorhexidine Gel, Lidocaine and,
Cetrimide Solution, Strong, I-492 Chewable Compound Magnesium III-752
Cetyl Alcohol, I-493, V-A40 Trisilicate Tablets, III-776 Chlorhexidine Gel, Lignocaine and, see
Cetyl Palmitate, I-494 Chewable Heavy Magnesium Carbonate Lidocaine and Chlorhexidine Gel
Cetylpyridinium Chloride, I-495, V-A40 and Calcium Carbonate Tablets, Chlorhexidine Gluconate Eye Drops,
Cetylpyridinium Chloride Monohydrate, III-238 III-294
V-A40 Chewable Magnesium Glycerophosphate Chlorhexidine Gluconate Gel, III-295
Cetylpyridinium Chloride VS, V-A143 Tablets, III-772 Chlorhexidine Gluconate Solution, I-510
Cetyltrimethylammonium Bromide, Chlorhexidine Hydrochloride, I-513,
V-A40 V-A41
page numbers in bold type relate to monograph titles Index V-A811

Chlorhexidine Irrigation Solution, 2-Chloro-5-Nitrobenzoioc Acid, V-A42 Cholecalciterol Concentrate, (Water


III-296 4-Chloro-o-cresol, V-A41 Dispersible Form) see Colecalciterol
Chlorhexidine Mouthwash, III-297 4-Chlorophenol, V-A42 Concentrate (Water Dispersible Form)
Chloride Buffer pH 2.0, 0.1M, V-A154 Chlorophenol, see 4-Chlorophenol Cholera Vaccine, IV-531
Chloride Standard Solution (5 ppm Cl), Chloroplatinic Acid Solution, V-A42 Cholera Vaccine, Freeze-dried, IV-532
V-A149 Chloroplatinic Acid, see Chloroplatinic(IV) Cholera Vaccine (Inactivated, Oral),
Chloride Standard Solution (8 ppm Cl), Acid IV-533
V-A149 Chloroplatinic(IV) Acid, V-A42 Cholera(oral), see Cholera Vaccine
Chloride Standard Solution (50 ppm 3-Chloropropane-1,3-diol, V-A42 (Inactivated, Oral)
Cl), V-A149 1-Chloropropyl(dimethyl)amine Cholera, see Cholera Vaccine
Chloride-free Ammonia, V-A25 Hyrochloride, V-A42 (5a)-Cholestane, V-A43
Chlorides, Reactions of, V-268 Chloroquine, V-S25 Cholesterinum, V-609
Chlorinated Lime, I-515 Chloroquine Phosphate, I-521 Cholesterol, I-534, V-A43
Chlormadinone Acetate, I-515 Chloroquine Phosphate Tablets, III-299 Cholesterol for Parenteral Use, I-536
Chlormethine Hydrochloride, I-517 Chloroquine Sulfate, I-522 Cholesteryl Benzoate, V-A43
Chlormethine Hydrochloride for Chloroquine Sulfate Injection, III-300 Choline Chloride, V-A43
Injection, III-298 Chloroquine Sulfate Tablets, III-300 Choline Salicylate, V-S26
Chlormethine Injection, III-298 Chloroquine Sulphate Injection, see Choline Salicylate Ear Drops, III-309
4-Chloroacetanilide, V-A41 Chloroquine Sulfate Injection Choline Salicylate Oromucosal Gel,
Chloroacetanilide, see 4-Chloroacetanilide Chloroquine Sulphate Tablets, see III-309
Chloroacetic Acid, V-A41 Chloroquine Sulfate Tablets Choline Salicylate Solution, I-537
3-Chloroaniline, V-A41 5-Chloroquinolin-8-ol, V-A42 Choline Theophyllinate, I-538, V-S27
Chloroaniline, see 4-Chloroaniline 4-Chlororesorcinol, V-A42 Choline Theophyllinate Tablets, III-309
Chloroauric Acid, V-A41 5-Chlorosalicylic Acid, V-A42 Chondroitin Sulfate Sodium, I-538
Chloroauric Acid Solution, V-A41 4-Chlorosulfamoylbenzoic Acid, V-A42 Chondroitinase ABC, V-A43
Chlorobenzene, V-A41 Chlorothiazide, V-A42 Chondroitinase AC, V-A43
4-Chlorobenzenesulfonamide, V-A41 Chlorotrimethylsilane, see Chorionic Gonadotrophin, I-541, V-A69
4-Chlorobenzenesulphonamide, see Trimethylchlorosilane Chorionic Gonadotrophin for Injection,
4-Chlorobenzenesulfonamide Chlorotriphenylmethane, V-A42 III-310
2-Chlorobenzoic Acid, V-A41 Chloroxylenol, I-523, V-S25 Chorionic Gonadotrophin Injection,
3-(4-Chlorobenzoyl)propionic Acid, Chloroxylenol Solution, III-301 III-310
V-A41 Chloroxylenol Cutaneous Solution, Chromatographic Separation
1-(2-Chlorobenzoyl)-3- III-301 Techniques, V-188
(4-triflumoromethoxyphenyl)ureaSee Chlorphenamine Injection, III-302 Chromatographic Tests, Materials Used
Triflumuron, V-A137 Chlorphenamine Maleate, I-524 in, V-741
1-Chlorobutane, V-A41 Chlorphenamine Oral Solution, III-302 Chromatography, Liquid, V-202
Chlorobutanol, I-511, V-A41 Chlorphenamine Tablets, III-303 Chromazurol S, see Chrome Azurol S
Chlorobutanol, Anhydrous see Anhydrous Chlorpheniramine Injection, see Chrome Azurol S, V-A43
Chlorobutanol Chlorphenamine Injection Chromic Acid Cleansing Mixture, see
Chlorobutanol Hemihydrate see Chlorpheniramine Oral Solution, see Chromic-Sulfuric Acid Mixture
Chlorobutanol Chlorphenamine Oral Solution Chromic Potassium Sulfate, see
Chlorocresol, I-519 Chlorpheniramine Tablets, see Chromium(iii) Potassium Sulfate
2-Chloro-2-deoxy-d-glucose, V-A41 Chlorphenamine Tablets Chromic Potassium Sulphate, see
1-Chloro-2,4-dinitrobenzene, V-A41 Chlorpromazine, I-525, V-S25 Chromic Potassium Sulfate
Chlorodyne, III-298 Chlorpromazine Elixir, III-304 Chromic-Sulfuric Acid Mixture, V-A43
2-Chloroethanol, V-A41 Chlorpromazine Hydrochloride, I-525 Chromic-Sulphuric Acid Mixture, see
2-Chloroethanol Solution, V-A41 Chlorpromazine Injection, III-303 Chromic-Sulfuric Acid Mixture
Chloroethylamine Hydrochloride, V-A41 Chlorpromazine Oral Solution, III-304 Chromium (51Cr) Edetate Injection,
(2-Chloroethyl)diethylamine Chlorpromazine Suppositories, III-304 IV-674
Hydrochloride, V-A41 Chlorpromazine Tablets, III-305 Chromium Liposoluble Standard
Chloroform, I-519, V-S24, V-A41 Chlorpropamide, I-527, V-S26 Solution (1000 ppm Cr), V-A149
Chloroform, Acidified, V-A41 Chlorpropamide Tablets, III-306 Chromium Standard Solution (0.1%
Chloroform and Morphine Tincture, Chlorprothixene Hydrochloride, I-528 Cr), V-A149
III-298 Chlorpyriphos, V-A42 Chromium Standard Solution (0.1 ppm
Chloroform, Ethanol-free, V-A42 Chlorpyriphos-methyl, V-A42 Cr), V-A149
Chloroform IR, V-A42 Chlortalidone, I-530, V-S26 Chromium Standard Solution (100 ppm
Chloroform Spirit, III-298 Chlortalidone Tablets, III-306 Cr), V-A149
Chloroform Stabilised with Amylene, Chlortalidone Tablets, Atenolol and, Chromium Trioxide, see Chromium(VI)
V-A42 III-405 Oxide
Chloroform Water, V-A42 Chlortetracycline Eye Ointment, III-307 Chromium(iii) Acetylacetonate, V-A43
Chloroform Water, Double-strength, Chlortetracycline Hydrochloride, I-531, Chromium(iii) Potassium Sulfate, V-A43
III-299 V-A43 Chromium(iii) Potassium Sulphate, see
Chloroformic Iodine Solution, V-A76 Chlortetracycline Ointment, III-308 Chromium(iii) Potassium Sulfate
Chlorogenic Acid, V-A42 Chocolate Basis for Tablets, III-76 Chromium(iii) Trichloride Hexahydrate,
5-Chloro-8-hydroxyquinoline, V-A42 Cholecalciterol Concentrate (Oily Form) V-A43
3-Chloro-2-methylaniline, V-A42 see Colecalciterol Concentrate (Oily Chromium(VI) Oxide, V-A43
2-Chloro-N-(2,6- Form) Chromogenic Substrate R1, V-A43
dimethylphenyl)acetamide, V-A42 Cholecalciterol Concentrate (Powder Chromogenic Substrate R2, V-A43
2-Chloronicotinic Acid, V-A42 Form) see Colecalciterol Concentrate Chromogenic Substrate R3, V-A43
2-Chloro-4-nitroaniline, V-A42 (Power Form) Chromogenic Substrate R4, V-A43
V-A812 Index

Chromogenic Substrate R5, V-A43 Ciprofloxacin Infusion, III-318 Clioquinol, I-582, V-S29
Chromophore Substrate R1, V-A43 Ciprofloxacin Intravenous Infusion, see Clioquinol Cream, Hydrocortisone and,
Chromophore Substrate R2, V-A43 Ciprofloxacin Infusion III-650
Chromophore Substrate R3, V-A43 Ciprofloxacin Tablets, III-320 Clobazam, I-584, V-S29
Chromotrope IIB, V-A43 Circular Dichroism, Determination of, Clobazam Oral Suspension, III-334
Chromotrope IIB Solution, V-A43 V-250 Clobazam Tablets, III-335
Chromotropic Acid, V-A43 Cisplatin, I-565 Clobetasol Cream, III-336
Chromotropic Acid Sodium Salt, V-A43 Cisplatin for Injection, III-322 Clobetasol Cutaneous Foam, III-337
Chromotropic Acid Sodium Salt Cisplatin Injection, III-321 Clobetasol Ointment, III-338
Solution, V-A43 Citalopram, V-S28 Clobetasol Propionate, I-585, V-S30,
Chromotropic Acid Solution, V-A43 Citalopram Hydrobromide, I-567 V-A45
Chromotropic Acid-Sulfuric Acid Citalopram Hydrochloride, I-568 Clobetasol Scalp Application, III-339
Solution, V-A43 Citalopram Oral Drops, III-323 Clobetasol Shampoo, III-340
Chromotropic Acid-Sulphuric Acid Citalopram Tablets, III-324 Clobetasone Butyrate, I-587
Solution, see Chromotropic Acid-Sulfuric Citral, V-A44 Clobetasone Cream, III-342
Acid Solution 0.25M Citrate Buffer Solution pH 3.0, Clodronate Disodium Tetrahydrate,
Chrysanthemin, V-A43 V-A155 II-835
Chymotrypsin, I-542 Citrate Buffer Solution pH 5.0, V-A155 Clobetasone Ointment, III-342
a-Chymotrypsin for Peptide Mapping, Citrate Buffered Saline, V-A44 Clofazimine, I-588, V-S30
V-A44 Citrated Rabbit Plasma, V-A45, V-A104 Clofazimine Capsules, III-343
Ciclesonide, I-543 Citrates, Reactions of, V-268 Clofibrate, I-589
Ciclopirox, I-544 Citric Acid, V-A45 Clofibrate Capsules, III-343
Ciclopirox Olamine, I-546 Citric Acid, Anhydrous, V-A45 Clomethiazole, I-590, V-S30
Ciclosporin, I-547, V-S27 Citric Acid, Anhydrous see Anhydrous Clomethiazole Capsules, III-344
Ciclosporin Concentrate, Sterile, III-311 Citric Acid Clomethiazole Edisilate, I-591, V-S31
Ciclosporin Eye Drops, III-312 Citric Acid Monohydrate, I-570 Clomethiazole Infusion, III-345
Ciclosporin Oral Solution, III-312 Citric-Molybdic Acid Solution, V-A45 Clomethiazole Intravenous Infusion, see
Cilastatin Sodium, I-549 Citronella Oil, IV-144 Clomethiazole Infusion
Cilazapril, I-551 Citronellal, V-A45 Clomethiazole Oral Solution, III-346
Cimetidine, I-552, V-S27 Citronellol, V-A45 Clomifene Citrate, I-592
Cimetidine Hydrochloride, I-554 Citronellyl Acetate, V-A45 Clomifene Tablets, III-347
Cimetidine Injection, III-313 Citro-phosphate Buffer pH 4.5, V-A155 Clomipramine Capsules, III-348
Cimetidine Oral Solution, III-314 Citro-phosphate Buffer pH 5.0, V-A155 Clomipramine Hydrochloride, I-594,
Cimetidine Oral Suspension, III-315 Citro-phosphate Buffer pH 6.0, V-A155 V-S31
Cimetidine Tablets, III-316 Citro-phosphate Buffer pH 6.5, V-A155 Clomipramine Tablets, Prolonged-
Cimifugin, V-A44 Citro-phosphate Buffer pH 6.8, V-A155 release, III-349
Cinchocaine Hydrochloride, I-556 Citro-phosphate Buffer pH 7.0, V-A155 Clonazepam, I-596, V-S31
Cinchona, see Cinchona Bark Citro-phosphate Buffer pH 7.2, V-A155 Clonazepam Concentrate, Sterile,
Cinchona Bark, IV-138 Citro-phosphate Buffer pH 7.6, V-A155 III-350
Cinchona Liquid Extract, Standardised, Citropten, V-A45 Clonazepam Injection, III-350
see Standardised Cinchona Liquid Citrullus Colocynthis Fruit for Clonazepam Oral Suspension, III-351
Extract Homoeopathic Preparations, IV-436 Clonazepam Tablets, III-352
Cinchonidine, V-A44 Cladribine, I-571 Clonidine Hydrochloride, I-597
Cinchonine, V-A44 Clarithromycin, I-573, V-S28 Clonidine Injection, III-354
Cineole, I-557, V-A44 Clarithromycin for Infusion, III-325 Clonidine Tablets, III-355
Cineole, Determination of, V-321 Clarithromycin Tablets, III-327 Clopamide, I-598
Cineole Type Niaouli Oil, IV-285 Clarithromycin Tablets, Prolonged- Clopidogrel Hydrogen Sulfate, I-599
Cineraria Maritima for Homoeopathic release, III-328 Closures for Containers for Aqueous
Preparations, IV-434 Clarity of Solution, V-234 Preparations for Parenteral Use,
Cinnamaldehyde, V-A44 Clavulanic Acid for Infusion, Ticarcillin Rubber, V-558
Cinnamamide, V-A44 and, III-1155 Clotrimazole, I-601
Cinnamic Acid, I-558, V-S28, V-A44 Clavulanic Acid for Intravenous Infusion, Clotrimazole and Hydrocortisone Acetate
Cinnamic Aldehyde, see Cinnamaldehyde Ticarcillin and, see Ticarcillin and Cream, III-357
Cinnamomum, V-609 Clavulanic Acid for Infusion, III-1155 Clotrimazole Cream, III-355
Cinnamon, IV-141 Clavulanic Acid Infusion, Ticarcillin and, Clotrimazole Pessaries, III-356
Cinnamon Bark, see Cinnamon III-1155 Clove, IV-146
Cinnamon Oil, see Ceylon Cinnamon Bark Clavulanic Acid Intravenous Infusion, Clove Oil, IV-147
Oil Ticarcillin and, see Ticarcillin and Cloxacillin Sodium, I-603
Cinnamon Tincture, IV-143 Clavulanic Acid for Infusion Clozapine, I-604, V-S32
Cinnamon Water, Concentrated, IV-143 Clebopride Malate, I-575 Clozapine Oral Suspension, III-359
Cinnamyl Acetate, V-A44 Clemastine Fumarate, I-577 Coagulation Factor II, human, Assay of
Cinnarizine, I-559 Clemastine Oral Solution, III-329 V-416
CIP, V-628 Clemastine Tablets, III-331 Coagulation Factor V Solution, V-A45
C.I.P. - Collection de Bacteries de Clematis Armandii Stem, IV-145 Coagulation Factor VII, human, Assay of
lInstitut Pasteur, address of, I-31, Clenbuterol Hydrochloride, I-578 V-417
II-31, III-31, IV-31, V-31 Clindamycin Capsules, III-332 Coagulation Factor X, human, Assay of
Ciprofibrate, I-560 Clindamycin Hydrochloride, I-580, V-419
Ciprofloxacin, I-562 V-S29 Coagulation Factor XI, human, Assay of
Ciprofloxacin Eye Drops, III-317 Clindamycin Injection, III-333 V-420
Ciprofloxacin Hydrochloride, I-563 Clindamycin Phosphate, I-581 Coagulation Factors, Activated V-420
page numbers in bold type relate to monograph titles Index V-A813

Coal Tar, II-976 Codeine Oral Solution, Paediatric, Colloidal, Anhydrous Silica,
Coal Tar and Salicylic Acid Ointment, III-385 Hydrophobic, II-807
III-1134 Codeine Phosphate, I-613, V-A46 Colloidal Hydrated Silica, II-806
Coal Tar and Zinc Ointment, III-1134 Codeine Phosphate and Paracetamol Colloidal Silver for External Use, II-808
Coal Tar Ointment, Calamine and, Tablets, Effervescent, see Effervescent Colony-forming Cell Assay for Human
III-228 Co-codamol Tablets Haematopoietic Progenitor Cells,
Coal Tar Paste, III-1133 Codeine Phosphate and Paracetamol V-459
Coal Tar Paste, Zinc and, III-1229 Tablets, see Co-codamol Tablets Colophony, IV-150
Coal Tar Solution, III-1134 Codeine Phosphate Injection, III-386 Colour Change Interval, V-789
Coal Tar Solution, Strong, III-1134 Codeine Phosphate Oral Solution, Colour of Certain Indicators, Reaction of
Co-amilofruse Tablets, III-360 III-386 Solution and, V-252
Co-amilozide Oral Solution, III-361 Codeine Phosphate, Paracetamol Colour of Solution, V-236
Co-amilozide Tablets, III-362 Capsules, see Co-codamol Capsules Colouring Agents, Permitted
Co-amoxiclav for Injection, III-363 Codeine Phosphate Sesquihydrate, I-615 Alternatives, I-11, II-11, III-11,
Co-amoxiclav Injection, III-363 Codeine Phosphate Tablets, III-387 IV-11, V-11
Co-amoxiclav Oral Suspension, III-365 Codeine Tablets, Aspirin and, see Co- Co-magaldrox Oral Suspension, III-401
Co-amoxiclav Tablets, III-366 codaprin Tablets Co-magaldrox Tablets, III-402
Co-amoxiclav Tablets, Dispersible, Codeine Tablets, Dispersible Aspirin Competent authority, Definition of, I-5,
III-368 and, see Co-codaprin Tablets, Dispersible II-5, III-5, IV-5, V-5
Coated Granules, III-49 Codergocrine Mesilate, I-617 Complementary Medicines, Crude
Coated Tablets, III-74 Codergocrine Tablets, III-388 Drugs; Traditional Herbal and, Status
Cobalt Chloride, see Cobalt(II) Chloride Cod-liver Oil (Type A), I-623 of, I-17, II-17, III-17, IV-17, V-17
Cobalt Nitrate, see Cobalt(II) Nitrate Cod-liver Oil (Type B), I-628 Complete Extraction of Alkaloids, V-335
Cobalt Standard Solution (100 ppm Co), Co-dydramol Tablets, III-389 Complexometric indicators, V-789
V-A149 Co-fluampicil Capsules, III-391 Complexometric Titrations, V-281,
Cobalt(II) Acetate, V-A45 Co-fluampicil Oral Suspension, III-392 V-788
Cobalt(II) Chloride, V-A45 Coix Seed, IV-148 compliance with the Pharmacopoeia,
Cobalt(II) Nitrate, V-A46 Cola, IV-149 Demonstration of, I-21, II-21, III-21,
Co-beneldopa Capsules, III-370 Colchicine, I-632 IV-21, V-21
Co-beneldopa Tablets, Dispersible, Colchicine Tablets, III-393 Composition of Fatty Acids, V-327
III-373 Cold Saturated Boric Acid Solution, Composition of Polysaccharide Vaccines,
Co-beneldopa Capsules, Prolonged- V-A34 V-466
release, III-371 Colecalciferol, I-633 Compound Alginate Antacid Oral
Cocaine, I-606, V-S32 Colecalciferol Concentrate (Oily Form), Suspension, III-113
Cocaine Eye Drops, III-374 I-635 Compound Aluminium Paste, III-120
Cocaine Hydrochloride, I-607 Colecalciferol Concentrate (Powder Compound Benzoic Acid Ointment,
Cocaine Hydrochloride, Hydrate see Form), I-636 III-175
Cocaine Hydrochloride Colecalciferol Concentrate (Water- Compound Benzoin Tincture, IV-98
Cocaine Intranasal Solution, Adrenaline dispersible Form), I-638 Compound Calamine Ointment, III-228
and, III-107 Colecalciferol Injection, III-394 Compound Cardamom Tincture, IV-128
Cocaine Intranasal Solution, Epinephrine Colecalciferol Tablets, III-395 Compound Docusate Enema, III-486
and, see Adrenaline and Cocaine Colecalciferol Tablets, Calcium and, Compound Gentian Infusion, IV-197
Intranasal Solution III-234 Compound Gentian Infusion,
Cocaine Paste, III-375 Colecalciferol Tablets, Chewable Concentrated, IV-197
Co-careldopa Tablets, III-376 Calcium and, III-235 Compound Glucose, Sodium Chloride
Cocculus for Homoeopathic Colestipol Granules, III-396 and Sodium Citrate Oral Solution,
Preparations, IV-437 Colestipol Hydrochloride, I-640 III-617
Cocculus Indicus for Homoeopathic Colestyramine, I-641, V-S33 Compound Magnesium Trisilicate
Preparations, see Cocculus for Colestyramine Oral Powder, III-396 Mixture, III-775
Homoeopathic Preparations Colistimethate Injection, III-397 Compound Magnesium Trisilicate Oral
Cochineal, I-608 Colistimethate Nebuliser Solution, see Powder, III-775
Cocoa Butter, see Theobroma Oil Colistimethate Sodium Powder for Compound Magnesium Trisilicate
Co-codamol Capsules, III-377 Nebuliser Solution Tablets, Chewable, III-776
Co-codamol Tablets, III-378 Colistimethate Sodium, I-643 Compound Orange Spirit, IV-304
Co-codamol Tablets, Effervescent, Colistimethate Sodium for Injection, Compound Podophyllin Cutaneous
III-380 III-397 Solution, IV-328
Co-codaprin Tablets, III-381 Colistimethate Sodium for Nebulisation, Compound Podophyllin Paint, IV-328
Co-codaprin Tablets, Dispersible, see Colistimethate Sodium Powder for Compound Rhubarb Tincture, IV-338
III-382 Nebuliser Solution Compound Sodium Bicarbonate Tablets,
Coconut Oil, I-608 Colistimethate Sodium Powder for III-1091
Cocoyl Caprylocaprate, I-609 Nebuliser Solution, III-398 Compound Sodium Chloride
Cod Liver Oil, Farmed see Farmed Cod Colistin Sulfate, I-644 Mouthwash, III-1093
Liver Oil Colistin Tablets, III-399 Compound Sodium Lactate Infusion,
Co-danthrusate Capsules, III-383 2,4,6-Collidine, V-A46 III-1102
Code of Practice, I-xiii, I-xxv Collodion, Flexible, III-400 Compound Sodium Lactate Injection,
Codeine, I-610, V-S32, V-A46 Collodion for the Preparation of Flexible III-1102
Codeine Hydrochloride, I-612 Collodion, III-401 Compound Sodium Lactate Intravenous
Codeine Linctus, III-384 Collodions, III-43 Infusion, see Compound Sodium Lactate
Codeine Linctus, Paediatric, III-385 Colloidal Anhydrous Silica, II-805 Infusion
Codeine Oral Solution, III-384
V-A814 Index

Compound Sodium Picosulfate Powder Containers for Pharmaceutical Use, Copper Sulphate, Anhydrous see
for Oral Soution, III-1105 Glass, V-548 Anhydrous Copper Sulfate
Compound Squill Linctus, IV-373 Containers for Preparations not for Copper Sulphate Pentahydrate see Copper
Compound Tolu Linctus, Paediatric, Parenteral Use, Polyethylene Sulfate Pentahydrate
IV-392 Terephthalate for, V-595 Copper Sulphate Solution pH 5.2,
Compound Tolu Oral Solution, Containers, Materials Used for the Buffered, see Copper Sulfate Solution
Paediatric, IV-392 Manufacture of, V-563 pH 5.2, Buffered
Compound Zinc Paste, III-1228 Containers for Blood and Blood Copper Sulphate Solution pH 4.0,
Compressed Lozenges, III-63 Components, V-555 Buffered, see Copper Sulfate Solution
Compressible Sugar, II-936, V-S33 Containers, Polyethylene, V-579 pH 4.0, Buffered
Concentrated Ammonia, V-A25 Contamination, Microbial Test for Copper Sulphate Solution pH 2.0, see
Concentrated Ammonia R1, V-A26 Specified Micro-organisms, V-700 Copper Sulfate Solution pH 2.0
Concentrated Anise Water, IV-73 Contamination, Microbial Test for Copper Sulphate Solution, Weak, see
Concentrated Camphor Water, III-243 Specified Micro-organisms, V-478 Copper Sulfate Solution, Weak
Concentrated Camphorated Opium Content of Active Ingredient in, III-41 Copper Sulphate Solution, see Copper
Tincture, IV-300 Capsules, III-41 Sulfate Solution
Concentrated Casein Substrate, V-A39 Content of Active Ingredient of, III-76 Copper Sulphate VS, see Copper Sulfate
Concentrated Cinnamon Water, IV-143 Tablets, III-76 VS
Concentrated Compound Gentian Content, Standards for, I-5, II-5, III-5, Copper Sulphate-Pyridine Reagent, see
Infusion, IV-197 IV-5, V-5 Copper Sulfate-Pyridine Reagent
Concentrated Hydrochloric Acid see Contents of the Appendices, V-A3 Copper Sulphate, see Copper Sulfate
Hydrochloric Acid Continuous Extraction of Drugs, V-334 Copper Tetrammine, Ammoniacal
Concentrated Orange Peel Infusion, Control of Impurities in Substances for Solution of, V-A46
IV-305 Pharmaceutical Use, V-742 Copper(II) Acetate, V-A46
Concentrated Peppermint Emulsion, Conventional terms, I-22, II-22, III-22, Copper(II) Chloride, V-A46
IV-320 IV-22, V-22 Copper(II) Nitrate, V-A46
Concentrated Phosphoric Acid, see Conversion tables for commonly used Copper(ii) Sulfate, V-A46
Phosphoric Acid units, V-627 Copper(ii) Sulphate, see Copper(ii) Sulfate
Concentrated Solutions for Injections, Coomassie Blue, see Acid Blue 92 Co-proxamol Tablets, III-402
III-66 Coomassie Blue Solution, see Acid Blue Corallin, V-A46
Concentrates for Injections or Infusions, 92 Solution Corallin Solution, Alkaline, V-A46
III-65 Coomassie Staining Solution, V-A46 Coriander, IV-151
Concentrations, Expression of, I-6, II-6, Coomassie Staining Solution R1, V-A46 Coriander Oil, IV-152
III-6, IV-6, V-6 Copovidone, I-645 Cornflower Root, Narrow-leaved, see
Conductivity, Determination of, V-256 Copper, V-A46 Echinacea Angustifolia Root
Coneflower Herb, Purple, see Echinacea Copper Acetate Monohydrate for Correction Factor, Definition of, V-638
Purpurea Herb Homoeopathic Preparations, IV-439 Corresponds, definition of, I-5, II-5,
Coneflower Root, Pale, see Echinacea Copper Acetate, see Copper(II) Acetate III-5, IV-5, V-5
Pallida Root Copper Carbonate, V-A46 Cortisone, V-A46
Coneflower Root, Purple, see Echinacea Copper Chloride-Pyridine Reagent, Cortisone Acetate, I-649, V-A47
Purpurea Root V-A46 Cortisone Tablets, III-404
Confidence Interval, V-657 Copper Edetate Solution, V-A46 Co-tenidone Tablets, III-405
Congo Red, V-A46 Copper for Homoeopathic Preparations, Co-triamterzide Tablets, III-406
Congo Red Fibrin, V-A46 IV-438 Co-trimoxazole Concentrate, Sterile,
Congo Red Paper, V-A46 Copper for Homoeopathic Use, see III-408
Congo Red Solution, V-A46 Copper for Homoeopathic Preparations Co-trimoxazole Infusion, III-407
Conjugated Estrogens, I-888 Copper Liposoluble Standard Solution Co-trimoxazole Intravenous Infusion,
Consistency, Measurement of, V-508 (1000 ppm Cu), V-A149 III-407
Consistency of Formulated Preparations, Copper Oxide Solution, Ammoniacal, Co-trimoxazole Oral Suspension, III-408
V-371 V-A46 Co-trimoxazole Oral Suspension,
Constant Weight, Definition of, I-6, II-6, Copper Standard Solution (0.1% Cu), Paediatric, III-409
III-6, IV-6, V-6 V-A149 Co-trimoxazole Tablets, III-410
Contact Points, V-667 Copper Standard Solution (0.1 ppm Co-trimoxazole Tablets, Dispersible,
Containers, I-25, II-25, III-25, IV-25, Cu), V-A149 III-410
V-548, V-555, V-25 Copper Standard Solution (10 ppm Cu), Co-trimoxazole Tablets, Paediatric,
for Blood and Blood Components, V-A149 III-411
V-555 Copper Sulfate, Anhydrous see Anhydrous Cotton, Absorbent see Absorbent Cotton
Containers and Closures, Plastic, V-553 Copper Sulfate Cottonseed Oil, Hydrogenated see
Containers and Closures for Parenteral Copper Sulfate Pentahydrate, I-648 Hydrogenated Cottonseed Oil
Preparations and Ophthalmic Copper Sulfate Solution, V-A46 Couch Grass Rhizome, IV-153
Preparations, Polypropylene for, V-584 Copper Sulfate Solution pH 5.2, Coumaphos, V-A47
Containers and Tubing for Total Buffered, V-A155 o-Coumaric Acid, V-A47
Parenteral Nutrition Preparations, Copper Sulfate Solution pH 2.0, V-A155 Coumarin, V-A47
Poly(ethylene - vinyl acetate) for, Copper Sulfate Solution pH 4.0, Coumestrol, V-A47
V-588 Buffered, V-A155 Cream of Tartar, see Potassium Hydrogen
Containers for Aqueous Solutions for Copper Sulfate Solution, Weak, V-A46 Tartrate
Parenteral Infusions, Plastic, V-554 Copper Sulfate VS, V-A143 Cream, Oily, III-660
Containers for Human Blood and Blood Copper Sulfate-Pyridine Reagent, V-A46 Creams, III-71, III-72
Components, Materials for, V-563 Copper Sulfate see Copper(II) Sulfate, Cresol, I-651, V-A47
V-A46 m-Cresol Purple, V-A47
page numbers in bold type relate to monograph titles Index V-A815

m-Cresol Purple Solution, V-A47 Cyanogen Bromide Solution, V-A48 Dantrolene Oral Suspension, III-426
Cresol Red, V-A47 1-Cyanoguanidine, V-A48 Dantrolene Sodium, I-676, V-S36
Cresol Red Solution, V-A47 Cyanoguanidine, see 1-Cyanoguanidine Dantron, I-677, V-S36
Cresol, see o-Cresol Cyanosilyl Silica Gel for Dantron and Docusate Sodium
Crocus for Homoeopathic Preparations, Chromatography, V-A115 Capsules, see Co-danthrusate Capsules
IV-440 Cyclizine, I-658, V-S33 Dantron, see 1,8-Dihydroxyanthraquinone
Croscarmellose Sodium, I-652 Cyclizine Hydrochloride, I-659, V-S34 Dapsone, I-678, V-S37
Crospovidone, I-654 Cyclizine Injection, III-414 Dapsone Tablets, III-427
Cross-linked Agarose for Cyclizine Tablets, III-415 Date, Effective dates, I-ix, II-vii, III-vii,
Chromatography, V-A22 Cyclizine Tablets, Dipipanone and, IV-vii, V-vii
Cross-linked Agarose for III-470 Dates of Implementation, V-677
Chromatography R1, V-A22 Cyclobutane-1,1-dicarboxylic Acid, Daunorubicin Hydrochloride, I-679
Cross-linked Dextran for V-A48 Deactivated Aluminium Oxide, V-A23
Chromatography R2, V-A50 -Cyclodextrin, V-A48 Debrisoquine Sulfate, I-680
Cross-linked Dextran for b-Cyclodextrin for Chiral Debrisoquine Sulphate, see Debrisoquine
Chromatography R3, V-A50 Chromatography, Modified, V-A48 Sulfate
Crotamiton, I-655 b-Cyclodextrin for Chiral Decanal, V-A49
Crotamiton Cream, III-411 Chromatography, Modified R1, V-A48 n-Decane, V-A49
Crotamiton Cutaneous Suspension, Cyclohexane, V-A48 Decane, see n-Decane
III-412 Cyclohexane R1, V-A48 Decan-1-ol, V-A49
Crotamiton Lotion, III-412 Cyclohexylamine, V-A48 Decanol, see Decan-1-ol
CRS, I-15, II-15, III-15, IV-15, V-628, Cyclohexylenedinitrilotetra-acetic Acid, Declaration of Interests, I-xiii
V-15 V-A48 Decolorised Fuchsin Solution, V-A67
Crude Cresol, I-652 Cyclohexylmethanol, V-A48 Decolorised Fuchsin Solution R1, V-A67
Crude Drugs, Macroscopical 3-Cyclohexylpropionic Acid, V-A49 Decolorised Pararosaniline Solution,
characteristics of, I-17, II-17, III-17, Cyclopenthiazide, I-660, V-S34 V-A99
IV-17, V-17 Cyclopenthiazide Tablets, III-416 Decyl Oleate, I-681
Crude Drugs; Traditional Herbal and Cyclopentolate, V-S34 DeFeroxamine Mesilate, see
Complementary Medicines, Status of, Cyclopentolate Eye Drops, III-417 Desferrioxamine Mesilate
I-17, II-17, III-17, IV-17, V-17 Cyclopentolate Hydrochloride, I-661 M, Definition of, I-7, II-7, III-7, IV-7,
Crushing of Tablets, Resistance to, Cyclophosphamide, I-662, V-S35 V-7
V-513 Cyclophosphamide for Injection, III-417 Definition, I-25, II-25, III-25, IV-25,
Crystal Violet, V-A47 Cyclophosphamide Injection, III-417 V-25
Crystal Violet Solution, V-A47 Cyclophosphamide Oral Solution, Definition of Terms, I-5, II-5, III-5,
Crystalline and Partially Crystalline III-418 IV-5, V-5
Solids by X-ray Powder Diffraction Cyclophosphamide Tablets, III-419 Definition, Status of, I-8, II-8, III-8,
(XRPD), Characterisation of, V-526 Cydonia Oblonga for Homoeopathic IV-8, V-8
Crystallinity, V-539 Preparations, IV-441 Deltamethrin, V-A49
Cupric Chloride, see Copper(II) Chloride Cyhalothrin, V-A49 Demeclocycline Capsules, III-428
Cupri-citric Solution, V-A47 p-Cymene, V-A49 Demeclocycline Hydrochloride, I-681,
Cupri-citric Solution R1, V-A47 Cynarin, V-A49 V-A49
Cupriethylenediamine hydroxide Cypermethrin, V-A49 Dementholised Mint Oil, IV-280
solution, V-A48, V-A143 Cyproheptadine, V-S35 Demethylflumazenil, V-A49
Cupri-tartaric Solution, V-A48 Cyproheptadine Hydrochloride, I-663 Demonstration of compliance with the
Cupri-tartaric Solution R1, V-A48 Cyproheptadine Tablets, III-420 Pharmacopoeia, I-21, II-21, III-21,
Cupri-tartaric Solution R2, V-A48 Cyproterone Acetate, I-664, V-S35 IV-21, V-21
Cupri-tartaric Solution R3, V-A48 Cyproterone Tablets, III-420 Demonstration of Uniformity of Dosage
Cupri-tartaric Solution R4, V-A48 L-Cysteine, V-A49 Units Using Large Samples Sizes,
Cuprum Aceticum for Homoeopathic Cysteine Hydrochloride, I-666, V-A49 V-390
Preparations, see Copper Acetate Cysteine Hydrochloride Monohydrate see Denatured Alcohol, Industrial, see
Monohydrate for Homoeopathic Cysteine Hydrochloride Industrial Methylated Spirit
Preparations Cystine, I-668, V-A49 Denatured Alcohol (Ketone-free),
Cuprum Metallicum for Homoeopathic Cytarabine, I-669, V-S36 Industrial, see Industrial Methylated
Preparations, see Copper for Cytarabine for Injection, III-423 Spirit (Ketone-free)
Homoeopathic Preparations Cytarabine Injection, III-422 Density, Determination of, V-245
Curacao Aloes, see Barbados Aloes Cytosine, V-A49 Density, Determination of Apparent,
Curcumin, V-A48 V-246
Curcuminoids, V-A48 Density of Solids, Determination of,
Cut Valerian, IV-398
Cutaneous Foams, III-43
D V-257
Density of Solids, Pycnometric, V-514
Dacarbazine, I-670, V-S36
Cyanoacetic Acid, V-A48 Density, Relative Density and Apparent
Dacarbazine for Injection, III-423
Cyanocobalamin, I-657, V-A48 Density, Determination of Weight per
Dacarbazine Injection, III-423
Cyanocobalamin (57Co) Capsules, Millilitre, V-245
Daidzein, V-A49
IV-674 Dental-type Silica, II-807
Daidzin, V-A49
Cyanocobalamin (57Co) Solution, IV-675 Deodorised Kerosene, V-A78
Dalteparin Sodium, I-672
Cyanocobalamin (58Co) Capsules, 2-Deoxy-d-ribose, V-A49
Dalteparin Sodium Injection, III-424
IV-676 2-Deoxyuridine, V-A49
Danaparoid Sodium, I-673
Cyanocobalamin (58Co) Solution, IV-676 Depressor Substances, Test for, V-409
Dandelion Herb with Root, IV-154
Cyanocobalamin Oral Solution, III-413 Deptropine Citrate, I-683
Dandelion Root, IV-155
Cyanocobalamin Tablets, III-413 Dequalinium Chloride, I-684
V-A816 Index

Desferrioxamine Injection, III-429 Deuterated Sodium Phosphate Buffer Chloride, Sodium Chloride and Glucose
Desferrioxamine Mesilate, I-687, V-S37 Solution pH 5.0, 0.2M, V-A155 Infusion
Desferrioxamine Mesilate for Injection, Deuterated Sodium Dextrose Infusion, Sodium Chloride and,
III-429 Trimethylsilylpropionate, V-A50 see Sodium Chloride and Glucose Infusion
Desflurane, I-689 Deuterium Chloride, V-A50 Dextrose Injection, Bupivacaine and,
Design of Biological Assays, V-653 Deuterium chloride solution, V-A50 III-218
Desipramine Hydrochloride, I-688, Deuterium Oxide, V-A50 Dextrose Intravenous Infusion,
V-S37 Deuterium Oxide, Isotopically Pure, Potassium Chloride and, see Potassium
Desipramine Tablets, III-430 V-A50 Chloride and Glucose Infusion
Deslanoside, I-691 Deuterium Oxide R1, V-A50 Dextrose Intravenous Infusion,
Desloratadine, I-692 Deuterochloroform, V-A50 Potassium Chloride, Sodium Chloride
Desmethylmisonidazole, V-A50 Devardas Alloy, V-A50 and, see Potassium Chloride, Sodium
Desmopressin, I-693 Developer Solution, V-A50 Chloride and Glucose Infusion
Desmopressin Injection, III-430 Devils Claw Dry Extract, IV-157 Dextrose Intravenous Infusion, Sodium
Desmopressin Intranasal Solution, Devils Claw Root, IV-156 Chloride and, see Sodium Chloride and
III-431 Dexamethasone, I-697, V-S38, V-A50 Glucose Infusion
Desmopressin Tablets, III-432 Dexamethasone Acetate, I-700 Dextrose, see D-Glucose
Desogestrel, I-695, V-S38 Dexamethasone and Neomycin Ear 8-b-D-Glucopyranosyl-7-hydroxy-3-
Desogestrel Tablets, III-433 Spray, III-438 (4-hydroxyphenyl)-4H-1-benzopyran-
Desoxycortone Acetate, I-696 Dexamethasone Eye Drops, Suspension, 4-one see Puerarin
4-Desoxypyridoxine Hydrochloride, III-435 Diacerein, I-719
V-A50 Dexamethasone Isonicotinate, I-702 3,3-Diaminobenzidine
Destaining Solution, V-A50 Dexamethasone Sodium Phosphate, Tetrahydrochloride, V-A50
Detection and Measurement of I-703 Diammonium 2,2-
Radioactivity, V-258 Dexamethasone Sodium Phosphate Eye azinobis(3-ethylbenzothiazoline-6-
Detection Limit, V-675 Drops, Solution, III-440 sulfonate), V-A50
Detector Tubes, Gas, V-312 Dexamethasone Sodium Phosphate Diammonium 2,2-
Determination of Aflatoxin B1 in Herbal Injection, III-441 azinobis(3-ethylbenzothiazoline-6-
Drugs, V-341 Dexamethasone Sodium Phosphate Oral sulphonate), see Diammonium 2,2 0 -
Determination of Carbon Dioxide in Solution, III-442 azinobis(3-ethylbenzothiazoline-
Medicinal Gases, V-310 Dexamethasone Tablets, III-436 6-sulfonate)
Determination of Cineole, V-321 Dexamfetamine Sulfate, I-706 Diammonium Hydrogen
Determination of Ethanol, V-283 Dexamfetamine Sulphate, see Orthophosphate, V-A50
Determination of Metal Catalyst or Dexamfetamine Sulfate Diamorphine Hydrochloride, I-721,
Metal Reagent Residues,V-302 Dexamfetamine Tablets, III-443 V-S39
Determination of Mycotoxins in Herbal Dexchlorpheniramine Maleate, I-706 Diamorphine Hydrochloride for
Drugs, V-341 Dexpanthenol, I-708 Injection, III-447
Determination of Nitrogen, V-287 Dextran 1 for Injection, I-709 Diamorphine Injection, III-446
Determination of N,N-Dimethylaniline, Dextran 40 for Injection, I-710 Diamorphine Injection, Bupivacaine and,
V-294 Dextran 40 Infusion, III-444 III-221
Determination of Ochratoxin A in Dextran 40 Injection, III-444 Diatomaceous Earth for Gas
Herbal Drugs, V-343 Dextran 40 Intravenous Infusion, III-444 Chromatography, see Diatomaceous
Determination of Oxygen in Medicinal Dextran 60 for Injection, I-711 Support, Acid-Washed
Gases, V-311 Dextran 70 for Injection, I-712 Diatomaceous Earth for GC R1, V-A50
Determination of Primary Aromatic Dextran 70 Infusion, III-444 Diatomaceous Earth for GC R1,
Amino-nitrogen, V-281 Dextran 70 Injection, III-444 Silanised, V-A51
Determination of Sorption-Desorption Dextran 70 Intravenous Infusion, III-444 Diatomaceous Earth for GC R2, V-A51
Isotherms and of Water Activity Dextran 2000, Blue, V-A33 Diatomaceous Earth, see Diatomaceous
Water-Solid Interactions, V-313 Dextran for Chromatography R3, Cross- Support
Determination of Sulfated Ash, V-306 linked, V-A50 Diatomaceous Filter-aid, Washed, Flux-
Determination of Sulfur Dioxide, V-306 Dextranomer, I-713 calcined, V-A51
Determination of Sulphated Ash, see Dextrin, I-713 Diatomaceous Support, V-A51
Determination of Sulfated Ash Dextromethorphan Hydrobromide, I-714 Diatomaceous Support, Acid-washed,
Determination of Sulphur Dioxide, see Dextromoramide, V-S38 V-A51
Determination of Sulfur Dioxide Dextromoramide Tablets, III-445 Diatomaceous Support, Alkali-washed,
Determination of Water, V-307 Dextromoramide Tartrate, I-716 V-A51
Determination of Water in Medicinal Dextropropoxyphene, V-S39 Diatomaceous Support, Silanised, V-A51
Gases, V-311 Dextropropoxyphene Capsules, III-446 Diazepam, I-722
Determination of Weight per Millilitre, Dextropropoxyphene Hydrochloride, Diazepam Injection, III-447
Density, Relative Density and I-716 Diazepam Oral Solution, III-448
Apparent Density, V-245 Dextropropoxyphene Hydrochloride and Diazepam Rectal Solution, III-448
Deuterated Acetic Acid, V-A50 Paracetamol Tablets, see Co-proxamol Diazepam Tablets, III-449
Deuterated Acetone, V-A50 Tablets Diazinon, V-A51
Deuterated Acetonitrile, V-A50 Dextropropoxyphene Napsilate, I-718, Diazobenzenesulfonic Acid Solution,
Deuterated Chloroform, see V-S39 V-A51
Deuterochloroform Dextrose Infusion, Potassium Chloride Diazobenzenesulfonic Acid Solution R1,
Deuterated Dimethyl Sulfoxide, V-A50 and, see Potassium Chloride and Glucose V-A51
Deuterated Dimethyl Sulphoxide, see Infusion Diazobenzenesulphonic Acid Solution
Deuterated Dimethyl Sulfoxide Dextrose Infusion, Potassium Chloride, R1, see Diazobenzenesulfonic Acid
Deuterated Methanol, V-A50 Sodium Chloride and, see Potassium Solution R1
page numbers in bold type relate to monograph titles Index V-A817

Diazobenzenesulphonic Acid Solution, Diclofenac Tablets, Gastro-resistant, Diffraction, Particle Size Analysis by
see Diazobenzenesulfonic Acid Solution III-454 Laser Light, V-522
Diazotised Nitroaniline Solution, V-A95 Diclofenac Tablets, Prolonged-release, Diflubenzuron, V-A54
Diazotised Sulfanilic Acid Solution, III-455 Diflucortolone Cream, III-459
V-A127 Diclofenac Tablets, see Gastro-resistant Diflucortolone Oily Cream, III-460
Diazoxide, I-724, V-S40 Diclofenac Tablets Diflucortolone Ointment, III-460
Diazoxide Injection, III-450 Dicloxacillin Sodium, I-735 Diflucortolone Valerate, I-745, V-S42
Diazoxide Tablets, III-450 Di-2-cyanoethyl Ether, V-A53 Diflunisal, I-xxix
Dibasic Calcium Phosphate, see Calcium Dicyclohexyl, V-A53 Diflunisal (Form B), V-S42
Hydrogen Phosphate Dicyclohexylamine, V-A53 Diflunisal Tablets, I-xxix
Dibenzosuberone, V-A51 1,3-Dicyclohexylurea, V-A53 Digitalis Leaf, IV-158
Dibrompropamidine Diisetionate see Dicyclohexylurea, see 1,3-Dicyclohexylurea Digitonin, V-A54
Dibrompropamidine Isetionate Dicyclomine Oral Solution, see Digitoxin, I-746, V-A54
Dibrompropamidine Isetionate, I-724, Dicycloverine Oral Solution Digitoxin Standard Solution, V-A149
V-S40 Dicyclomine Tablets, see Dicycloverine Digitoxin Tablets, III-461
Dibutyl Ether, V-A51 Tablets Digoxin, I-747
Dibutyl Phthalate, I-726, V-A51 Dicycloverine Hydrochloride, I-736, Digoxin Injection, III-461
Dibutylamine, V-A51 V-S41 Digoxin Injection, Paediatric, III-462
Dibutylamine, see Di-n-butylamine Dicycloverine Oral Solution, III-456 Digoxin Oral Solution, Paediatric,
Dibutylammonium Phosphate for Ion- Dicycloverine Tablets, III-456 III-462
pairing, V-A51 Didanosine, I-737 Digoxin Reagent, V-A54
Dicarboxidine Hydrochloride, V-A51 Didocosahexaenoin, V-A53 Digoxin Tablets, III-462
Dichlofenthion, V-A51 Didodecyl 3,3-thiodipropionate, V-A53 Dihydrocapsaicin, V-A54
Dichloroacetic Acid, V-A51 Dieldrin, V-A53 10,11-Dihydrocarbamazepine, V-A54
Dichloroacetic Acid Solution, V-A52 Diethanolamine, V-A53 Dihydrocarvone, V-A54
3,5-Dichloroaniline, V-A52 Diethanolamine Buffer Solution Dihydrocodeine, V-S43
1,2-Dichlorobenzene, V-A52 pH 10.0, V-A155 Dihydrocodeine Hydrogen Tartrate see
Dichlorobenzene, see 1,2-Dichlorobenzene 2,5-Diethoxytetrahydrofuran, V-A53 Dihydrocodeine Tartrate
2,4-Dichlorobenzoic acid, V-A52 Diethoxytetrahydrofuran, see 2,5- Dihydrocodeine Injection, III-463
2,4-Dichlorobenzyl Alcohol, I-727 Diethoxytetrahydrofuran Dihydrocodeine Oral Solution, III-463
2,3-Dichloro-5,6-dicyanobenzoquinone, Diethyl Phthalate, I-739, V-A54 Dihydrocodeine Tablets, III-464
V-A52 Diethylamine, V-A53 Dihydrocodeine Tartrate, I-750
1,2-Dichloroethane, V-A52 Diethylamine R1, V-A53 Dihydroergocristine Mesilate, I-752
2,7-Dichlorofluorescein, V-A52 Diethylamine Salicylate, I-740, V-S41 Dihydroergotamine Mesilate, I-754
Dichlorofluorescein, see 2,7- Diethylamine Salicylate Cream, III-457 Dihydroergotamine Tartrate, I-756
Dichlorofluorescein Diethylaminoethyldextran, V-A53 Dihydrotachysterol, I-757
5,7-Dichloro-8-hydroxyquinoline, V-A52 Diethylammonium Phosphate Buffer 1,8-Dihydroxyanthraquinone, V-A54
Dichloromethane, I-728, V-A52 Solution pH 6.0, V-A155 2,5-Dihydroxybenzoic Acid, V-A54
Dichloromethane, Acidified, V-A52 Diethylcarbamazine, V-S42 7,4-Dihydroxy-8-C-glucosyliso-haloprone
Dichloromethane IR, V-A52 Diethylcarbamazine Citrate, I-740 see Puerarin, V-A110
Dichloromethane Reagent, V-A52 Diethylcarbamazine Tablets, III-457 5,7-Dihydroxy-4-methylcoumarin, V-A54
2,4-Dichloro-1-naphthol, V-A52 N,N-Diethylaniline, V-A53 2,7-Dihydroxynaphthalene Solution, see
Dichlorophen, I-729 Diethylene Glycol, V-A53 Naphthalenediol Solution
Dichlorophen Tablets, III-451 Diethylene Glycol in Ethoxylated 1,3-Dihydroxynaphthalene, see
2,6-Dichlorophenol, V-A52 Substances, Ethylene Glycol and, Naphthalene-1,3-diol
2,6-Dichlorophenolindophenol Sodium V-288 5,7-Di-iodo-8-hydroxyquinoline, V-A54
Salt, V-A52 Diethylene Glycol Monoethyl Ether, 1,5-Di-iodopentane, V-A54
Dichlorophenolindophenol, Sodium Salt, I-742 5,7-Di-iodoquinolin-8-ol, V-A54
see 2,6-Dichlorophenolindophenol Sodium Diethylene Glycol Palmitostearate, I-743 Di-isobutyl Ketone, V-A54
Salt N,N-Diethylethane-1,2-diamine, see Di-isobutyloctadecylsilyl Silica Gel for
2,6-Dichlorophenolindophenol Solution, N,N-Diethylenediamine Chromatography, V-A115
V-A52 N,N-Diethylethylenediamine, V-A53 Di-isopropyl Ether, V-A54
2,6-Dichlorophenolindophenol Solution, N,N-Diethyl-p-phenylenediamine Di-isopropyl Ether, Stabiliser-free,
Double-strength, Standard, V-A52 Sulfate, V-A54 V-A54
Dichlorophenolindophenol Solution, N,N-Diethyl-p-phenylenediamine Diisopropylcyanopropylsilyl silica gel for
Standard, V-A52 Sulphate, see N,N-Diethyl-p- chromatography, V-A115
5,7-Dichloroquinolin-8-ol, V-A52 phenylenediamine Sulfate Di-isopropylethylamine, V-A55
Dichloroquinonechlorimide, see 2,6- Di(2-ethylhexyl) Phthalate, V-A53 Dill Oil, IV-159
Dichloroquinone-4-chloroimide Diethylphenylenediamine Sulfate Dillapiole, V-A55
2,6-Dichloroquinone-4-chloroimide, Solution, V-A54 Diloxanide Furoate, I-759, V-S43
V-A53 Diethylphenylenediamine Sulfate, see Diloxanide Tablets, III-465
Dichlorvos, V-A53 N,N-Diethyl-p-phenylenediamine Sulfate Diltiazem Hydrochloride, I-759
Diclofenac, V-S40 Diethylphenylenediamine Sulphate Diltiazem Tablets, Prolonged-release,
Diclofenac Capsules, Prolonged-release, Solution, see Diethylphenylenediamine III-465
III-452 Sulfate Solution Dilute Acetic Acid, V-A20
Diclofenac Diethylamine, I-730, V-S41 Diethylphenylenediamine Sulphate, see Dilute Acetic Acid, see Acetic Acid
Diclofenac Gel, III-453 Diethylphenylenediamine Sulfate (6 per cent)
Diclofenac Potassium, I-731 Diethylstilbestrol, I-744 Dilute Adrenaline Injection 1 in
Diclofenac Sodium, I-733 Diethylstilbestrol Pessaries, III-458 10,000/Dilute Epinephrine Injection 1
Diethylstilbestrol Tablets, III-459 in 10,000, III-106
V-A818 Index

Dilute Ammonia Buffer pH 10.9, N,N-Dimethyltetradecylamine, V-A57 Dimethylformamide Diethylacetal,


V-A153 N,N-Diphenylbenzidine, V-A58 V-A56
Dilute Ammonia R1, V-A26 Dimethyl Phthalate, I-765, V-S44, Dimethylglyoxime, V-A56
Dilute Ammonia R2, V-A26 V-A57 1,3-Dimethyl-2-imidazolidinone, V-A56
Dilute Ammonia R3, V-A26 Dimethyl Sulfone, V-A57 Dimethyloctadecylsilyl Silica Gel for
Dilute Ammonia Solution, III-137 Dimethyl Sulfoxide, I-765, V-A57 Chromatography, V-A115
Dilute Ammonium Carbonate Solution, Dimethyl Sulfoxide, Deuterated, V-A50 2,5-Dimethylphenol, V-A56
V-A26 Dimethyl Sulfoxide R1, V-A57 Dimethylpiperazine, see N,N-
Dilute Ethanols, I-900 Dimethyl Sulphone, see Dimethyl Sulfone Dimethylpiperazine
Dilute Hydrobromic Acid, V-A72 Dimethyl Sulphoxide R1, see Dimethyl Dimethylstearamide, see
Dilute Hydrobromic Acid R1, V-A72 Sulfoxide R1 Dimethylstearylamide
Dilute Hydrochloric Acid, I-1151, V-A72 Dimethyl Sulphoxide, see Dimethyl Dimethylstearylamide, V-A57
Dilute Hydrochloric Acid R1, V-A73 Sulfoxide 2,4-Dimethyl-6-tert-butylphenol, V-A56
Dilute Hydrochloric Acid R2, V-A73 Dimethyl Yellow, V-A57 Dimeticone, I-766, V-S44, V-A57
Dilute Hydrogen Peroxide Solution see Dimethyl Yellow and Oracet Blue 2R Dimetindene Maleate, I-767
Hydrogen Peroxide Solution (3 per cent) Solution, V-A57 Dimidium Bromide, V-A57
Dilute Nitric Acid, V-A94 Dimethyl Yellow and Oracet Blue Dimidium Bromide-Sulfan Blue Mixed
Dilute Phosphomolybdotungstic Reagent, Solution, V-A57 Solution, V-A57
V-A103 Dimethyl Yellow Solution, V-A57 Dimidium Bromide-Sulphan Blue Mixed
Dilute Phosphoric Acid, II-572, V-A103 Dimethylacetamide, I-764, V-A55 Solution, see Dimidium Bromide-Sulfan
Dilute Potassium Dichromate Solution, Dimethylamine, V-A55 Blue Mixed Solution
V-A107 Dimethylamine Hydrochloride, V-A55 Di-n-butylamine, V-A51
Dilute Potassium Hexacyanoferrate(III) Dimethylamine solution, V-A55 1,3-Dinitrobenzene, V-A57
Solution, V-A107 4-Dimethylaminobenzaldehyde, V-A55 Dinitrobenzene Solution, V-A57
Dilute Potassium Iodide Solution, Dimethylaminobenzaldehyde Reagent, Dinitrobenzene, see 1,3-Dinitrobenzene
V-A108 V-A55 3,5-Dinitrobenzoic Acid, V-A57
Dilute Potassium Iodobismuthate Dimethylaminobenzaldehyde Solution, Dinitrobenzoic Acid Solution, V-A57
Solution, V-A108 Alcoholic, V-A55 Dinitrobenzoic Acid, see 3,5-
Dilute Potassium Permanganate Dimethylaminobenzaldehyde Solution Dinitrobenzoic Acid
Solution, V-A109 R1, V-A55 Dinitrobenzoyl Chloride, V-A57
Dilute Sodium Carbonate Solution, Dimethylaminobenzaldehyde Solution 2,4-Dinitrophenylhydrazine, V-A57
V-A121 R2, V-A55 Dinitrophenylhydrazine-aceto-
Dilute Sodium Hydroxide Solution, Dimethylaminobenzaldehyde Solution hydrochloric Solution, V-A58
V-A123 R6, V-A55 Dinitrophenylhydrazine-hydrochloric
Dilute Sodium Hypochlorite Solution, Dimethylaminobenzaldehyde Solution Solution, V-A58
III-1101, V-A123 R7, V-A55 Dinitrophenylhydrazine, see 2,4-
Dilute Sulfuric Acid, II-954, V-A128 Dimethylaminobenzaldehyde Solution Dinitrophenylhydrazine
Dilute Sulphuric Acid, see Dilute Sulfuric R8, V-A55 Dinitrophenylhydrazine-sulfuric Acid
Acid Dimethylaminobenzaldehyde solution Solution, V-A58
Dilute Tetramethylammonium R9, V-A55 Dinitrophenylhydrazine-sulphuric Acid
Hydroxide Solution, V-A131 Dimethylaminobenzaldehyde, see Solution, see Dinitrophenylhydrazine-
Diluted Isosorbide Dinitrate, I-1267 4-Dimethylaminobenzaldehyde sulfuric Acid Solution
Diluted Isosorbide Mononitrate, I-1269 4-Dimethylaminocinnamaldehyde, Dinonyl Phthalate, V-A58
Diluted Potassium Clavulanate, II-625 V-A55 Dinoprost Trometamol, I-769
Dilution of Creams, III-72 4-Dimethylaminocinnamaldehyde Dinoprostone, I-770, V-S44
Dilution of Ointments, III-73 Solution, V-A55 Dinoprostone Oral Solution, III-467
Dimenhydrinate, I-761, V-S43 2-(Dimethylamino)ethyl Methacrylate, Dioctadecyl Disulfide, V-A58
Dimenhydrinate Tablets, III-466 V-A55 Dioctadecyl Disulphide, see Dioctadecyl
Dimercaprol, I-763 Dimethylaminonaphthalenesulfonyl Disulfide
Dimercaprol Injection, III-467 Chloride, V-A55 Dioctadecyl 3,3-Thiodipropionate,
2,5-Dimethoxybenzaldehyde, V-A55 Dimethylaminonaphthalenesulphonyl V-A58
4,4-Dimethoxybenzophenone, V-A55 Chloride, see 2,2-Di(octadecyloxy)-5,5-spirobi(1,3,2-
3,4-Dimethoxyphenethylamine, V-A55 Dimethylaminonaphthalenesulfonyl dioxaphosphorinane, V-A58
2,2-Dimethoxypropane, V-A55 Chloride Dioctyl Sodium Sulfosuccinate, V-A58
Dimethoxypropane, see 2,2- 3-Dimethylaminophenol, V-A56 Dioctyl Sodium Sulfosuccinate VS,
Dimethoxypropane 2-(Dimethylamino)thioacetamide V-A143
N,N-Dimethylaniline, Determination of, hydrochloride, V-A56 Dioctyl Sodium Sulphosuccinate VS, see
V-294 2,4-Dimethylaniline, V-A56 Dioctyl Sodium Sulfosuccinate VS
N,N-Dimethyldodecylamine N-oxide, N,N-Dimethylaniline, Determination of, Dioctyl Sodium Sulphosuccinate, see
V-A56 V-294 Dioctyl Sodium Sulfosuccinate
N,N-Dimethyl-L-phenylalanine, V-A56 2,6-Dimethylaniline Hydrochloride, Diol Silica Gel for Chromatography,
N,N-Dimethylaniline, V-A56 V-A56 V-A115
Dimethyl Carbonate, V-A56 Dimethylaniline, see N,N-Dimethylaniline Dioscorea Oppositifolia Rhizome, IV-160
N,N-Dimethylformamide dimethylacetal, Dimethyl-b-cyclodextrin, V-A56 Diosmin, I-771
V-A56 Dimethyldecylamine, V-A56 1,4-Dioxan, V-A58
N,N-Dimethyloctylamine, V-A56 1,1-Dimethylethyl Methyl Ether, V-A56 Dioxan and Ethylene Oxide, Residual,
N,N-Dimethylpiperazine, V-A57 1,1-Dimethylethyl Methyl Ether R1, V-293
N,N-Dimethyl-p-nitrosoaniline, V-A56 V-A56 Dioxan Solution, V-A58
N,N-Dimethyl-p-phenylenediamine 1,1-Dimethylethylamine, V-A56 Dioxan Solution R1, V-A58
Dihydrochloride, V-A56 Dimethylformamide, V-A56 Dioxan Stock Solution, V-A58
page numbers in bold type relate to monograph titles Index V-A819

Dioxan, see 1,4-Dioxan Diphtheria, Tetanus, Pertussis, Disintegration Test for Tablets and
Diphenhydramine Hydrochloride, I-773, Poliomyelitis (Inactivated) and Capsules, V-346
V-S45 Haemophilus Type b Conjugate Disodium Arsenate, V-A59
Diphenhydramine Oral Solution, III-468 Vaccine (Adsorbed), see Diphtheria, Disodium Bicinchoninate, V-A59
Diphenhydramine Tablets, III-469 Tetanus, Pertussis (Whole Cell), Disodium Catechol-3,5-disulfonate,
Diphenoxylate Hydrochloride, I-774 Poliomyelitis (Inactivated) and V-A59
Diphenylamine, V-A58 Haemophilus Type b Conjugate Vaccine Disodium Catechol-3,5-disulphonate, see
Diphenylamine Solution, V-A58 (Adsorbed) Disodium Catechol-3,5-disulfonate
Diphenylamine Solution R1, V-A58 Diphtheria, Tetanus, Pertussis (Whole Disodium Edetate, I-787, V-A59
Diphenylamine Solution R2, V-A58 Cell) and Poliomyelitis (Inactivated) Disodium Edetate Eye Drops, III-476
9,10-Diphenylanthracene, V-A58 Vaccine (Adsorbed), IV-562 Disodium Edetate VS, V-A143
Diphenylanthracene, see 9,10- Diphtheria, Tetanus, Pertussis (Whole Disodium Ethanedisulfonate, V-A59
Diphenylanthracene Cell), Poliomyelitis (Inactivated) and Disodium Ethanedisulphonate, see
Diphenylboric Acid Aminoethyl Ester, Haemophilus Type b Conjugate Disodium Ethanedisulfonate
V-A58 Vaccine (Adsorbed), IV-560 Disodium Hydrogen Citrate, II-816,
1,5-Diphenylcarbazide, V-A58 Diphtheria Vaccine (Adsorbed), Assay of V-A59
Diphenylcarbazide Solution, V-A58 (2.7.6.), V-436 Disodium Hydrogen Orthophosphate,
Diphenylcarbazide, see 1,5- Diphtheria and Tetanus Toxins and V-A59
Diphenylcarbazide Toxoids (Ramon assay), V-452 Disodium Hydrogen Orthophosphate,
1,5-Diphenylcarbazone, V-A58 Diphtheria and Tetanus Vaccine, Anhydrous, V-A59
Diphenylcarbazone Mercuric Reagent, (Adsorbed), see Adsorbed Diphtheria Disodium Hydrogen Orthophosphate
V-A59 and Tetanus Vaccine Dihydrate, V-A59
Diphenylcarbazone, see 1,5- Diphtheria Vaccine, (Adsorbed), see Disodium Hydrogen Phosphate
Diphenylcarbazone Adsorbed Diphtheria Vaccine Anhydrous, I-788
2,2-Diphenylglycine, V-A59 Diphtheria Vaccine (Adsorbed, Reduced Disodium Hydrogen Phosphate,
1,2-Diphenylhydrazine, V-A59 Antigen Content), IV-536 Anhydrous, see Disodium Hydrogen
Diphenylmethanol, V-A59 Dipipanone, V-S45 Orthophosphate, Anhydrous
Diphenyloxazole, V-A59 Dipipanone and Cyclizine Tablets, Disodium Hydrogen Phosphate
Diphenylphenylene Oxide Polymer, III-470 Dihydrate, I-788
V-A59 Dipipanone Hydrochloride, I-776 Disodium Hydrogen Phosphate
Diphenylpyraline Hydrochloride, I-775, Dipivefrine Eye Drops, III-471 Dihydrate, see Disodium Hydrogen
V-S45 Dipivefrine Hydrochloride, I-771, V-S46 Orthophosphate Dihydrate
Diphtheria and Tetanus Vaccine Dipotassium Clorazepate, I-778 Disodium Hydrogen Phosphate
(Adsorbed, Reduced Antigen(s) Dipotassium Edetate, V-A59 Dodecahydrate, I-789
Content), IV-538 Dipotassium Hydrogen Orthophosphate, Disodium Hydrogen Phosphate Solution,
Diphtheria Antitoxin, IV-518 V-A59 V-A59
Diphtheria, Tetanus and Hepatitis B Dipotassium Hydrogen Phosphate, I-779 Disodium Hydrogen Phosphate, see
(rDNA) Vaccine (Adsorbed), IV-539 Dipotassium Hydrogen Phosphate Disodium Hydrogen Orthophosphate
Diphtheria, tetanus and pertussis Injection, III-471 Disodium Pamidronate, V-S46
(acellular component) vaccine Dipotassium Hydrogen Phosphate Disodium Pamidronate Intravenous
(adsorbed, reduced antigen(s) Trihydrate, V-A59 Infusion, see Pamidronate Disodium
content), IV-543 Dipotassium Phosphate see Dipotassium Intravenous Infusion
Diphtheria, Tetanus and Pertussis Hydrogen Phosphate Disodium Phosphate, Anhydrous, see
Vaccine (Adsorbed), see Diphtheria, Dipotassium Phosphate Injection, Disodium Hydrogen Phosphate,
Tetanus and Pertussis (Whole Cell) III-471 Anhydrous
Vaccine (Adsorbed) Dipotassium Sulfate, see Potassium Sulfate Disodium Phosphate, Dihydrate, see
Diphtheria, Tetanus and Pertussis Dipotassium Sulphate, see Dipotassium Disodium Hydrogen Phosphate,
(Whole Cell) Vaccine (Adsorbed), Sulfate Dihydrate
IV-540 Dipotassium ()-Tartrate, V-A59 Disodium Tetraborate, see Sodium
Diphtheria, Tetanus and Poliomyelitis Diprophylline, I-780 Tetraborate
(Inactivated) Vaccine (Adsorbed, Dip/Ser, see Diphtheria Antitoxin Disodium thiosulfate, see Sodium
Reduced Antigen(s) Content), IV-550 Dipyridamole, I-781 Thiosulfate, Anhydrous
Diphtheria, Tetanus, Pertussis (Acellular, Dipyridamole Capsules, Prolonged- Disopyramide, I-790, V-S47
Component) and Poliomyelitis release, III-472 Disopyramide Capsules, III-477
(Inactivated) Vaccine (Adsorbed, Dipyridamole Infusion, III-473 Disopyramide Phosphate, I-791
Reduced Antigen(s) Content), IV-552 Dipyridamole Oral Suspension, III-474 Disopyramide Phosphate Capsules,
Diphtheria, Tetanus, Pertussis (Acellular, Dipyridamole Tablets, III-475 III-477
Component), Hepatitis B (rDNA), 2,2-Dipyridyl, V-A59 Dispersible Aciclovir Tablets, III-99
Poliomyelitis (Inactivated) and 2,2-Dipyridylamine, V-A59 Dispersible Amoxicillin and Potassium
Haemophilus Type b Conjugate Dipyrimadole, V-S46 Clavulanate Tablets, see Dispersible
Vaccine (Adsorbed), IV-557 Dipyrone, I-783 Co-amoxiclav Tablets, III-368
Diphtheria, Tetanus, Pertussis (Acellular, Direct titrations, V-788 Dispersible Aspirin and Codeine Tablets,
Component), Poliomyelitis Dirithromycin, I-785 see Co-codaprin Tablets, Dispersible
(Inactivated) and Haemophilus Type b Disintegration, V-346 Dispersible Aspirin Tablets, III-152
Conjugate Vaccine (Adsorbed), IV-554 Disintegration of Tablets and Capsules Dispersible Benserazide Hydrochloride
Diphtheria, Tetanus, Pertussis and V-346 and Levodopa Tablets, see Dispersible
Poliomyelitis (Inactivated) Vaccine Disintegration of Tablets and Capsules Co-beneldopa Tablets
(Adsorbed), see Diphtheria, Tetanus, (2.9.1.) (5.8.), V-700 Dispersible Cellulose, I-475
Pertussis (Whole Cell) and Poliomyelitis Disintegration Test for Suppositories and Dispersible Co-amoxiclav Tablets,
(Inactivated) Vaccine (Adsorbed), Pessaries, V-349 III-368
V-A820 Index

Dispersible Co-beneldopa Tablets, Dobutamine Infusion, III-483 Dried Calcium Sulphate, see Dried
III-373 Dobutamine Intravenous Infusion, Calcium Sulfate
Dispersible Co-codaprin Tablets, III-382 III-483 Dried Epsom Salts, II-178
Dispersible Co-trimoxazole Tablets, Docetaxel Anhydrous, I-796 Dried Factor IX Fraction, IV-485
III-410 Docetaxel Trihydrate, I-798 Dried Factor VII Fraction, IV-470
Dispersible Doxycycline Tablets, III-501 Docosahexaenoic Acid Methyl Ester, Dried Factor VIIa (rDNA), IV-472
Dispersible Lamotrigine Tablets, III-733 V-A60 Dried Factor VIII Fraction, IV-478
Dispersible Paracetamol Tablets, III-950 Docusate Capsules, III-486 Dried Factor VIII (rDNA), IV-477
Dispersible Risperidone Tablets, III-1063 Docusate Enema, Compound, III-486 Dried Factor XI Fraction, IV-486
Dispersible Tablets, III-75 Docusate Oral Solution, III-487 Dried Ferrous Sulfate, I-951
Dispersible Trimethoprim and Docusate Oral Solution, Paediatric, Dried Fibrinogen, IV-488
Sulfamethoxazole Tablets, III-410 III-487 Dried Lemon Peel, IV-244
Dissolution, V-350 Docusate Sodium, I-800, V-S47, V-A60 Dried Magnesium Sulfate, II-178
Dissolution, Apparent, V-368 Docusate Sodium Capsules, Dantron Dried Magnesium Sulphate, see Dried
Dissolution, Intrinsic, V-368 and, see Co-danthrusate Capsules Magnesium Sulfate
Dissolution limits, V-649 Dodecan-1-ol, V-A60 Dried Prothrombin Complex, IV-487
Dissolution Test for Lipophilic Solid Dodecyl Gallate, I-801 Dried/Cholera, see Freeze-dried Cholera
Dosage Forms V-362 4-Dodecylresorcinol, V-A60 Vaccine
Dissolution Test for Medicated Chewing Dodecyltrimethylammonium Bromide, Droperidol, I-823, V-S49
Guns, V-363 V-A60 Droperidol Injection, III-502
Dissolution Test for Tablets and Dog Rose, IV-160 Droperidol Tablets, III-503
Capsules, Additional points for the Domiphen Bromide, I-802, V-S48, Droppers, V-A19
British Pharmacopoeia, V-357 V-A60 Drops, III-47, III-60
Dissolution Test for Transdermal Domperidone, I-802 Eye, III-47
Patches V-360 Domperidone Tablets, III-488 Nasal, III-60
Dissolution Testing of Solid Oral Dosage D-Dopa, V-A60 Drops (Nasal) and Sprays (liquid Nasal),
Forms, V-645 Dopamine Concentrate, Sterile, III-490 III-59
Dissolution Testing, Recommendations Dopamine Hydrochloride, I-806, V-S48 Drops, Oral, III-57
on, V-358 Dopamine Hydrochloride for Injection, Drospirenone, I-824
Distillation Range, Determination of, III-490 Dry Extracts, IV-48
V-242 Dopamine Infusion, III-489 Dry Residue of Extracts, V-339
Distilled Water, V-A140 Dopamine Intravenous Infusion, III-489 Drying and ignition to constant mass,
Distribution Estimation By Analytical Dopexamine Hydrochloride, I-807 I-24, II-24, III-24, IV-24, V-24
Sieving, Particle-size, V-503 Dorzolamide and Timolol Eye Drops, Drying, Determination of Loss on,
Distribution Estimation By Analytical III-492 V-309
Sieving, Particle-size, V-702 Dorzolamide Eye Drops, III-491 Drynaria Rhizome, IV-161
Disulfiram, I-792, V-S47 Dorzolamide Hydrochloride, I-809 DTaP/HepB/IPV/Hib, see Diphtheria,
Disulfiram Tablets, III-478 Dosulepin Capsules, III-494 Tetanus, Pertussis (Acellular,
Ditalimphos, V-A59 Dosulepin Hydrochloride, I-811, V-S48 Component), Hepatitis B (rDNA),
5,5-Dithiobis(2-nitrobenzoic) Acid, Dosulepin Oral Solution, III-495 Poliomyelitis (Inactivated) and
V-A60 Dosulepin Tablets, III-496 Haemophilus Type b Conjugate Vaccine
Dithioerythritol, V-A60 Dothiepin Tablets, see Dosulepin Tablets (Adsorbed)
Dithiol, V-A60 Dotriacontane, V-A60 DTaP/HepB, see Diphtheria, Tetanus,
Dithiol Reagent, V-A60 Double-strength Chloroform Water, Pertussis (Acellular Component) and
Dithiothreitol, V-A60 III-299 Hepatitis B(rDNA) Vaccine, Adsorbed
Dithizone, V-A60 Double-strength Standard 2,6- DTaP/Hib, see Diphtheria, Tetanus,
Dithizone R1, V-A60 Dichlorophenolindophenol Solution, Pertussis (Acellular Component) and
Dithizone Solution, V-A60 V-A52 Haemophilus Type b Conjugate Vaccine,
Dithizone Solution R2, V-A60 Doxapram Hydrochloride, I-812, V-S49 Adsorbed
Dithranol, I-793 Doxapram Injection, III-497 DTaP/IPV/Hib, see Diphtheria, Tetanus,
Dithranol and Salicylic Acid Ointment, Doxazosin Mesilate, I-813 Pertussis (Acellular, Component),
III-482 Doxepin Capsules, III-497 Poliomyelitis (Inactivated) and
Dithranol Cream, III-479 Doxepin Hydrochloride, I-815, V-S49 Haemophilus Type b Conjugate Vaccine
Dithranol Ointment, III-480 Doxorubicin Hydrochloride, I-817 (Adsorbed)
Dithranol Paste, III-481, V-785 Doxorubicin Hydrochloride for Injection, DTaP/IPV, see Diphtheria, Tetanus,
Divanadium Pentoxide, V-A60 III-500 Pertussis (Acellular Component) and
Divanadium Pentoxide Solution in Doxorubicin Injection, III-499 Inactivated Poliomyelitis Vaccine,
Sulfuric Acid, V-A60 Doxycycline, V-A61 Adsorbed
Divanadium Pentoxide Solution in Doxycycline Capsules, III-500 dTaP/IPV, see Diphtheria, Tetanus,
Sulphuric Acid, see Divanadium Doxycycline Hyclate, I-818 Pertussis (Acellular, Component) and
Pentoxide Solution in Sulfuric Acid Doxycycline Monohydrate, I-820 Poliomyelitis (Inactivated) Vaccine
Divinylbenzene and Vinylpyrrolidone Doxycycline Tablets, Dispersible, III-501 (Adsorbed, Reduced Antigen(s) Content)
Copolymer for Chromatography, Doxylamine Succinate, I-821 DTaP, see Diphtheria, Tetanus,and
V-A60 Dried Aluminium Hydroxide, I-117 Pertussis (Acellular Component) Vaccine,
DNA, V-628 Dried Aluminium Phosphate, I-119 (Adsorbed)
Dobutamine Concentrate, Sterile, Dried Bilberry, IV-100 DT/HepB, see Diphtheria, Tetanus and
III-483 Dried Bitter-Orange Peel, IV-304 Hepatitis B (rDNA) Vaccine
Dobutamine Hydrochloride, I-794 Dried Calcium Acetate, V-A36 DT, see Diphtheria and Tetanus Vaccine,
Dobutamine Hydrochloride for Injection, Dried Calcium Sulfate, I-389 Adsorbed
III-485
page numbers in bold type relate to monograph titles Index V-A821

dT, see Diphtheria and Tetanus Vaccine Elder Flower, IV-172 End-capped Phenylhexylsilyl Silica Gel
(Adsorbed, Reduced Antigen(s) Content) Electrolyte Reagent for the for Chromatography, V-A117
DTwP/IPV/Hib, see Diphtheria, Tetanus, Determination of Water, V-A61 End-capped Phenylsilyl Silica Gel for
Pertussis, Poliomyelitis (Inactivated) and Electrophoresis, V-205 Chromatography, V-A117
Haemophilus Type b Conjugate Vaccine Electrophoresis (2.2.31.) (5.8.), V-699 End-capped Polar-embedded
(Adsorbed) Electrophoresis, Capillary (2.2.47.) Octadecylsilyl Amorphous Organosilica
DTwP/IPV, see Diphtheria, Tetanus, (5.8.), V-699 Polymer, V-A98
Pertussis and Poliomyelitis (Inactivated) Electrophoresis, Capillary (2.2.47.), End-capped Propoxybenzene Silica Gel
Vaccine (Adsorbed) V-210 for Chromatography, V-A117
DTwP, see Adsorbed Diphtheria, Tetanus Elementary Standard Solutions for End-capped with Embedded Polar
and Pertussis Vaccine Atomic Spectometry, 1.000 g/L, Groups Octadecylsilyl Silica Gel for
Duloxetine Hydrochloride, I-826 V-A149 Chromatography, V-A116
Dusting Powders, III-68 Elements, Names, Symbols and Atomic End-capped with Polar Incorporated
Dwarf Pine Oil, IV-324 Weights of, V-629 Groups Octadecylsilyl Silica Gel for
Dydrogesterone, I-830, V-S50 Eleutherococcus, IV-174 Chromatography, V-A117
Dydrogesterone Tablets, III-504 Elixirs, III-58 End-capped with Polar Incorporated
Embonic Acid, V-A61 Groups Octylsilyl Silica Gel for
Emedastine Fumarate, I-837 Chromatography, V-A117
E Emetine Dihydrochloride, V-A61
Emetine Hydrochloride Pentahydrate,
Endoprotease LysC, V-A61
a-Endosulfan, V-A61
Ear Drops and Ear Sprays, III-44
I-839 b-Endosulphan, see b-Endosulfan
Ear Powders, III-44
Emodin, V-A61 Endotoxins, Bacterial, Guidelines for
Ear Preparations, III-43
Empty Sterile Containers of Plasticised Using the Test for (5.1.10.), V-641
Ear Preparations, Semi-solid, III-44
Poly(Vinyl Chloride) for Human Endotoxins, Test for Bacterial, V-404
Ear Sprays and Ear Drops, III-44
Blood and Blood Components, V-557 Endrin, V-A61
Ear Tampons, III-44
Emulsifying Cetostearyl Alcohol Enoxaparin Sodium, I-843
Ear Washes, III-44
(Type A), I-488 Enoxaparin Sodium Injection, III-508
Ebastine, I-832
Emulsifying Cetostearyl Alcohol Enoxolone, I-845
Echinacea Angustifolia Root, IV-162
(Type B), I-489 Entacapone, I-847
Echinacea Pallida Root, IV-164
Emulsifying Ointment, III-506 Enteric-coated Aspirin Tablets, see
Echinacea Purpurea Herb, IV-166
Emulsifying Wax, III-507 Gastro-resistant Aspirin Tablets
Echinacea Purpurea Root, IV-168
Emulsions, III-58 Enteric-coated Diclofenac Tablets, see
Echinacoside, V-A61
Oral, III-58 Gastro-resistant Diclofenac Tablets
Eclipta Herb, IV-170
Emulsions, Solutions and Suspensions, Enteric-coated Naproxen Tablets, see
Eclipta Prostrata Whole Plant, IV-171
Oral, III-57 Gastro-resistant Naproxen Tablets
Econazole, I-833
Enalapril Maleate, I-840 Enteric-coated Sodium Valproate
Econazole Cream, III-505
Enalapril Tablets, III-507 Tablets, see Gastro-resistant Sodium
Econazole Nitrate, I-834
Enalaprilat Dihydrate, I-841 Valproate Tablets
Econazole Pessaries, III-505
End-capped, Amorphous, Octadecylsilyl Enteric-coated Sulfasalazine Tablets, see
ED50, Definition of, I-30, II-30, III-30,
Organosilica Polymer for Mass Gastro-resistant Sulfasalazine Tablets
IV-30, V-30
Spectrometry, V-A98 Eosin, V-A61
Edetic Acid, I-835
End-capped Butylsilyl Silica Gel for EPBRP, I-15, II-15, III-15, IV-15,
Edotreotide, V-A61
Chromatography, V-A115 V-628, V-15
Edrophonium Chloride, I-836, V-S50
End-capped Dodecylsilyl Silica Gel for EPCRS, I-15, II-15, III-15, IV-15,
Edrophonium Injection, III-506
Chromatography, V-A115 V-628, V-15
(E,E)-Farnesol, V-A65
End-capped Extra-dense bonded Ephedra Herb, IV-176
Effective date, I-ix, I-xxii, II-vii, III-vii,
Octadecylsilyl Silica Gel for Ephedrine, I-848, V-S50
IV-vii, V-vii
Chromatography, V-A116 Ephedrine Concentrate, Sterile, III-512
Effervescent Aspirin Tablets, III-152
End-capped Hexadecylamidylsilyl Silica Ephedrine Elixir, III-510
Effervescent Calcium Gluconate Tablets,
Gel for Chromatography, V-A115 Ephedrine Hydrochloride, I-850, V-S51
III-243
End-capped Nitrile Silica Gel for Ephedrine Hydrochloride, Racemic, see
Effervescent Co-codamol Tablets,
Chromatography, V-A116 Racephedrine Hydrochloride
III-380
End-capped Octadecylsilyl Silica Gel for Ephedrine Hydrochloride Tablets,
Effervescent Granules, III-49
Chromatography, V-A116 III-513
Effervescent Paracetamol Tablets,
End-capped Octadecylsilyl Silica Gel for Ephedrine Injection, III-511
III-950
Chromatography compatible with Ephedrine Nasal Drops, III-512
Effervescent Potassium Chloride Tablets,
100% aqueous mobile phases, V-A117 Ephedrine Oral Solution, see Ephedrine
III-1004
End-capped Octadecylsilyl Silica Gel for Elixir
Effervescent Ranitidine Tablets, III-1056
Chromatography R1, V-A118 (E)-4-Phenylbut-3-en-2-one, V-A102
Effervescent Soluble Aspirin Tablets,
End-capped Octylsilyl Silica Gel for Epinastine Hydrochloride, I-851
III-152
Chromatography, V-A117 Epinephrine, I-75
Effervescent Tablets, III-75
End-capped Organosilica Polymer for Epinephrine Acid Tartrate, I-76
Efficacy of Antimicrobial Preservation,
Mass Spectrometry, Amorphous, Epinephrine (Adrenaline), V-S51
V-494, V-653
Octadecylsilyl, V-A98 Epinephrine and Cocaine Intranasal
Efficacy of Antimicrobial Preservation,
End-capped Palmitamidopropylsilyl Solution, see Adrenaline and Cocaine
Supplementary Information, V-653
Silica Gel for Chromatography, Intranasal Solution
n-Eicosane, V-A61
V-A117 Epinephrine Eye Drops, see Adrenaline
EID50, Definition of, I-30, II-30, III-30,
End-capped Phenylethyl Silica Gel for Eye Drops,
IV-30, V-30
Chromatography, V-A117 Epinephrine Injection, Bupivacaine and,
EID50, V-628
see Bupivacaine and Adrenaline Injection
V-A822 Index

Epinephrine Injection, Dilute (1 in Erythropoietin Injection, III-527 Ethanolic Sodium Hydroxide VS,
10,000), III-106 Esculetin, V-A61 V-A146
Epinephrine Injection, Lidocaine and, see Esculin, V-A61 Ethanolic Sulfuric Acid, V-A128
Lidocaine and Adrenaline Injection Esketamine Hydrochloride, I-876 Ethanols, Dilute, I-900
Epinephrine Solution/Adrenaline Esomeprazole Magnesium Trihydrate, Ethanol, see Ethanol, Absolute
Solution, III-106 I-879 Ethanol-soluble Extractive,
Epirubicin Hydrochloride, I-852 Essential Oils, IV-44, V-321 Determination of, V-332
Epirubicin Injection, III-513 Essential Oils in Herbal Drugs, Ether, I-902, V-A62
Epsom Salts, II-177 Determination of, V-333 Ether, Peroxide-free, V-A62
Epsom Salts, see Magnesium Sulfate Ester Value, V-317 Ethical Considerations, Unlicensed
Heptahydrate Esters, Reactions of, V-268 Medicines, V-781
Epsom Salts, Dried, II-178 Estimated Potency, I-14, II-14, III-14, Ethinylestradiol, I-903
Equivalence point, V-789 IV-14, V-657, V-14 Ethinylestradiol Tablets, III-539
Equivalent Texts, European 17a-Estradiol, V-A61 Ethinylestradiol Tablets, Levonorgestrel
Pharmacopoeia, V-A13 Estradiol and Norethisterone Acetate and, III-745
Ergocalciferol, I-854 Tablets, III-534 Ethion, V-A62
Ergocalciferol Injection, III-515 Estradiol and Norethisterone Tablets, Ethionamide, I-905
Ergocalciferol Tablets, III-515 III-532 Ethosuximide, I-906
Ergocalciferol Tablets, Calcium and, Estradiol Benzoate, I-881 Ethosuximide Capsules, III-540
III-236 Estradiol Hemihydrate, I-883 Ethosuximide Oral Solution, III-540
Ergocalciferol Tablets, Chewable Estradiol Injection, III-530 Ethoxychrysoidine Hydrochloride, V-A62
Calcium and, III-237 Estradiol Transdermal Patches, III-531 Ethoxychrysoidine Solution, V-A62
Ergometrine and Oxytocin Injection, Estradiol Valerate, I-884 2-Ethoxyethanol, V-A62
III-517 Estragole, V-A61 Ethoxylated Substances, Ethylene Glycol
Ergometrine Injection, III-516 Estramustine Phosphate Capsules, and Diethylene Glycol in, V-288
Ergometrine Maleate, I-856 III-536 Ethyl Acetate, I-908, V-A62
Ergometrine Tablets, III-517 Estramustine Sodium Phosphate, I-885, Ethyl Acetate, Treated, V-A62
Ergotamine Sublingual Tablets, III-518 V-S53 Ethyl Acrylate, V-A62
Ergotamine Tartrate, I-857 Estriol, I-886 Ethyl Benzoate, V-A62
Error, Fiducial Limits of, I-14, II-14, Estriol Cream, III-536 Ethyl 5-Bromovalerate, V-A62
III-14, IV-14, V-657, V-14 Estropipate, I-891, V-S53 Ethyl Cinnamate, I-909, V-S55, V-A63
Erucamide, V-A61 Estropipate Tablets, III-537 Ethyl Cyanoacetate, V-A63
Erythritol, I-859, V-A61 Etacrynic Acid, V-S54 Ethyl Formate, V-A63
Erythromycin, I-860, V-S51 Etamiphylline, V-S54 Ethyl Gallate, I-909
Erythromycin and Zinc Acetate Etamiphylline Camsilate, V-S54 Ethyl Hydroxybenzoate, I-910, V-A63
Cutaneous Solution, see Erythromycin Etamsylate, I-893 Ethyl Hydroxybenzoate Sodium, I-911
and Zinc Acetate Lotion Ethacridine Lactate Monohydrate, I-894 Ethyl Methanesulfonate, V-A63
Erythromycin and Zinc Acetate Lotion, Ethambutol Hydrochloride, I-895, V-S55 Ethyl Methanesulfonate in Active
III-526 Ethambutol Tablets, III-538 Substances, see Methyl, Ethyl and
Erythromycin Capsules, Gastro-resistant, Ethane-1,2-diol, V-A61 Isopropyl Methanesulfonate in Active
III-519 Ethanol, I-896 Substances
Erythromycin Estolate, I-863, V-S52 Ethanol (20 per cent), I-900 Ethyl Methanesulfonate in
Erythromycin Estolate Capsules, III-522 Ethanol (25 per cent), I-900 Methanesulfonic Acid, see Methyl,
Erythromycin Ethyl Succinate, I-865 Ethanol (45 per cent), I-900 Ethyl and Isopropyl Methanesulfonate in
Erythromycin Ethyl Succinate Oral Ethanol (50 per cent), I-900 Methanesulfonic Acid
Suspension, III-522 Ethanol (60 per cent), I-900 Ethyl Methyl Ketone, see Butan-2-one
Erythromycin Ethyl Succinate Tablets, Ethanol (70 per cent), I-900 Ethyl Oleate, I-913
III-523 Ethanol (80 per cent), I-900 Ethyl Parahydroxybenzoate, V-A63
Erythromycin Ethylsuccinate, V-S52 Ethanol (90 per cent), I-900 4-[(Ethylamino)methyl]pyridine, V-A63
Erythromycin Lactobionate, I-867, Ethanol (96%), V-A62 Ethylbenzene, V-A63
V-S52 Ethanol (96%), Aldehyde-free, V-A62 4-Ethylcatechol, V-A63
Erythromycin Lactobionate for Infusion, Ethanol (96 per cent), I-898 Ethylcellulose, I-913
III-524 Ethanol, Absolute, V-A61 Ethylene Bis[3,3-di(3-(1,1-
Erythromycin Lactobionate for Ethanol, Determination of, V-283 dimethyl)ethyl-4-
Intravenous Infusion, see Erythromycin Ethanol R1, Absolute, V-A62 hydroxyphenyl)butyrate], V-A63
Lactobionate for Infusion Ethanol R1, see Ethanol R1, Absolute Ethylene Bis[3,3-di(3-tert-butyl-4-
Erythromycin Lactobionate Infusion, Ethanolamine, I-901, V-A62 hydroxyphenyl)butyrate], V-A63
III-524 Ethanolamine Oleate Injection, III-539 Ethylene Chloride, see 1,2-Dichloroethane
Erythromycin Lactobionate Intravenous Ethanol-free Chloroform, V-A42 Ethylene Glycol and Diethylene Glycol
Infusion, see Erythromycin Lactobionate Ethanolic Aceticammonia Buffer in Ethoxylated Substances, V-288
Infusion pH 3.7, see Buffer Solution pH 3.7 Ethylene Glycol Monoethyl Ether, see
Erythromycin Stearate, I-869, V-S53 Ethanolic Hydrochloric Acid, V-A72 2-Ethoxyethanol
Erythromycin Stearate Tablets, III-525 Ethanolic Iron(III) Chloride Solution, Ethylene Glycol Monomethyl Ether,
Erythromycin Tablets, Gastro-resistant, V-A77 V-A63
III-521 Ethanolic Phosphomolybdic Acid Ethylene Glycol Monomethyl Ether, see
Erythromycin Tablets, see Gastro-resistant Solution, V-A103 2-Methoxyethanol
Erythromycin Tablets Ethanolic Potassium Hydroxide, V-A108 Ethylene Glycol Monostearate, I-914
Erythropoietin Concentrated Solution, Ethanolic Potassium Hydroxide VS, Ethylene Glycol, see Ethane-1,2-diol
I-872 V-A145 Ethylene Oxide, V-A63
Erythropoietin for Injection, III-530 Ethanolic Sodium Hydroxide, V-A122
page numbers in bold type relate to monograph titles Index V-A823

Ethylene Oxide and Dioxan, Residual, Excipients, Use of, I-11, II-11, III-11, Fatty Oils, Sterols in, V-329
V-293 IV-11, V-11 Fc function of immunoglobulin, Text
Ethylene Oxide Solution, V-A63 Expert Advisory Groups, I-xii, V-667 for, V-426
Ethylene Oxide Solution R1, V-A63 Expression of content, I-24, II-24, Felbinac, I-933, V-S57
Ethylene Oxide Solution R2, V-A63 III-24, IV-24, V-24 Felbinac Cutaneous Foam, III-547
Ethylene Oxide Solution R3, V-A63 Expression of Standards, I-5, II-5, III-5, Felbinac Gel, III-548
Ethylene Oxide Solution R4, V-A63 IV-5, V-5 Felodipine, I-934
Ethylene Oxide Solution R5, V-A63 Exsiccated Calcium Sulfate, see Dried Felodipine Tablets, Prolonged-release,
Ethylene Oxide Stock Solution, V-A63 Calcium Sulfate III-549
Ethylene Oxide Stock Solution R1, Extemporaneous Preparation, Status of, Felypressin, I-936
V-A64 I-9, II-9, III-9, IV-9, V-9 Fenbufen, I-937, V-S57, V-A65
Ethylenediamine, I-915, V-A64 Extemporaneous Preparations, V-785 Fenbufen Capsules, III-550
Ethylenediaminetetra-acetic Acid, V-A64 Extractable Volume of Parenteral Fenbufen Tablets, III-551
(Ethylenedinitrilo)tetra-acetic Acid, see Preparations, Test for, V-374 Fenchlorphos, V-A65
Ethylenediaminetetra-acetic Acid Extractable Volume of Parenteral Fenchone, V-A65
2-Ethylhexane-1,3-diol, V-A64 Preparations, Test for (2.9.17.) (5.8.), Fennel, Bitter, see Bitter Fennel
2-Ethylhexanoic Acid, V-A64 V-701 Fenofibrate, I-938
2-Ethylhexanoic Acid, Determination of, Extraction of Alkaloids, Complete, Fenoprofen, V-S57
V-295 V-335 Fenoprofen Calcium, I-940, V-S58
1,1-Ethylidenebis(tryptophan), V-A64 Extraction of Drugs, Continuous, V-334 Fenoprofen Tablets, III-552
N-Ethylmaleimide, V-A64 Extraction Resin, Strontium Selective, Fenoterol Hydrobromide, I-940
2-Ethyl-2-methylsuccinic Acid, V-A64 V-A126 Fentanyl, I-942
Ethylmorphine Hydrochloride, I-916 Extractive, Determination of Ethanol- Fentanyl Citrate, I-943
2-Ethylpyridine, V-A64 soluble, V-332 Fentanyl Injection, III-553
1-Ethylquinaldinium Iodide, V-A64 Extractive, Determination of Water- Fentanyl Injection, Bupivacaine and,
Ethylvinylbenzene-Divinylbenzene soluble, V-332 III-221
Copolymer, V-A64 Extracts, Dry, IV-48 Fenticonazole Nitrate, I-945
Ethylvinylbenzene-Divinylbenzene Extracts, Dry Residue of, V-339 Fenugreek, IV-186
Copolymer R1, V-A64 Extracts, Liquid, IV-47 Fenvalerate, V-A65
Etidronate Disodium, I-917 Extracts, Loss on Drying of, V-339 0.1M Ferric Ammonium Sulfate, see
Etidronate Sodium, V-S55 Extracts, Soft, IV-48 Ammonium Iron(III) Sulfate VS
Etidronate Tablets, III-540 Extraneous Agents in Viral Vaccines, Ferric Ammonium Sulfate, see
Etilefrine Hydrochloride, I-918 V-492 Ammonium Iron(III) Sulfate
Etodolac, I-919, V-S56 Extraneous Agents in Viral Vaccines, Ferric Ammonium Sulfate Solution R1,
Etodolac Capsules, III-541 Tests for, V-658 see Ammonium Iron(III) Sulfate Solution
Etodolac Tablets, III-543 Eye, III-47 R1
Etofenamate, I-921 Drops, III-47 Ferric Ammonium Sulfate Solution R2,
Etomidate, I-923 Ointments, III-47 see Ammonium Iron(III) Sulfate Solution
Etoposide, I-924, V-S56 Eye Drops, III-45, V-610 R2
Etoposide Capsules, III-544 Codes for Single-dose Containers, Ferric Ammonium Sulfate Solution R5,
Etoposide Concentrate, Sterile, III-545 V-610 see Ammonium Iron(III) Sulfate Solution
Etoposide Infusion, III-545 Eye Drops, Alkaline, III-669 R5
Etoposide Intravenous Infusion, see Eye Drops, Preservative-free, V-783 Ferric Ammonium Sulfate Solution R6,
Etoposide Infusion Eye Lotions, III-45 see Ammonium Iron(III) Sulfate Solution
Etynodiol Diacetate, I-928, V-S56 Eye Ointment Basis, III-1085 R6
Eucalyptus, V-609 Eye Ointment, Simple, III-1085 Ferric Ammonium Sulphate Solution R2,
Eucalyptus Leaf, IV-177 Eye Preparations, III-45 see Ferric Ammonium Sulfate Solution
Eucalyptus Oil, IV-178 Eye Preparations of the BP, III-47 R2
Eucommia Bark, IV-179 Eye Preparations of the BP, Additional Ferric Ammonium Sulphate Solution R5,
Eugenol, I-928, V-A64 Requirements for, III-47 see Ferric Ammonium Sulfate Solution
Euglobulins, Bovine, V-A64 Eye Preparations, Semi-solid, III-46 R5
Euglobulins, Human, V-A65 Ferric Ammonium Sulphate Solution R6,
European Goldenrod, IV-208 see Ferric Ammonium Sulfate Solution
European Pharmacopoeia, I-3, I-xxiv,
II-3, III-3, IV-3, V-3
F R6
Ferric Ammonium Sulphate, see Ferric
Factor IX (rDNA) Concentrated
European Pharmacopoeia Commission, Ammonium Sulfate
Solution, IV-479
Membership of the, V-676 Ferric Chloride, Anhydrous, see Iron(III)
Factor VII-deficient Plasma, V-A104
European Pharmacopoeia Equivalent Chloride, Anhydrous
Factor VIII fraction, Assay of, V-418
Texts, V-A13 Ferric Chloride Hexahydrate, I-948
Factor Xa Solution, Bovine, V-A34
European Pharmacopoeia General Ferric Chloride Solution, Ethanolic, see
Factor Xa Solution R1, Bovine, V-A34
Methods, V-A13 Iron(III) Chloride Solution, Ethanolic
Factor IX fraction, Assay of, V-419
European Pharmacopoeia, General Ferric Chloride Solution R3, V-A65
Famotidine, I-930
Notices of the, I-20, II-20, III-20, Ferric Chloride Solution, Radiolabelled
Famotidine Tablets, III-546
IV-20, V-20 [59Fe], V-A66
Farmed Cod-liver Oil, I-619
European Pharmacopoeia, Ferric Chloride Solution, Radiolabelled
Farmed Salmon Oil, II-787
Supplementary Chapter IV, V-676 [59Fe], Concentrated, V-A66
Fast Blue B Salt, V-A65
European Viper Venom Antiserum, Ferric Chloride Solution R1, see Iron(III)
Fast Red B Salt, V-A65
IV-519 Chloride Solution R1
Fatty Oils and Resinified Essential Oils
Excipients, Functionality-related Ferric Chloride Solution R2, see Iron(III)
in Essential Oils, V-321
Characteristics of (5.15.), V-773 Chloride Solution R2
V-A824 Index

Ferric Chloride Solution, see Iron(III) Filters, Sieves and, V-501 Fluocortolone Hexanoate, I-986, V-S61
Chloride Solution Finasteride, I-958 Fluocortolone Pivalate, I-988
Ferric Chloride, see Iron(III) Chloride Finasteride Tablets, III-559 Fluoranthene, V-A66
Hexahydrate FIP, V-628 Fluorene, V-A66
Ferric Chloride-Sulfamic Acid Reagent, Fish Oil, Rich in Omega-3-Acids, I-959 9-Fluorenone, V-A66
see Iron(III) Chloride-sulfamic Acid Fixed Oils, V-322 Fluorenone Solution, V-A66
Reagent Fixing Solution, V-A66 (9-Fluorenyl)methyl Chloroformate,
Ferric Chloride-Sulphamic Acid Reagent, Fixing Solution for Isoelectric Focusing V-A66
see Ferric Chloride-Sulfamic Acid in Polyacrylamide Gel, V-A66 Fluoren-9-ylmethyl chloromethanoate
Reagent Flavoxate Hydrochloride, I-961, V-S58 See (9-Fluorenyl)methyl
Ferric Nitrate, see Iron(III) Nitrate Flavoxate Tablets, III-561 Chloroformate, V-A66
Ferric Sulfate Pentahydrate, see Iron(III) Flecainide Acetate, I-963, V-S59 Fluorescamine, V-A66
Sulfate Pentahydrate Flecainide Injection, III-561 Fluorescein, I-989, V-A66
Ferric Sulfate, see Iron(III) Sulfate Flecainide Tablets, III-562 Fluorescein Eye Drops, III-571
Ferric Sulphate, see Ferric Sulfate Flocculation value (Lf) of diphtheria and Fluorescein Injection, III-572
Ferricyanide Standard Solution (50 ppm tetanus toxins and toxoids (Ramon Fluorescein Sodium, I-991, V-S61,
Fe(CN)6), V-A149 assay), V-A448 V-A66
Ferrocyanide Standard Solution Fleeceflower Root, IV-188 Fluorescein, Soluble see Fluorescein
(100 ppm Fe(CN)6), V-A149 Flexible Collodion, III-400 Sodium
Ferrocyphen, V-A66 Flow Cytometry, V-185 Fluorescein-conjugated Rabies
Ferrocyphen Solution, V-A66 Flowability, V-507 Antiserum, V-A112
Ferrocyphene, see Ferrocyphen Flu(adj), see Inactivated Influenza Vaccine Fluorescence Spectrophotometry, V-179
Ferroin Solution, V-A66 (Surface Antigen) Fluoride (18F) Solution for
Ferroin, see Ferroin solution Flu(adj), see Influenza Vaccine (Surface Radiolabelling, IV-681
0.1M Ferrous Ammonium Sulfate, see Antigen, Inactivated, Prepared in Cell Fluoride Standard Solution (1 ppm F),
Ammonium Iron(II) Sulfate VS Cultures) V-A149
Ferrous Ammonium Sulfate, see Flu(adj), see Influenza Vaccine (Whole Fluoride Standard Solution (10 ppm F),
Ammonium Iron(II) Sulfate Virion, Inactivated, Prepared in Cell V-A149
Ferrous Ammonium Sulphate, see Ferrous Cultures) Fluorimetry, V-179
Ammonium Sulfate Flubendazole, I-964 2-Fluoro-2-deoxy-D-glucose, V-A66
Ferrous Fumarate, I-948 Flucloxacillin and Ampicillin Capsules, 2-Fluoro-2-deoxy-D-mannose, V-A66
Ferrous Fumarate and Folic Acid see Co-fluampicil Capsules 1-Fluoro-2,4-dinitrobenzene, V-A66
Tablets, III-556 Flucloxacillin and Ampicillin Oral Fluorodinitrobenzene, see 1-Fluoro-2,4-
Ferrous Fumarate Capsules, III-554 Suspension, see Co-fluampicil Oral dinitrobenzene
Ferrous Fumarate Oral Suspension, Suspension Fluorodopa (18F) Injection, IV-682
III-554 Flucloxacillin Capsules, III-563 Fluorodopa (18F) (Prepared by
Ferrous Fumarate Tablets, III-555 Flucloxacillin Injection, III-564 Electrophilic Substitution) Injection,
Ferrous Gluconate, I-950 Flucloxacillin Magnesium, V-S59 see Fluorodopa (18F) Injection
Ferrous Gluconate Tablets, III-557 Flucloxacillin Magnesium Octahydrate, DL-6-Fluorodopa Hydrochloride, V-A66
Ferrous Sulfate Heptahydrate, I-952 I-965 6-Fluorolevodopa Hydrochloride, V-A67
Ferrous Sulfate Oral Solution, Paediatric, Flucloxacillin Oral Solution, III-564 Fluorometholone, V-S61
III-557 Flucloxacillin Oral Suspension, III-565 Fluorometholone, I-992
Ferrous Sulfate Solution R2, see Iron(II) Flucloxacillin Sodium, I-967, V-S59 Fluorometholone Eye Drops, III-573
Sulfate Solution R2 Flucloxacillin Sodium for Injection, Fluoromisonidazole, V-A67
Ferrous Sulfate Tablets, III-557 III-564 Fluoromisonidazole (18F) Injection,
Ferrous Sulfate Tablets, Prolonged- Fluconazole, I-969 IV-684
release, III-558 Flucytosine, I-971, V-S60 1-Fluoro-2-nitro-4-
Ferrous Sulfate, see Iron(II) Sulfate Flucytosine Tablets, III-566 trifluoromethylbenzene, V-A67
Ferrous Sulphate Solution R2, see Ferrous Fludarabine Phosphate, I-973 Fluorouracil, I-993, V-S62
Sulfate Solution R2 Fludeoxyglucose (18F) Injection, IV-677 Fluorouracil Cream, III-574
Ferrous Sulphate Tablets, see Ferrous Fludrocortisone Acetate, I-975 Fluorouracil Injection, III-575
Sulfate Tablets Fludrocortisone Tablets, III-566 Fluoxetine, V-S62
Ferrous Sulphate, see Ferrous Sulfate Flufenamic Acid, V-A66 Fluoxetine Capsules, III-575
Ferrum Metallicum for Homoeopathic Flumazenil, I-977, V-A66 Fluoxetine Hydrochloride, I-995, V-S62
Preparations, see Iron for Homoeopathic Flumazenil (N-[11C]methyl) Injection, Fluoxetine Oral Solution, III-577
Preparations IV-680 Flupentixol Decanoate, I-997, V-S63
Ferulic Acid, V-A66 Flumequine, I-978 Flupentixol Dihydrochloride see
Feverfew, IV-186 Flumetasone Pivalate, I-979 Flupentixol Hydrochloride
Fexofenadine Hydrochloride, I-953, Flunarizine Dihydrochloride, I-981 Flupentixol Hydrochloride, I-998
V-S58 Flunitrazepam, I-982, V-A66 Flupentixol Injection, III-578
Fexofenadine Tablets, III-558 Fluocinolone Acetonide Dihydrate, Fluphenazine Decanoate, I-994
Fibrin Blue, V-A66 V-S60 Fluphenazine Decanoate Injection,
Fibrin Congo Red, see Congo Red Fibrin Fluocinolone Acetonide, I-983 III-579
Fibrin Sealant Kit, IV-489 Fluocinolone Acetonide Dihydrate, I-984 Fluphenazine Dihydrochloride see
Fibrinogen, V-A66 Fluocinolone Cream, III-567 Fluphenazine Hydrochloride
Fiducial Limits of Error, I-14, II-14, Fluocinolone Ointment, III-568 Fluphenazine Enantate, I-1001
III-14, IV-14, V-657, V-14 Fluocinonide, I-985, V-S60 Fluphenazine Hydrochloride, I-1003
Fig, IV-188 Fluocinonide Cream, III-569 Fluphenazine Tablets, III-579
Filgrastim Concentrated Solution, I-955 Fluocinonide Ointment, III-569 Flurazepam Capsules, III-580
Films, Orodispersible, III-63 Fluocortolone Cream, III-570
page numbers in bold type relate to monograph titles Index V-A825

Flurazepam Monohydrochloride, I-1005, Formulated Preparations, I-37, III-37, Furfuraldehyde, V-A68


V-S63 IV-37 Furosemide, I-1048
Flurbiprofen, I-1006, V-S63 General Monographs, I-37, III-37, Furosemide Injection, III-598
Flurbiprofen Eye Drops, III-581 IV-37 Furosemide Tablets, III-599
Flurbiprofen Sodium, I-1007, V-S64 Formulated Preparations, Consistency of, Furosemide Tablets, Amiloride and, see
Flurbiprofen Suppositories, III-582 V-371 Co-amilofruse Tablets
Flurbiprofen Tablets, III-582 Formulated Preparations, General Fusidic Acid, I-1050, V-S66
Flu, see Inactivated Influenza Vaccine Monographs for, I-3, I-5, II-3, II-5, Fusidic Acid Cream, III-600
(Surface Antigen) III-3, III-5, IV-3, IV-5, V-3, V-5 Fusidic Acid Eye Drops, III-601
Flu, see Inactivated Influenza Vaccine Formulated Preparations, Manufacture Fusidic Acid Oral Suspension, III-602
(Whole Virion) of, I-9, II-9, III-9, IV-9, V-9
Flu, see Influenza Vaccine (Surface Foscarnet Infusion, III-594
Antigen, Inactivated, Prepared in Cell
Cultures)
Foscarnet Intravenous Infusion, see
Foscarnet Infusion, III-594
G
Gabapentin, I-1053
Flu, see Influenza Vaccine (Surface Foscarnet Sodium, I-1034, V-S65
Galactose, I-1054, V-A68
Antigen, Inactivated, Virosome) Foscarnet Sodium Hexahydrate see
Galactose, see D-Galactose
Flu, see Influenza Vaccine (Whole Virion, Foscarnet Sodium
Galantamine Hydrobromide, I-1055
Inactivated, Prepared in Cell Cultures) Fosfestrol Injection, III-595
Gallic Acid, V-A68
Fluspirilene, I-1008 Fosfestrol Sodium, I-1035, V-S65
Gallium (67Ga) Citrate Injection, IV-686
Flutamide, I-1009 Fosfestrol Tablets, III-596
Gallium (68Ga) Chloride Solution,
Fluticasone Cream, III-583 Fosfomycin Calcium, I-1037
V-A68
Fluticasone Inhalation Powder, III-587 Fosfomycin Sodium, I-1038
Gallium (68Ga) Chloride Solution for
Fluticasone Inhalation Powder, pre- Fosfomycin Trometamol, I-1039
Radiolabelling, IV-687
dispensed, III-588 Fosinopril, V-S65
Gallium (68Ga) Edotreotide Injection,
Fluticasone Nasal Drops, III-584 Fosinopril Sodium, I-1040
IV-688
Fluticasone Nasal Spray, III-585 Fosinopril Tablets, III-597
Ganciclovir, I-1058
Fluticasone Ointment, III-586 Fractionated Palm Kernel Oil, II-488
Gargles, III-61
Fluticasone powder for Inhalation, Framycetin Sulfate, I-1043
Garlic for Homoeopathic Preparations,
metered-dose powder inhaler, see Framycetin Sulphate see Framycetin
see Allium Sativum for Homoeopathic
Fluticasone Inhalation Powder Sulfate
Preparations
Fluticasone Powder for Inhalation, pre- Frangula Bark, IV-189
Garlic Powder, IV-195
metered units, see Fluticasone Inhalation Frangula Bark Dry Extract,
Gas Adsorption, Specific Surface Area
Powder, pre-dispensed Standardised, see Standardised Frangula
by, V-515
Fluticasone Pressurised Inhalation, Bark Dry Extract
Gas Chromatography, V-198
III-589 Fraxinus Rhynchophylla Bark, IV-192
Gas Detector Tubes, V-312
Fluticasone Propionate, I-1010, V-S64 Free Formaldehyde, V-464
Gas-gangrene Antitoxin (Novyi), IV-520
Flutrimazole, I-1013 Freezing Point, Determination of, V-242
Gas-gangrene Antitoxin (Oedermatiens),
Fluvastatin Sodium, I-1014 Fresh Bilberry, IV-100
see Gas-gangrene Antitoxin (Novyi)
Fluvoxamine Maleate, I-1016, V-S64 Freshly Prepared, Definition of, I-10,
Gas-gangrene Antitoxin (Perfringens),
Fluvoxamine Tablets, III-590 II-10, III-10, IV-10, V-10
IV-521
Flux-calcined Diatomaceous Filter-aid, Friability, V-510
Gas-gangrene Antitoxin (Septicum),
Washed, V-A51 Friability of Granules and Spheroids,
IV-522
Foams, Cutaneous, III-43 V-511
Gas/Ser, see Mixed Gas-gangrene Antitoxin
Foams, Rectal, III-70 Friability of Uncoated Tablets, V-510
Gastric Juice, Artificial, V-A68
Foams, Vaginal, III-81 Friars Balsam, IV-98
Gastro-resistant Aspirin Tablets, III-153
Foeniculum Vulgare, V-609 Fructose, I-1045, V-A67
Gastro-resistant Bisacodyl Tablets,
Folic Acid, I-1018, V-A67 Fructose Infusion, III-598
III-199
Folic Acid Injection, III-592 Fructose Intravenous Infusion, see
Gastro-resistant Diclofenac Tablets,
Folic Acid Tablets, III-593 Fructose Infusion
III-454
Folic Acid Tablets, Ferrous Fumarate Fructose, see D-Fructose
Gastro-resistant Erythromycin Capsules,
and, III-556 Frusemide Injection, see Furosemide
III-519
Follitropin, I-1020 Injection
Gastro-resistant Erythromycin Tablets,
Follitropin Concentrated Solution, Frusemide Tablets, see Furosemide Tablets
III-521
I-1025 Fuchsin, Basic, V-A67
Gastro-resistant Granules, III-49
Foreign Esters in Essential Oils, V-321 Fuchsin Solution, Basic, V-A67
Gastro-resistant Lansoprazole Capsules,
Foreign Matter, V-333 Fuchsin Solution, Decolorised, V-A67
III-735
Formaldehyde, see Formaldehyde Solution Fuchsin Solution R1, Decolorised,
Gastro-resistant Lansoprazole Tablets,
Formaldehyde Solution, I-1031, V-A67 V-A67
III-736
Formaldehyde Solution (35 per cent) see L-Fucose, V-A67
Gastro-resistant Mesalazine Tablets,
Formaldehyde Solution Fucose, see L-Fucose
III-805
Formaldehyde Standard Solution (5 ppm Fulvestrant, I-1046
Gastro-resistant Naproxen Tablets,
CH2O), V-A149 Fumaric Acid, V-S66, V-A67
III-879
Formalin see Formaldehyde Solution Fuming Nitric Acid, V-A94
Gastro-resistant Omeprazole Capsules,
Formamide, V-A67 Fumitory, IV-193
III-913
Formamide R1, V-A67 Functionality-Related Characteristics of
Gastro-resistant Omeprazole Tablets,
Formamide, Treated, V-A67 Excipients, I-29, II-29, III-29, IV-29,
III-917
Formic Acid, V-A67 V-29
Gastro-resistant Pancreatin Tablets,
Formic Acid, Anhydrous, V-A67 Functionality-related Characteristics of
III-942
Formononetin, V-A67 Excipients, V-773
Formoterol Fumarate Dihydrate, I-1032 Furazolidone, I-1048, V-S66
V-A826 Index

Gastro-resistant Peppermint Oil Gingival Solutions, III-62 Glutamyl endopeptidase for peptide
Capsules, IV-321 Ginkgo Leaf, IV-199 mapping, V-A69
Gastro-resistant Prednisolone Tablets, Ginseng, IV-203 L-g-Glutamyl-L-cysteine, V-A69
III-1015 Ginseng Dry Extract, IV-205 Glutaraldehyde, V-A69
Gastro-resistant Sodium Valproate Ginsenoside Rb1, V-A68 Glutaraldehyde Solution, III-618
Tablets, III-1109 Ginsenoside Re, V-A68 Glutaraldehyde Solution, Strong, I-1086
Gastro-resistant Sulfasalazine Tablets, Ginsenoside Rf, V-A68 Glutaric Acid, V-A69
III-1120 Ginsenoside Rg1, V-A68 Glutathione, I-1087
Gastro-resistant Tablets, III-75 Ginsenoside Rg2, V-A68 L-Glutathione, Oxidised, V-A69
GC Concentrical Column, V-A68 Gitoxin, V-A68 Glycan Analysis of Glycoproteins, V-228
Gees Linctus, IV-373 Glacial Acetic Acid, I-55, V-A20 Glycerin, see Glycerol
Gelatin, I-1060, V-A68 Glass Containers for Pharmaceutical Glycerin Suppositories, III-619
Gelatin, Hydrolysed, V-A68 Use, V-548 Glycerol, I-1089, V-A69
Gels, Texture Analysis of Semi-Solids or, Glassware, Requirements for, I-6, II-6, Glycerol (85%), V-A69
V-510 III-6, IV-6, V-6 Glycerol (85 per cent), I-1090
Gels, III-71, III-72 Glibenclamide, I-1069 Glycerol (85 per cent) R1, V-A69
Gels for Injections, III-66 Glibenclamide Tablets, III-610 Glycerol 1-decanoate, V-A69
Gemcitabine Hydrochloride, I-1061 Gliclazide, I-1070, V-S67 Glycerol Dibehenate, I-1092
Gemfibrozil, I-1063, V-S67 Gliclazide Tablets, III-612 Glycerol Distearate, I-1093
Gemfibrozil Capsules, III-603 Glimepiride, I-1072, V-S67 Glycerol Eye Drops, III-618
Gemfibrozil Tablets, III-604 Glimepiride Tablets, III-613 Glycerol Formal, I-1094
Gene Transfer Medicinal Products for Glipizide, I-1074, V-S68 Glycerol Injection, Phenol and, III-978
Human Use, V-760 Glipizide Tablets, III-614 Glycerol Monocaprylate, I-1095
General Chapters, V-A13 Gliquidone, I-1077, V-S68 Glycerol Monocaprylocaprate, I-1096
General Chapters of the European Gliquidone Tablets, III-615 Glycerol Monolinoleate, I-1097
Pharmacopoeia, V-25 Glossary, III-39 Glycerol Mono-oleate, I-1098
General Methods of the European Glucagon for Injection, Human, III-616 Glycerol Monostearate 40-55, I-1099
Pharmacopoeia, V-A13 Glucagon, Human, I-1071 Glycerol 1-octanoate, V-A69
General Monograph for Unlicensed Glucosamine Hydrochloride, I-1079, Glycerol R1, V-A69
Medicines, III-78 V-A68 Glycerol Suppositories, III-619
General monographs, I-21, II-21, III-21, Glucosamine Sulfate Sodium Chloride, Glyceryl Monostearate, Self-emulsifying,
IV-21, V-21 I-1080 I-1100
General Monographs for Formulated Glucose, I-1081, V-A68 Glyceryl Trinitrate Ointment, III-619
Preparations, I-3, I-5, II-3, II-5, III-3, Glucose, Anhydrous, I-1077 Glyceryl Trinitrate Solution, I-1100
III-5, IV-3, IV-5, V-3, V-5 Glucose Infusion, III-617 Glyceryl Trinitrate Sublingual Spray,
General Notices, I-1, I-xxii, II-1, III-1, Glucose Infusion, Potassium Chloride III-620
IV-1, V-1 and, see Potassium Chloride and Glucose Glyceryl Trinitrate Sublingual Tablets,
General Notices of the European Infusion see Glyceryl Trinitrate Tablets
Pharmacopoeia, I-20, II-20, III-20, Glucose Infusion, Potassium Chloride, Glyceryl Trinitrate Tablets, III-621
IV-20, V-20 Sodium Chloride and, see Potassium Glyceryl Trinitrate Transdermal Patches,
General Notices, Part III, I-xxii Chloride, Sodium Chloride and Glucose III-622
General Statements of the European Infusion Glycidol, V-A69
Pharmacopoeia, V-20 Glucose Infusion, Sodium Chloride and, Glycine, I-1102, V-S68, V-A69
Gentamicin and Hydrocortisone Acetate see Sodium Chloride and Glucose Infusion Glycine Buffer pH 2.9, V-A155
Ear Drops, III-609 Glucose Injection, Bupivacaine and, Glycine Buffer pH 11.3, V-A155
Gentamicin Cream, III-605 III-218 Glycine Buffer Solution, V-A155
Gentamicin Ear Drops, III-606 Glucose Intravenous Infusion, Potassium Glycine Irrigation Solution, III-623
Gentamicin Eye Drops, III-606 Chloride and, see Potassium Chloride Glycollic Acid, V-A69
Gentamicin Injection, III-607 and Glucose Infusion Glycopyrronium Bromide, I-1103
Gentamicin Ointment, III-608 Glucose Intravenous Infusion, Potassium Glycopyrronium Bromide Oral Solution,
Gentamicin Sulfate, I-1064 Chloride, Sodium Chloride and, see III-624
Gentian, IV-196 Potassium Chloride, Sodium Chloride and Glycyrrhetic Acid, see Glycyrrhetinic Acid
Gentian Infusion, Compound, IV-197 Glucose Infusion Glycyrrhetinic Acid, V-A69
Gentian Infusion, Concentrated Glucose Intravenous Infusion, Sodium Glyoxal Bis(2-hydroxyanil), V-A69
Compound, IV-197 Chloride and, see Sodium Chloride and Glyoxal Sodium Bisulfite, V-A69
Gentian Mixture, Acid, IV-197 Glucose Infusion Glyoxal Sodium Bisulphite, see Glyoxal
Gentian Mixture, Alkaline, IV-198 Glucose Intravenous Infusion, see Glucose Sodium Bisulphite
Gentian Oral Solution, Acid, IV-197 Infusion Glyoxal Solution, V-A69
Gentian Oral Solution, Alkaline, IV-198 Glucose Irrigation Solution, III-617 Glyoxal Standard Solution (2 ppm
Gentian Root, see Gentian Glucose, Liquid, I-1078 C2H2O2), V-A150
Gentian Tincture, IV-197 Glucose, Monohydrate see Glucose Glyoxal Standard Solution (20 ppm
Geraniol, V-A68 D-Glucose Monohydrate, V-A68 C2H2O2), V-A150
Geranyl Acetate, V-A68 Glucose, Sodium Chloride and Sodium Glyoxalhydroxyanil, see Glyoxal
Germanium Standard Solution (100 ppm Citrate Oral Solution, Compound, Bis(2-hydroxyanil)
Ge), V-A149 III-617 Goldenrod, IV-207
Gestodene, I-1066 Glucose Spray-dried Liquid, I-1085 Goldenseal Root, IV-210
Ginger, IV-198 Glucose Standard Solution, V-A150 Gonadorelin Acetate, I-1105
Ginger Essence, IV-199 Glucose, see D-Glucose Gonadotrophin, Chorionic, V-A69
Ginger Tincture, Strong, IV-199 D-Glucuronic Acid, V-A68 Gonadotrophin, Serum, V-A70
Ginger Tincture, Weak, IV-199 Glutamic Acid, I-1085, V-A69 Goserelin, I-1107
page numbers in bold type relate to monograph titles Index V-A827

Goserelin Implants, III-624 Haloperidol Oral Solution, III-639 HepA/Typhoid, see Hepatitis A
Grade of materials, I-21, II-21, III-21, Haloperidol Oral Solution, Strong, (Inactivated, Adsorbed) and Typhoid
IV-21, V-21 III-640 Polysacchatide Vaccine
Graduated Glassware, Requirements for, Haloperidol Tablets, III-640 HepB, see Hepatitis B Vaccine (rDNA)
I-6, II-6, III-6, IV-6, V-6 Halothane, I-1125 Heptachlor, V-A70
Granules, Friability of, V-513 Hamamelis Leaf, IV-211 Heptachlor Epoxide, V-A70
Gramicidin, I-1109 Hard Fat, I-932 Heptafluorobutyric Acid, V-A70
Granisetron Hydrochloride, I-1110 Hard Paraffin, II-499 Heptafluorobutyric Anhydride, V-A70
Granules and Powders for Oral Solutions Harmonisation, Pharmacopoeial, V-699 Heptafluoro-N-methyl-N-
and Suspensions, III-57 Harmonised dissolution limits, V-649 (trimethylsilyl)butanamide, V-A70
Granules and Powders for Syrups, III-58 Harpagophytum, see Devils Claw Root Heptaminol Hydrochloride, I-1135
Granules, Coated, III-49 Harpagoside, V-A70 Heptane, V-A71
Granules, Effervescent, III-49 Hartmanns Solution for Injection, 2-Heptylamine, V-A71
Granules, Gastro-resistant, III-49 III-1102 Herbal and Complementary Medicines,
Granules, Modified-release, III-49 Hawthorn Berries, IV-212 Crude Drugs; Traditional, Status of,
Graphic Formula, Status of, I-4, II-4, Hawthorn Leaf and Flower, IV-214 I-17, II-17, III-17, IV-17, V-17
III-4, IV-4, V-4 Hawthorn Leaf and Flower Dry Extract, Herbal Drug Preparations, IV-44
Graphitised Carbon for IV-215 Herbal Drugs, IV-43
Chromatography, V-A38 Heavy Bismuth Subnitrate, I-300 Herbal Drugs, Aristolochic Acids I and
Greater Burnet Root, IV-117 Heavy Kaolin, II-45 II in, Test for, V-339, V-341
Greater Celandine, IV-134 Heavy Magnesium Carbonate, II-162 Herbal Drugs, Determination of
Griseofulvin, I-1112, V-S69 Heavy Magnesium Carbonate and Mycotoxins in, V-341
Griseofulvin Tablets, III-628 Calcium Carbonate Tablets, Herbal Drugs for Homoeopathic
Guaiacol, I-1113, V-A70 Chewable, III-238 Preparations, IV-414
Guaiacum Resin, V-A70 Heavy Magnesium Oxide, II-171, V-A82 Herbal Drugs, Microscopic Examination
Guaiazulene, V-A70 Heavy Metal-free Nitric Acid, V-A94 of, V-345
Guaifenesin, I-1115 Heavy Metal-free Sulfuric Acid, V-A128 Herbal Drugs, Processed, see Processed
Guaiphenesin, V-A70 Hedera Helix for Homoeopathic Herbal Drugs
Guanethidine Monosulfate, I-1116 Preparations, IV-442 Herbal drugs- sampling and sample
Guanethidine Monosulphate see Hederacoside C, V-A70 preparation, V-344
Guanethidine Monosulfate Hederagenin, V-A70 Herbal Medicinal Products for Oral Use,
Guanethidine Tablets, III-629 a-Hederin, V-A70 Microbiological Examination of,
Guanidine Hydrochloride, V-A70 Helium, I-1127, V-A70 V-497
Guanidine- Helium for Chromatography, V-A70 Herbal Medicinal Products for Oral Use,
tris(hydroxymethyl)aminomethane- Helium for Chromatography, see Helium Microbiological Quality of, V-500
EDTA buffer solution pH 8.5, Heparin, V-A70 Herbal Medicines, Traditional, I-xxii,
V-A155, V-A159 Heparin, Assay of, V-423 V-792
Guanine, V-A70 Heparin Calcium, I-1128 Herbal Reference Materials, see Reference
Guar, I-1117 Heparin Injection, III-641 Materials
Guar Galactomannan, I-1117 Heparin Sodium, I-1130 Herbal Teas, IV-48
Guidance, Unlicensed Medicines, V-781 Heparinase I, V-A70 Herbal Teas, Instant, see Instant Herbal
Guidelines for Using the Test for Heparinase II, V-A70 Teas
Bacterial Endotoxins, V-641 Heparinase III, V-A70 Hesperidin, V-A71
Guidelines for Using the Test for Heparins, Low-molecular-mass see Low- Hexachlorobenzene, V-A71
Sterility, V-775 molecular-weight Heparins d-Hexachlorocyclohexane, V-A71
Guinea-pigs, I-15, II-15, III-15, IV-15, Heparins, Low-molecular-weight, 1-1126 Hexachlorophene, I-1136, V-S69
V-15 HepA, see Hepatitis A Vaccine Hexachlorophene Dusting Powder,
(Inactivated, Virosome) III-642
HepA, see Inactivated Hepatitis A Vaccine Hexachlorophene Dusting Powder, Zinc
H Hepatitis A vaccine, Assay of, V-445
Hepatitis A Immunoglobulin, IV-497
and, III-642
Hexacosane, V-A71
Haemodialysis Solutions, III-630
Hepatitis A (Inactivated, Adsorbed) and Hexadecylamidylsilyl Silica Gel for
Haemofiltration and Haemodiafiltration
Typhoid Polysaccharide Vaccine, Chromatography, V-A115
Solutions, III-634
IV-573 Hexadecylamidylsilyl Silica Gel for
Haemoglobin, V-A70
Hepatitis A (Inactivated) and Hepatitis B Chromatography, End-capped,
Haemoglobin Solution, V-A70
(rDNA) Vaccine, IV-575 V-A115
Haemophilus Type b and Meningococcal
Hepatitis A Vaccine (Inactivated, Hexadimethrine Bromide, V-A71
Group C Conjugate Vaccine, IV-567
Adsorbed), see Inactivated Hepatitis A 2,2,2,6,6,6-Hexa-(1,1-dimethylethyl)-
Haemophilus Type b Conjugate Vaccine,
Vaccine 4,4,4-[2,4,6-trimethyl-1,3,5-
IV-564
Hepatitis A Vaccine (Inactivated, benzenetriyltrismethylene]-triphenol,
Halibut-liver Oil, I-1118
Virosome), IV-570 V-A71
Halibut-liver Oil Capsules, III-636
Hepatitis B Immunoglobulin, IV-498 1,1,1,3,3,3-Hexafluoropropan-2-ol,
Halofantrine Hydrochloride, I-1120
Hepatitis B Immunoglobulin for V-A71
Haloperidol, I-1121, V-S69
Intravenous Use, IV-498 Hexamethyldisilazane, V-A71
Haloperidol Capsules, III-638
Hepatitis B Vaccine (rDNA), IV-575 Hexamethylenetetramine, V-A71
Haloperidol Decanoate, I-1123
Hepatitis B Vaccine (rDNA), Assay of, Hexamidine Diisetionate see Hexamidine
Haloperidol Injection, III-639
V-446 Isetionate
Haloperidol Oral Drops, Strong, III-640
HepA/HepB see Hepatitis A (Inactivated) Hexamidine Isetionate, I-1136
Haloperidol Oral Drops, see Haloperidol
and Hepatitis B (rDNA) Vaccine Hexamine, V-A71
Oral Solution,
n-Hexane, V-A71
V-A828 Index

Hexane, Purified, V-A71 Human Coagulation Factor XI, see Dried Hydrochloric Acid, Heavy Metal-free,
Hexetidine, I-1138 Factor XI Fraction V-A72
Hexosamines in Polysaccharide Vaccines, Human Euglobulins, V-A65 Hydrochloric Acid, Lead-free, V-A73
V-467 Human Glucagon, I-1077 Hydrochloric Acid, Methanolic, V-A73
Hexylamine, V-A71 Human Glucagon for Injection, III-616 Hydrochloric Acid R1, V-A73
Hexylresorcinol, I-1139 Human Haematopoietic Progenitor Hydrochloric Acid R1, Dilute, V-A73
Hexylsilyl Silica Gel for Cells, Colony-forming Cell Assay for, Hydrochloric Acid R2, Dilute, V-A73
Chromatography, V-A115 V-459 Hydrochloric Acid, Stannated, V-A73
Hib/MenC, see Haemophilus Type b and Human Haematopoietic Stem Cells, Hydrochloric Acid VS, V-A144
Meningococcal Group C Conjugate IV-491 Hydrochloric Methanol, V-A85
Vaccine Human Insulin, I-1215 Hydrochlorothiazide, I-1151, V-S71
Hib, see Haemophilus Type b Conjugate Human Papillomavirus Vaccine (rDNA), Hydrochlorothiazide Oral Solution,
Vaccine IV-599 Amiloride and, see Co-amilozide Oral
Highly Purified Water, II-1177 Human Plasminogen, V-A105 Solution
Histamine Dihydrochloride, I-1140, Human a-1-proteinase Inhibitor, IV-499 Hydrochlorothiazide Tablets, III-645
V-A71 Human Tissue Factor Solution, V-A72 Hydrochlorothiazide Tablets, Amiloride
Histamine Phosphate, V-A71 Hyaluronate Solution, V-A72 and, see Co-amilozide Tablets
Histamine Solution, V-A71 Hyaluronidase, I-1148 Hydrochlorothiazide Tablets,
Histamine, Test for, V-410 Hyaluronidase Diluent, V-A72 Triamterene and, III-406
Histidine, I-1141, V-A71 Hyaluronidase for Injection, III-643 Hydrocodone Hydrogen Tartrate
Histidine Hydrochloride Monohydrate, Hyaluronidase Injection, III-643 Hydrate, I-1153
I-1142 Hydralazine, V-S70 Hydrocodone Hydrogen Tartrate 2.5
Histidine Monohydrochloride, V-A71 Hydralazine Hydrochloride, I-1149, Hydrate see Hydrocodone Hydrogen
HIV, V-628 V-S70 Tartrate Hydrate
Holmium Oxide, V-A71 Hydralazine Hydrochloride for Injection, Hydrocortisone, I-1155, V-A73
Holmium Perchlorate Solution, V-A71 III-643 Hydrocortisone Acetate, I-1158, V-S71,
Homatropine, V-S70 Hydralazine Injection, III-643 V-A73
Homatropine Eye Drops, III-642 Hydralazine Tablets, III-644 Hydrocortisone Acetate and Neomycin
Homatropine Hydrobromide, I-1144 Hydrastine Hydrochloride, V-A72 Ear Drops, III-654
Homatropine Methylbromide, I-1145 Hydrastis Canadensis for Homoeopathic Hydrocortisone Acetate and Neomycin
DL-Homocysteine, V-A71 Preparations, IV-443 Eye Drops, III-654
L-Homocysteine Thiolactone Hydrated Aluminium Hydroxide for Hydrocortisone Acetate and Neomycin
Hydrochloride, V-A72 Adsorption, I-116 Eye Ointment, III-655
Homoeopathic Medicines, Status of, Hydrated Dihydralazine Sulfate, I-749 Hydrocortisone Acetate Cream, III-648
I-18, II-18, III-18, IV-18, V-18 Hydrated Iron (III) Phosphate for Hydrocortisone Acetate Cream,
Homoeopathic Pillules, Impregnated, see Homoeopathic Preparations, Hydrated Miconazole and, III-841
Impregnated Homoeopathic Pillules Iron (II) and, IV-447 Hydrocortisone Acetate Ear Drops,
Homoeopathic Preparations, IV-413 Hydrated Iron(II) and Iron(III) Phosphate Gentamicin and, III-609
Homoeopathic Preparations, Materials for Homoeopathic Preparations, Hydrocortisone Acetate Injection,
for use in the Manufacture of, V-794 IV-447 III-648
Homoeopathic Use, Approved Synonyms Hydrated Iron(III) Phosphate for Hydrocortisone Acetate Ointment,
for, V-609 Homoeopathic Preparations, IV-446 III-649
Honey, I-1147 Hydrated Manganese Glycerophosphate, Hydrocortisone Acetate Oral Suspension,
Honey Bee for Homoeopathic II-187 III-650
Preparations, see Apis for Homoeopathic Hydrated Sodium Glycerophosphate, Hydrocortisone and Clioquinol Cream,
Preparations II-846 III-650
Honokiol, V-A72 Hydrated Sodium Perborate see Sodium Hydrocortisone and Clioquinol
Hop Strobile, IV-216 Perborate Ointment, III-651
Horsetail, IV-219 Hydrazine, V-A72 Hydrocortisone and Neomycin Cream,
HPV, see Human Papillomavirus Vaccine Hydrazine Hydrate, V-A72 III-652
rDNA Hydrazine Sulfate, V-A72 Hydrocortisone and Neomycin Ear
Human Albumin, V-A22 Hydrazine Sulphate, see Hydrazine Sulfate Drops, III-654
Human Albumin Coated Silica Gel for Hydrindantin, V-A72 Hydrocortisone and Neomycin Eye
Chromatography, V-A116 Hydriodic Acid, V-A72 Drops, III-654
Human Albumin Injection Iodinated Hydrobromic Acid, 30 per cent, V-A72 Hydrocortisone Cream, III-646
(125I), see Iodinated (125I) Albumin Hydrobromic Acid, 47 per cent, V-A72 Hydrocortisone Cream, Miconazole and,
Injection Hydrobromic Acid, Dilute, V-A72 III-838
Human Albumin Solution, V-A22 Hydrobromic Acid R1, Dilute, V-A72 Hydrocortisone Hydrogen Succinate,
Human Albumin Solution R1, V-A22 Hydrocarbons (Type L), Low-vapour- I-1160
Human Coagulation Factor VII, see Dried pressure, V-A72 Hydrocortisone Ointment, III-647
Factor VII Fraction Hydrochloric Acid, I-1150, V-A72 Hydrocortisone Ointment, Miconazole
Human Coagulation Factor VIIa Hydrochloric Acid, Brominated, V-A72 and, III-840
(rDNA) Concentrated Solution, Hydrochloric Acid, Concentrated see Hydrocortisone Oromucosal Tablets,
IV-472 Hydrochloric Acid III-647
Human Coagulation Factor VIII, see Hydrochloric Acid, Dilute, I-1145, Hydrocortisone Sodium Phosphate,
Dried Factor VIII Fraction V-A72 I-1162, V-S71
Human Coagulation Factor VIII Hydrochloric Acid, Dilute, Heavy Metal- Hydrocortisone Sodium Phosphate
(rDNA), see Dried Factor VIII (rDNA) free, V-A72 Injection, III-656
Human Coagulation Factor IX, see Dried Hydrochloric Acid, Ethanolic, V-A72 Hydrocortisone Sodium Phosphate Oral
Factor IX Fraction Solution, III-657
page numbers in bold type relate to monograph titles Index V-A829

Hydrocortisone Sodium Succinate, Hydroxocobalamin Acetate, I-1167 Hyoscyamine Sulphate, see Hyoscyamine
V-S72 Hydroxocobalamin Chloride, I-1168 Sulfate
Hydrocortisone Sodium Succinate for Hydroxocobalamin Injection, III-660 Hyoscyamus for Homoeopathic
Injection, III-658 Hydroxocobalamin Sulfate, I-1170 Preparations, IV-444
Hydrocortisone Sodium Succinate Hydroxocobalamin Sulphate see Hypericin, V-A74
Injection, III-658 Hydroxocobalamin Sulfate Hypericum for Homoeopathic
Hydroflumethiazide, I-1163, V-S72 4-Hydroxybenzaldehyde, V-A73 Preparations, IV-445
Hydroflumethiazide Tablets, III-659 2-Hydroxybenzimidazole, V-A73 Hyperoside, V-A74
Hydrofluoric Acid, V-A73 4-Hydroxybenzohydrazide, V-A73 Hypophosphorous Reagent, V-A74
Hydrogen, V-A73 4-Hydroxybenzoic Acid, V-A73 Hypoxanthine, V-A74
Hydrogen for Chromatography, V-A73 4-Hydroxybiphenyl, V-A73 Hypromellose, I-1188
Hydrogen Peroxide Mouthwash, III-659 Hydroxycarbamide, I-1171, V-S72 Hypromellose Eye Drops, III-669
Hydrogen Peroxide Solution, I-1164 Hydroxycarbamide Capsules, III-661 Hypromellose Phthalate, I-1190
Hydrogen Peroxide Solution Hydroxychloroquine, V-S73
(3 per cent), I-1163 Hydroxychloroquine Sulfate, I-1172
Hydrogen Peroxide Solution (6 per
cent), I-1164
Hydroxychloroquine Tablets, III-662
4-Hydroxycoumarin, V-A73
I
Ibuprofen, I-1191, V-S73
Hydrogen Peroxide Solution (10 vol), 6-Hydroxydopa, V-A73
Ibuprofen Capsules, Prolonged-release,
V-A73 Hydroxyethyl Salicylate, I-1173
III-670
Hydrogen Peroxide Solution (20 vol), Hydroxyethyl Starches, II-904
Ibuprofen Cream, III-671
V-A73 Hydroxyethylcellulose, I-1174
Ibuprofen Gel, III-672
Hydrogen Peroxide Solution (30 per Hydroxyethylmethylcellulose, I-1176
Ibuprofen Oral Suspension, III-673
cent), I-1164 2-[4-(2-Hydroxyethyl)piperazin-1-
Ibuprofen Tablets, III-674
Hydrogen Peroxide Solution (100 vol), yl]ethanesulphonic Acid, see 2-[4-
Ibuprofen Tablets, Prolonged-release,
V-A73 (2-Hydroxyethyl)piperazin-1-
III-675
Hydrogen Peroxide Solution (200 vol), yl]ethanesulfonic Acid
Iceland Moss, IV-220
V-A73 4-Hydroxyisophthalic Acid, V-A74
Ichthammol, I-1194
Hydrogen Peroxide Solution, Dilute, Hydroxyl Value, V-317
Ichthammol Cream, Zinc and, III-1230
V-A73 Hydroxylamine Hydrochloride, V-A74
ID50, Definition of, I-30, II-30, III-30,
Hydrogen Peroxide Solution, Dilute see Hydroxylamine Hydrochloride Solution
IV-30, V-30
Hydrogen Peroxide Solution (3 per cent) R2, V-A74
ID50, V-628
Hydrogen Peroxide Solution, Strong, Hydroxylamine Solution, Alcoholic,
Identification, I-12, I-27, II-12, II-27,
V-A73 V-A74
III-12, III-27, IV-12, IV-27, V-12,
Hydrogen Peroxide Standard Solution Hydroxylamine Solution, Alkaline,
V-27
(2 ppm H2O2), V-A150 V-A74
Identification of Fixed Oils By Thin-layer
Hydrogen Sulfide, V-A73 Hydroxylamine Solution R1, Alkaline,
Chromatography, V-322, V-325
Hydrogen Sulfide R1, V-A73 V-A74
Identification of Phenothiazines By Thin-
Hydrogen Sulfide Solution, V-A73 Hydroxylated Polymethacylate Gel,
Layer Chromatography, V-197
Hydrogen Sulphide R1, see Hydrogen V-A106
Identification of Steroids, V-198
Sulfide R1 Hydroxymethylfurfural, V-A74
Idoxuridine, I-1195
Hydrogen Sulphide Solution, see Hydroxynaphthol Blue Sodium Salt,
Idoxuridine Eye Drops, III-676
Hydrogen Sulfide Solution V-A74
Ifosfamide, I-1196, V-S74
Hydrogen Sulphide, see Hydrogen Sulfide 4-(4-Hydroxyphenyl)butan-2-one, V-A74
Ifosfamide for Injection, III-677
Hydrogenated Arachis Oil, I-189 Hydroxypropyl Starch, II-909
Ifosfamide Injection, III-677
Hydrogenated Castor Oil, I-426 Hydroxypropyl Starch, Pregelatinised see
IMI, V-628
Hydrogenated Cottonseed Oil, I-650 Pregelatinised Hydroxypropyl Starch
IMI - International Mycological Institute,
Hydrogenated Peanut Oil see Hydroxypropylbetadex, I-1177
address of, I-31, II-31, III-31, IV-31,
Hydrogenated Arachis Oil 2-Hydroxypropylbetadex for
V-31
Hydrogenated Polyoxyl Castor Oil, I-428 Chromatography, V-A74
Imidazole, V-A74
Hydrogenated Soya Oil, II-893 Hydroxypropylcellulose, I-1179
Imidazole Buffer Solution pH 7.3,
Hydrogenated Soya-bean Oil see Hydroxypropyl-b-cyclodextrin, V-A74
V-A155
Hydrogenated Soya Oil 8-Hydroxyquinoline, V-A74
Imidazole Buffer Solution pH 6.5,
Hydrogenated Vegetable Oil, II-1153 12-Hydroxystearic Acid, V-A74
V-A155
Hydrogenated Vegetable Oils, Nickel in, 5-Hydroxyuracil, V-A74
Imidazole, Recrystallised, V-A74
V-299 Hydroxyurea Capsules, see
Imidazole Solution, V-A74
Hydrogenated Wool Fat, II-1189 Hydroxycarbamide Capsules
ImidazoleMercury Reagent, V-A75
Hydrolysed Gelatin, V-A68 Hydroxyzine Hydrochloride, I-1180
Iminodibenzyl, V-A75
Hydrolysed Starch, V-A126 Hydroxyzine Oral Solution, III-663
Imipenem see Imipenem Monohydrate
Hydromorphone Hydrochloride, I-1165 Hydroxyzine Tablets, III-664
Imipenem Monohydrate, I-1197
Hydrophilic Silica Gel for Hymecromone, I-1181
Imipramine Hydrochloride, I-1199
Chromatography, V-A116 Hyoscine, I-1182
Imipramine Tablets, III-678
Hydrophobic Colloidal Anhydrous Silica, Hyoscine Butylbromide, I-1183, V-S73
Immunoassays, V-653
II-807 Hyoscine Butylbromide Injection, III-667
Immunochemical Methods, V-402
Hydroquinone, V-A73 Hyoscine Butylbromide Tablets, III-668
Immunological Products, V-436
Hydroquinone Solution, V-A73 Hyoscine Eye Drops, III-665
Immunosera, IV-511
Hydrotalcite, I-1166 Hyoscine Hydrobromide, I-1185, V-A74
Immunosera (Antisera) and Vaccines,
Hydrotalcite Tablets, III-660 Hyoscine Injection, III-666
Phenol in, V-464
Hydrous Benzoyl Peroxide, I-263 Hyoscine Tablets, III-666
Immunosera for Human Use, Animal, see
Hydrous Ointment, III-660 Hyoscyamine Sulfate, I-1186, V-A74
Immunosera
Hydrous Wool Fat, II-1190
V-A830 Index

Imperatorin, V-A75 Industrial Methylated Spirits, II-248 Interferons, Assay of, V-456
Implants, III-66 Influenza Vaccine (Surface Antigen, Intermediate Precision, V-674
Implementation, Dates of, V-677 Inactivated, Prepared in Cell International Nonproprietary Names,
Implementation of pharmacopoeial Cultures), IV-585 V-659
methods, I-22, II-22, III-22, IV-22, Influenza Vaccine (Surface Antigen, International Reference Preparation,
V-22 Inactivated, Virosome), IV-587 I-14, II-14, III-14, IV-14, V-14
Impregnated Homoeopathic Pillules, Influenza Vaccine (Whole Virion, International System Of Units, I-31,
IV-426 Inactivated, Prepared in Cell II-31, III-31, IV-31, V-31
Impurities, I-29, II-29, III-29, IV-29, Cultures), IV-579 International Unit, Definition of, I-14,
V-29 Infrared Reference Spectra, I-xxiii II-14, III-14, IV-14, V-14
Impurities, Expression of Limits for, Infrared Reference Spectra, Preparation Intranasal Solutions, III-60
V-638 of, V-S2 Intranasal Suspensions, III-60
Impurities in Substances for Infrared Spectrophotometry, V-162 Intrinsic Dissolution V-368
Pharmaceutical Use, Control of, Infusions, III-50, III-65, III-66 Invert Syrup, III-1129
V-742 Infusions, III-66 Iobenguane (123I) Injection, IV-693
Impurities, Limitation of Potential, I-4, Inhalations, III-55 Iobenguane (131I) Injection for
II-4, III-4, IV-4, V-4 Pressurised, III-55 Diagnostic Use, IV-694
Impurities, Statements of, V-639 Injectable Insulin Preparations, III-684 Iobenguane (131I) Injection for
Impurity Limits, Status of, I-13, II-13, Injection volume, Liquid Therapeutic Use, IV-695
III-13, IV-13, V-13 Chromatography, V-204 Iobenguane Sulfate for
Impurity Statements, Status of, I-4, II-4, Injections, III-64, III-66 Radiopharmaceutical Preparations,
III-4, IV-4, V-4 Concentrated Solutions for, III-66 IV-663
IMS, II-248 Injections, Gels for, III-66 Iobenguane Sulphate for
IMS, see Industrial Methylated Spirit Injections or Infusions, Concentrates for, Radiopharmaceutical Preparations, see
Inactivated Hepatitis A Vaccine, IV-568 III-65 Iobenguane Sulfate for
Inactivated Influenza Vaccine (Split Injections or Infusions, Powders for, Radiopharmaceutical Preparations
Virion), IV-581 III-65 Iodic Acid, V-A75
Inactivated Influenza Vaccine (Surface INN, V-659 Iodide Standard Solution (10 ppm I),
Antigen), IV-583 Inosine, V-A75 V-A150
Inactivated Influenza Vaccine (Whole Inositol Nicotinate, I-1208, V-S75 Iodide Standard Solution (20 ppm I),
Virion), IV-577 Inositol Nicotinate Tablets, III-683 V-A150
Inactivated Poliomyelitis Vaccine, IV-611 myo-Inositol, I-1201 Iodide-free Starch Solution, V-A126
2-Indanamine hydrochloride, V-A75 Inserts, Ophthalmic, III-46 Iodides, Reactions of, V-268
Indapamide, I-1200 Instant Herbal Teas, IV-49 Iodinated (125I) Albumin Injection,
Indapamide Tablets, III-679 Insulin Aspart, I-1208 IV-668
Indian Frankincense, IV-191 Insulin Aspart Injection, III-687 Iodinated (131I) Norcholestrol Injection,
Indian Squill, IV-372 Insulin, Biphasic Isophane, III-689 see Iodomethylnorcholesterol (131I)
Indicators, V-789 Insulin, Bovine, see Bovile Insulin Injection
Indicators, Use of Chemical, I-7, II-7, Insulin Glargine, I-1213 Iodinated Potassium Iodide Solution,
III-7, IV-7, V-7 Insulin Glargine Injection, III-689 V-A108
Indigo Carmine, V-A75 Insulin, Human, see Human Insulin Iodinated Povidone, II-640
Indigo Carmine Solution, V-A75 Insulin Injection, III-687 Iodinated Zinc Chloride Solution,
Indigo Carmine Solution R1, V-A75 Insulin Injection, Biphasic, III-688 V-A141
Indinavir Sulfate, I-1202 Insulin Injection, Biphasic Isophane, Iodine, I-1232, V-A75
Indinavir Sulphate see Indinavir Sulfate III-689 Iodine-123 and Ruthenium-106 Spiking
Indium (111In) Chloride Solution, Insulin Injection, Isophane, III-689 Solution, V-A75
IV-690 Insulin Injection, Protamine Zinc, Iodine Bromide, V-A75
Indium (111In) Oxine Solution, IV-691 III-692 Iodine Bromide Solution, V-A75
Indium (111In) Pentetate Injection, Insulin Injection, Soluble, see Insulin Iodine Chloride, V-A75
IV-692 Injection Iodine Chloride Solution, V-A75
Indometacin, I-1204, V-S74, V-A75 Insulin Lispro, I-1218 Iodine Monochloride Reagent, Strong,
Indometacin Capsules, III-681 Insulin Lispro Injection, III-691 V-A75
Indometacin Suppositories, III-682 Insulin, Porcine, see Porrine Insulin Iodine Monochloride Solution, V-A75
Indoramin, V-S74 Insulin Preparations, Injectable, III-684 Iodine Oral Solution, Aqueous, III-696
Indoramin Hydrochloride, I-1206 Insulin Preparations, see Injectable Insulin Iodine, Oxygen-flask Combustion
Indoramin Tablets, III-682 Preparations Method for, V-281
Inductively Coupled Plasma-atomic Insulin Zinc Suspension, III-692 Iodine Pentoxide, Recrystallised, V-A75
Emission Spectrometry, V-175 Insulin Zinc Suspension (Amorphous), Iodine Solution, Alcoholic, III-696,
Inductively Coupled Plasma-mass III-693 V-A75
Spectrometry (2.2.58.), V-182 Insulin Zinc Suspension (Crystalline), Iodine Solution, Chloroformic, V-A76
Industrial Denatured Alcohol (Ketone- III-693 Iodine Solution R1, V-A76
free), see Industrial Methylated Spirit Interchangeable methods, I-22, II-22, Iodine Solution R2, V-A76
(Ketone-free) III-22, IV-22, V-22 Iodine Solution R3, V-A76
Industrial Denatured Alcohol, see Interferon Alfa-2 Concentrated Solution, Iodine Solution R4, V-A76
Industrial Methylated Spirit I-1223 Iodine Trichloride, V-A76
Industrial Methylated Spirit, II-248 Interferon Alfa-2a Injection, III-694 Iodine Value, V-318
Industrial Methylated Spirit (95%), Interferon Beta-1a Concentrated Iodine VS, V-A144
V-A75 Solution, I-1226 Iodipamide, V-S75
Industrial Methylated Spirit (Ketone- Interferon Gamma-1b Concentrated Iodised Oil Fluid Injection, III-696
free), II-248 Solution, I-1228 Iodixanol, I-1233
page numbers in bold type relate to monograph titles Index V-A831

Iodoacetamide, V-A76 Iron Standard Solution (0.1% Fe), Isoelectric Focusing, V-216
Iodoacetic Acid, V-A76 V-A150 Isoelectric Focusing (2.2.54.) (5.8.),
2-Iodobenzoic Acid, V-A76 Iron Standard Solution (1 ppm Fe), V-699
3-Iodobenzylammonium Chloride, V-A150 Isoelectric Focusing, Anolyte for, V-A29
V-A76 Iron Standard Solution (2 ppm Fe), Isoelectric Focusing in Polyacrylamide
Iodoethane, V-A76 V-A150 Gel, Fixing Solution for, V-A66
2-Iodohippuric Acid, V-A76 Iron Standard Solution (10 ppm Fe), Isoelectric Focusing pH 3 to 5,
Iodomethane, V-A76 V-A150 Catholyte for, V-A39
Iodomethylnorcholesterol (131I) Iron Standard Solution (20 ppm Fe), Isoflurane, I-1256
Injection, IV-696 V-A150 IsohexaneSee 2-Methylpentane, V-A89
Iodoplatinate Reagent, V-A76 Iron Standard Solution (250 ppm Fe), Isoleucine, I-1257, V-A77
Iodoplatinate Reagent R1, V-A76 V-A150 Isomalt, I-1259, V-A77
2-Iodopropane, V-A76 Iron Sucrose Injection, III-707 Isomaltitol, V-A77
Iodosulphurous Reagent, see Iodosulfurous Iron(II) and Hydrated Iron(III) Phosphate Isomenthol, V-A78
Reagent for Homoeopathic Preparations, ()-Isomenthone, V-A78
5-Iodouracil, V-A76 Hydrated, IV-447 Isometheptene, V-S76
Iofendylate Injection, III-697 Iron(II) Sulfate, V-A77 Isometheptene Mucate, I-1260
Iohexol, I-1236 Iron(II) Sulfate Solution R2, V-A77 Isomethyleugenol, V-A78
Ion-exchange Resin, Strongly Acidic, Iron(II) Sulfate VS, V-A144 Isoniazid, I-1262, V-S77, V-A78
V-A76 Iron(II) Sulfate-Citrate Solution, V-A77 Isoniazid Injection, III-710
Ion-exclusion Resin for Chromatography, Iron(II) Sulphate Solution R2, see Iron(ii) Isoniazid Oral Solution, III-710
V-A76 Sulfate Solution R2 Isoniazid Solution, V-A78
Ionic Concentration, Potentiometric Iron(II) Sulphate VS, see Iron(II) Sulfate Isoniazid Tablets, III-711
Determination of, Using Ion-selective VS Isonicotinamide, V-A78
Electrodes, V-282 Iron(II) Sulphate-Citrate Solution, see Isopentyl Benzoate, V-A78
Iopamidol, I-1240, V-S75 Iron(ii) Sulfate-Citrate Solution Isophane Insulin Injection, Biphasic,
Iopamidol Injection, III-697 Iron(II) Sulphate, see Iron(ii) Sulfate III-689
Iopamidol Oral Solution, III-699 Iron(III) Chloride, Anhydrous, V-A77 Isophane Insulin Injection, III-689
Iopanoic Acid, I-1242, V-S76 Iron(III) Chloride Hexahydrate, V-A77 Isophane Insulin, see Isophane Insulin
Iopanoic Acid Tablets, III-700 Iron(III) Chloride Solution, V-A77 Injection
Iopromide, I-1243 Iron(III) Chloride Solution, Ethanolic, Isophane Insulin (NPH), see Isophane
Iotrolan, I-1246 V-A77 Insulin Injection
Ioxaglic Acid, I-1248 Iron(III) Chloride Solution R1, V-A77 Isoprenaline Concentrate, Sterile, III-712
IP, V-628 Iron(III) Chloride Solution R2, V-A77 Isoprenaline Hydrochloride, I-1262
I.P. - Collection Nationale de Culture de Iron(III) Chloride-Sulfamic Acid Reagent, Isoprenaline Injection, III-711
Microorganismes (C.N.C.M.) Institut V-A77 Isoprenaline Sulfate, I-1264
Pasteur, address of, I-31, II-31, Iron(III) Chloride-Sulphamic Acid Isoprenaline Sulphate see Isoprenaline
III-31, IV-31, V-31 Reagent, see Iron(iii) Chloride-Sulfamic Sulfate
Ipecacuanha, IV-221 Acid Reagent Isopropyl Alcohol, I-1264
Ipecacuanha Emetic Mixture, Paediatric, Iron(III) Nitrate, V-A77 Isopropyl Iodide, V-A78
IV-225 Iron(III) Nitrate Solution, V-A77 Isopropyl Methanesulfonate, V-A78
Ipecacuanha Emetic, Paediatric, IV-225 Iron(III) Phosphate for Homoeopathic Isopropyl Methanesulfonate in Active
Ipecacuanha Liquid Extract, IV-223 Preparations, Hydrated, IV-446 Substances, see Methyl, Ethyl and
Ipecacuanha Oral Solution, Paediatric, Iron(III) Phosphate for Homoeopathic Isopropyl Methanesulfonate in Active
IV-225 Preparations, Hydrated Iron(II) and, Substances
Ipecacuanha Prepared, IV-222, see Hydrated, IV-447 Isopropyl Methanesulfonate in
Prepared Ipecacuanha Iron(III) Sulfate, V-A77 Methanesulfonic Acid, see Methyl,
Ipratropium Bromide, I-1250 Iron(III) Sulfate Pentahydrate, V-A77 Ethyl and Isopropyl Methanesulfonate in
Ipratropium Inhalation Powder, hard Iron(III) Sulphate Pentahydrate, see Methanesulfonic Acid
capsule, III-702 Iron(iii) Sulfate Pentahydrate Isopropyl Myristate, I-1265, V-A78
Ipratropium Nebuliser Solution, III-701 Iron(III) Sulphate, see Iron(iii) Sulfate Isopropyl Palmitate, I-1266
Ipratropium Powder for Inhalation, see IR, see Infrared Spectrophotometry Isopropylamine, V-A78
Ipratropium Inhalation powder, hard Irreversibility of Pertussis Toxoid, 4-Isopropylphenol, V-A78
capsule Residual Pertussis Toxin and, V-452 Isopulegol, V-A78
Ipratropium Pressurised Inhalation, Isatin, V-A77 Isoquercitroside, V-A78
III-703 Isatin Reagent, V-A77 Isosilibinin, V-A78
IPV, see Inactivated Poliomyelitis Vaccine Isatis Root, IV-225 Isosorbide Dinitrate, V-S77
Irbesartan, I-1252, V-S76 ISO, V-628 Isosorbide Dinitrate, Diluted, I-1267
Irbesartan Tablets, III-705 Isoamyl Alcohol, V-A77 Isosorbide Dinitrate Injection, III-713
Irisflorentin, V-A76 Isoamyl Benzoate, V-A77 Isosorbide Dinitrate Sublingual Tablets,
Iron, V-A76 Isoandrosterone, V-A77 III-715
Iron and Iron Salts, Reactions of, V-268 Isobutyl Acetate, V-A77 Isosorbide Dinitrate Tablets, III-714
Iron Dextran Injection, III-706 N-Isobutyldodecatetraenamide, V-A77 Isosorbide Mononitrate Capsules,
Iron for Homoeopathic Preparations, N-Isobutyldodecatetraenamide Solution, Prolonged-release, III-716
IV-446 V-A77 Isosorbide Mononitrate, Diluted, I-1269
Iron for Homoeopathic Use, see Iron for Isoconazole, I-1253 Isosorbide Mononitrate Tablets, III-718
Homoeopathic Preparations Isoconazole Nitrate, I-1254 Isosorbide Mononitrate Tablets,
Iron Salicylate Solution, V-A77 Isoconazole Pessaries, III-709 Prolonged-release, III-719
Iron Standard Solution (8 ppm Fe), Isoconazole Vaginal Tablets, III-709 Isotopically Pure Deuterium Oxide,
V-A150 Isodrin, V-A77 V-A50
V-A832 Index

Isotretinoin, I-1271 Ketoprofen Capsules, III-725 Lanthanum Trioxide, V-A79


Isotretinoin Capsules, III-720 Ketoprofen Gel, III-726 Largehead Atractylodes Rhizome, IV-83
Isotretinoin Gel, III-721 Ketorolac Trometamol, II-54 Laser Light Diffraction, Particle Size
Isoxsuprine Hydrochloride, I-1273 Ketotifen Fumarate, II-55 Analysis by, V-522
Ispaghula Husk, IV-226 Ketotifen Hydrogen Fumarate, see Lassars Paste, III-1230
Ispaghula Husk Effervescent Granules, Ketotifen Fumarate Lauric Acid, V-A79
IV-227 Kieselguhr, V-A78 Lauromacrogol 400, II-78
Ispaghula Husk Granules, IV-227 Kieselguhr G, V-A78 Lauroyl Macrogolglycerides, II-81
Ispaghula Husk Oral Powder, IV-227 Kilogram, Definition of, I-32, II-32, Lauryl Alcohol, see Dodecan-1-ol
Ispaghula Seed, IV-228 III-32, IV-32, V-32 Lavandulol, V-A79
Isradipine, I-1274, V-S77 Knotgrass, IV-234 Lavandulyl Acetate, V-A80
Isradipine Tablets, III-722 Krypton (81mKr) Inhalation Gas, IV-697 Lavender Flower, IV-238
Italic Type, Significance of, I-8, II-8, Kudzuvine Root, IV-235 Lavender Oil, IV-239
III-8, IV-8, V-8 Kudzuvine Root, Thomson, IV-236 Lavender Oil, Spike, IV-240
Itraconazole, I-1276 LCR, see Nucleic acid amplification, ligase
IU, V-628 chain reaction (LCR)
IU, Definition of, I-14, II-14, III-14,
IV-14, V-14
L LD50, Definition of, I-30, II-30, III-30,
IV-30, V-30
L/10 dose, Definition of, I-30, II-30,
IUPAC, V-628 LD50, V-628
III-30, IV-30, V-30
Ivermectin, I-1278 L dose, Definition of, I-30, II-30,
Labelled Potency, V-657
Ivy Leaf, IV-228 III-30, IV-30, V-30
Labelling, I-29, II-29, III-29, IV-29,
Lead Acetate, V-A80
V-29
Lead Acetate Cotton, V-A80
Labelling of Unlicensed Medicinal
J Products, V-782
Lead Acetate Paper, V-A80
Lead Acetate Solution, V-A80
Java Tea, IV-230 Labelling, Requirements for, I-16, II-16,
Lead and Lead Compounds, Reactions
Javanese Turmeric, IV-394 III-16, IV-16, V-16
of, V-269
Josamycin, II-39 Labetalol, V-S78
Lead Dioxide, V-A80
Josamycin Propionate, II-42 Labetalol Hydrochloride, II-57
Lead Liposoluble Standard Solution
Juniper, IV-231 Labetalol Injection, III-727
(1000 ppm Pb), V-A150
Juniper Oil, IV-232 Labetalol Tablets, III-727
Lead Nitrate, V-A80
Justified and Authorised, Definition of, Lacidipine, II-59, V-S78
Lead Nitrate Solution, V-A80
I-5, II-5, III-5, IV-5, V-5 Lacidipine Tablets, III-728
Lead Nitrate VS, V-A144
Lactates, Reactions of, V-268
Lead Standard Solution (0.1% Pb),
Lactic Acid, II-61, V-A79
V-A150
K (S)-Lactic Acid, II-61
Lactic Acid Pessaries, III-729
Lead Standard Solution (0.1% Pb) R1,
Kali Muriaticum, V-609 V-A150
Lactic Reagent, V-A79
Kalium Bichomicum for Homoeopathic Lead Standard Solution (0.1 ppm Pb),
Lactitol Monohydrate, II-62
Preparations, see Potassium Dichromate V-A150
Lactobionic Acid, II-64, V-A79
for Homoeopathic Preparations Lead Standard Solution (0.5 ppm Pb),
Lactose, II-65, V-A79
Kanamycin Acid Sulfate, II-43 V-A150
Lactose, Anhydrous, II-66
Kanamycin Acid Sulphate, see Lead Standard Solution (0.25 ppm Pb),
a-Lactose Monohydrate, V-A79
Kanamycin Acid Sulfate V-A150
Lactulose, II-68
Kanamycin Monosulfate, see Kanamycin Lead Standard Solution (1 ppm Pb),
Lactulose Oral Powder, III-729
Sulfate V-A150
Lactulose Solution, II-70
Kanamycin Sulfate, II-44 Lead Standard Solution (2 ppm Pb),
LAL Test, see Test for Bacterial Endotoxins
Kanamycin Sulphate, see Kanamycin V-A150
Lamivudine, II-72, V-S79
Sulfate Lead Standard Solution (10 ppm Pb),
Lamivudine Tablets, III-731
Kaolin and Morphine Mixture, III-723 V-A150
Lamivudine Tablets, Zidovudine and, see
Kaolin and Morphine Oral Suspension Lead Standard Solution (10 ppm Pb)
Zidovudine and Lamivudine Tablets
see Kaolin and Morphine Mixture, R1, V-A150
Lamotrigine, II-75
III-723 Lead Standard Solution (10 ppm Pb)
Lamotrigine Tablets, III-732
Kaolin, Heavy, II-45 R2, V-A150
Lamotrigine Tablets, Dispersible, III-733
Kaolin, Light, II-46, V-A78 Lead Standard Solution (20 ppm Pb),
Lanatoside C, V-A79
Kaolin, Light (Natural), II-47 V-A150
Lansoprazole, II-77
Kaolin Mixture, III-723 Lead Standard Solution (100 ppm Pb),
Lansoprazole Capsules, Gastro-resistant,
Kaolin Oral Suspension, III-723 V-A150
III-735
Kaolin Poultice, III-724 Lead Subacetate Solution, V-A80
Lansoprazole Capsules, see Gastro-
Karaya Gum, see Sterculia Lead-free Ammonia, V-A25
resistant Lansoprazole Capsules
Karl Fischer Reagent VS, V-A144 Lead-free Hydrochloric Acid, V-A73
Lansoprazole Tablets, Gastro-resistant,
mkat, V-628 Lead-free Nitric Acid, V-A95
III-736
Kelp, IV-233 Lead-free Potassium Cyanide Solution,
Lansoprazole Tablets, see Gastro-resistant
Kelvin, Definition of, I-32, II-32, III-32, V-A107
Lansoprazole Tablets
IV-32, V-32 Lead(II) Acetate, V-A80
Lanthanum Chloride Heptahydrate,
Kerosene, Deodorised, V-A78 Lead(II) Acetate, see Lead Acetate
V-A79
Ketamine Hydrochloride, II-48 Lead(II) Nitrate, V-A80
Lanthanum Chloride Solution, V-A79
Ketamine Injection, III-725 Lead(IV) Oxide, V-A80
0.1M Lanthanum Nitrate VS, V-A144
11-Keto-b-boswellic acid, V-A78 Lead(IV) Oxide, see Lead Dioxide
Lanthanum Nitrate, V-A79
Ketoconazole, II-50 Leflunomide, II-82
Lanthanum Nitrate Solution, V-A79
Ketoprofen, II-52, V-S78
page numbers in bold type relate to monograph titles Index V-A833

Legal Requirements, Unlicensed Light Kaolin, II-46, V-A78 Lindane, V-A80


Medicines, V-781 Light Kaolin (Natural), II-47 Linearity, V-674
Leiocarposide, V-A80 Light Liquid Paraffin, II-500 Liniments, III-43
Lemon Balm, IV-241 Light Liquid Paraffin Eye Drops, III-960 Linoleic Acid, V-A81
Lemon Balm Dry Extract, IV-243 Light Magnesium Carbonate, II-163 Linolenic Acid, V-A81
Lemon Oil, IV-244, V-A80 Light Magnesium Oxide, II-171 Linolenyl Alcohol, V-A81
Lemon Oil, Terpeneless, IV-246 Light Petroleum, V-A100 Linoleoyl Macrogolglycerides, II-113
Lemon Peel, Dried, IV-244 Light Petroleum R1, V-A100 Linoleyl Alcohol, V-A81
Lemon Spirit, IV-246 Light Petroleum R2, V-A100 Linseed, IV-249
Lemon Syrup, IV-247 Light Petroleum R3, V-A100 Linseed Oil, Virgin, II-114
Lemon Verbena Leaf, IV-247 Light petroleum R4, V-A100 Linsidomine Hydrochloride, V-A81
Letrozole, II-83 Light, Protected from, Definition of, Liothyronine Sodium, II-115
Leucine, II-84, V-A80 I-12, II-12, III-12, IV-12, V-12 Liothyronine Tablets, III-755
Leuprorelin, II-86 Light, Protection from, V-197 Lipase Solvent, V-A81
Leuprorelin for Injection, III-737 Light, Subdued, Definition of, I-12, Lipophilic Solid Dosage Forms,
Leuprorelin Injection, III-737 II-12, III-12, IV-12, V-12 Dissolution Test for, V-362
Levamisole Hydrochloride, II-87 Lignin, Reactions of, V-269 Lipophilic Suppositories, Softening Time
Levetiracetam, II-89 Lignocaine and Chlorhexidine Gel, see Determination of, V-513
Levobunolol Eye Drops, III-739 Lidocaine and Chlorhexidine Gel Liquefied Phenol, II-544, V-A101
Levobunolol Hydrochloride, II-91, Lignocaine Gel, see Lidocaine Gel Liquid Chromatography, V-202
V-S79 Lignocaine Injection, see Lidocaine Liquid Chromatography, Injection
Levocabastine Hydrochloride, II-92 Injection volume, V-204
Levocarnitine, II-94 Lignocaine Ointment, see Lidocaine Liquid Chromatography, Resolution
Levodopa, II-95, V-S79, V-A80 Ointment factor, V-204
Levodopa and Carbidopa Tablets, Lignocaine Solution, Sterile, see Lidocaine Liquid Chromatography, Run time,
III-376 Solution, Sterile V-204
Levodopa Capsules, III-740 Lime, Chlorinated, I-515 Liquid Chromatography, Secondary
Levodopa Capsules, Benserazide Lime Flower, IV-248 peaks, V-204
Hydrochloride and, see Co-beneldopa Lime Water, III-243 Liquid Extracts, IV-47
Capsules Limit of Detection, V-675 Liquid Glucose, I-1084
Levodopa Tablets, III-740 Limit of Quantitation, V-675 Liquid Glucose, Spray-dried, I-1079
Levodropropizine, II-97 Limit Test for Aluminium, V-270 Liquid Lactulose, see Lactulose Solution
Levomenol, V-A80 Limit Test for Ammonium, V-270 Liquid Maltitol, II-184
Levomenthol, II-98 Limit Test for Arsenic, V-271 Liquid Paraffin, II-501, V-A99
Levomenthol Cream, III-741, V-785 Limit Test for Calcium, V-271 Liquid Paraffin and Magnesium
Levomepromazine, V-S80 Limit Test for Carbon Monoxide in Hydroxide Oral Emulsion, III-961
Levomepromazine Hydrochloride, II-100 Medical Gases, V-309 Liquid Paraffin Light, II-500
Levomepromazine Injection, III-742 Limit Test for Chlorides, V-272 Liquid Paraffin Oral Emulsion, III-960
Levomepromazine Maleate, II-100 Limit Test for Fluorides, V-272 Liquid Scintillation Cocktail, V-A81
Levomepromazine Tablets, III-742 Limit Test for Heavy Metals, V-272 Liquid Scintillation Cocktail R1, V-A81
Levomethadone Hydrochloride, II-101 Limit test for Heavy Metals in Herbal Liquid Sorbitol (Crystallising), II-890
Levonorgestrel, II-103 Drugs and Herbal Drug Preparations, Liquid Sorbitol (Non-crystallising),
Levonorgestrel and Ethinylestradiol V-276 II-891
Tablets, III-745 Limit Test for Iron, V-275 Liquids for Cutaneous Application,
Levonorgestrel Tablets, III-743 Limit Test for Lead in Sugars, V-276 III-42
Levothyroxine Oral Solution, III-746 Limit Test for Magnesium, V-276 Liquids for Cutaneous Application of the
Levothyroxine Sodium, II-106 Limit Test for Magnesium and Alkaline- BP, III-43
Levothyroxine Tablets, III-747 earth Metals, V-276 Liquorice, IV-250
Lf dose, Definition of, I-30, II-30, Limit Test for Nickel in Polyols, V-278 Liquorice Dry Extract for Flavouring
III-30, IV-30, V-30 Limit Test for Phosphates, V-278 Purposes, IV-251
Lidocaine, II-108 Limit Test for Potassium, V-279 Liquorice Liquid Extract, IV-253
Lidocaine (1), V-S80 Limit Test for Sulfates, V-279 Liquorice Root for use in TCM, IV-254
Lidocaine (2), V-S80 Limit Tests, V-270 Liquorice Root for use in Traditional
Lidocaine and Adrenaline Injection, Limitation of Impurities, Expression of, Chinese Medicine, see Liquorice Root
III-751 V-638 for use in TCM
Lidocaine and Chlorhexidine Gel, Limits, Application of, I-13, II-13, Lisinopril Dihydrate, II-116
III-752 III-13, IV-13, V-13 Lisinopril Oral Solution, III-756
Lidocaine and Epinephrine Injection, see Limits of Error, Fiducial, V-657 Lisinopril Tablets, III-757
Lidocaine and Adrenaline Injection Limonene, V-A80 Lithium, V-A81
Lidocaine Cutaneous Solution, Sterile, Linalol, V-A80 Lithium and Sodium
III-751 Linalool, V-A80 Molybdotungstophosphate Solution,
Lidocaine Gel, III-748 Linalool, see Linalol see Phosphomolybdotugstic Reagent
Lidocaine Hydrochloride, II-110 Linalyl Acetate, V-A80 Lithium Carbonate, II-118, V-A81
Lidocaine Injection, III-749 Lincomycin Capsules, III-753 Lithium Carbonate Tablets, III-758
Lidocaine Injection, Intraocular, III-749 Lincomycin Hydrochloride, II-111, Lithium Carbonate Tablets, Prolonged-
Lidocaine Intraocular Injection, III-749 V-S81 release, III-759
Lidocaine Ointment, III-750 Lincomycin Injection, III-754 Lithium Carbonicum, V-609
Lidocaine Solution, Sterile, III-751 Linctus, Paediatric Simple, III-1085 Lithium Chloride, V-A81
Ligatures, Sterile Non-absorbable, see Linctus, Simple, III-1085 Lithium Citrate, II-119
Sterile Non-absorbable Sutures Linctuses, III-58 Lithium Citrate Oral Solution, III-759
V-A834 Index

Lithium Hydroxide, V-A81 lr/100 dose, Definition of, I-30, II-30, Macrogol 40 Sorbitol Heptaoleate,
Lithium Metaborate, Anhydrous, V-A81 III-30, IV-30, V-30 II-157
Lithium Methoxide VS, V-A144 L-Serine, see Serine Macrogol Cetostearyl Ether, II-149
Lithium Standard Solution (100 ppm Lumiflavine, V-A82 Macrogol Glycerol Cocoates, II-151
Li), V-A150 Luteolin-7-glucoside, V-A82 Macrogol Lauryl Ether, II-153
Lithium Sulfate, V-A81 Lymecycline, II-140 Macrogol Oleate, II-154
Lithium Sulphate, see Lithium Sulfate Lymecycline Capsules, III-768 Macrogol Oleyl Ether, II-155
Lithium trifluoromethanesulfonate, Lynestrenol, II-142 Macrogol Poly(vinyl alcohol) Grafted
V-A81 Lyophilisates, Oral, III-76 Copolymer, II-155
Lithium trifluoromethanesulphonate, see Lysine Acetate, II-144 Macrogol 20,000, see Polyethylene Glycol
Lithium Trifluoromethanesulfonate Lysine Hydrochloride, II-145 20,000
Litmus, V-A81 Lysyl endopeptidase, V-A82 Macrogol 200, see Polyethylene Glycol 200
Litmus Paper, V-A81 Macrogol 300, see Polyethylene Glycol 300
Litmus Paper, Blue, V-A81 Macrogol 400, see Polyethylene Glycol 400
Litmus Paper, Red, V-A81
Litmus Solution, V-A81
M Macrogol 1000, see Polyethylene Glycol
1000
0.5M Ammonium acetate buffer solution
L-Leucine, see Leucine Macrogol 1500, see Polyethylene Glycol
pH 4.5, see Ammonium acetate buffer
Lo/10 dose, Definition of, I-30, II-30, 1500
pH 4.5, 0.5M
III-30, IV-30, V-30 Macrogol Stearate, II-158
0.01M Ammonium and Cerium Nitrate,
Lobeline Hydrochloride, II-119 Macrogol Stearyl Ether, II-158
see Ammonium Cerium(IV) Nitrate VS
Lofepramine Hydrochloride, II-121 Macrogolglycerides, Caprylocoproyl
0.1M Ammonium and Cerium Sulfate,
Lofepramine Hydrochloride (Form A), I-397
see Ammonium Cerium(IV) Sulfate VS
V-S81 Macrogolglycerol Hydroxystearate, see
0.0167M Bromide-bromate, see Bromine
Lofepramine Hydrochloride (Form B), Hydrogenated Polyoxyl Castor Oil
VS
V-S81 Macrogols, II-146
0.25M Citrate Buffer Solution pH 3.0,
Lofepramine Tablets, III-759 Macroscopical characteristics of Crude
V-A155
Loganin, V-A81 Drugs, I-17, II-17, III-17, IV-17,
M, Definition of, V-7
Lomustine, II-122, V-S82 V-17
0.1M Ferric Ammonium Sulfate, see
Lomustine Capsules, III-760 Magaldrate, II-159
Ammonium Iron(III) Sulfate VS
Long Pepper, IV-256 Magaldrate Oral Suspension, III-771
0.1M Ferrous Ammonium Sulfate, see
Longifolene, V-A81 Magnesium, V-A82
Ammonium Iron(II) Sulfate VS
Loosestrife, IV-258 Magnesium Acetate, V-A82
0.1M Lanthanum Nitrate VS, V-A144
Loperamide Capsules, III-761 Magnesium Acetate Tetrahydrate, II-161
0.2M Phosphate Buffer Solution pH 7.5,
Loperamide Hydrochloride, II-123 Magnesium and Magnesium Salts,
see Phosphate buffer pH 7.5, 0.2M
Loperamide Oxide Monohydrate, II-125 Reactions of, V-269
0.1M Phosphate Buffer Solution pH 7.0,
Lopinavir, II-126 Magnesium Aspartate, II-161
see Phosphate Buffer pH 7.0, 0.1M
Loprazolam Mesilate, II-130, V-S82 Magnesium Aspartate Dihydrate, see
Mixed
Loprazolam Tablets, III-762 Magnesium Aspartate
0.2M Phosphate Buffer Solution pH 2.5,
Loratadine, II-131, V-S82 Magnesium Carbonate, Heavy, II-162
see Phosphate Buffer Solution pH 2.5,
Loratadine Tablets, III-763 Magnesium Carbonate Heavy and
0.2M
Lorazepam, II-133, V-S83 Calcium Carbonate Tablets,
0.1M Phosphate Buffer Solution pH 6.7
Lorazepam Injection, III-764 Chewable, III-238
see Phosphate Buffer Solution pH 6.7,
Lorazepam Tablets, III-765 Magnesium Carbonate, Light, II-163
0.1M, V-A157
Lormetazepam, II-135, V-S83 Magnesium Carbonate Mixture,
0.1M Phosphate Buffer Solution pH 6.3,
Lormetazepam Tablets, III-766 Aromatic, III-771
V-A157
Losartan, V-S83 Magnesium Carbonate Oral Suspension,
0.05M Phosphate Buffer Solution
Losartan Potassium, II-136 Aromatic, III-771
pH 7.5, see Phosphate Buffer Solution
Losartan Potassium Tablets, III-767 Magnesium Chloride, V-A82
pH 7.5, 0.05M
Loss on Drying, Definition of Magnesium Chloride Hexahydrate,
0.05M Tris-hydrochloride Buffer Solution
Temperature Range, I-12, II-12, II-164
pH 7.5, see Tris-chloride Buffer pH 7.5
III-12, IV-12, V-12 Magnesium Chloride 45 Hydrate, see
R1
Loss on Drying, Determination of, Magnesium Chloride, Partially Hyrdated
3M Tris-hydrochloride Buffer Solution
V-309 Magnesium Chloride Injection, III-772
pH 8.8, see Tris-chloride Buffer pH 8.8
Loss on Drying of Extracts, V-339 Magnesium Chloride, Partially Hyrdated,
1M Tris-hydrochloride Buffer Solution
Lotions, III-43 II-165
pH 8.0, V-A159
Lotions, Powders for, III-43 Magnesium Chloride VS, V-A145
Macrogol 20,000 2-Nitrophthalate, see
Lovage Root, IV-259 Magnesium Citrate, Anhydrous, II-166
Polyethylene Glycol 20,000
Lovastatin, II-138 Magnesium Citrate Dodecahydrate,
2-Nitroterephthalate
Low-molecular-mass Heparins see Low- II-166
Macrogol 200 R1, see Polyethylene Glycol
molecular-weight Heparins Magnesium Citrate Nonahydrate, II-167
200 R1
Low-molecular-weight Heparins, I-1132 Magnesium Gluconate, II-168
Macrogol 6 Glycerol Caprylocaprate,
Low-Oxygen Nitrogen, II-389 Magnesium Glycerophosphate, II-169
II-150
Low-substituted Carmellose Sodium, Magnesium Glycerophosphate Oral
Macrogol 15 Hydroxystearate, II-152
I-419 Solution, III-772
Macrogol 20 Glycerol Monostearate,
Low-vapour-pressure Hydrocarbons Magnesium Glycerophosphate Tablets,
II-151
(Type L), V-A72, V-A82 Chewable, III-772
Macrogol 23 Lauryl Ether, V-A82
Lozenges and Pastilles, III-63 Magnesium Hydroxide, II-169
Macrogol 30 Dipolyhydroxystearate,
Lozenges, Compressed, III-63 Magnesium Hydroxide and Aluminium
II-150
Lp/10 dose, Definition of, I-30, II-30, Hydroxide Tablets, III-402
III-30, IV-30, V-30 Magnesium Hydroxide Mixture, III-773
page numbers in bold type relate to monograph titles Index V-A835

Magnesium Hydroxide Oral Emulsion, Magnesium Trisilicate Tablets, Mastic, IV-270


Liquid Paraffin and, III-961 Chewable Aluminium Hydroxide and, Materials Based on Plasticised Poly(Vinyl
Magnesium Hydroxide Oral Suspension, III-776 Chloride) for Containers for Human
III-773 Magnesium Trisilicate Tablets, Blood and Blood Components, V-562
Magnesium Hydroxide Oral Suspension, Chewable Compound, III-776 Materials Based on Plasticised Poly(Vinyl
Aluminium Hydroxide and, III-401 Magneson, V-A82 Chloride) for Tubing Heal Insets for
Magnesium Lactate Dihydrate, II-170 Magneson Reagent, V-A82 the Transfusion of Blood and Blood
Magnesium Muriaticum, V-609 Magneson Solution, V-A82 Components, V-565
Magnesium Nitrate, V-A82 Magnolia Officinalis Bark, IV-260 Materials Based on Non-plasticised
Magnesium Nitrate Solution, V-A82 Magnolia Officinalis Flower, IV-262 Poly(Vinyl Chloride) for Containers
Magnesium Nitrate Solution R1, V-A82 Magnolol, V-A82 for Non-injectable, Aqueous Solutions,
Magnesium Oxide, V-A82 Maize Oil, V-A83 V-568
Magnesium Oxide, Heavy, II-171, Maize Oil, Refined, II-179 Materials Based on Non-plasticised
V-A82 Maize Starch, II-912 Poly(Vinyl Chloride) for Dry Dosage
Magnesium Oxide, Light, II-171 Maize Starch, Pregelatinised see Forms for Oral Administration, V-569
Magnesium Oxide R1, V-A82 Pregelatinised Starch Materials Based on Plasticised Poly(Vinyl
Magnesium Peroxide, II-172 Malachite Green, V-A83 Chloride) for Aqueous Solutions for
Magnesium Phosphate for Malachite Green Solution, V-A83 Intravenous Infusion, V-571
Homoeopathic Preparations, IV-448 Malathion, II-180, V-A83 Materials for Containers for Human
Magnesium Phosphoricum for Malathion Lotion, III-776 Blood and Blood Components, V-563
Homoeopathic Preparations, see Malathion Shampoo, III-777 Materials for use in the Manufacture of
Magnesium Phosphate for Homoeopathic Maleate Buffer Solution pH 7.0, V-A155 Homoeopathic Preparations, V-794
Preparations Maleic Acid, II-181, V-A83 Materials Used for the Manufacture of
Magnesium Pidolate, II-173 Maleic Anhydride, V-A83 Containers (3.1.), V-563
Magnesium Silicate for Pesicide Residue Maleic Anhydride Solution, V-A83 Materials Used in Chromatographic
Analysis, V-A82 Malic Acid, II-182, V-A83 Tests, V-741
Magnesium Standard Solution (0.1% Mallow Flower, IV-264 Matricaria Flowers, IV-270
Mg), V-A150 Mallow Leaf, IV-265 Matricaria Liquid Extract, IV-274
Magnesium Standard Solution (10 ppm Maltitol, II-183, V-A83 Matricaria Oil, IV-272
Mg), V-A150 Maltitol, Liquid, II-184 m-Cresol, V-A47
Magnesium Standard Solution (10 ppm Maltodextrin, II-185 Meadowsweet, IV-275
Mg) R1, V-A150 Maltotriose, V-A83 Measles Immunoglobulin, IV-498
Magnesium Standard Solution (100 ppm Mandarin Epicarp and Mesocarp, IV-266 Measles, Mumps and Rubella Vaccine,
Mg), V-A150 Mandarin Oil, IV-267 Live, IV-591
Magnesium Standard Solution Mandelic Acid, V-A83 Measles, Mumps, Rubella and Varicella
(1000 ppm Mg), V-A150 Manganese Gluconate, II-186 Vaccine (Live), IV-592
Magnesium Stearate, II-175 Manganese Glycerophosphate, Hydrated, Measles Vaccine, Live, IV-589
Magnesium Sulfate, V-A82 II-187 Measles, see Measles Vaccine, Live
Magnesium Sulfate, Dried, II-178 Manganese Standard Solution (100 ppm Measures, Expression of Weights and,
Magnesium Sulfate Heptahydrate, II-177 Mn), V-A151 I-6, II-6, III-6, IV-6, V-6
Magnesium Sulfate Injection, III-773 Manganese Standard Solution Measurement of Consistency and
Magnesium Sulfate Mixture, III-774 (1000 ppm Mn), V-A150 Texture Analysis, V-508
Magnesium Sulfate Oral Suspension, Manganese Sulfate, II-188 Measurement of Consistency by
III-774 Manganese Sulfate Monohydrate, II-188 Penetrometry, V-508
Magnesium Sulfate Paste, III-774 Manganese Sulfate, see Manganese(ii) Mebendazole, II-193, V-A83
Magnesium Sulfate VS, V-A145 Sulfate Mebeverine, V-S84
Magnesium Sulfuricum, V-609 Manganese Sulphate, see Manganese Mebeverine Hydrochloride, II-194,
Magnesium Sulphate, Dried, see Sulfate V-S84
Magnesium Sulfate Dried Manganese Sulphate Monohydrate, see Mebeverine Tablets, III-779
Magnesium Sulphate Heptahydrate, see Manganese Sulfate Monohydrate Meclozine Dihydrochloride, see Meclozine
Magnesium Sulfate Heptahydrate Manganese(ii) Sulfate, V-A83 Hydrochloride
Magnesium Sulphate Injection, see Manganese(ii) Sulphate, see Meclozine Hydrochloride, II-195, V-A83
Magnesium Sulfate Injection Manganese(ii) Sulfate Medicago Sativa for Homoeopathic
Magnesium Sulphate Mixture, see Mannitol, II-189, V-A83 Preparations, IV-448
Magnesium Sulfate Mixture Mannitol Infusion, III-778 Medical Air, I-79
Magnesium Sulphate Paste, see Mannitol Intravenous Infusion, see Medicated Chewing Gums, III-49
Magnesium Sulfate Paste Mannitol Infusion Medicated Chewing Gums, Dissolution
Magnesium Sulphate VS, see Magnesium Mannitol, see D-Mannitol Test for, V-363
Sulfate VS D-Mannose, V-A83 Medicated Foams, III-47
Magnesium Sulphate, see Magnesium Mannose, see D-Mannose Medicated Plasters, III-72
Sulfate Manufacture of Formulated Medicated Tampons, III-76
Magnesium Trisilicate, II-178 Preparations, I-9, II-9, III-9, IV-9, Medicated Vaginal Tampons, III-81
Magnesium Trisilicate Mixture, III-775 V-9 Medicinal Air see Medical Air
Magnesium Trisilicate Mixture, Manufacture of Unlicensed Medicines, Medicinal Products for Human Use,
Compound, III-775 V-782 Gene Transfer, V-760
Magnesium Trisilicate Oral Powder, Maprotiline Hydrochloride, II-191 Medicines, Unlicensed, V-781
Compound, III-775 Marrubiin, V-A83 Medium-chain Triglycerides, II-1101
Magnesium Trisilicate Oral Suspension, Marshmallow Leaf, IV-268 Medronic Acid for Radiopharmaceutical
III-775 Marshmallow Root, IV-269 Preparations, IV-663
Mass Spectrometry, V-180
V-A836 Index

Medroxyprogesterone Acetate, II-197, Mercuric Acetate Solution, see Metal Catalyst or Metal Reagent
V-S84 Mercury(II) Acetate Solution Residues, V-775
Medroxyprogesterone Injection, III-779 Mercuric Acetate, see Mercury(II) Acetate Metanil Yellow, V-A85
Medroxyprogesterone Tablets, III-780 Mercuric Bromide Paper, see Mercury(II) Metanil Yellow Solution, V-A85
Mefenamic Acid, II-199, V-S85 Bromide Paper Metaphosphoric Acid, V-A85
Mefenamic Acid Capsules, III-782 Mercuric Bromide, see Mercury(II) Metaraminol Injection, III-809
Mefenamic Acid Tablets, III-782 Bromide Metaraminol Tartrate, II-229
Mefloquine Hydrochloride, II-200 Mercuric Chloride, II-219 Metered-dose Preparations for
Megestrol Acetate, II-202, V-S85 Mercuric Chloride Solution, see Inhalation, Pressurised, III-55
Megestrol Tablets, III-783 Mercury(II) Chloride Solution Metformin Hydrochloride, II-229, V-S88
Meglumine, II-204 Mercuric Chloride, see Mercury(II) Metformin Oral Solution, III-810
Meglumine Amidotrizoate Injection, Chloride Metformin Tablets, III-811
III-784 Mercuric Iodide, see Mercury(II) Iodide Methacrylate Copolymer, Basic
Meglumine Iodipamide Injection, III-784 Mercuric Nitrate, see Mercury(II) Nitrate Butylated, II-231
Melaleuca Oil, see Tea Tree Oil Mercuric Oxide, see Mercury(II) Oxide, Methacrylic Acid, V-A85
Melamine, V-A83 Yellow Methacrylic Acid - Ethyl Acrylate
Melatonin, II-205, V-S85 Mercuric Sulfate Solution, see Copolymer (11), II-233
Melatonin Capsules, III-785 Mercury(ii) Sulfate Solution, V-A84 Methacrylic Acid - Ethyl Acrylate
Melilot, IV-276 Mercuric Sulphate Solution, see Mercuric Copolymer (11) Dispersion
Meloxicam, II-206, V-S86 Sulfate Solution 30 per cent, II-234
Meloxicam Tablets, III-787 Mercuric Thiocyanate Solution, see Methacrylic Acid - Methyl Methacrylate
Melphalan, II-208, V-S86 Mercury(II) Thiocyanate Solution Copolymer (11), II-235
Melphalan for Injection, III-788 Mercuric Thiocyanate, see Mercury(II) Methacrylic Acid - Methyl Methacrylate
Melphalan Injection, III-788 Thiocyanate Copolymer (12), II-236
Melphalan Tablets, III-790 Mercurius Corrosivus, V-609 Methadone, V-S89
Melting Point, Determination of, V-238 Mercurius Sublimatus Corrosivus, V-609 Methadone Hydrochloride, II-237
Membership of the European Mercury, V-A84 Methadone Hydrochloride Oral
Pharmacopoeia Commission, V-676 Mercury and Mercury Compounds, Concentrate, III-813
Menadiol Phosphate Injection, III-791 Reactions of, V-269 Methadone Injection, III-811
Menadiol Phosphate Tablets, III-792 Mercury, Nitric Acid Solution of, V-A84 Methadone Linctus, III-812
Menadiol Sodium Phosphate, II-210, Mercury Standard Solution (5 ppm Hg), Methadone Oral Solution (1 mg per
V-S86 V-A151 mL), III-812
Menadione, II-211, V-S87, V-A83 Mercury Standard Solution Methadone Oral Solution see Methadone
MenC(conj), see Meningococcal Group C (10 ppm Hg), V-A151 Linctus
Conjugate Vaccine Mercury Standard Solution Methadone Tablets, III-813
Meningococcal Group C Conjugate (100 ppm Hg), V-A151 Methane, V-A85
Vaccine, IV-593 Mercury Standard Solution Methane R1, V-A85
Meningococcal Polysaccharide Vaccine, (1000 ppm Hg), V-A151 Methanesulfonic Acid, V-A85
IV-595 Mercury(II) Acetate, V-A84 Methanesulfonic Acid, Methanesulfonyl
Menotrophin, II-212 Mercury(II) Acetate Solution, V-A84 Chloride in, V-301
Menotrophin for Injection, III-792 Mercury(II) Bromide, V-A84 Methanesulfonic Acid, Methanolic,
Menotrophin Injection, III-792 Mercury(II) Bromide Paper, V-A84 V-A85
Men, see Meningococcal Polysaccharide Mercury(II) Chloride, V-A84 Methanesulfonic Acid, Methyl, Ethyl and
Vaccine Mercury(II) Chloride Solution, V-A84 Isopropyl Methanesulfonate in, V-300
Menthofuran, V-A83 Mercury(II) Iodide, V-A84 Methanesulfonyl chloride, V-A85
Menthol, V-A83 Mercury(II) Nitrate, V-A84 Methanesulfonyl Chloride in
Menthol and Benzoin Inhalation, IV-277 Mercury(II) Nitrate VS, V-A145 Methanesulfonic Acid, V-301
Menthol and Benzoin Inhalation Vapour, Mercury(II) Oxide, Yellow, V-A84 Methanesulphonic Acid, Methanolic, see
IV-277 Mercury(ii) Sulfate Solution, V-A84 Methanesulfonic Acid, Methanolic
Menthol in Aqueous Cream, see Mercury(ii) Sulphate Solution, see Methanesulphonic Acid, see
Levomenthol Cream Mercury(ii) Sulfate Solution Methanesulfonic Acid
Menthol, Racemic, see Racementhol Mercury(II) Thiocyanate, V-A84 Methanesulphonyl chloride, V-A85
Menthone, V-A83 Mercury(II) Thiocyanate Solution, V-A85 Methanol, II-238, V-S89, V-A85
Menthyl Acetate, V-A84 Meropenem Trihydrate, II-219 Methanol, Acidifed, V-A85
Mepivacaine Hydrochloride, II-213 Mesalazine, II-221, V-S88 Methanol, Aldehyde-free, V-A85
Meprobamate, II-215 Mesalazine Enema, III-796 Methanol and Propan-2-ol,
Meptazinol Hydrochloride, II-215, Mesalazine Foam Enema, III-798 Determination of, V-286
V-S87 Mesalazine Granules, Prolonged-release, Methanol and 2-propanol, Test for
Meptazinol Injection, III-793 III-800 (2.9.11.), V-286
Meptazinol Tablets, III-793 Mesalazine Rectal Suspension, III-796 Methanol, Anhydrous, V-A85
Mepyramine Maleate, II-217, V-S87 Mesalazine Suppositories, III-803 Methanol, Deuterated, V-A50
Mepyramine Tablets, III-794 Mesalazine Tablets, Gastro-resistant, Methanol, Hydrochloric, V-A85
Mercaptoacetic Acid, V-A84 III-805 Methanol R1, V-A85
2-Mercaptobenzimidazole, V-A84 Mesalazine Tablets, Prolonged-release, Methanol R2, V-A85
2-Mercaptoethanol, V-A84 III-807 Methanolic Ammonia, V-A25
Mercaptopurine, II-218, V-S88, V-A84 Mesityl Oxide, V-A85 Methanolic Hydrochloric Acid, V-A73
Mercaptopurine Oral Suspension, Mesna, II-224 Methanolic Methanesulfonic Acid,
III-795 Mesterolone, II-225 V-A85
Mercaptopurine Tablets, III-795 Mestranol, II-227 Methanolic Potassium Hydroxide,
Mercaptopurine, see 6-Mercaptopurine Metacresol, II-227 V-A108
page numbers in bold type relate to monograph titles Index V-A837

Methanolic Sodium Hydroxide, V-A122 Methyl Acetate, V-A86 Methyl Parahydroxybenzoate, see Methyl
Methanolic Sodium Hydroxide Solution, Methyl 4-acetylbenzoate, V-A86 4-hydroxybenzoate
V-A123 Methyl 4-acetylbenzoate Reagent, V-A86 Methyl Pelargonate, V-A89
Methanolic Sodium Hydroxide Solution Methyl Alcohol, see Methanol Methyl Red, V-A90
R1, V-A123 Methyl 4-aminobenzoate, V-A86 Methyl Red Mixed Solution, V-A90
Methanolic Sulfuric Acid, V-A128 Methyl Anthranilate, V-A86 Methyl Red Solution, V-A90
Methanolic Methyl Arachidate, V-A86 Methyl Salicylate, II-247, V-A90
Tris(hydroxymethyl)methylamine Methyl Behenate, see Methyl Docosanoate Methyl Salicylate Cutaneous Emulsion,
Solution, V-A138 Methyl Benzenesulfonate, V-A86 III-818
Methenamine, II-239 Methyl Benzenesulphonate, see Methyl Methyl Salicylate Liniment, III-818
Methimazole, V-A85 Benzenesulfonate Methyl Salicylate Ointment, III-818
Methionine, II-240, II-241, V-A85 Methyl Benzoate, V-A86 Methyl Salicylate Ointment, Strong,
11
L-Methionine ([ C]Methyl) Injection, Methyl Caprate, see Methyl Decanoate III-818
IV-698 Methyl Caproate, V-A87 Methyl Stearate, V-A90
Method I, V-238, V-287 Methyl Caprylate, V-A87 Methyl Thymol Blue, V-A90
Method I, V-307 Methyl Cinnamate, V-A87 Methyl Tricosanoate, V-A90
Method II, V-306, V-319, V-336 Methyl Decanoate, V-A87 Methyl Tridecanoate, V-A90
Method II, V-306, V-320, V-336 Methyl Docosanoate, V-A87 Methyl 3,4,5-Trimethoxybenzoate,
Method II Determination of Water By Methyl Eicosenoate, V-A87 V-A90
Distillation, V-308 Methyl Erucate, V-A88 Methylal, V-A86
Method III, V-239 Methyl, Ethyl and Isopropyl 4-Methylaminophenol sulfate, V-A86
Method III, V-283 Methanesulfonate in Active Methylaminophenol-Sulfite Reagent,
Method III (Coulometric Titration), Substances, V-300 V-A86
V-308 Methyl, Ethyl and Isopropyl Methylaminophenol-Sulphite Reagent,
Method III (Rotating Viscometer Methanesulfonate in Methanesulfonic see Methylaminophenol-Sulfite Reagent
Method), V-247 Acid, V-300 3-(Methylamino)-1-phenylpropan-1-ol,
Method IV, V-240 Methyl Ethyl Ketone, see Butan-2-one V-A86
Method IV (Falling Ball Viscometer Methyl Green, V-A88 Methylamphetamine Hydrochloride,
Method), V-250 Methyl Green-Iodomercurate Paper, V-A86
Methods of Analysis, Monograph V-A88 Methylated Spirit, Industrial, II-248
Development, V-671 Methyl Hydroxybenzoate, II-245, V-A88 Methylated Spirit (Ketone-free),
Methods of Preparation of Methyl Iodide, V-A88 Industrial, II-248
Homoeopathic Stocks and Methyl Isobutyl Ketone, V-A88 Methylated Spirits, Industrial, II-248
Potentisation, IV-415 Methyl Isobutyl Ketone R1, V-A88 3-Methylbenzothiazolin-2-one hydrazone
Methods of Preparation of Sterile Methyl Isobutyl Ketone R3, V-A88 hydrochloride, V-A86
Products - Methods of Sterilisation, Methyl Isobutyl Ketone R1, see Methylbenzothiazolone hydrazone
V-544 4-Methylpentan-2-one R1 hydrochloride, V-A86
Methods of Sterilisation, V-546 Methyl Isobutyl Ketone R3, see 2-Methylbutane, V-A87
Methods of Sterilisation for Parenteral 4-Methylpentan-2-one R3 2-Methylbut-2-ene, V-A87
Preparations, III-66 Methyl Isobutyl Ketone, see 9-[(3-Methylbut-2-enyl)oxy]-7H-
Methods of Sterilisation (Methods of 4-Methylpentan-2-one furo[3,2-g][1]benzopyran-7-oneSee
Preparation of Sterile Products), Methyl Laurate, V-A88 Imperatorin, V-A75
V-544 Methyl Lignocerate, V-A88 Methylcellulose, II-248
Method V, V-240 Methyl Linoleate, V-A88 Methylcellulose 450, V-A87
Method VI, V-241 Methyl Linolenate, V-A88 Methylcellulose Granules, III-818
Methotrexate, II-242 Methyl Margarate, V-A88 Methylcellulose Tablets, III-819
Methotrexate Injection, III-814 Methyl Methacrylate, V-A88 Methyldopa, II-250, V-S90
Methotrexate Oral Solution, III-815 Methyl Methanesulfonate, V-A88 Methyldopa, racemic, V-A87
Methotrexate Tablets, III-816 Methyl Methanesulfonate in Methyldopa Tablets, III-819
Methotrimeprazine Injection, see Methanesulfonic Acid, see Methyl, Methyldopate Hydrochloride, II-252,
Levomepromazine Injection Ethyl and Isopropyl Methanesulfonate in V-S91
Methotrimeprazine Tablets, see Methanesulfonic Acid Methyldopate Injection, III-820
Levomepromazine Tablets Methyl Myristate, V-A89 Methylene blue, V-A87
Methoxamine Hydrochloride, II-244, Methyl Nervonate, V-A89 Methylene Blue Injection, see
V-S90 Methyl Nicotinate, II-246, V-S90 Methylthioninium Injection
Methoxamine Injection, III-817 Methyl N-methylanthranilate, V-A88 Methylene chloride, V-A87
Methoxyazobenzene, V-A85 Methyl Oleate, V-A89 Methylene chloride, acidified, V-A88
Methoxychlor, V-A86 Methyl Orange, V-A89 Methylene Chloride, Acidified, see
trans-2-Methoxycinnamaldehyde, V-A86 Methyl Orange Mixed Solution, V-A89 Dichloromethane, Acidified
2-Methoxyethanol, V-A86 Methyl Orange Solution, V-A89 Methylene Chloride, see Dichloromethane
7-Methoxy-8-isopentenylcoumarinSee Methyl Orange-Xylene Cyanol FF Methylenebisacrylamide, V-A87
Osthole, V-A98 Solution, V-A89 4,4-Methylenebis-N,N-dimethylaniline,
3-Methoxy-L-tyrosine, V-A86 Methyl Palmitate, V-A89 V-A87
7-Methoxy-8-(3-methylbut-2-enyl)-2H-1- Methyl Palmitoleate, V-A89 4,4-Methylenebis-N,N-dimethylaniline
benzopyran-2-oneSee Osthole, V-A98 Methyl Paraben, see Methyl Reagent, V-A87
1-(6-Methoxynaphthalen-2-yl)ethanone, Hydroxybenzoate Methylergometrine Maleate, II-253
V-A86 Methyl Parahydroxybenzoate, V-A89 Methyleugenol, V-A88
6-Methoxy-2-naphthoic acid, V-A86 Methyl Parahydroxybenzoate, see Methyl N-Methylglucamine, V-A88
Methoxyphenylacetic Acid, V-A86 Hydroxybenzoate Methylhydroxyethylcellulose see
Methoxyphenylacetic Reagent, V-A86 Hydroxyethylmethylcellulose
V-A838 Index

2-Methylimidazole, V-A88 Metronidazole, II-281, V-S93 Microkatal, Definition of, I-32, II-32,
1-Methylimidazole R1, V-A88 Metronidazole Benzoate, II-282, V-S93 III-32, IV-32, V-653, V-32
N-Methyl-m-toluidine, V-A90 Metronidazole Gel, III-831 Microscopic Examination of Herbal
2-Methyl-1,4-naphthoquinone, V-A89 Metronidazole Infusion, III-832 Drugs, V-345
2-Methyl-5-nitroimidazole, V-A89 Metronidazole Intravenous Infusion, see Microscopy, Optical, V-521
2-Methyl-2-nitropropane-1,3-diol, V-A89 Metronidazole Infusion MID, V-628
2-Methylpentane, V-A89 Metronidazole Oral Suspension, III-832 Midazolam, II-291, V-S95
4-Methylpentan-2-ol, V-A89 Metronidazole Suppositories, III-833 Midazolam Injection, III-843
3-Methylpentan-2-one, V-A89 Metronidazole Tablets, III-834 Midazolam Oral Solution, III-843
4-Methylpentan-2-one R1, V-A89 Metyrapone, II-283 Midazolam Oromucosal Solution,
4-Methylpentan-2-one R3, V-A89 Metyrapone (1), V-S94 III-844
Methylpentosesin Polysaccharide Metyrapone (2), V-S94 Milk-thistle Fruit, IV-278
Vaccines, V-467 Metyrapone Capsules, III-834 Minimising the Risk of Transmitting
4-Methylphenazone, V-A89 Mexenone, II-284, V-S94 Animal Spongiform Encephalopathy
Methylphenidate Hydrochloride, II-254 Mexenone Cream, III-835 Agents Via Human and Veterinary
Methylphenobarbital, II-256, V-S91 Mexiletine Capsules, III-835 Medicinal Products, V-611
Methylphenobarbital Tablets, III-820 Mexiletine Hydrochloride, II-284, V-S95 Minocycline Capsules, Prolonged-release,
Methylphenyloxazolybenzene, V-A89 Mexiletine Injection, III-836 III-845
1-Methyl-4-phenyl-1,2,3,6- Mianserin Hydrochloride, II-286, V-S95 Minocycline Hydrochloride, V-A90
tetrahydropyridine, V-A89 Mianserin Tablets, III-836 Minocycline Hydrochloride see
Methylpiperazine, V-A89 Mice, I-15, II-15, III-15, IV-15, V-15 Minocycline Hydrochloride Dihydrate
Methylpiperazine, see N-Methylpiperazine Miconazole, II-288 Minocycline Hydrochloride Dihydrate,
4-(4-Methylpiperidin-1-yl)pyridine, Miconazole and Hydrocortisone Acetate II-294
V-A89 Cream, III-841 Minocycline Tablets, III-846
Methylprednisolone, II-257, V-S91 Miconazole and Hydrocortisone Cream, Minoxidil, II-295, V-S96
Methylprednisolone Acetate, II-260, III-838 Minoxidil Scalp Application, III-848
V-S92 Miconazole and Hydrocortisone Minoxidil Scalp Cutaneous Solution,
Methylprednisolone Acetate Injection, Ointment, III-840 III-848
III-822 Miconazole Cream, III-837 Mirtazapine, II-297, V-S96
Methylprednisolone Hydrogen Succinate, Miconazole Nitrate, II-289 Mirtazapine Oral Solution, III-849
II-262 Miconazole Oromucosal Gel, III-838 Mirtazapine Tablets, III-850
Methylprednisolone Tablets, III-821 Microbial Contamination, V-657 Mirtazapine Tablets, Orodispersible,
2-Methylpropan-1-ol, V-A90 Microbial Contamination, III-851
2-Methylpropanol, see 2-Methylpropan-1- Supplementary Information, V-657 Misoprostol, II-298
ol Microbial Enumeration Tests, V-483 Mitobronitol, II-300, V-S96
Methylpyrrolidone, II-264 Microbial Quality of Pharmaceutical Mitobronitol Tablets, III-852
Methylrosanilinium Chloride, II-265 Preparations, V-658 Mitomycin, II-300
Methylsilyl Silica Gel for Microbiological Assay of Antibiotics, Mitoxantrone Concentrate, Sterile,
Chromatography, V-A116 V-396, V-655 III-853
Methyltestosterone, II-266 Microbiological Control of Cellular Mitoxantrone Hydrochloride, II-302
5-Methylthiazol-2-ylamine, V-A90 Products, V-496 Mitoxantrone Infusion, III-853
Methylthioninium Chloride, II-267 Microbiological Examination of Herbal Mitoxantrone Intravenous Infusion,
Methylthioninium Injection, III-823 Medicinal Products for Oral Use, III-853
Methylthymol Blue, V-A90 V-497 Mitozantrone Intravenous Infusion, see
Methylthymol Blue Mixture, V-A90 Microbiological Examination of Non- Mitoxantrone Intravenous Infusion
N-Methyltrimethylsilyl- Sterile Products, V-478 Mixed Gas-gangrene Antitoxin, IV-522
trifluoroacetamide, V-A90 Microbiological Examination of Non- Mixed Phosphate Buffer pH 7.0, 0.1M,
N-Methylpyrrolidine, V-A90 sterile Products: Microbial V-A156
N-Methylpyrrolidone, V-A90 Enumeration Tests, V-700 Mixed Phosphate Buffer pH 5.4, V-A156
Methysergide Maleate, II-269, V-S92 Microbiological Quality, Alternative Mixed Phosphate Buffer pH 4.0, V-A156
Methysergide Tablets, III-823 Methods for Control of, V-745 Mixed Phosphate Buffer pH 6.8, V-A156
Metipranolol, II-270, V-S92 Microbiological Quality of Herbal Mixed Phosphate Buffer pH 7.0, V-A156
Metipranolol Eye Drops, III-824 Medicinal Products for Oral Use, Mixed Phosphate Buffer pH 10, V-A156
Metixene Hydrochloride, II-271 V-500 Mixtures, III-58
Metoclopramide, II-272 Microbiological Quality of Non-sterile MLD, V-628
Metoclopramide Hydrochloride, II-273 Pharmaceutical Preparations and MMR, see Measles, Mumps and Rubella
Metoclopramide Injection, III-825 Substances for Pharmaceutical Use, Vaccine, Live
Metoclopramide Oral Solution, III-826 V-495 MMRVar, see Measles, Mumps, Rubella
Metoclopramide Tablets, III-827 Microbiological Quality of Herbal and Varicella Vaccine (Live)
Metolazone, II-274 Medicinal Products for Oral Use Modafinil, II-303
Metoprolol, V-S93 V-500 Moderately Coarse Powder, Definition
Metoprolol Injection, III-828 Microcalorimetry, Characterisation of of, V-501
Metoprolol Succinate, II-275 Crystalline Solids by, V-539 Modified b-Cyclodextrin for Chiral
Metoprolol Tartrate, II-277 Microcrystalline Cellulose, I-475 Chromatography R1, V-A48
Metoprolol Tartrate Tablets, III-829 Microcrystalline Cellulose and Modified-release Granules, III-49
Metoprolol Tartrate Tablets, Prolonged- Carmellose Sodium, I-478 Modified-release Tablets, III-75
release, III-830 Microcrystalline Cellulose, see Cellulose Molarity, Definition of, I-7, II-7, III-7,
Metre, Definition of, I-32, II-32, III-32, for chromatography R1 IV-7, V-7, V-A141
IV-32, V-32 Microfine Powder, Definition of, V-501 Mole, Definition of, I-32, II-32, III-32,
Metrifonate, II-279 IV-32, V-32
page numbers in bold type relate to monograph titles Index V-A839

Molecular Formula, Status of, I-4, II-4, Morphine Tincture, Chloroform and, Naloxone Hydrochloride, II-335
III-4, IV-4, V-4 III-298 Naloxone Hydrochloride Dihydrate see
Molecular Mass Distribution in 2-[N-Morpholino]ethanesulfonic Acid, Naloxone Hydrochloride
Dextrans, V-201 V-A91 Naloxone Injection, III-874
Molecular Sieve, V-A90 Morpholine, V-A91 Naloxone Injection, Neonatal, III-876
Molecular Sieve for Chromatography, Morpholine for Chromatography, V-A91 Naltrexone Hydrochloride, II-337
V-A90 Mother Tinctures for Homoeopathic Names of Herbal Drugs Used in
Molecular Weight, Status of, I-4, II-4, Preparations, IV-425 Traditional Chinese Medicine (5.22.),
III-4, IV-4, V-4 Motherwort, IV-282 V-792
Molgramostim Concentrated Solution, Mouthwashes, III-61 Names of Medicinal Substances and
II-304 Moxifloxacin Hydrochloride, II-318 Preparations, V-659
Molsidomine, II-307 Moxifloxacin Injection, Intracameral, Names, Symbols and Atomic Weights of
Molybdenum(VI) Oxide, V-A90 III-866 Elements, V-629
Molybdovanadic Reagent, V-A90 Moxifloxacin Intracameral Injection, Nandrolone Decanoate, II-339, V-S99
Mometasone Aqueous Nasal Spray, III-866 Nandrolone Decanoate Injection, III-876
III-855 Moxisylyte Hydrochloride, II-319, V-S97 Nandrolone Phenylpropionate, II-341,
Mometasone Cream, III-855 Moxisylyte Tablets, III-867 V-S100
Mometasone Cutaneous Suspension see Moxonidine, II-320 Nandrolone Phenylpropionate Injection,
Mometasone Scalp Application, III-854 MRI, V-628 III-877
Mometasone Furoate, II-309 Mucic Acid, V-S97 Naphazoline Hydrochloride, II-341
Mometasone Ointment, III-856 Mucoadhesive Preparations, III-63 Naphazoline Nitrate, II-343
Mometasone Scalp Application, III-854 Mullein Flower, IV-283 Naphthalene, V-A91
Monoclonal Antibodies for Human Use, Mumps Vaccine, Live, IV-597 Naphthalene-1,3-diol, V-A91
IV-509 Mumps, see Mumps Vaccine, Live Naphthalenediol Reagent Solution,
Monocyte-Activation Test, V-410 Mupirocin, II-321, V-S98 V-A92
Monodocosahexaenoin, V-A90 Mupirocin Calcium, II-322 Naphthalenediol Solution, V-A92
Monoethanolamine, see Ethanolamine Mupirocin Cream, III-868 Naphtharson, V-A92
Monograph Development, V-668, V-669 Mupirocin Nasal Ointment, III-869 Naphtharson Solution, V-A92
Mechanism, V-668 Mupirocin Ointment, III-870 2-Naphthol, V-A92
Monograph Revisions, I-xxiii Murexide, V-A91 2-Naphthol Solution, V-A92
Monograph Selection, Unlicensed Mustine Hydrochloride for Injection, see b-Naphthol Solution R1, V-A92
Medicines, V-783 Chlormethine Hydrochloride for Injection 1-Naphthol Solution, Strong, V-A92
Monograph Titles, Changes in, V-659 Mustine Hydrochloride, see Chlormethine a-Naphthol Solution, see 1-Naphthol
Monograph Titles for Formulated Hydrochloride Solution
Preparations, V-659 Mustine Injection, see Chlormethine Naphthol Yellow, V-A92
Monographs, V-598 Injection Naphthol Yellow S, V-A92
Abbreviated Titles of, V-598 Mycobacteria, V-492 1-Naphtholbenzein, V-A92
Monolithic Octadecylsilyl Silica Gel for Mycobacteria, Test for, V-658 1-Naphtholbenzein Solution, V-A92
Chromatography, V-A116 Mycophenolate Mofetil, II-324 Naphtholbenzein Solution, see
Montelukast Granules, III-857 Mycoplasmas, Test for, V-657 1-Naphtholbenzein Solution
Montelukast Sodium, II-311 Mycoplasmas, Test for Absence of, Naphtholbenzein, see 1-Naphtholbenzein
Montelukast Tablets, III-859 V-487 a-Naphthol, see 1-Naphthol
Montelukast Tablets, Chewable, III-860 Mycotoxins in Herbal Drugs, 2-Naphthylacetic Acid, V-A92
Mordant Black 11, V-A90 Determination of, V-341 1-Naphthylamine, V-A92
Mordant Black 11 Solution, V-A91 Myosmine, V-A91 Naphthylamine, see 1-Naphthylamine
Mordant Black 11 Triturate, V-A91 b-Myrcene, V-A91 N-(1-Naphthyl)ethylenediamine
Mordant black 11 triturate R1, V-A91 Myristic Acid, V-A91 Dihydrochloride, V-A92
Mordant Black 11 Mixed Triturate, Myristicine, V-A91 Naphthylethylenediamine
V-A90 Myristyl Alcohol, V-A91 Dihydrochloride Solution, V-A92
Mordant Blue 3, V-A91 Myrrh, IV-284 Naphthylethylenediamine
Morisons Paste, III-774 Myrrh Tincture, IV-285 Dihydrochloride, see N-
Morphine, V-S97 Myrtillin, V-A91 (1-Naphthyl)ethylenediamine
Morphine and Atropine Injection, Dihydrochloride
III-865 Naproxen, II-344, V-S100
Morphine, Anhydrous, V-A91
Morphine Hydochloride, V-A91
N Naproxen Oral Suspension, III-877
Naproxen Sodium, II-346
Nabumetone, II-326, V-S98
Morphine Hydrochloride, II-314 Naproxen Suppositories, III-878
Nabumetone Oral Suspension, III-871
Morphine Oral Suspension, Kaolin and Naproxen Tablets, III-878
Nabumetone Tablets, III-872
see Kaolin and Morphine Mixture Naproxen Tablets, Gastro-resistant,
Nadolol, II-328
Morphine Sulfate, II-316 III-879
Nadroparin Calcium, II-329
Morphine Sulfate Injection, III-864 Naringin, V-A92
Naftidrofuryl, V-S98
Morphine Sulphate, see Morphine Nasal, III-60
Naftidrofuryl Capsules, III-873
Sulfate, III-864 Drops, III-60
Naftidrofuryl Hydrogen Oxalate see
Morphine Sulphate Injection, see Spray, III-60
Naftidrofuryl Oxalate
Morphine Sulfate Injection, III-864 Nasal Drops and Liquid Nasal Sprays,
Naftidrofuryl Oxalate, II-332
Morphine Suppositories, III-862 III-59
Nalidixic Acid, II-334, V-S99
Morphine Tablets, III-863 Nasal Powders, III-60
Nalidixic Acid Oral Suspension, III-874
Morphine Tablets, Prolonged-release, Nasal Preparations, III-58
Nalidixic Acid Tablets, III-874
III-864 Nasal Preparations of the BP, III-60
Nalorphine Hydrochloride, V-A91
Nasal Preparations, Semi-solid, III-60
V-A840 Index

Nasal Sticks, III-60 Neurovirulence, V-464 Nicoumalone Tablets, see Acenocoumarol


Nasal Washes, III-60 Neurovirulence of live virus vaccines, Tablets
Nateglinide, II-348 Test for, V-464 Nicoumalone, see Acenocoumarol
Natrium Carbonicum, V-609 Neurovirulence of poliomyelitis vaccine Nifedipine, II-373, V-S102
Natrium Muriaticum, V-609 (oral), Test for, V-465 Nifedipine Capsules, III-894
Natrium Sulfuricum, V-609 Neutral Adrenaline Eye Drops/Neutral Nifedipine Capsules, Prolonged-release,
Natural Camphor, I-390 Epinephrine Eye Drops, III-104 III-895
Natural Light Kaolin, II-47 Neutral Aluminium Oxide, V-A23 Nifedipine Tablets, Prolonged-release,
Natural Vitamin A Ester Concentrate, Neutral Insulin, see Insulin Injection III-897
II-1168 Neutral Insulin Injection, see Insulin Niflumic Acid, II-374
NCIMB, V-628 Injection Nifuroxazide, II-376
NCIMB - National Collection of Neutral Red, V-A93 Nikethamide, II-377, V-S102
Industrial and Marine Bacteria, Neutral Red Solution, V-A93 Nikethamide Injection, III-898
address of, I-31, II-31, III-31, IV-31, Nevirapine Anhydrous, II-358 Nile Blue A, V-A93
V-31 Nevirapine Hemihydrate, II-359 Nile Blue A Solution, V-A93
NCPF, V-628 Niaouli Oil, Cineole Type, IV-285 Nilutamide, II-378
NCPF - National Collection of Nicergoline, II-360 Nimba Leaf, see Azadirachta Indica Leaf
Pathogenic Fungi, address of, I-31, Nickel Chloride Solution, Ammoniacal, Nimesulide, II-379
II-31, III-31, IV-31, V-31 V-A93 Nimodipine, II-381
NCTC, V-628 Nickel Chloride, see Nickel(II) Chloride Nimodipine Infusion, III-898
NCTC - National Collection of Type Nickel in Hydrogenated Vegetable Oils, Nimodipine Intravenous Infusion, see
Cultures, address of, I-31, II-31, V-299 Nimodipine Infusion,
III-31, IV-31, V-31 Nickel Liposoluble Standard Solution Nimodipine Tablets, III-899
NCYC, V-628 (1000 ppm Ni), V-A151 Ninhydrin, V-A93
NCYC - National Collection of Yeast Nickel Nitrate Hexahydrate, V-A93 Ninhydrin and Stannous Chloride
Cultures, address of, I-31, II-31, Nickel Standard Solution (0.1 ppm Ni), Reagent, V-A93
III-31, IV-31, V-31 V-A151 Ninhydrin and Stannous Chloride
N,N-Diethylaniline, V-A53 Nickel Standard Solution (0.2 ppm Ni), Reagent R1, V-A93
N,N-Dimethylaniline, V-A56 V-A151 Ninhydrin Reagent I, V-A93
N,N-Dimethylformamide dimethylacetal, Nickel Standard Solution (5 ppm Ni), Ninhydrin Solution, V-A94
V-A56 V-A151 Ninhydrin Solution R1, V-A94
N,N-Dimethyloctylamine, V-A56 Nickel Standard Solution (10 ppm Ni), Ninhydrin Solution R2, V-A94
N,N-Dimethylpiperazine, V-A57 V-A151 Ninhydrin Solution R3, V-A94
N,N-Dimethyl-p-nitrosoaniline, V-A56 Nickel Sulfate, see Nickel(ii) Sulfate, Ninhydrin Solution R4, V-A94
N,N-Dimethyl-p-phenylenediamine V-A93 Nitrate Standard Solution (2 ppm NO3),
Dihydrochloride, V-A56 Nickel Sulphate, see Nickel Sulfate V-A151
N,N-Dimethyltetradecylamine, V-A57 Nickel-Aluminium Alloy, V-A93 Nitrate Standard Solution (10 ppm
N,N-Diphenylbenzidine, V-A58 Nickel-Aluminium Alloy (Halogen-free), NO3), V-A151
Near-infrared Spectrophotometry, V-163 V-A93 Nitrate Standard Solution (100 ppm
Neohesperidin, V-A92 Nickel(II) Chloride, V-A93 NO3), V-A151
Neohesperidin-Dihydrochalcone, II-350 Nickel(II) Chloride Hexahydrate, V-A93 Nitrate-free Water, V-A140
Neomycin Cream, Hydrocortisone and, Nickel(ii) Sulfate, V-A93 Nitrates, Reactions of, V-269
III-652 Nickel(ii) Sulphate, see Nickel(ii)Sulfate Nitrazepam, II-382, V-A94
Neomycin Ear Drops, Hydrocortisone Niclosamide, V-S101 Nitrazepam Impurity A, V-A94
Acetate and, III-654 Niclosamide, Anhydrous, II-362 Nitrazepam Oral Suspension, III-901
Neomycin Ear Drops, Hydrocortisone Niclosamide Monohydrate, II-363 Nitrazepam Tablets, III-901
and, III-654 Niclosamide Tablets, III-884 Nitrendipine, II-383
Neomycin Ear Spray, Dexamethasone Niclosamide see Niclosamide, Anhydrous Nitric Acid, II-385, V-A94
and, III-438 Nicorandil, II-364, V-S101 Nitric Acid, Cadmium- and Lead-free,
Neomycin Eye Drops, III-880 Nicorandil Tablets, III-885 V-A94
Neomycin Eye Drops, Hydrocortisone Nicotinamide, II-365, V-S101 Nitric Acid, Dilute, V-A94
Acetate and, III-654 Nicotinamide Tablets, III-887 Nitric acid, Dilute R1, V-A94
Neomycin Eye Ointment, III-881 Nicotinamide-adenine Dinucleotide, Nitric acid, dilute R2, V-A94
Neomycin Eye Ointment, V-A93 Nitric Acid, Fuming, V-A94
Hydrocortisone Acetate and, III-655 Nicotinamide-adenine Dinucleotide Nitric Acid, Heavy Metal-free, V-A94
Neomycin Sulfate, II-352 Solution, V-A93 Nitric Acid, Lead-free, V-A95
Neomycin Sulphate see Neomycin Sulfate Nicotine, II-366, V-S102 Nitric Acid, Lead-free, Dilute, V-A95
Neomycin Tablets, III-882 Nicotine Ditartrate Dihydrate, II-367 Nitric Acid, Lead-free R1, V-A95
Neonatal Naloxone Injection, III-876 Nicotine Inhalation Cartridges, III-887 Nitric Acid Solution of Mercury, V-A84
Neostigmine Bromide, II-353 Nicotine Nasal Spray, III-888 Nitric Acid VS, V-A145
Neostigmine Injection, III-883 Nicotine Resinate, II-369 Nitric Oxide, II-385
Neostigmine Metilsulfate, II-355 Nicotine Resinate Medicated Chewing Nitrile Silica Gel for Chromatography,
Neostigmine Tablets, III-884 Gum, III-892 V-A116
Neroli Oil, IV-287 Nicotine Sublingual Tablets, III-890 Nitrile Silica Gel for Chromatography
trans-Nerolidol, V-A92 Nicotine Transdermal Patches, III-891 R1, V-A118
Neryl Acetate, V-A93 Nicotinic Acid, II-370, V-A93 Nitrile Silica Gel for Chromatography
Nessler Cylinders, V-270 Nicotinic Acid Tablets, III-894 R2, V-A118
Netilmicin Sulfate, II-356 Nicotinyl Alcohol Tablets, III-894 Nitrilotriacetic Acid, V-A95
Netilmicin Sulphate see Netilmicin Sulfate Nicotinyl Alcohol Tartrate, II-372 Nitrite Standard Solution (20 ppm
Nettle Leaf, IV-288 NO2), V-A151
page numbers in bold type relate to monograph titles Index V-A841

4-Nitroaniline, V-A95 Nonoxinol 9, II-395 Nucleic acid amplification, isothermal


Nitroaniline Solution, Diazotised, V-A95 Non-sterile Pharmaceutical Preparations ribonucleic acid (RNA) amplification,
Nitroaniline, see 4-Nitroaniline and Substances for Pharmaceutical V-451
2-Nitrobenzaldehyde, V-A95 Use, Microbiological Quality of, V-702 Nucleic acid amplification, ligase chain
Nitrobenzaldehyde Paper, V-A95 Non-sterile Products, Microbiological reaction (LCR), V-451
Nitrobenzaldehyde Solution, V-A95 Examination of (Microbial Nucleic acid amplification, polymerase
Nitrobenzaldehyde, see Enumeration Tests), V-700 chain reaction (PCR), V-451
2-Nitrobenzaldehyde Non-sterile Products, Microbiological Nucleic acid amplification techniques,
Nitrobenzene, V-A95 Examination of (Test for Specified V-451
4-Nitrobenzoic Acid, V-A95 Micro-organisms), V-478 Nucleic Acids in Polysaccharide
Nitrobenzoyl Chloride, V-A95 Non-sterile Products, Microbiological Vaccines, V-466
4-Nitrobenzyl Bromide, V-A95 Examination of (Test for Specified Numeration of CD34/CD45 Cells in
4-Nitrobenzyl Chloride, V-A95 Micro-organisms), V-700 Haematopoietic Products, V-458
Nitrobenzyl Chloride, see 4-Nitrobenzyl Nonylamine, V-A96 Nutmeg Oil, IV-291
Chloride Noradrenaline Acid Tartrate, V-A96 Nystatin, II-416
4-(4-Nitrobenzyl)pyridine, V-A95 Noradrenaline Acid Tartrate / Nystatin Ointment, III-911
Nitrochromic Reagent, V-A95 Norepinephrine Acid Tartrate, II-395 Nystatin Oral Drops, III-911
Nitroethane, V-A95 Noradrenaline Concentrate, Sterile, Nystatin Oral Suspension, III-911
2-Nitroethanol, V-A95 III-905 Nystatin Pastilles, III-911
Nitrofurantoin, II-386, V-A95 Noradrenaline Hydrochloride / Nystatin Pessaries, III-912
Nitrofurantoin Oral Suspension, III-902 Norepinephrine Hydrochloride, II-397 Nystatin Tablets, III-912
Nitrofurantoin Tablets, III-903 Noradrenaline Injection, III-904
Nitrofurazone, II-387 Noradrenaline Tartrate see Noradrenaline
(5-Nitro-2-furyl)methylene Diacetate,
V-A95
Acid Tartrate / Norepinephrine Acid
Tartrate
O
Oak Bark, IV-292
Nitrogen, II-388, V-A95 Nordazepam, V-A96
N,O-Bis(trimethylsilyl)acetamide, V-A33
Nitrogen, Determination of, V-287 Norepinephrine Concentrate, Sterile,
Ochratoxin A in Herbal Drugs,
Nitrogen Dioxide, V-A95 III-905
Determination of, V-343
Nitrogen Dioxide in Medical Gases, Norepinephrine Injection, III-904
Ochratoxin A Solution, V-A96
Determination of Nitrogen Monoxide Norethisterone, II-399
Octadecan-1-ol, V-A96
and,V-311 Norethisterone Acetate, II-400
Octadecanoylaminopropylsilyl Silica Gel
Nitrogen for Chromatography, V-A95 Norethisterone Acetate Tablets, Estradiol
for Chromatography, V-A116
Nitrogen Gas Mixture, V-A95 and, III-534
Octadecyl [3-[3,5-bis(1,1-dimethylethyl)-
Nitrogen Monoxide, V-A95 Norethisterone Tablets, III-906
4-hydroxyphenyl]-propionate], V-A96
Nitrogen Monoxide and Nitrogen Norethisterone Tablets, Estradiol and,
Octadecylsilyl Amorphous Organosilica
Dioxide in Medicinal Gases, III-532
Polymer, V-A98
Determination of, V-311 Norfloxacin, II-402
Octadecylsilyl Amorphous Organosilica
Nitrogen, Oxygen-free, V-A95 Norfloxacin Eye Drops, III-907
Polymer, End-capped Polar-
Nitrogen R1, V-A95 Norfloxacin Tablets, III-907
embedded, V-A98
Nitrogen-free Sulfuric Acid, V-A129 Norflurane, II-404
Octadecylsilyl Silica Gel for
Nitroglycerin Tablets, see Glyceryl Norgestimate, II-410
Chromatography, V-A116
Trinitrate Tablets Norgestrel, II-411
Octadecylsilyl Silica Gel for
Nitromethane, V-A95 Norgestrel Tablets, III-908
Chromatography R1, V-A118
Nitro-molybdovanadic Reagent, see Nitro- DL-Norleucine, V-A96
Octadecylsilyl Silica Gel for
vanado-molybdic Reagent Normal Immunoglobulin, IV-492
Chromatography R2, V-A118
4-Nitrophenol, V-A96 Normal Immunoglobulin for Intravenous
Octadecylsilyl Vinyl Polymer for
4-Nitrophenylcarbamidesilyl Silica Gel Use, IV-494
Chromatography, V-A139
for Chromatography, V-A116 Normal Immunoglobulin Injection, see
Octanal, V-A96
5-Nitrosalicylic Acid, V-A96 Normal Immunoglobulin
Octane, V-A96
N-Nitrosodiethanolamine, V-A96 Noroxymorphone, V-A96
Octanoic Acid, II-417, V-A97
Nitrosodipropylamine, V-A96 Norpseudoephedrine Hydrochloride,
Octan-1-ol, V-A97
Nitrosodipropylamine Solution, V-A96 V-A96
Octan-1-ol, see Octanol
Nitrotetrazolium Blue, V-A96 Nortriptyline Capsules, III-909
3-Octanone, V-A97
Nitrous Oxide, II-390, V-A96 Nortriptyline Hydrochloride, II-412
Octoxinol 10, II-418, V-A97
Nitrous Oxide in Gases, Determination Nortriptyline Tablets, III-910
Octreotide Acetate, V-A97
of, V-312 Noscapine, II-414
Octyl Gallate, II-419
Nitro-vanado-molybdic Reagent, V-A96 Noscapine Hydrochloride, II-415, V-A96
Octylamine, V-A97
Nizatidine, II-391, V-S103 Notices, I-ix, II-vii, III-vii, IV-vii, V-vii
Octylamine Phosphate Buffer pH 3.0,
Nizatidine Infusion, III-903 Notices, General, I-1, II-1, III-1, IV-1,
V-A155
Nizatidine Intravenous Infusion, see V-1
Octyldodecanol, II-420
Nizatidine Infusion, Notoginseng Root, IV-290
Octylsilyl Silica Gel for Chromatography,
Nizatidine Sterile Concentrate, III-903 Nov/Ser, see Gas-gangrene Antitoxin
V-A117
NMR, see Nuclear Magnetic Resonance (Novyi)
Octylsilyl Silica Gel for Chromatography
Spectrometry Nuclear Magnetic Resonance
R1, V-A118
N-Nitrosodiisopropanolamine, V-A96 Spectrometry, V-170
Octylsilyl Silica Gel for Chromatography
Nomegestrol Acetate, II-394 Nucleated Cell Count and Viability,
R2, V-A118
Non-aqueous Titration, V-280 V-460
Octylsilyl Silica Gel for Chromatography
Non-ionic Emulsifying Wax, see Nucleic acid amplification, branched
R3, V-A118
Cetomacrogol Emulsifying Wax deoxyribonucleic acid (bDNA), V-451
Nonivamide, V-A96
V-A842 Index

3-O-Desacyl-4-Monophosphoryl Lipid Opium Tincture, IV-299 Oromucosal Preparations, III-61


A, I-685 Opium Tincture, Camphorated, IV-300 Oromucosal Preparations, Semi-solid,
Odour, V-270 Opium Tincture, Concentrated III-62
Odour and Taste of Essential Oils, Camphorated, IV-300 Oromucosal Solutions and Oromucosal
V-321 Optical Microscopy, V-521 Suspensions, III-62
Official, Definition of, I-3, II-3, III-3, Optical Rotation, Determination of, Orphenadrine Citrate, II-448
IV-3, V-3 V-244 Orphenadrine Hydrochloride, II-449
Official Standards, I-4, II-4, III-4, IV-4, OPV, see Poliomyelitis Vaccine, Live Orphenadrine Hydrochloride Tablets,
V-4 (Oral) III-924
Official Titles, I-7, II-7, III-7, IV-7, V-7 Oracet Blue 2R, V-A97 Orthophosphoric Acid, V-A98
Ofloxacin, II-421 Oracet Blue 2R Solution, V-A97 Orthophosphorous Acid, V-A98
Oils Rich in Omega-3-acids, V-327 Oracet Blue B, V-A97 Orthophosphorous Acid, see Phosphorous
Oily Cream, III-660 Oracet Blue B Solution, V-A97 Acid
Oily Phenol Injection, III-977 Oracet Blue Solution, Dimethyl Yellow Oseltamivir Oral Solution, Paediatric,
Ointment, Simple, III-1085 and, V-A57 III-925
Ointments, III-47, III-71, III-72 Oral, III-58 Oseltamivir Phosphate, II-451
Eye, III-47 Emulsions, III-58 Osmium Tetroxide, V-A98
Olanzapine, II-422 Oral Drops, III-57 Osmium Tetroxide Solution, V-A98
Old Tuberculin, IV-645 Oral Liquid, III-56 Osmolality, Determination of, V-255
Oleamide, V-A97 Oral Liquids, Bioequivalence of, V-784 Osthole, V-A98
Oleanolic Acid, V-A97 Oral Liquids of the BP, III-58 Ouabain, II-453
Oleic Acid, II-424, V-A97 Oral Liquids, Preservative-free, V-783 Oxacillin Sodium Monohydrate, II-454
Oleoresins, IV-48 Oral Liquids, Unlicensed, III-79 Oxalic Acid, V-A98
Oleoyl Macrogolglycerides, II-425 Oral Lyophilisates, III-76 Oxalic Acid and Sulfuric Acid Solution,
Oleuropein, V-A97 Oral Powders, III-66 V-A98
Oleyl Alcohol, II-426, V-A97 Oral Rehydration Salts, III-921 Oxalic Acid and Sulphuric Acid
Olive Leaf, IV-292 Oral Solutions, Emulsions and Solution, see Oxalic Acid and Sulfuric
Olive Leaf Dry Extract, IV-294 Suspensions, III-57 Acid Solution
Olive Oil, V-A97 Oral Suspensions, Unlicensed, III-79 Oxaliplatin, II-457
Olive Oil Ear Drops, III-912 Oral Use, Liquid Preparations for, III-56 Oxazepam, II-459, V-S104, V-A98
Olive Oil Refined, II-427 Orange Oil, IV-302 Oxazepam Tablets, III-926
Olive Oil Substrate Emulsion, V-A97 Orange Oil, Terpeneless, IV-303 Oxcarbazepine, II-461
Olive Oil Virgin, II-426 Orange Peel Infusion, IV-305 Oxeladin Hydrogen Citrate, II-463
Olive Oil see Virgin Olive Oil Orange Peel Infusion, Concentrated, Oxetacaine, II-464, V-S104
Olmesartan Medoxomil, II-428 IV-305 Oxidising Substances, V-321
Olsalazine Sodium, II-430 Orange Spirit, Compound, IV-304 Oxitropium Bromide, II-465
Omega-3-Acid Ethyl Esters 60, II-433 Orange Syrup, IV-306 Oxolinic Acid, II-466
Omega-3-Acid Ethyl Esters 90, II-435 Orange Tincture, IV-305 Oxprenolol, V-S104
Omega-3-Marine Triglycerides, II-437 Orcinol, V-A97 Oxprenolol Hydrochloride, II-467
Omeprazole, II-439 Orciprenaline Oral Solution, III-922 Oxprenolol Tablets, III-927
Omeprazole Capsules, Gastro-resistant, Orciprenaline Sulfate, II-446 2,2-Oxybis(N,N-dimethylethylamine,
III-913 Orciprenaline Sulphate see Orciprenaline V-A98
Omeprazole Magnesium, II-441 Sulfate Oxybuprocaine Eye Drops, III-927
Omeprazole Oral Suspension, III-915 Orciprenaline Tablets, III-923 Oxybuprocaine Hydrochloride, II-468
Omeprazole Sodium, II-442 Oregano, IV-306 Oxybutynin, V-S105
Omeprazole Tablets, Gastro-resistant, Organ Preservation Solutions, III-923 Oxybutynin Hydrochloride, II-470
III-917 Organosilica Polymer, Amorphous, Oxybutynin Oral Solution, III-928
3-O-Methyldopamine hydrochloride, Octadecylsilyl, V-A98 Oxybutynin Tablets, III-929
V-A87 Organosilica Polymer, Amorphous, Oxycodone, V-S105
3-O-Methylestrone, V-A88 Octadecylsilyl, End-capped, V-A98 Oxycodone Capsules, III-932
Omissions, I-xxiii Organosilica Polymer, Amorphous, Oxycodone Hydrochloride, II-471
Omissions, List of, I-xxix Polar-embedded Octadecylsilyl, End- Oxycodone Injection, III-933
Ondansetron, V-S103 capped, V-A98 Oxycodone Oral Solution, III-934
Ondansetron Hydrochloride, V-S103 Organosilica Polymer, Amorphous, Oxycodone Tablets, Prolonged-release,
Ondansetron Hydrochloride Dihydrate, Propyl-2-phenylsilyl, End-capped, III-936
II-444 V-A98 Oxygen, II-473, V-A98
Ondansetron Injection, III-918 Organosilica Polymer for Mass Oxygen (15O), IV-700
Ondansetron Tablets, III-919 Spectrometry, Amorphous, Oxygen (93 per Cent), II-473
Opacity, Standard Preparation of, Octadecylsilyl, End-capped, V-A98 Oxygen in Medicinal Gases,
V-A160 Oriental Cashew for Homoeopathic Determination of, V-311
o,p-DDT, V-A49 Preparations, see Anacardium for Oxygen R1, V-A98
Ophthalmic Inserts, III-46 Homoeopathic Preparations Oxygen-flask Combustion, V-281
Opiate Linctus for Infants, IV-373 Orientvine Stem, IV-307 Oxygen-free Nitrogen, V-A95
Opiate Squill Linctus, IV-373 Orodispersible Films, III-63 Oxymetazoline Hydrochloride, II-475
Opiate Squill Linctus, Paediatric, IV-373 Orodispersible Mirtazapine Tablets, Oxymetholone, II-476, V-S105
Opiate Squill Oral Solution, IV-373 III-851 Oxymetholone Tablets, III-937
Opiate Squill Oral Solution, Paediatric, Orodispersible Tablets, III-75 Oxytetracycline Calcium, II-479
IV-373 Oromucosal Capsules, III-63 Oxytetracycline Capsules, III-937
Opium, IV-294 Oromucosal Drops, Oromucosal Sprays Oxytetracycline Dihydrate, II-477
Opium Prepared, IV-296 and Sublingual Sprays, III-62
page numbers in bold type relate to monograph titles Index V-A843

Oxytetracycline Hydrochloride, II-480, Palladium Standard Solution (500 ppm Paracetamol Tablets, Codeine Phosphate
V-A98 Pd), V-A151 and, Effervescent, see Effervescent Co-
Oxytetracycline Tablets, III-938 Palladium(II) Chloride, V-A98 codamol Tablets
Oxytocin, II-482 Palm Kernel Oil, Fractionated, II-488 Paracetamol Tablets, Codeine Phosphate
Oxytocin Concentrated Solution, II-483 Palmatine Chloride, V-A98 and, see Co-codamol Tablets
Oxytocin Injection, III-940 Palmitic Acid, II-487, V-A98 Paracetamol Tablets, Codeine
Oxytocin Injection, Ergometrine and, Palmitoleic Acid, V-A99 Phosphate, Caffeine and, see
III-517 Palmityl Alcohol, V-A99 Paracetamol, Codeine Phosphate and
Pamidronate Disodium for Infusion, Caffeine Tablets
III-940 Paracetamol Tablets,
P Pamidronate Disodium for Intravenous
Infusion, III-940
Dextropropoxyphene Hydrochloride
and, see Co-proxamol Tablets
Paclitaxel, II-484
Pamidronate Disodium Infusion, III-940 Paracetamol Tablets, Dihydrocodeine
Paediatric Alimemazine Oral Solution,
Pamidronate Disodium Intravenous and, see Co-dydramol Tablets
III-115
Infusion, III-940 Paracetamol Tablets, Dispersible, III-950
Paediatric Alimemazine Oral Solution,
Pamidronate Disodium Pentahydrate, Paracetamol Tablets, Effervescent,
Strong, III-116
II-488 III-950
Paediatric Codeine Linctus, III-385
Pancreas Powder, V-A99 Paracetamol Tablets, Soluble, III-951
Paediatric Codeine Oral Solution see
Pancreatic Extract, II-489 Paraffin, Hard, II-499
Paediatric Codeine Linctus
Pancreatin, II-492 Paraffin, Light Liquid, II-500
Paediatric Compound Tolu Linctus,
Pancreatin, Assay of, V-416 Paraffin, Liquid, II-501, V-A99
IV-392
Pancreatin Granules, III-941 Paraffin Ointment, III-960
Paediatric Compound Tolu Oral
Pancreatin Tablets, Gastro-resistant, Paraffin Oral Emulsion, Liquid, III-960
Solution, IV-392
III-942 Paraffin, Soft White, II-502
Paediatric Co-trimoxazole Oral
Pancreatin Tablets, see Gastro-resistant Paraffin, White Soft, V-A99
Suspension, III-409
Pancreatin Tablets Paraffin, Yellow Soft, II-502
Paediatric Co-trimoxazole Tablets,
Pancuronium Bromide, II-493 Paraldehyde, II-503, V-A99
III-411
Pancuronium Injection, III-942 Paraldehyde Injection, III-961
Paediatric Digoxin Injection, III-462
Panels of Experts, I-xii Parametric Release, I-4, II-4, III-4,
Paediatric Digoxin Oral Solution, III-462
Pantoprazole Sodium Sesquihydrate, IV-4, V-4
Paediatric Docusate Oral Solution,
II-494 Pararosaniline Hydrochloride, V-A99
III-487
Papain, V-A99 Pararosaniline Solution, Decolorised,
Paediatric Ferrous Sulfate Oral Solution,
Papaveretum, II-495 V-A99
III-557
Papaveretum Injection, III-943 Parenteral Preparations, III-64
Paediatric Ferrous Sulphate Oral
Papaverine Hydrochloride, II-496, Parenteral Preparations of the BP, III-66
Solution, see Paediatric Ferrous Sulfate
V-S106, V-A99 Parenteral Preparations, Test for
Oral Solution
Papaverine Injection, III-944 Extractable Volume of, V-374
Paediatric Ipecacuanha Emetic, IV-225
Paper Chromatography, V-204 Parenteral Preparations, Test for
Paediatric Ipecacuanha Emetic Mixture,
Paper Chromatography Performance Extractable Volume of, V-701
IV-225
Test Solutions, V-A99 Parenteral Preparations, Water for Use in
Paediatric Ipecacuanha Emetic Oral
Paper for Chromatography, V-A99 Manufacture of, III-66
Solution, IV-225
Paracetamol, II-498, V-S106, V-A99 Parnaparin Sodium, II-504
Paediatric Opiate Squill Linctus, IV-373
Paracetamol, 4-Aminophenol-free, Paroxetine Hydrochloride, Anhydrous,
Paediatric Opiate Squill Oral Solution,
V-A99 II-504
IV-373
Paracetamol and Caffeine Tablets, Paroxetine Hydrochloride Hemihydrate,
Paediatric Oseltamivir Oral Solution,
III-952 II-507
III-925
Paracetamol and Caffeine Tablets, Paroxetine Tablets, III-961
Paediatric Paracetamol Oral Solution,
Soluble, III-953 Parthenolide, V-A99
III-945
Paracetamol and Dihydrocodeine Partially Dehydrated Liquid Sorbitol,
Paediatric Paracetamol Oral Suspension,
Tablets, see Co-dydramol Tablets II-889
III-947
Paracetamol Capsules, III-944 Partially Hydrated Magnesium Chloride,
Paediatric Phenobarbital Oral Solution,
Paracetamol Capsules, Codeine II-165
III-976
Phosphate and, see Co-codamol Capsules Particle characterisation by Microscopy,
Paediatric Simple Linctus, III-1085
Paracetamol Capsules, Codeine V-521
Paediatric Trimethoprim and
Phosphate, Caffeine and, see Particle Size Analysis by Laser Light
Sulfamethoxazole Oral Suspension,
Paracetamol, Codeine Phosphate and Diffraction, V-522
III-409
Caffeine Capsules Particle Size of Powders, V-501
Paediatric Trimethoprim and
Paracetamol, Codeine Phosphate and Particle Size Classification of Powders,
Sulfamethoxazole Tablets, III-411
Caffeine Capsules, III-955 V-501
Paediatric Vitamins A, C and D Oral
Paracetamol, Codeine Phosphate and Particle-free Water, V-A140
Drops, III-1217
Caffeine Tablets, III-957 Particles, Sub-visible, Particulate
Paeonol CRS, V-A160
Paracetamol Oral Solution, Paediatric, Contamination, V-393
Paints, III-43
III-945 Particles, Visible, Particulate
Palladium, V-A98
Paracetamol Oral Suspension, III-946 Contamination, V-395
Palladium Chloride Solution, V-A98
Paracetamol Oral Suspension, Paediatric, Particle-size Distribution Estimation By
Palladium Standard Solution (0.5 ppm
III-947 Analytical Sieving, V-503
Pd), V-A151
Paracetamol Suppositories, III-948 Particulate Contamination, V-658
Palladium Standard Solution (20 ppm
Paracetamol Tablets, III-949 Particulate Contamination, Limit Tests
Pd), V-A151
for, V-393
V-A844 Index

Particulate Contamination Sub-visible Pentobarbital Sodium, II-524 Petroleum Jelly, Yellow see Paraffin, Soft
ParticlesV-701 Pentobarbital Tablets, III-968 Yellow
Particulate Contamination, Visible Pentoxifylline, II-525 Petroleum, Light, V-A100
Particles, V-395 Pentoxyverine Citrate, II-527 Petroleum, light R4, V-A100
Passion Flower, IV-310 Pentoxyverine Hydrogen Citrate, see Petroleum R1, Light, V-A100
Passion Flower Dry Extract, IV-311 Pentoxyverine Citrate Petroleum R2, Light, V-A100
Pastes, III-72, III-73 tert-Pentyl Alcohol, V-A100 Petroleum R3, Light, V-A100
Pastilles and Lozenges, III-63 Pepper, IV-315 Petroleum Spirit, V-A100
Patches, Transdermal, Dissolution Test Peppermint Emulsion, Concentrated, Petroleum Spirit (boiling range, 408 to
for, V-360 IV-320 608), Aromatic-free, V-A101
Patents, I-ix, II-vii, III-vii, IV-vii, V-vii Peppermint Essence, IV-320 PFU, I-30, II-30, III-30, IV-30, V-30
p-Coumaric Acid, V-A47 Peppermint Leaf, IV-317 pH Indicator Strip, V-A101
p-Cresol, V-A47 Peppermint Leaf Dry Extract, IV-321 pH Values, Determination of, V-252
PCR, see Nucleic acid amplification, Peppermint Oil, IV-319 Pharmaceutical Preparations, III-37,
polymerase chain reaction (PCR) Peppermint Oil Capsules, Gastro- IV-37
PD50, Definition of, I-30, II-30, III-30, resistant, IV-321 Pharmaceutical Preparations,
IV-30, V-30 Peppermint Spirit, IV-320 Microbiological Quality of, V-658
PD50, V-628 Pepsin, II-528, V-A100 Pharmacopoeial Calculations, V-786
p,p-DDD, V-A49 Pepsin Powder, V-A100 Pharmacopoeial Harmonisation, V-699
o,p-DDE, V-A49 Pepsin Powder, see Pepsin pharmacopoeial methods,Implementation
p,p-DDT, V-A49 Peptide Identification by Nuclear of, I-22, II-22, III-22, IV-22, V-22
Pea Starch, II-913 Magnetic Resonance Spectrometry, pharmacopoeial methods,Validation of,
Peanut Oil see Arachis Oil V-187 I-22, II-22, III-22, IV-22, V-22
Pefloxacin Mesilate, II-509 Peptide Mapping, V-218 Pharmacopoeial Quantitative Analysis,
Pelargonium Root, IV-312 Peptide Mapping (2.2.55.) (5.8.), V-699 V-786
Pemetrexed Disodium Heptahydrate, Peptide N-glycosidase F, V-A100 Pharmacopoeial Requirements, Basis of,
II-511 Perchloric Acid, V-A100 V-635
Penbutolol Sulfate, II-514 Perchloric Acid Solution, V-A100 a-Phellandrene, V-A101
Penbutolol Sulphate, see Penbutolol Perchloric Acid VS, V-A145 Phenacetin, V-A101
Sulfate Perfloxacin Mesilate Dihydrate, see Phenanthrene, V-A101
Penetrometry, Measurement of Perfloxacin Mesilate Phenanthroline Hydrochloride, V-A101
Consistency by, V-508 Perf/Ser, see Gas-gangerene Antitoxin Phenazone, II-537, V-A101
Penicillamine, II-515 (Perfringens) Phenelzine Sulfate, II-538
Penicillamine Tablets, III-963 Pergolide Mesilate, II-529 Phenelzine Sulphate, see Phenelzine
Penicillinase Solution, V-A99 Perindopril tert-Butylamine, see Sulfate
Pentaerythrityl Tetrakis[3-(3,5-di-tert- Perindopril Erbumine Phenelzine Tablets, III-974
butyl-4-hydroxyphenyl)propionate, Perindopril Erbumine, II-531 Phenindamine Tartrate, II-538
V-A99 Perindopril Erbumine Tablets, III-968 Phenindione, II-539, V-S109
Pentaerythrityl Tetranitrate, II-517 Periodic Acetic Acid Solution, V-A100 Phenindione Tablets, III-975
Pentaerythrityl Tetranitrate, Diluted Periodic Acid, V-A100 Pheniramine Maleate, II-540
II-517 Periodic Acid Reagent, V-A100 Phenobarbital, II-541, V-S109
Pentafluoropropanoic Acid, V-A99 Periodic Acid Solution, V-A100 Phenobarbital Elixir, III-975
Pentafluoropropionic Anhydride, V-A99 Peritoneal Dialysis Solutions, III-970 Phenobarbital Injection, III-976
Pentagastrin, II-519 Permethrin, V-A100 Phenobarbital Oral Solution, Paediatric,
Pentagastrin Injection, III-964 Peroxide Test Strips, V-A100 III-976
Pentamidine Diisectionate, see Peroxide Value, V-319 Phenobarbital Oral Solution see
Pentamidine Isetionate Peroxide-free Ether, V-A62 Phenobarbital Elixir
Pentamidine Injection, III-964 Peroxyacetic Acid Solution, V-A100 Phenobarbital Sodium, II-543
Pentamidine Isetionate, II-520, V-S106 Perphenazine, II-534, V-S108 Phenobarbital Sodium Tablets, III-977
Pentamidine Isetionate for Injection, Perphenazine Tablets, III-972 Phenobarbital Tablets, III-976
III-964 Pertussis Vaccine (Acellular Phenol, II-544, V-A101
n-Pentane, V-A100 Component), Adsorbed, IV-581 Phenol and Glycerol Injection, III-978
1,2-Pentanediol, V-A100 Pertussis Vaccine (Acellular, Co- Phenol in Immunosera (Antisera) and
Pentane, see n-Pentane purified), Adsorbed, IV-582 Vaccines, V-464
Pentan-1-ol, V-A100 Pertussis Vaccine (Whole Cell, Phenol Injection, Aqueous, III-977
Pentanol, see Pentan-1-ol Adsorbed), IV-602 Phenol Injection, Oily, III-977
3-Pentanone, V-A100 Pertussis Vaccine (Whole Cell), Assay of, Phenol, Liquefied, II-544, V-A101
Pentazocine, II-521 V-440 Phenol Red, V-A101
Pentazocine Capsules, III-965 Pertussis Vaccine (acellular), V-446 Phenol Red Solution, V-A101
Pentazocine (Form B), V-S107 Peru Balsam, IV-322 Phenol Red Solution R1, V-A101
Pentazocine Hydrochloride, II-521 Perylene, V-A100 Phenol Red Solution R2, V-A101
Pentazocine Injection, III-966 Pessaries, III-80 Phenol Red Solution R3, V-A101
Pentazocine Lactate, II-522, V-S107 Pesticide Residues, V-336 Phenoldisulfonic Acid Solution, V-A101
Pentazocine Suppositories, III-967 Pethidine, V-S108 Phenoldisulphonic Acid Solution, see
Pentazocine Tablets, III-967 Pethidine Hydrochloride, II-535, V-S108 Phenoldisulfonic Acid Solution
Pentetate Sodium Calcium for Pethidine Injection, III-973 Phenolphthalein, II-545, V-A101
Radiopharmaceutical Preparations, Pethidine Tablets, III-974 Phenolphthalein Paper, V-A101
IV-664 Petroleum Jelly, White see Paraffin, Soft Phenolphthalein solution, V-A101
Pentetic Acid, V-A100 White Phenolphthalein Solution R1, V-A101
Pentobarbital, II-523, V-S107
page numbers in bold type relate to monograph titles Index V-A845

Phenolphthalein-Thymol Blue Solution, Phloroglucide, V-A102 Phosphate Buffer Solution pH 7.0 R5,
V-A101 Phloroglucinol, V-A102 V-A157
Phenolsulfonphthalein, II-546 Phloroglucinol, Anhydrous, II-566 Phosphate Buffer Solution pH 6.0, see
Phenolsulphonphthalein, see Phloroglucinol Dihydrate, II-568 Citro-phosphate Buffer pH 6.0
Phenolsulfonphthalein Phloroglucinol Solution, V-A102 Phosphate Buffer Solution pH 6.8, see
Phenothiazines, Related Substance in, Pholcodine, II-570, V-S110 Citro-phosphate Buffer pH 6.8
V-197 Pholcodine Linctus, III-987 Phosphate Buffer Solution pH 7.0, see
Phenoxyacetic Acid, V-A101 Pholcodine Linctus, Strong, III-988 Citro-phosphate Buffer pH 7.0
2-Phenoxyaniline, V-A102 Pholcodine Oral Solution, Strong see Phosphate Buffer Solution pH 7.2, see
Phenoxybenzamine Capsules, III-978 Pholcodine Linctus, Strong Citro-phosphate Buffer pH 7.2
Phenoxybenzamine Hydrochloride, Pholcodine Oral Solution see Pholcodine Phosphate Buffer Solution pH 3.5, see
II-546, V-S109, V-A102 Linctus Phosphate Buffer pH 3.5
Phenoxyethanol, II-547, V-A102 Phosalone, V-A102 Phosphate Buffer Solution pH 3.25, see
Phenoxyethanol, see 2-Phenoxyethanol Phosphate Buffer, 0.025M Standard, Phosphate Buffer pH 3.25
Phenoxymethylpenicillin, II-548 V-A156 Phosphate Buffer Solution pH 3.2,
Phenoxymethylpenicillin Oral Solution, Phosphate Buffer pH 7.5, 0.2M, V-A156 V-A156, V-A157
III-980 Phosphate Buffer pH 6.8, 0.2M Mixed, Phosphate Buffer Solution pH 2.0,
Phenoxymethylpenicillin Potassium, V-A156 V-A156
II-550 Phosphate Buffer pH 2.5 R1, see Buffer Phosphate Buffer Solution pH 2.8,
Phenoxymethylpenicillin Tablets, III-981 Solution pH 2.5 V-A156
Phentolamine Injection, III-982 Phosphate Buffer pH 2.5, see Buffer Phosphate Buffer Solution pH 3.0,
Phentolamine Mesilate, II-552 Solution pH 2.5 V-A156
Phenyl Benzoate, V-A102 Phosphate Buffer pH 3.0, V-A156 Phosphate Buffer Solution pH 3.5,
Phenyl Isothiocyanate, V-A102 Phosphate Buffer pH 3.5, V-A156 V-A156
Phenyl Silica Gel for Chromatography, Phosphate Buffer pH 5.4, Mixed, Phosphate Buffer Solution pH 7.4,
V-A117 V-A156 V-A157
Phenylacetic Acid, V-A102 Phosphate Buffer pH 4.0, V-A156 Phosphate Buffer Solution pH 5.4,
Phenylalanine, II-554, V-A102 Phosphate Buffer pH 4.0, Mixed, 0.067m, V-A157
o-Phenylbenzoic Acid, V-A102 V-A156 Phosphate Buffer Solution pH 6.5,
Phenylbutazone, II-555 Phosphate Buffer pH 4.75, V-A156 V-A157, V-A158
N-Phenylcarbazole, V-A102 Phosphate Buffer pH 4.9, V-A156 Phosphate Buffer Solution pH 7.5,
p-Phenylenediamine Dihydrochloride, Phosphate Buffer pH 6.8, Mixed, 0.05m, V-A158
V-A102 V-A156 Phosphate Buffer Solution pH 5.0,
Phenylephrine, II-557 Phosphate Buffer pH 7.0, Mixed, V-A156
Phenylephrine Eye Drops, III-983 V-A156 Phosphate Buffer Solution pH 5.5,
Phenylephrine Hydrochloride, II-558 Phosphate Buffer pH 10, Mixed, V-A156 V-A157
Phenylephrine Injection, III-984 Phosphate Buffer pH 3.25, V-A156 Phosphate Buffer Solution pH 5.6,
Phenylephrine Injection, Intracameral, 0.2M Phosphate Buffer Solution pH 7.5, V-A157
III-984 see Phosphate buffer pH 7.5, 0.2M Phosphate Buffer Solution pH 5.8,
Phenylephrine Intracameral Injection, 0.1M Phosphate Buffer Solution pH 7.0, V-A157
III-984 see Phosphate Buffer pH 7.0, 0.1M Phosphate Buffer Solution pH 6.0,
DL-Phenylglycine, V-A102 Mixed V-A157
-Phenylglycine, see DL-Phenylglycine 0.2M Phosphate Buffer Solution pH 2.5, Phosphate Buffer Solution pH 6.8,
Phenylhexylsilyl Silica Gel for see Phosphate Buffer Solution pH 2.5, V-A157
Chromatography, V-A117 0.2M Phosphate Buffer Solution pH 7.0,
Phenylhydrazine, V-A102 0.1M Phosphate Buffer Solution pH 6.7 V-A157
Phenylhydrazine Hydrochloride, V-A102 see Phosphate Buffer Solution pH 6.7, Phosphate Buffers, V-A155
Phenylhydrazine Hydrochloride Solution, 0.1M Phosphate Oral Solution, III-989
V-A102 0.1M Phosphate Buffer Solution pH 6.3, Phosphate Standard Solution (5 ppm
Phenylhydrazine-Sulfuric Acid Solution, V-A157 PO4), V-A151
V-A102 0.05M Phosphate Buffer Solution Phosphate Standard Solution (100 ppm
Phenylhydrazine-Sulphuric Acid pH 7.5, see Phosphate Buffer Solution PO4), V-A151
Solution, see Phenylhydrazine-Sulfuric pH 7.5, 0.05M Phosphate Standard Solution (200 ppm
Acid Solution Phosphate Buffer solution pH 7.0, PO4), V-A151
Phenylmercuric Acetate, II-560 0.05m, V-A157 Phosphate-albumin Buffered Saline
Phenylmercuric Borate, II-560 Phosphate Buffer Solution pH 7.5, pH 7.2, V-A158
Phenylmercuric Nitrate, II-561 0.33m, V-A158 Phosphate-albumin Buffered Saline
1-Phenylpiperazine, V-A102 Phosphate Buffer Solution pH 3.0, 0.1M, pH 7.2 R1, V-A158
Phenylpropanolamine Hydrochloride, V-A156, V-A157, V-A158 Phosphate-buffered Saline pH 6.4,
II-562 Phosphate Buffer Solution pH 6.8 R1, V-A158
Phenylsilyl Silica Gel for see Phosphate Buffer pH 6.8, 0.2M Phosphate-buffered Saline pH 6.8,
Chromatography, V-A117 Mixed V-A158
Phenylsilyl Silica Gel for Phosphate Buffer Solution pH 3.2 R1, Phosphate-buffered Saline pH 7.4,
Chromatography R1, V-A118 V-A156, V-A157 V-A158
Phenytoin, II-563, V-S110 Phosphate Buffer Solution pH 7.0 R2, PhosphateCitrate Buffer Solution
Phenytoin Capsules, III-985 V-A157 pH 5.5, V-A158
Phenytoin Injection, III-985 Phosphate Buffer Solution pH 7.0 R3, Phosphates Enema, III-988
Phenytoin Oral Suspension, III-986 V-A157 Phosphates (Orthophosphates),
Phenytoin Sodium, II-564 Phosphate Buffer Solution pH 7.0 R4, Reactions of, V-269
Phenytoin Tablets, III-987 V-A157 Phospholipid, V-A102
V-A846 Index

Phosphomolybdic Acid, V-A103 Piperazine Citrate Elixir, III-995 Poliomyelitis Vaccine, (inactivated), In
Phosphomolybdic Acid Solution, V-A103 Piperazine Citrate Oral Solution, III-995 vivo assay of, IV-611
Phosphomolybdic Acid Solution, Piperazine Dipicrate Solution, V-A104 Poliomyelitis Vaccine (Oral), Test for
Ethanolic, V-A103 Piperazine Hydrate, II-593, V-A104 neurovirulence of, V-448
Phosphomolybdotungstic Reagent, Piperazine Phosphate, II-594 Poliomyelitis Vaccine, Live (Oral),
V-A103 Piperazine Phosphate Tablets, III-995 IV-615
Phosphomolybdotungstic Reagent, Piperazine Phosphate Tablets, Chewable, Poloxamer 124, V-A105
Dilute, V-A103 III-996 Poloxamer 188, V-A105
Phosphoric Acid, II-571, V-A103 1,4-Piperazinediethanesulfonic Acid, Poloxamers, II-605
Phosphoric Acid, Dilute, II-572, V-A103 V-A104 Polyacrylamide Gel, Fixing Solution for
Phosphoric Acid, Dilute R1, V-A103 Piperidine, V-A104 Isoelectric Focusing in, V-A66
Phosphoric Vanillin Solution, V-A139 Piperine, V-A104 Polyacrylate Dispersion (30 per cent),
Phosphorous Acid, V-A103 Piperitone, V-A104 II-606
Phosphorus in Polysaccharide Vaccines, Piperonyl Butoxide CRS, V-A160 Polyamine grafted poly(vinyl alcohol)
V-466 Piracetam, II-595 copolymer, V-A105
Phosphorus Pentoxide, V-A103 Pirenzepine Dihydrochloride Poly[(cyanopropyl)
Phosphotungstic Acid Solution, V-A103 Monohydrate, see Pirenzepine methylphenylmethylsiloxane], V-A105
Phthalaldehyde, V-A103 Hydrochloride Poly[(cyanopropyl)(methyl)][(phenyl)
Phthalaldehyde Reagent, V-A103 Pirenzepine Hydrochloride, II-596 (methyl)]siloxane, see
Phthalate Buffer pH 3.6, V-A158 Piretanide, II-597 Poly[(cyanopropyl)
Phthalate Buffer Solution pH 6.4, 0.5M, Pirimiphos-ethyl, V-A104 methylphenylmethylsiloxane]
V-A158 Piroxicam, II-598 Poly(cyanopropylphenyl)(14)(methyl)
Phthalate Buffer Solution pH 4.4, Piroxicam Capsules, III-996 (86)siloxane, V-A105
V-A158 Piroxicam Gel, III-997 Poly[(cyanopropyl)(phenyl)][dimethyl]
Phthalazine, V-A103 Pivampicillin, II-600 siloxane, V-A105
Phthalein Purple, V-A103 Pivmecillinam Hydrochloride, II-602 Poly(cyanopropyl)(7)(phenyl)(7)methyl)
Phthalic Acid, V-A103 Pizotifen, V-S111 (86)siloxane, V-A105
Phthalic Anhydride, V-A103 Pizotifen Malate, II-603, V-S112 Poly(cyanopropyl)(phenylmethyl)
Phthalic Anhydride Solution, V-A103 Pizotifen Tablets, III-997 siloxane, V-A105
Phthalylsulfathiazole, II-572 Plantain, IV-326 Poly(cyanopropyl)siloxane, V-A105
Phyllanthus Emblica Pericarp, IV-323 Plasma, Citrated Rabbit, V-A104 Poly(dimethyl)(85)(diphenyl)(15)
Physostigmine Salicylate, II-573 Plasma, Factor VII-deficient, V-A104 siloxane, V-A106
Phytomenadione, II-574 Plasma for Fractionation, IV-463 Poly(dimethyl)(75)(diphenyl)(25)
Phytomenadione Injection, III-989 Plasma, Platelet-poor, V-A104 siloxane, V-A105
Phytomenadione Tablets, III-990 Plasma (Pooled and Treated for Virus Poly(dimethyl)(diphenyl)(divinyl)
Phytosterol, II-576 Inactivation), IV-465 siloxane, V-A105
Picein, V-A103 Plasma, Substrate, V-A104 Poly(dimethyl)(diphenyl)siloxane,
Picotamide Monohydrate, II-577 Plasma Substrate Deficient in Factor V, V-A105
Picric Acid, V-A103 V-A104 Poly(dimethyl)(diphenyl)siloxane, base-
Picric Acid Solution, V-A103 Plasma Substrate R1, V-A104 deactivated, V-A105
Picric Acid Solution R1, V-A103 Plasma Substrate R2, V-A105 Poly(dimethyl)siloxane, V-A105
Picrolonic Acid, V-A103 Plasma Substrate R3, V-A105 Polyether Hydroxylated Gel for
Picrotin, V-A104 Plasmin inhibitor, Assay of, V-422 Chromatography, V-A106
Picrotoxinin, V-A104 Plasminogen, Human, V-A105 Polyethylene, V-579
Pillules for Homoeopathic Preparations, Plaster of Paris, see Dried Calcium Sulfate Polyethylene Without Additives for
IV-426 Plastic Additives, V-592 Containers for Parenteral Preparations
Pilocarpine Hydrochloride, II-578 Plastic Containers and Closures, V-553 and for Ophthalmic Preparations,
Pilocarpine Hydrochloride Eye Drops, Plastic Containers for Aqueous Solutions V-579
III-990 for Parenteral Infusions, V-554 Polyethylene With Additives for
Pilocarpine Nitrate, II-580, V-S110 Plastic Containers for Human Blood and Containers for Parenteral Preparations
Pilocarpine Nitrate Eye Drops, III-991 Blood Conponents Sterile, V-555 and for Ophthalmic Preparations,
Pimobendan, II-581 Platelet Substitute, V-A105 V-579
Pimozide, II-582, V-S111 Platelet-poor Plasma, V-A104 Poly(ethylene - vinyl acetate) for
Pimozide Tablets, III-992 Platinum Standard Solution (30 ppm Containers and Tubing for Total
Pindolol, II-584, V-S111 Pt), V-A151 Parenteral Nutrition Preparations,
Pindolol Tablets, III-993 Plutonium-242 Spiking Solution, V-588
Pine Silvestris Oil, IV-325 V-A105 Polyethylene Glycol 20,000
a-Pinene, V-A104 Pneumococcal Polysaccharide Conjugate 2-Nitroterephthalate, V-A106
Pioglitazone Hydrochloride, II-585 Vaccine (Adsorbed), IV-609 Polyethylene Glycol 200 R1, V-A106
Pipemidic Acid Trihydrate, II-586 Pneumococcal Polysaccharide Vaccine, Polyethylene Glycol 20,000, V-A106
Piperacillin, II-588 IV-607 Polyethylene Glycol 200, V-A106
Piperacillin for Infusion, III-994 Pneumo(conj), see Pneumococcal Polyethylene Glycol 300, V-A106
Piperacillin for Intravenous Infusion, see Polysaccharide Conjugate Vaccine Polyethylene Glycol 400, V-A106
Piperacillin for Infusion (Adsorbed) Polyethylene Glycol 1000, V-A106
Piperacillin Infusion, III-994 Pneumo, see Pneumococcal Polysaccharide Polyethylene Glycol 1500, V-A106
Piperacillin Intravenous Infusion, see Vaccine Polyethylene Glycol Adipate, V-A106
Piperacillin Infusion Podophyllin Paint, Compound, IV-328 Polyethylene Glycol Succinate, V-A106
Piperacillin Sodium, II-589 Podophyllum Resin, IV-327 Polyethylene Terephthalate for
Piperazine Adipate, II-591 Poldine Metilsulfate, II-604, V-S112 Containers for Preparations not for
Piperazine Citrate, II-592 Poldine Tablets, III-998 Parenteral Use, V-595
page numbers in bold type relate to monograph titles Index V-A847

Polyethyleneglycol, Polar-deactivated, Potassium Antimonate(V), V-A106 Potassium Clavulanate Injection,


V-A106 Potassium Antimonate(V) Solution, Amoxicillin and, see Co-amoxiclav
Polymethacrylate Gel, V-A106 V-A106 Injection
Polymethacrylate Gel, Hydroxylated, Potassium Ascorbate Eye Drops, Potassium Clavulanate Intravenous
V-A106 III-1003 Infusion, Ticarcillin Sodium and, see
Poly[methyl(94)phenyl(5)vinyl(1)] Potassium Bicarbonate, II-619 Ticarcillin and Clavulanic Acid Infusion
siloxane, V-A106 Potassium Bicarbonate Solution, Potassium Clavulanate Oral Suspension,
Poly[methyl(95)phenyl(5)]siloxane, Saturated Methanolic, see Saturated Amoxicillin and, see Co-amoxiclav Oral
V-A106 Methanolic Potassium Hydrogen Suspension
Polymethylphenylsiloxane, V-A106 Carbonate Solution Potassium Clavulanate Tablets,
Poly[methyl(trifluoropropylmethyl) Potassium Bicarbonate, see Potassium Amoxicillin and, see Co-amoxiclav
siloxane], V-A106 Hydrogen Carbonate Tablets
Polymorphism, V-A161 Potassium Borohydride, V-A106 Potassium Clavulanate Tablets,
Polymyxin and Bacitracin Eye Ointment, Potassium Bromate, V-A106, V-A141 Dispersible Amoxicillin and, see
III-999 Potassium Bromate VS, V-A145 Dispersible Co-amoxiclav Tablets
Polymyxin and Bacitracin Ointment, Potassium Bromide, II-619, V-A106 Potassium Cyanide, V-A107
III-1001 Potassium Carbonate, II-620, V-A107 Potassium Cyanide Solution, V-A107
Polymyxin B Sulfate, II-608 Potassium Carbonate Sesquihydrate, Potassium Cyanide Solution, Lead-free,
Polymyxin B Sulphate, see Polymyxin B V-A107 V-A107
Sulfate Potassium Chlorate, V-A107 Potassium Cyanide Solution PbT,
Polyolefines, V-575 Potassium Chloride, II-621, V-A107 V-A107
Polyoxyethylated Castor Oil, V-A106 Potassium Chloride and Dextrose Potassium Dichromate, V-A107, V-A141
Polyoxyethylene 20 Sorbitan Infusion, see Potassium Chloride and Potassium Dichromate for
Monolaurate, see Polysorbate 20 Glucose Infusion Homoeopathic Preparations, IV-449
Polyoxyethylene 20 Sorbitan Potassium Chloride and Dextrose Potassium Dichromate Solution, V-A107
Monopalmitate, see Polysorbate 40 Intravenous Infusion, see Potassium Potassium Dichromate Solution, Dilute,
Polyoxyethylene 20 Sorbitan Chloride and Glucose Infusion V-A107
Monostearate, see Polysorbate 60 Potassium Chloride and Glucose Potassium Dichromate Solution R1,
Polyoxyethylene 20 Sorbitan Mono- Infusion, III-1005 V-A107
oleate, see Polysorbate 80 Potassium Chloride and Glucose Potassium Dichromate VS, V-A145
Polyoxyethylene 23 Lauryl Ether, Intravenouse Infusion, see Potassium Potassium Dihydrogen Citrate, V-A107
V-A106 Chloride and Glucose Infusion Potassium Dihydrogen Orthophosphate,
Polyoxyl Castor Oil, I-427 Potassium Chloride and Sodium V-A107
Polyoxyl Castor Oil, Hydrogenated I-428 Chloride Infusion, III-1006 Potassium Dihydrogen Phosphate,
Polypropylene for Containers and Potassium Chloride and Sodium II-627, V-A107
Closures for Parenteral Preparations Chloride Intravenous Infusion, see Potassium Dihydrogen Phosphate
and Ophthalmic Preparations, V-584 Potassium Chloride and Sodium Chloride Concentrate, Sterile, III-1007
Polysaccharide Vaccines, Composition Infusion Potassium Dihydrogen Phosphate, 0.2M,
of, V-466 Potassium Chloride Concentrate, Sterile, V-A107
Polysorbate 20, V-A106 III-1004 Potassium Dihydrogen Phosphate Oral
Polysorbate 40, II-610 Potassium Chloride, 0.1M, V-A107 Solution, III-1008
Polysorbate 60, II-611 Potassium Chloride Oral Solution, Potassium Ferricyanide Solution, see
Polysorbate 80, II-612, V-A106 III-1004 Potassium Hexacyanoferrate(III) Solution
Polysorbate 20, II-609 Potassium Chloride, Sodium Chloride Potassium Ferricyanide, see Potassium
Polystyrene, V-S3, V-S4 and Dextrose Infusion, see Potassium Hexacyanoferrate(III)
Polystyrene 9001000, V-A106 Chloride, Sodium Chloride and Glucose Potassium Ferriperiodate Solution,
Polythiazide, II-614, V-S112 Infusion V-A107
Polythiazide Tablets, III-1002 Potassium Chloride, Sodium Chloride Potassium Ferrocyanide Solution, see
Poly(vinyl acetate), II-614 and Dextrose Intravenous Infusion, see Potassium Hexacyanoferrate(II) Solution
Poly(vinyl acetate) Dispersion Potassium Chloride, Sodium Chloride and Potassium Ferrocyanide, see Potassium
30 per cent, II-616 Glucose Infusion Hexacyanoferrate(II)
Poly(vinyl alcohol), II-617 Potassium Chloride, Sodium Chloride Potassium Fluoride, V-A107
Porcine Insulin, I-1221 and Glucose Infusion, III-1006 Potassium Hexacyanoferrate(II), V-A107
Pore-size Distribution of Solids by Potassium Chloride, Sodium Chloride Potassium Hexacyanoferrate(II) Solution,
Mercury Porosimetry, Porosity and, and Glucose Intravenous Infusion, see V-A107
V-531 Potassium Chloride, Sodium Chloride and Potassium Hexacyanoferrate(III), V-A107
Poria, IV-329 Glucose Infusion Potassium Hexacyanoferrate(III) Solution,
Porosity and Pore-size Distribution of Potassium Chloride Tablets, V-A107
Solids by Mercury Porosimetry, V-531 Effervescent, III-1004 Potassium Hexacyanoferrate(III) Solution,
Potable Water, I-10, II-10, III-10, Potassium Chloride Tablets, Prolonged- Dilute, V-A107
IV-10, V-10 release, III-1005 Potassium Hyaluronate, V-A107
Potash Solution, III-1008 Potassium Chromate, V-A107 Potassium Hyaluronate Stock Solution,
Potassium Acetate, II-618, V-A106 Potassium Chromate Solution, V-A107 V-A107
Potassium Acid Phosphate Injection, Potassium Citrate, II-622, V-A107 Potassium Hydrogen Aspartate
III-1007 Potassium Citrate Mixture, III-1007 Hemihydrate, II-628
Potassium Acid Phosphate Oral Solution, Potassium Citrate Oral Solution, Potassium Hydrogen Carbonate, V-A108
see Potassium Dihydrogen Phosphate Oral III-1007 Potassium Hydrogen Carbonate, see
Solution Potassium Clavulanate, II-623 Potassium Bicarbonate
Potassium and Potassium Salts, Potassium Clavulanate Diluted, II-625 Potassium Hydrogen Carbonate
Reactions of, V-269 Solution, Saturated, V-A108
V-A848 Index

Potassium Hydrogen Phthalate, V-A108, Potassium Iodobismuthate Solution, Potency of Antibiotics, I-14, II-14,
V-A141 Dilute, V-A108 III-14, IV-14, V-14
Potassium Hydrogen Phthalate, 0.2M, Potassium Iodobismuthate Solution R1, Potency, Stated, I-14, II-14, III-14,
V-A108 V-A108 IV-14, V-657, V-14
Potassium Hydrogen Phthalate VS, Potassium Iodobismuthate Solution R2, Potency, True, V-657
V-A145 V-A108 Potential Adulteration, I-26, II-26,
Potassium Hydrogen Sulfate, V-A108 Potassium Iodobismuthate Solution R3, III-26, IV-26, V-26
Potassium Hydrogen Sulphate, see V-A108 Potentiometric Determination of Ionic
Potassium Hydrogen Sulfate Potassium Iodobismuthate Solution R4, Concentration Using Ion-selective
Potassium Hydrogen Tartrate, II-629, V-A108 Electrodes, V-282
V-A108 Potassium Iodobismuthate Solution R5, Potentiometric Titration, V-280
Potassium Hydrogen Tartrate, see V-A109 Poultices, III-72
Potassium Hydrogen ()-Tartrate Potassium Iodoplatinate Solution, Povidone, II-637, V-A109
Potassium Hydroxide, II-629, V-A108 V-A109 Povidone, Iodinated, II-640
Potassium Hydroxide, Alcoholic, see Potassium Mercuri-iodide Solution, Povidone-Iodine Eye Drops, III-1010
Potassium Hydroxide VS, Ethanolic Alkaline, V-A109 Povidone-Iodine Mouthwash, III-1010
Potassium Hydroxide, Ethanolic, V-A108 Potassium Metabisulfite, II-632 Povidone-Iodine Solution, III-1011
Potassium Hydroxide in Alcohol Potassium Metabisulphite, see Potassium Powder fineness, V-501
(10% v/v), 0.5M, V-A108 Metabisulfite Powder Flow, V-518
Potassium Hydroxide in Alcohol Potassium Nitrate, II-633, V-A109 Powder, Microfine, Definition of, V-501
(60% v/v), see Potassium Hydroxide in Potassium Perchlorate, II-633 Powder, Moderately Coarse, Definition
Ethanol (60%) VS Potassium Periodate, V-A109 of, V-501
Potassium Hydroxide in Ethanol (60%) Potassium Permanganate, II-634, Powder, Superfine, Definition of, V-501
VS, V-A146 V-A109 Powdered Cellulose, I-479
Potassium Hydroxide in Ethanol (90%) Potassium Permanganate and Phosphoric Powders, III-68
VS, V-A146 Acid Solution, V-A109 Dusting, III-68
Potassium Hydroxide, 2M Alcoholic, Potassium Permanganate Solution, Powders and Granules for Oral Solutions
V-A108 V-A109 and Suspensions, III-57
Potassium Hydroxide, Methanolic, Potassium Permanganate Solution, Powders and Granules for Syrups, III-58
V-A108 Dilute, V-A109 Powders and Tablets for Rectal Solutions
Potassium Hydroxide Solution, III-1008 Potassium Permanganate VS, V-A146 and Suspensions, III-70
Potassium Hydroxide Solution, Potassium Perrhenate, V-A109 Powders, Ear, III-44
Alcoholic, V-A108 Potassium Persulfate, V-A109 Powders for Eye Drops and Powders for
Potassium Hydroxide Solution R1, Potassium Persulphate, see Potassium Eye Lotions, III-46
Alcoholic, V-A108 Persulfate Powders for Injections or Infusions,
Potassium Hydroxide VS, V-A145 Potassium phosphate buffer solution III-65
Potassium Hydroxide VS, Ethanolic, pH 7.0, V-A158 Powders for Lotions, III-43
V-A145 Potassium Plumbite Solution, V-A109 Powders for Oral Drops, III-57
Potassium Hydroxyquinoline Sulfate, Potassium Pyroantimonate Solution, see Powders, Nasal, III-60
II-630 Potassium Antimonate(V) Solution Powders, Particle Size of, V-501
Potassium Hydroxyquinoline Sulfate and Potassium Pyroantimonate, see Potassium Powders, Particle Size Classification of,
Benzoyl Peroxide Cream, III-1008 Antimonate(V) V-501
Potassium Hydroxyquinoline Sulphate Potassium Sodium ()-Tartrate, V-A109 Powders, Topical, III-67
and Benzoyl Peroxide Cream, see Potassium Sodium Tartrate Powders, Wettability of Porous Solids
Potassium Hydroxyquinoline Sulfate and Tetrahydrate, II-635 Including, V-536
Benzoyl Peroxide Cream Potassium Sorbate, II-635, V-A109 ppm, V-628
Potassium Hydroxyquinoline Sulphate, Potassium Standard Solution ppm, Definition of, I-6, II-6, III-6, IV-6,
see Potassium Hydroxyquinoline Sulfate (0.2 per cent K), V-A151 V-6
Potassium Iodate, II-631, V-A108, Potassium Standard Solution (20 ppm Pramipexole Dihydrochloride
V-A141 K), V-A151 Monohydrate, II-640
Potassium Iodate Tablets, III-1009 Potassium Standard Solution (100 ppm Pravastatin Sodium, II-642
Potassium Iodate VS, V-A146 K), V-A151 Pravastatin Tablets, III-1011
Potassium Iodide, II-631, V-A108 Potassium Standard Solution (600 ppm Prazepam, II-644
Potassium Iodide and Starch Solution, K), V-A151 Praziquantel, II-645
V-A108 Potassium Sulfate, II-636, V-A109 Prazosin, V-S113
Potassium Iodide Solution, V-A108 Potassium Sulphate, see Potassium Sulfate Prekallikrien activator, Test for, V-421
Potassium Iodide Solution, Dilute, Potassium Tartrate, see Dipotassium Prazosin Hydrochloride, II-646
V-A108 ()-Tartrate Prazosin Tablets, III-1012
Potassium Iodide Solution, Iodinated, Potassium Tetraiodomercurate Solution, Precipitation Indicators, V-789
V-A108 V-A109 Precipitation Titrations, V-788
Potassium Iodide Solution, Iodinated Potassium Tetraiodomercurate Solution, Precision, V-674
R1, V-A108 Alkaline, V-A109 Prednicarbate, II-648
Potassium Iodide Solution, Saturated, Potassium Tetroxalate, V-A109 Prednisolone, II-649, V-S113, V-A109
V-A108 Potassium Thiocyanate, V-A109 Prednisolone Acetate, II-652, V-A109
Potassium Iodide VS, V-A146 Potassium Thiocyanate Solution, Prednisolone Acetate Injection, III-1017
Potassium Iodobismuthate Solution, V-A109 Prednisolone Enema, III-1013
V-A108 Potato Starch, II-913 Prednisolone Pivalate, II-653
Potassium Iodobismuthate Solution, Potency, Estimated, I-14, II-14, III-14, Prednisolone Sodium Phosphate, II-655
Acid, V-A108 IV-14, V-657, V-14 Prednisolone Sodium Phosphate Ear
Potency, Labelled, V-657 Drops, III-1018
page numbers in bold type relate to monograph titles Index V-A849

Prednisolone Sodium Phosphate Eye Prochlorperazine Injection, III-1024 Prolonged-release Mesalazine Granules,
Drops, III-1019 Prochlorperazine Maleate, II-667 III-800
Prednisolone Sodium Phosphate Oral Prochlorperazine Mesilate, II-668, Prolonged-release Mesalazine Tablets,
Solution, III-1020 V-S115 III-807
Prednisolone Tablets, III-1014 Prochlorperazine Oral Solution, III-1024 Prolonged-release Metoprolol Tartrate
Prednisolone Tablets, Gastro-resistant, Prochlorperazine Tablets, III-1026 Tablets, III-830
III-1015 Procyclidine, V-S116 Prolonged-release Minocycline Capsules,
Prednisone, II-656 Procyclidine Hydrochloride, II-669, III-845
Preface, I-x V-S116 Prolonged-release Morphine Tablets,
Pregelatinised Hydroxypropyl Starch, Procyclidine Injection, III-1026 III-864
II-910 Procyclidine Tablets, III-1027 Prolonged-release Nifedipine Capsules,
Pregelatinised Maize Starch see Production, I-25, II-25, III-25, IV-25, III-895
Pregelatinised Starch V-25 Prolonged-release Nifedipine Tablets,
Pregelatinised Starch, II-914 Production and Testing of Vaccines, III-897
Preparation of Unlicensed Medicines, V-463 Prolonged-release Oxybutynin Tablets,
V-782 Production, Status of, I-9, II-9, III-9, III-931
Preparations, Extemporaneous, V-785 IV-9, V-9 Prolonged-release Oxycodone Tablets,
Preparations for Inhalation, III-50, Products of Fermentation, I-946 III-936
V-375 Products of Recombinant DNA Prolonged-release Potassium Chloride
Aerodynamic Assessment of Fine Technology, II-732 Tablets, III-1005
Particles, V-375 Products with Risk of Transmitting Prolonged-release Potassium Tablets,
Preparations for Inhalation of the BP, Agents of Animal Spongiform Bumetanide and, see Bumetanide and
III-55 Encephalopathies, II-900 Prolonged-release Potassium Tablets
Preparations for Irrigation, III-55 Progesterone, II-670, V-S116 Prolonged-release Propranolol Capsules,
Preparations for Nebulisation, V-387 Progesterone Injection, III-1028 III-1035
Characterisation, V-387 Proguanil Hydrochloride, II-671, V-S117 Prolonged-release Salbutamol Capsules,
Prepared Belladonna, IV-91 Proguanil Tablets, III-1029 III-1067
Prepared Calamine, I-351 Proline, II-672, V-A109 Prolonged-release Salbutamol Tablets,
Prepared Chalk, I-496 Prolonged-release Alfuzosin Tablets, III-1077
Prepared Ipecacuanha, IV-222 III-112 Prolonged-release Tamsulosin Capsules,
Prepared Opium, IV-296 Prolonged-release Aminophylline III-1131
Prepared Stramonium, IV-381 Tablets, III-129 Prolonged-release Tamsulosin Tablets,
Preservative-free Eye Drops, V-783 Prolonged-release Bezafibrate Tablets, III-1132
Preservative-free Oral Liquids, V-783 III-196 Prolonged-release Theophylline Tablets,
Preservative-free Unlicensed Medicines, Prolonged-release Cefaclor Tablets, III-1148
V-783 III-253 Prolonged-release Tramadol Capsules,
Pressurised Inhalations, III-55 Prolonged-release Clarithromycin III-1167
Pressurised Pharmaceutical Preparations, Tablets, III-328 Prolonged-release Tramadol Tablets,
III-68 Prolonged-release Clomipramine Tablets, III-1168
Pre-washed Manganese(IV) Oxide, V-A83 III-349 Prolonged-release Trospium Chloride
Prilocaine, II-658, V-S113 Prolonged-release Co-Beneldopa Capsules, III-1190
Prilocaine Hydrochloride, II-659 Capsules, III-371 Prolonged-release Venlafaxine Capsules,
Prilocaine Injection, III-1021 Prolonged-release Diclofenac Capsules, III-1205
Primaquine Diphosphate, see Primaquine III-452 Prolonged-release Venlafaxine Tablets,
Phosphate Prolonged-release Diclofenac Tablets, III-1208
Primaquine Phosphate, II-661 III-455 Prolonged-release Verapamil Capsules,
Primary Standards, V-A141 Prolonged-release Diltiazem Tablets, III-1209
Primidone, II-662, V-S114 III-465 Prolonged-release Verapamil Tablets,
Primidone Oral Suspension, III-1021 Prolonged-release Dipyridamole III-1211
Primidone Tablets, III-1022 Capsules, III-472 D-Prolyl-L-phenylalanyl-L-arginine
Primula Root, IV-330 Prolonged-release Felodipine Tablets, 4-Nitroanilide Hydrochloride, V-A109
Probenecid, II-664, V-S114 III-549 Promazine, V-S117
Probenecid Tablets, III-1022 Prolonged-release Ferrous Sulfate Promazine Hydrochloride, II-674
Procainamide, V-S114 Tablets, III-558 Promazine Injection, III-1030
Procainamide Hydrochloride, II-664 Prolonged-release Ferrous Sulphate Promazine Tablets, III-1030
Procainamide Injection, III-1023 Tablets, see Prolonged-release Ferrous Promethazine, V-S117
Procainamide Tablets, III-1023 Sulfate Tablets Promethazine Hydrochloride, II-675
Procaine Benzylpenicillin, II-665 Prolonged-release Ibuprofen Capsules, Promethazine Hydrochloride Tablets,
Procaine Hydrochloride, II-667, V-A109 III-670 III-1032
Processed Angelica Sinensis Root, IV-65 Prolonged-release Ibuprofen Tablets, Promethazine Injection, III-1031
Processed Herbal Drugs, IV-44 III-675 Promethazine Oral Solution, III-1031
Processed Liquorice Root for use in Prolonged-release Indapamide Tablets, Promethazine Teoclate, II-676
TCM, IV-255 III-680 Promethazine Teoclate Tablets, III-1033
Processed Salvia Miltiorrhiza Rhizome Prolonged-release Isosorbide Propacetamol Hydrochloride, II-677
and Root, IV-351 Mononitrate Capsules, III-716 Propafenone Hydrochloride, II-678
Processed White Peony Root, IV-314 Prolonged-release Isosorbide propane, Bis-tris, V-A109
Prochlorperazine (1), V-S115 Mononitrate Tablets, III-719 Propane-1,2-diol, V-A109
Prochlorperazine (2), V-S115 Prolonged-release Lithium Carbonate Propanol, II-680, V-A109
Prochlorperazine Buccal Tablets, Tablets, III-759 Propanol and Methanol, 2-, Test for
III-1025 (2.9.11.), V-286
V-A850 Index

Propan-2-ol and Methanol, Protirelin, II-696 Pharmaceutical Use, Microbiological


Determination of, V-286 Protopine Hydrochloride, V-A110 (5.1.4.) (5.8.), V-702
Propan-2-ol R1, V-A109 Protriptyline, V-S119 Quality systems, I-20, II-20, III-20,
2-Propanol R2, V-A109 Protriptyline Hydrochloride, II-697 IV-20, V-20
2-Propanol R1, see Propan-2-ol R1 Protriptyline Tablets, III-1039 Quantified Hawthorn Leaf and Flower
Propanol, see Propan-1-ol Proxymetacaine, V-S119 Liquid Extract, IV-216
Propantheline Bromide, II-682 Proxymetacaine Eye Drops, III-1040 Quantified St. Johns Wort Dry Extract,
Propantheline Tablets, III-1033 Proxymetacaine Hydrochloride, II-698, IV-375
Propetamphos, V-A110 V-S120 Quantitation Limit, V-675
Propidium Iodide, V-A110 Proxyphylline, II-699 Quantitative Analysis, Pharmacopoeial,
Propionaldehyde, V-A110 Prunus Spinosa Fruit for Homoeopathic V-786
Propionic Acid, V-A110 Preparations, IV-450 Quantities, I-23, II-23, III-23, IV-23,
Propionic Anhydride, V-A110 Pseudoephedrine, V-S120 V-23
Propionic Anhydride Reagent, V-A110 Pseudoephedrine Hydrochloride, II-700 Quercetin Dihydrate, V-A111
Propofol, II-683, V-S118 Pseudoephedrine Oral Solution, III-1040 Quercitrin, V-A111
Propofol Injection, III-1034 Pseudoephedrine Tablets, III-1041 Quetiapine Fumarate, II-709
Propranolol, V-S118 Psyllium Seed, IV-331 Quillaia, IV-332
Propranolol Capsules, Prolonged-release, Pteroic Acid, V-A110 Quillaia Bark, IV-333
III-1035 Puerarin, V-A110 Quillaia Bark, see Quillaia
Propranolol Hydrochloride, II-685, Pulegone, V-A110 Quillaia Liquid Extract, IV-334
V-A110 Pumice Powder, V-A110 Quillaia Saponins, Purified, V-A111
Propranolol Injection, III-1036 Purified Hexane, V-A71 Quillaia Tincture, IV-334
Propranolol Tablets, III-1037 Purified Talc, II-970 Quinaldine Red, V-A111
Propyl Acetate, V-A110 Purified Water, II-1175 Quinaldine Red Solution, V-A111
Propyl Gallate, II-686 Putrescine, V-A110 Quinapril Hydrochloride, II-712
Propyl Hydroxybenzoate, II-687, V-A110 Pycnometric Density of Solids, V-514 Quinhydrone, V-A111
Propyl Parahydroxybenzoate, V-A110 Pygeum Bark, IV-331 Quinidine, V-A111
Propyl Parahydroxybenzoate, see Propyl Pyrantel Embonate, II-701 Quinidine Bisulfate, II-714
Hydroxybenzoate Pyrazinamide, II-702 Quinidine Bisulphate, see Quinidine
Propylene Glycol, II-688, V-S118, Pyrazinamide (1), V-S120 Bisulfate
V-A110 Pyrazinamide (2), V-S121 Quinidine Sulfate, II-715, V-A111
Propylene Glycol Cutaneous Solution, Pyrazinamide Oral Suspension, III-1042 Quinidine Sulfate Tablets, III-1045
see Propylene Glycol Solution Pyrazinamide Tablets, III-1043 Quinidine Sulphate Tablets, see Quinidine
Propylene Glycol Dicaprylocaprate, Pyrazine-2-carbonitrile, V-A110 Sulfate Tablets
II-689 Pyridin-2-amine, V-A110 Quinidine Sulphate, see Quinidine Sulfate
Propylene Glycol Dilaurate, II-690 Pyridine, V-A110 Quinine, V-A111
Propylene Glycol Monolaurate, II-691 Pyridine, Anhydrous, V-A110 Quinine Bisulfate, II-717
Propylene Glycol Monopalmitostearate, Pyridine Bromide Solution, V-A110 Quinine Bisulfate Tablets, III-1046
II-692 Pyridine-3-carboxaldehyde, V-A110 Quinine Bisulphate Tablets, see Quinine
Propylene Glycol Monostearate, see Pyridinium Hydrobromide Perbromide, Bisulfate Tablets
Propylene Glycol Monopalmitostearate V-A110 Quinine Bisulphate, see Quinine Bisulfate
Propylene Glycol Solution, III-1037 Pyridostigmine Bromide, II-703 Quinine Dihydrochloride, II-718
Propylene Oxide, V-A110 Pyridostigmine Tablets, III-1043 Quinine Dihydrochloride Infusion,
Propylparaben, see Propyl Pyridoxine Hydrochloride, II-704, III-1047
Hydroxybenzoate V-S121 Quinine Dihydrochloride Sterile
Propylsilyl Silica Gel for Pyridoxine Tablets, III-1044 Concentrate, III-1048
Chromatography, V-A117 2-Pyridylamine, V-A110 Quinine Hydrochloride, II-719, V-A111
Propylthiouracil, II-693, V-S119 Pyrid-2-ylamine, see 2-Pyridylamine Quinine Sulfate, II-721, V-A111
Propylthiouracil Tablets, III-1038 Pyridylazonaphthol, V-A110 Quinine Sulfate Tablets, III-1049
Propyphenazone, II-693 Pyridylazonaphthol Solution, V-A111 Quinine Sulphate Tablets, see Quinine
Protamine Sulfate, II-695, V-A110 4-(2-Pyridylazo)resorcinol Monosodium Sulfate Tablets
Protamine Sulfate Injection, III-1039 Salt, V-A111 Quinine Sulphate, see Quinine Sulfate
Protamine Sulphate Injection, see Pyrimethamine, II-706, V-S121 Quinoline, V-A111
Protamine Sulfate Injection Pyrimethamine Tablets, III-1045 Quinoline Solution, V-A112
Protamine Sulphate, see Protamine Sulfate Pyrocatechol, see Catechol Quinolin-8-ol, V-S122
Protamine Zinc Insulin Injection, III-692 Pyrogallol, V-A111
Protamine Zinc Insulin, see Protamine Pyrogallol Solution, Alkaline, V-A111
Zinc Insulin Injection
Protected from Light, Definition of,
Pyrogens, Test for, V-408
Pyroxylin, II-707
R
Rabbit Erythrocyte Suspension, V-A112
I-12, II-12, III-12, IV-12, V-197, Pyrrolidine, V-A111
Rabies Antiserum, Fluorescein-
V-12 Pyrrolidone, II-708, V-A111
conjugated, V-A112
Protein in Polysaccharide Vaccines, Pyruvic Acid, V-A111
Rabies Immunoglobulin, IV-500
V-466
Rabies Vaccine, IV-620
Protein C, human, Assay of, V-424
Rabies Vaccine for Human Use Prepared
Protein S, human, Assay of, V-425
Protein in Blood Products,
Q in Cell Cultures, see Rabies Vaccine
Q values, V-649 Rab, see Rabies Vaccine
Determination of, V-288
Qualitative Reactions and Tests, V-266 Racecadotril, II-722
Protein, Total, Determination of, V-296
Quality of Non-sterile Pharmaceutical Racementhol, II-724
2-l-protein, see inhibitor, Assay of
Preparations and Substances for Racemic Camphor, I-392
a-l-Proteinase inhibitor, Assay of
page numbers in bold type relate to monograph titles Index V-A851

Racemic Ephedrine Hydrochloride, see Reference Spectra, I-12, II-12, III-12, Resin for Reversed-phase Ion
Racephedrine Hydrochloride IV-12, V-12 Chromatography, V-A112
Racemic Menthol, see Racementhol Reference Spectra, Concordance of, Resistance to Crushing of Tablets, V-513
Racephedrine Hydrochloride, II-725 I-12, II-12, III-12, IV-12, V-12 Resolution factor, Liquid
Raclopride ([11C]Methoxy) Injection, Reference Spectra, Preparation of Chromatography, V-204
IV-701 Infrared, V-S2 Resorcinol, II-737, V-A112
Raclopride Tartrate, V-A112 Reference Standards, I-29, II-29, III-29, Resorcinol Reagent, V-A112
Radian, Definition of, I-32, II-32, IV-29, V-757, V-29 Restharrow Root, IV-334
III-32, IV-32, V-32 Reference Substances and Reference Resveratrol, V-A112
Radionuclides, Table of Physical Preparations, I-15, II-15, III-15, Retinol Concentrate (Oily Form),
Characteristics (5.7.), IV-656 IV-15, V-15 Synthetic, II-738
Radiopharmaceutical Preparations, Reference Substances (BP), Retinol Concentrate (Powder Form),
IV-651 Supplementary Information, V-673 Synthetic, II-739
Raft strength, see Appendix XVII F2 References to regulatory documents, Retinol Concentrate Solubilisate/
Raloxifene Hydrochloride, II-726 I-23, II-23, III-23, IV-23, V-23 Emulsion, Synthetic, II-740
Raman Spectrometry, V-184 Refined Almond Oil, I-102 L-Rhamnose, V-A112
Ramipril, II-727, V-S122 Refined and Quantified Ginkgo Dry Rhamnose, see L-Rhamnose
Ramipril Capsules, III-1050 Extract, IV-201 Rhaponticin, V-A112
Ramipril Tablets, III-1051 Refined and Standardised Capsicum Rhatany Root, IV-335
(1R)-()-Ammonium Oleoresin, IV-122 Rhatany Tincture, IV-336
10-Camphorsulfonate, V-A26 Refined and Standardised Fresh Bilberry Rheum Palmatum, V-609
(1R)-()-Ammonium Fruit Dry Extract, IV-101 Rhodamine 6 G, V-A112
10-Camphorsulphonate, see (1R)-()- Refined and Standardised Milk Thistle Rhodamine B, V-A112
Ammonium 10-Camphorsulfonate Dry Extract, IV-279 Rhubarb, IV-337
Range, V-675 Refined Arachis Oil see Arachis Oil Rhubarb Tincture, Compound, IV-338
Ranitidine Hydrochloride, II-730, Refined Borage Oil, I-305 Rhus Toxicodendron for Homoeopathic
V-S122 Refined Borage (Starflower) Oil, , see Preparations, see Toxicodendron
Ranitidine Injection, III-1053 Refined Borage Oil Quercifolium for Homoeopathic
Ranitidine Oral Solution, III-1054 Refined Castor Oil, I-429 Preparations
Ranitidine Tablets, III-1055 Refined Evening Primrose Oil, I-930 Ribavirin, II-742, V-S123
Ranitidine Tablets, Effervescent, Refined Maize Oil, II-179 Ribavirin for Nebulisation, see Ribavirin
III-1056 Refined Olive Oil, II-427 Powder for Nebuliser Solution
Rapeseed Oil, V-A112 Refined Rapeseed Oil, II-732 Ribavirin Nebuliser Solution, see
Rapeseed Oil, Refined, II-732 Refined Safflower Oil, II-778 Ribavirin Powder for Nebuliser Solution
Ratanhia, V-609 Refined Sesame Oil, II-799 Ribavirin Powder for Nebuliser Solution,
Reaction of Solution and Colour of Refined Soya Oil, II-894 III-1057
Certain Indicators, V-252 Refined Soya-bean Oil, see Refined Soya Riboflavin, II-743
Reagents, I-24, II-24, III-24, IV-24, Oil Riboflavin Sodium Phosphate, II-745
V-24 Refined Starflower Oil, see Refined Borage Ribose in Polysaccharide Vaccines,
Reagents, Descriptions of, I-7, II-7, Oil V-468, V-A112
III-7, IV-7, V-7 Refined Sunflower Oil, II-965 Rice Starch, II-915
Recently Prepared, Definition of, I-10, Refined Wheat-germ Oil, II-1184 Ricinoleic Acid, V-A112
II-10, III-10, IV-10, V-10 Refractive Index, Determination of, Rifabutin, II-747
Recombinant DNA Technology, V-244 Rifampicin, II-748, V-S123
Products of, II-732 regulatory documents,References to, Rifampicin Capsules, III-1058
Recommendations on Dissolution I-23, II-23, III-23, IV-23, V-23 Rifampicin Oral Suspension, III-1059
Testing, V-358 Rehydration Salts, Oral, III-921 Rifamycin Sodium, II-750
Recrystallised Imidazole, V-A74 Reichsteins Substance S, V-A112 Rifaximin, II-751
Recrystallised Iodine Pentoxide, V-A75 Related substances in phenothiazines, Rilmenidine Dihydrogen Phosphate,
Rectal Capsules, III-69 V-197 II-753
Rectal Foams, III-70 Related Substances, Tests for, V-637 Ringer-Lactate Solution for Injection,
Rectal Preparations, III-68 Relative Atomic and Molecular Masses, III-1102
Rectal Preparations, Semi-solid, III-70 I-25, II-25, III-25, IV-25, V-25 Risedronate Sodium 2.5-Hydrate, II-754
Rectal Solutions, Emulsions and Relative Density, V-245 Risperidone, II-756
Suspensions, III-69 Relative Density, Determination of, Risperidone Oral Solution, III-1060
Rectified Spirit, I-900 V-245 Risperidone Tablets, III-1061
Red Cinchona Bark, see Cinchona Bark Release Assay, V-657 Risperidone Tablets, Dispersible,
Red Litmus Paper, V-A81 Repaglinide, II-734 III-1063
Red Poppy Petals, IV-329 Repeatability, V-674 Ritodrine Hydrochloride, II-758, V-S123
Redox Indicators, V-789 Reproducibility, V-675 Ritodrine Injection, III-1065
Redox Titrations, V-788 Requirements, Pharmacopoeial, I-xxv Ritodrine Tablets, III-1066
Reducing Mixture, V-A112 Reserpine, II-736, V-A112 Ritonavir, II-759
Reference Materials, V-A160 Residual Ethylene Oxide and Dioxan, Rivastigmine, II-763
Reference Materials and Spectra, I-12, V-293 Rivastigmine Hydrogen Tartrate, II-764
II-12, III-12, IV-12, V-12 Residual Pertussis Toxin and Rizatriptan Benzoate, II-766, V-S124
Reference Materials, Chemical and Irreversibility of Pertussis Toxoid, (R)-()-a-Methylbenzyl IsoCyanate,
Biological, see Reference Materials V-450 V-A87
Reference Preparation, International, Residual Solvents, V-289, V-639, V-678 (15R)-15-Methylprostaglandin F2a,
I-14, II-14, III-14, IV-14, V-14 Residue on Evaporation of Essential Oils, V-A90
V-321 Robustness, V-675
V-A852 Index

Rocuronium Bromide, II-768 Salbutamol Inhalation Powder, III-1072 Schisandrin, V-A113


Roman Chamomile Flower, see Salbutamol Inhalation Powder, pre- Scintillation Cocktail, Liquid, V-A81
Chamomile Flowers dispensed, III-1073 Sclareol, V-A113
Ropivacaine Hydrochloride Salbutamol Injection, III-1068 Scopoletin, V-A113
Monohydrate, II-770 Salbutamol Nebuliser Solution, III-1070 Scutellariae Baicalensis Root, IV-359
Roselle, IV-338 Salbutamol Oral Solution, III-1071 (S)-3,5-Dichloro-2,6-dihydroxy-N-
Rosemary Leaf, IV-339 Salbutamol Powder for Inhalation, [(1-ethylpyrrolidin-2-
Rosemary Oil, IV-341 metered-dose powder inhalers, see yl)methyl]benzamide hydrobromide,
Rosmarinic Acid, V-A112 Salbutamol Inhalation Powder V-A52
Rosmarinic acid CRS, V-A160 Salbutamol Powder for Inhalation, pre- SDS-PAGE Running Buffer, V-A113
Rotavirus (live, oral), see Rotavirus metered units, see Salbutamol SDS-PAGE Sample Buffer
Vaccine (Live, Oral) Inhalation Powder, pre-dispensed (Concentrated), V-A114
Rotavirus Vaccine (Live, Oral), IV-622 Salbutamol Pressurised Inhalation, SDS-PAGE Sample Buffer for Reducing
Round Amomum Fruit, IV-342 III-1075 Conditions (Concentrated), V-A114
Roxithromycin, II-772 Salbutamol Sulphate, see Salbutamol Second, Definition of, I-32, II-32,
RRR-Alpha Tocopheryl Hydrogen Sulfate III-32, IV-32, V-32
Succinate, II-1060 Salbutamol Sulfate, II-781, V-S124 Secondary Band, Definition of, V-197
RRR-Alpha-Tocopherol, II-1053 Salbutamol Tablets, III-1076 Secondary Peak, Definition of, V-200
RRR-a-Tocopherol see RRR-Alpha- Salbutamol Tablets, Prolonged-release, Secondary peaks, Liquid
Tocopherol III-1077 Chromatography, V-204
RRR-Alpha-Tocopheryl Acetate, II-1055 Salcatonin, see Calcitonin (Salmon) Secondary Spot, Definition of, V-197
RRR-a-Tocopheryl Acetate see RRR- Salcatonin Injection, see Calcitonin Selegiline, V-S125
Alpha-Tocopheryl Acetate (Salmon) Injection Selegiline Hydrochloride, II-792
RRR-a-Tocopheryl Hydrogen Succinate Salicin, V-A113 Selegiline Oral Solution, III-1079
see RRR-Alpha-Tocopheryl Hydrogen Salicylaldehyde, V-A113 Selegiline Tablets, III-1080
Succinate Salicylaldehyde Azine, V-A113 Selenious Acid, V-A114
(RS)-Methotrexate, V-A85 Salicylates, Reactions of, V-269 Selenium, V-A114
(1RS)-1-(6-Methoxynaphthalen-2- Salicylic Acid, II-784, V-S125, V-A113 Selenium Dioxide, V-A114
yl)ethanol, V-A86 Salicylic Acid Collodion, III-1078 Selenium Disulfide, see Selenium Sulfide
Rubber Closures for Containers for Salicylic Acid Cream, III-1079 Selenium Standard Solution (1 ppm Se),
Aqueous Parenteral Preparations, Salicylic Acid Ointment, III-1079, V-785 V-A151
V-558 Salicylic Acid Ointment, Coal Tar and, Selenium Standard Solution (100 ppm
Rubella Immunoglobulin, IV-501 III-1134 Se), V-A151
Rubella Vaccine, Live, IV-625 Salicylic Acid Ointment, Dithranol and, Selenium Sulfide, II-793
Rubella, see Rubella Vaccine, Live III-482 Selenium Sulfide Application, III-1082
Run time, Liquid Chromatography, Salicylic Acid Paste, Zinc and, III-1230 Selenium Sulfide Scalp Application,
V-204 Saline pH 7.2, Phosphate-albumin III-1082
Ruscogenins, V-A112 Buffered, V-A158 Selenium Sulphide, see Selenium Sulfide
Ruthenium-106, Iodine-123 and, Spiking Saline pH 7.4, Phosphate-buffered, Selenium Sulphide Scalp Application, see
Solution, V-A75 V-A158 Selenium Sulfide Scalp Application
Ruthenium Red, V-A112 Saline pH 7.2 R1, Phosphate-albumin Self-emulsifying Glyceryl Monostearate,
Ruthenium Red Solution, V-A112 Buffered, V-A158 I-1100
Rutin, V-A112 Saline Solution, V-A113 Self-emulsifying Mono- and Diglycerides
Rutoside Trihydrate, II-774 Salmeterol Xinafoate, II-786 of Food Fatty Acids, see Self-
Salmon Oil, Farmed, II-787 emulsifying Glyceryl Monostearate
Salvia Miltiorrhiza Root and Rhizome, Self-emulsifying Monostearin, see Self-
S IV-350
Salvianolic Acid B, V-A113
emulsifying Glyceryl Monostearate
Selfheal Fruit-Spike, IV-360
Sabinene, V-A112
Salvianolic Acid B CRS, V-A160 Semicarbazide Acetate Solution, V-A114
Saccharin, II-776, V-A113
Sand, V-A113 Semicarbazide Hydrochloride, V-A114
Saccharin Sodium, II-777, V-A113
Sanguisorba Root, see Greater Burnet Root Semi-solid Ear Preparations, III-44
Sarcharin Soluble, see Saccharin Sodium
Santonin, V-A113 Semi-solid Eye Preparations, III-46
Safflower Flower, IV-344
Saponification Value, Determination of, Semi-solid Nasal Preparations, III-60
Safflower Oil, Refined II-778
V-319 Semi-solid Oromucosal Preparations,
Saffron for Homoeopathic Use, see
Saquinavir Mesilate, II-790 III-62
Crocus for Homoeopathic Preparations
Sarafloxacin Hydrochloride, V-A113 Semi-solid Rectal Preparations, III-70
Safrole, V-A113
Saturated Methanolic Potassium Semi-solid Vaginal Preparations, III-81
Sage Leaf, IV-345
Hydrogen Carbonate, V-A108 Semi-solids or Gels, Texture Analysis of,
Sage Leaf, Three-lobed, IV-347
Saturated Potassium Iodide Solution, V-510
Sage Oil, IV-348
V-A108 Senega, V-609
Sage Oil, Spanish, IV-349
Saturated Sodium Chloride Solution, Senega Root, IV-361
Sage Tincture, IV-346
V-A121 Senna Fruit, Alexandrian, IV-362
Sal Volatile Solution, see Aromatic
Saw Palmetto Extract, IV-353 Senna Fruit, Tinnerally, IV-363
Ammonia Solution
Saw Palmetto Fruit, IV-356 Senna Granules, Standardised, IV-364
Sal Volatile Spirit, see Aromatic Ammonia
(1S)-()-10-Camphorsulfonic Acid, Senna Leaf, IV-365
Spirit
V-A37 Senna Liquid Extract, IV-364
Salannin CRS, V-A160
(1S)-()-10-Camphorsulphonic Acid, Senna Tablets, IV-365
Salbutamol, II-779, V-S124
see (1S)-()-10-Camphorsulfonic Sep/Ser, see Gas-gangerene Antitoxin
Salbutamol Capsules, Prolonged-release,
Acid, V-A37 (Septicum)
III-1067
Schisandra Fruit, IV-357 Serine, II-794, V-A114
page numbers in bold type relate to monograph titles Index V-A853

Sertaconazole Nitrate, II-795 Silica Gel for Chromatography, Silica Gel for Chromatography,
Sertraline Hydrochloride, II-796 Aminohexadecylsilyl, V-A115 Octadecylsilyl, with Embedded Polar
Sertraline Hydrochloride (A), V-S125 Silica Gel for Chromatography, Groups, End-capped, V-A116
Sertraline Hydrochloride (B), V-S126 Aminopropylmethylsilyl, V-A115 Silica Gel for Chromatography,
Sertraline Tablets, III-1082 Silica Gel for Chromatography, Octadecylsilyl, with Polar Incorporated
Serum Gonadotrophin, V-A70 Aminopropylsilyl, V-A115 Groups, End-capped, V-A117
Sesame Oil, V-A114 Silica Gel for Chromatography, Amylose- Silica Gel for Chromatography,
Sesame Oil, Refined, II-799 derivative of, V-A115 Octylsilyl, V-A117
Sesame Oil, see Refined Sesame Oil Silica Gel for Chromatography, Silica Gel for Chromatography,
Sesame Seed, IV-367 Butylsilyl, V-A115 Octylsilyl, Base-deactivated, V-A117
Sets for the Transfusion of Blood and Silica Gel for Chromatography, Silica Gel for Chromatography,
Blood Components, V-560 Butylsilyl, End-capped, V-A115 Octylsilyl, End-capped, V-A117
Sevoflurane, II-801 Silica Gel for Chromatography Silica Gel for Chromatography,
Shampoos, III-42 compatible with 100% aqueous mobile Octylsilyl, End-capped, Base-
Shellac, II-802 phases, Octadecylsilyl, End-capped, deactivated, V-A117
Shingles (Herpes Zoster) Vaccine (Live), V-A117 Silica Gel for Chromatography,
IV-627 Silica Gel for Chromatography, Crown- Octylsilyl, with Polar Incorporated
Shingles (live), see Shingles (Herpes ether, V-A115 Groups, End-capped, V-A117
Zoster) Vaccine Silica Gel for Chromatography, Silica Gel for Chromatography,
SI, V-628 Cyanosilyl, V-A115 Oxypropionitrilsilyl, V-A117
SI Units, I-31, II-31, III-31, IV-31, Silica Gel for Chromatography, Di- Silica Gel for Chromatography,
V-31 isobutyloctadecylsilyl, V-A115 Palmitamidopropylsilyl, End-capped,
SI Units, Use of, I-6, II-6, III-6, IV-6, Silica gel for chromatography, V-A117
V-6 Diisopropylcyanopropylsilyl, V-A115 Silica Gel for Chromatography, Phenyl,
Sialic Acid in Polysaccharide Vaccines, Silica Gel for Chromatography, V-A117
V-468 Dimethyloctadecylsilyl, V-A115 Silica Gel for Chromatography,
Sialic Acid, see N-Acetylneuraminic Acid Silica Gel for Chromatography, Diol, Phenylethyl, End-capped, V-A117
Siam Benzoin, IV-94 V-A115 Silica Gel for Chromatography,
Siam Benzoin Tincture, IV-95 Silica Gel for Chromatography, Phenylhexylsilyl, V-A117
Sieve Test, V-501 Dodecylsilyl, End-capped, V-A115 Silica Gel for Chromatography,
Sieve Test, see Particle Size of Powders Silica Gel for Chromatography, Phenylhexylsilyl, End-capped, V-A117
Sieves and Filters, V-501 Hexadecylamidylsilyl, V-A115 Silica Gel for Chromatography,
Sieving, Analytical, Particle-size Silica Gel for Chromatography, Phenylsilyl, V-A117
Distribution Estimation By (2.9.38.), Hexadecylamidylsilyl, End-capped, Silica Gel for Chromatography,
V-503 V-A115 Phenylsilyl, End-capped, V-A117
Sieving, Analytical, Particle-size Silica Gel for Chromatography, Silica Gel for Chromatography,
Distribution Estimation By (2.9.38.) Hexylsilyl, V-A115 Propoxybenzene, End-capped, V-A117
(5.8.), V-702 Silica Gel for Chromatography, Silica Gel for Chromatography,
Silanised Diatomaceous Earth for GC Hexylsilyl, End-capped, V-A116 Propylsilyl, V-A117
R1, V-A51 Silica Gel for Chromatography, Human Silica Gel for Chromatography R1,
Silanised Diatomaceous Support, V-A51 Albumin, V-A116 Octadecylsilyl, End-capped, V-A118
Silanised Silica Gel H, V-A119 Silica Gel for Chromatography, Silica Gel for Chromatography R1,
Silanised Silica Gel HF254, V-A119 Hydrophilic, V-A116 Octadecylsilyl, End-capped, Base-
Sildenafil Citrate, II-803 Silica Gel for Chromatography, deactivated, V-A118
Silibinin, V-A114 Methylsilyl, V-A116 Silica Gel for Chromatography R1,
Silica, Colloidal Anhydrous, Ii-805 Silica Gel for Chromatography, Nitrile, Aminopropylsilyl, V-A115
Silica, Colloidal Hydrated, II-806 V-A116 Silica Gel for Chromatography R1,
Silica, Dental-type, II-807 Silica Gel for Chromatography, Nitrile, Nitrile, V-A118
Silica, Hydrophobic Colloidal, End-capped, V-A116 Silica Gel for Chromatography R1,
Anhydrous, II-807 Silica Gel for Chromatography, Octadecylsilyl, V-A118
Silica Gel, V-A114 4-Nitrophenylcarbamidesilyl, V-A116 Silica Gel for Chromatography R1,
Silica Gel AD for Chiral Separation, Silica Gel for Chromatography, Octylsilyl, V-A118
V-A114 Octadecanoylaminopropylsilyl, V-A116 Silica Gel for Chromatography R1,
Silica Gel AGP for Chiral Silica gel for Chromatography, Phenylsilyl, V-A118
Chromatography, V-A114 Octadecylsilyl, V-A116 Silica Gel for Chromatography R2,
Silica Gel, Anhydrous, V-A114 Silica Gel for Chromatography, Nitrile, V-A118
Silica Gel BC for Chiral Octadecylsilyl, Base-deactivated, Silica Gel for Chromatography R2,
Chromatography, V-A114 V-A116 Octadecylsilyl, V-A118
Silica Gel F254, V-A118 Silica Gel for Chromatography, Silica Gel for Chromatography R2,
Silica Gel for Chiral Chromatography, Octadecylsilyl, End-capped, V-A116 Octylsilyl, V-A118
Urea Type, V-A114 Silica Gel for Chromatography, Silica Gel for Chromatography R3,
Silica Gel for Chromatography, V-A114 Octadecylsilyl, End-capped, Base- Octylsilyl, V-A118
Silica Gel for Chromatography, Alkyl- deactivated, V-A116 Silica Gel for Chromatography, Strong
bonded for use with Highly Aqueous Silica Gel for Chromatography, cation-exchange, V-A118
Mobile Phases, V-A114 Octadecylsilyl, Extra-dense bonded, Silica Gel for Chromatography, Strong-
Silica Gel for Chromatography, Alkyl- End-capped V-A116 anion-exchange, V-A118
bonded for use with Highly Aqueous Silica Gel for Chromatography, Silica Gel for Chromatography,
Mobile Phases, End-capped, V-A115 Octadecylsilyl, Monolithic, V-A116 Trimethylsilyl, V-A118
Silica Gel for chromatography, Silica Gel for HPTLC, Octadecylsilyl,
Amidohexadecylsilyl, V-A115 V-A118
V-A854 Index

Silica Gel for Size-exclusion SMV(live), see Smallpox Vaccine (Live) Sodium Calcium Edetate Concentrate,
Chromatography, V-A118 SN50, V-628 Sterile, III-1091
Silica Gel G, V-A119 Soap, Soft, II-813 Sodium Calcium Edetate Infusion,
Silica Gel GF254, V-A119 Soap Spirit, III-1088 III-1091
Silica Gel H, V-A119 Soda, Caustic, see Sodium Hydroxide Sodium Calcium Edetate Injection, see
Silica Gel H, Silanised, V-A119 Soda Lime, II-814 Sodium Calcium Edetate Infusion
Silica Gel HF254, V-A119 Soda Mint Tablets, III-1091 Sodium Calcium Edetate Intravenous
Silica Gel HF254, Silanised, V-A119 Sodium, V-A120 Infusion, see Sodium Calcium Edetate
Silica Gel OC for Chiral Separations, Sodium Acetate, V-A120 Infusion
V-A119 Sodium Acetate ([1-11C]) Injection, Sodium Caprylate, II-829
Silica Gel OD for Chiral Separations, IV-702 Sodium Carbonate, V-A121
V-A119 Sodium Acetate, Anhydrous, V-A120 Sodium Carbonate, Anhydrous, V-A121,
Silica Gel OJ for Chiral Separations, Sodium Acetate Buffer pH 7.0, V-A158 V-A141
V-A119 Sodium Acetate Buffer Solution pH 4.0, Sodium Carbonate, Anhydrous, II-830
Silica Gel Plate, TLC, V-A134 0.1 M, V-A158 Sodium Carbonate Decahydrate, II-830
Silicates, Reactions of, V-269 Sodium Acetate Buffer Solution pH 4.5, Sodium Carbonate Monohydrate, II-831,
Silicone, V-590 V-A158 V-A121
Silicone Oil Used as a Lubricant, V-589 Sodium Acetate Concentrate, Sterile, Sodium Carbonate Solution, V-A121
Silicone Elastomer for Closures and III-1089 Sodium Carbonate Solution, Dilute,
Tubing, V-589 Sodium Acetate Solution pH 6.0, V-A121
Silicotungstic Acid, V-A120 Buffered, V-A158 Sodium Carbonate Solution R1, V-A121
Silicristin, V-A120 Sodium Acetate Trihydrate, II-815 Sodium Carbonate Solution R2, V-A121
Silidianin, V-A120 Sodium Acid Citrate, II-816 Sodium Cetostearyl Sulfate, II-831,
Silver and Silver Compounds, Reactions Sodium Alendronate, II-816 V-A121
of, V-269 Sodium Alendronate Tablets, see Sodium Cetostearyl Sulphate, see Sodium
Silver, Colloidal, for External Use, Alendronic Acid Tablets Cetostearyl Sulfate
II-808 Sodium Alginate, II-817 Sodium Chloride, II-833, V-A121,
Silver Diethyldithiocarbamate, V-A120 Sodium Amidotrizoate, II-818, V-S126 V-A141
Silver Manganese Paper, V-A120 Sodium Aminosalicylate Dihydrate, Sodium Chloride and Dextrose Infusion,
Silver Nitrate, II-809, V-A120 II-819 III-1095
Silver Nitrate Cutaneous Solution, see Sodium and Sodium Salts, Reactions of, Sodium Chloride and Dextrose Infusion,
Silver Nitrate Solution V-269 Potassium Chloride, see Potassium
Silver Nitrate Reagent, V-A120 Sodium Arsenite, V-A120 Chloride, Sodium Chloride and Glucose
Silver Nitrate Solution, III-1084, V-A120 Sodium arsenite solution, V-A120 Infusion
Silver Nitrate Solution, Ammoniacal, Sodium Arsenite VS, V-A146 Sodium Chloride and Dextrose
V-A120 Sodium Ascorbate, II-821 Intravenous Infusion, Potassium
Silver Nitrate Solution in Pyridine, Sodium Ascorbate Solution, V-A120 Chloride, see Potassium Chloride,
V-A120 Sodium Aurothiomalate, II-823 Sodium Chloride and Glucose Infusion
Silver Nitrate Solution R1, V-A120 Sodium Aurothiomalate Injection, Sodium Chloride and Dextrose
Silver Nitrate Solution R2, V-A120 III-1089 Intravenous Infusion, see Sodium
Silver Nitrate Solution, Sterile, III-1084 Sodium Azide, V-A121 Chloride and Glucose Infusion
Silver Nitrate VS, V-A146 Sodium Benzoate, II-824 Sodium Chloride and Glucose Infusion,
Silver Oxide, V-A120 Sodium Bicarbonate, II-825 III-1095
Silver Standard Solution (5 ppm Ag), Sodium Bicarbonate Ear Drops, III-1089 Sodium Chloride and Glucose Infusion,
V-A151 Sodium Bicarbonate Eye Lotion, Potassium Chloride, see Potassium
Simeticone, II-810 III-1089 Chloride, Sodium Chloride and Glucose
Simeticone for Oral Use, II-811 Sodium Bicarbonate Infusion, III-1090 Infusion
Simeticone Suspension for Infants, Sodium Bicarbonate Intravenous Sodium Chloride and Glucose
III-1084 Infusion, see Sodium Bicarbonate Intravenous Infusion, Potassium
Similar Biological Medicinal Products, Infusion Chloride, see Potassium Chloride,
V-795 Sodium Bicarbonate Oral Solution, Sodium Chloride and Glucose Infusion
Similar, Definition of, I-5, II-5, III-5, III-1090 Sodium Chloride and Glucose
IV-5, V-5 Sodium Bicarbonate Powder for Oral Intravenous Infusion, see Sodium
Simple Eye Ointment, III-1085 Solution, III-1090 Chloride and Glucose Infusion
Simple Linctus, III-1085 Sodium Bicarbonate Solution, see Sodium Sodium Chloride and Sodium Citrate
Simple Linctus, Paediatric, III-1085 Hydrogen Carbonate Solution Oral Solution, Compound Glucose,
Simple Ointment, III-1085 Sodium Bicarbonate Tablets, III-617
Simvastatin, II-812, V-S126 Compound, III-1091 Sodium Chloride Eye Drops, III-1092
Simvastatin Tablets, III-1087 Sodium Bicarbonate, see Sodium Sodium Chloride Eye Lotion, III-1092
Sinensetin, V-A120 Hydrogen Carbonate Sodium Chloride Eye Ointment,
Sinomenine, V-A120 Sodium Bismuthate, V-A121 III-1092
Sitostanol, V-A120 Sodium Borate, see Borax Sodium Chloride Infusion, III-1092
b-Sitosterol, V-A120 Sodium Bromide, II-826, V-A121 Sodium Chloride Infusion, Potassium
Size-exclusion Chromatography, V-200 Sodium Butanesulfonate, V-A121 Chloride and, see Potassium Chloride
Size-exclusion Chromatography, Silica Sodium Butanesulphonate, see Sodium and Sodium Chloride Infusion
Gel for, V-A118 Butanesulfonate Sodium Chloride Intravenous Infusion,
(S)-Lactic Acid, II-61 Sodium Butyl Hydroxybenzoate, II-827 Potassium Chloride and, see Potassium
Smallpox Vaccine (Live), IV-628 Sodium Butylparaben, II-827 Chloride and Sodium Chloride Infusion
(S)-(-)-a-Methylbenzyl Isocyanate, Sodium Calcium Edetate, II-827, Sodium Chloride Intravenous Infusion,
V-A87 V-A121 see Sodium Chloride Infusion
page numbers in bold type relate to monograph titles Index V-A855

Sodium Chloride Irrigation Solution, Sodium Dodecyl Sulphate, see Sodium Sodium Hydroxide Solution, Strong,
III-1093 Dodecyl Sulfate V-A123
Sodium Chloride Mouthwash, Sodium Edetate, V-A122 Sodium Hydroxide VS, V-A146
Compound, III-1093 Sodium Edetate, see Disodium Edetate Sodium Hydroxide VS, Ethanolic,
Sodium Chloride Nebuliser Solution, Sodium Etacrynate for Injection, V-A146
III-1093 III-1097 Sodium 2-Hydroxybutyrate, V-A123
Sodium Chloride Oral Solution, III-1094 Sodium Etacrynate Injection, III-1097 Sodium Hypobromite Solution, V-A123
Sodium Chloride Solution, III-1094, Sodium Feredetate, II-841, V-S127 Sodium Hypochlorite Solution, V-A123
V-A121 Sodium Feredetate Oral Solution, Sodium Hypochlorite Solution (3% Cl),
Sodium Chloride Solution, Saturated, III-1098 V-A123
V-A121 Sodium Fluoresceinate, V-A122 Sodium Hypochlorite Solution, Dilute,
Sodium Chloride Tablets, Soluble, Sodium Fluoresceinate, see Fluorescein III-1101, V-A123
III-1094 Sodium Sodium Hypochlorite Solution, Strong,
Sodium Cholate, V-A121 Sodium Fluoride, II-842, V-A122 III-1101, V-A123
Sodium Chromate (51Cr) Sterile Sodium Fluoride (18F) Injection, IV-704 Sodium Hypochlorite Solution, Strong,
Solution, IV-703 Sodium Fluoride Mouthwash, III-1098 see Sodium Hypochlorite Solution (3%
Sodium Citrate, II-834, V-A121 Sodium Fluoride Oral Drops, III-1099 Cl)
Sodium Citrate Buffer Solution pH 7.8 Sodium Fluoride Oral Solution, III-1099 Sodium Hypophosphite, V-A123
(0.034M Sodium Citrate, 0.101M Sodium Fluoride Tablets, III-1100 Sodium Iodide, II-850, V-A123
Sodium Chloride), V-A158 Sodium Formate, V-A122 Sodium Iodide (123I) Injection, IV-705
Sodium Citrate Eye Drops, III-1095 Sodium Fusidate, II-843 Sodium Iodide (123I) Solution for
Sodium Citrate Irrigation Solution, Sodium Fusidate Ointment, III-1100 Radiolabelling, IV-706
III-1095 Sodium Glucuronate, V-A122 Sodium Iodide (131I) Capsules for
Sodium Citrate Oral Solution, Sodium Glycocholate, V-A122 Diagnostic Use, IV-707
Compound Glucose, Sodium Chloride Sodium Glycerophosphate, Hydrated, Sodium Iodide (131I) Capsules for
and, III-617 II-846 Therapeutic Use, IV-708
Sodium Citrate Solution for Bladder Sodium Heptanesulfonate, V-A122 Sodium Iodide (131I) Solution, IV-709
Irrigation, Sterile, III-1095 Sodium Heptanesulfonate Monohydrate, Sodium Iodide (131I) Solution For
Sodium Clodronate Tetrahydrate, II-835 V-A122 Radiolabelling, IV-710
Sodium Cobaltinitrite, V-A121 Sodium Heptanesulphonate Sodium Iodide Injection, III-1101
Sodium Cobaltinitrite Solution, V-A121 Monohydrate, see Sodium Sodium Iodobismuthate Solution,
Sodium Cromoglicate, II-836 Heptanesulfonate Monohydrate V-A123
Sodium Cromoglicate Eye Drops, Sodium Heptanesulphonate, see Sodium Sodium Iodohippurate (123I) Injection,
III-1096 Heptanesulfonate IV-710
Sodium Cromoglicate Inhalation Sodium Hexanesulfonate, V-A122 Sodium Iodohippurate (131I) Injection,
Powder, hard capsule, III-1096 Sodium Hexanesulfonate Monohydrate IV-711
Sodium Cromoglicate Powder for for Ion-pair Chromatography, V-A122 Sodium Iodohippurate Dihydrate for
Inhalation, see Sodium Cromoglicate Sodium Hexanesulphonate Radiopharmaceutical Preparations,
Inhalation Powder, hard capsule Monohydrate, see Sodium IV-666
Sodium Cyclamate, II-838 Hexanesulfonate Monohydrate Sodium Lactate Infusion, III-1102
Sodium Decanesulfonate, V-A121 Sodium Hexanesulphonate, see Sodium Sodium Lactate Injection, III-1102
Sodium Decanesulphonate, see Sodium Hexanesulfonate Sodium Lactate Injection, Compound,
Decanesulfonate Sodium Hyaluronate, II-847 III-1102
Sodium Decyl Sulfate, V-A121 Sodium Hydrogen Carbonate, V-A122 Sodium Lactate Intravenous Infusion,
Sodium Decyl Sulphate, see Sodium Decyl Sodium Hydrogen Carbonate, see Sodium Compound, III-1102
Sulfate Bicarbonate Sodium Lactate Intravenous Infusion, see
Sodium Deoxycholate, V-A121 Sodium Hydrogen Carbonate Oral Sodium Lactate Infusion
Sodium Deoxyribonucleate, V-A121 Solution, see Sodium Bicarbonate Oral Sodium Lactate Solution, II-850
Sodium Diethyldithiocarbamate, V-A121 Solution Sodium (s)-Lactate, II-851
Sodium Diethyldithiocarbamate Sodium Hydrogen Carbonate Solution, Sodium (s)-Lactate Solution, II-851
Solution, V-A121 V-A122 Sodium Laurilsulfate, V-A123
Sodium Dihydrogen Orthophosphate, Sodium Hydrogen Sulfate, V-A122 Sodium Laurilsulfate, see Sodium Dodecyl
V-A121 Sodium Hydrogen Sulphate, see Sodium Sulfate
Sodium Dihydrogen Orthophosphate, Hydrogen Sulfate Sodium Lauryl Sulfate, II-853, V-A123
Anhydrous, V-A122 Sodium Hydrogensulfite, V-A122 Sodium Lauryl Sulfate, see Sodium
Sodium Dihydrogen Orthophosphate Sodium Hydrogensulphite, see Sodium Dodecyl Sulfate
Monohydrate, V-A122 Hydrogensulfite Sodium Lauryl Sulphate, see Sodium
Sodium Dihydrogen Phosphate, V-A122 Sodium Hydroxide, II-849, V-A122 Dodecyl Sulfate
Sodium Dihydrogen Phosphate, Sodium Hydroxide, Ethanolic, V-A122 Sodium Lauryl Sulphate, see Sodium
anhydrous, II-839, V-A122 Sodium Hydroxide, Methanolic, V-A122 Lauryl Sulfate
Sodium Dihydrogen Phosphate Sodium Hydroxide Solution, V-A122 Sodium Lauryl Sulfate, see Sodium Lauryl
Dihydrate, II-840 Sodium Hydroxide Solution, Carbonate- Sulphate
Sodium Dihydrogen Phosphate free, V-A123 Sodium Laurylsulfonate for
Monohydrate, II-840, V-A122 Sodium Hydroxide Solution, Dilute, Chromatography, V-A123
Sodium Dioctyl Sulfosuccinate, V-A122 V-A123 Sodium Lauryl sulphonate for
Sodium Dithionite, V-A122 Sodium Hydroxide Solution, Methanolic, Chromatography, see Sodium Lauryl
Sodium Dodecyl Sulfate, V-A122 V-A123 sulfonate for Chromatography
Sodium Dodecyl Sulfate VS, V-A146 Sodium Hydroxide Solution R1, Sodium Metabisulfite, II-853, V-A123
Sodium Dodecyl Sulphate VS, see Methanolic, V-A123 Sodium Metabisulphite, see Sodium
Sodium Dodecyl Sulfate VS Metabisulfite
V-A856 Index

Sodium Methanesulfonate, V-A123 Sodium Picosulfate, II-860 Sodium Tartrate, see Sodium ()-Tartrate
Sodium Methoxide VS, V-A147 Sodium Picosulfate Elixir, III-1104 Sodium Taurodeoxycholate, V-A125
Sodium Methyl Hydroxybenzoate, II-854 Sodium Picosulfate Oral Powder, see Sodium Tetraborate, V-A125
Sodium Methylparaben, see Sodium Compound Sodium Picosulfate Powder for Sodium Tetraborate, see Borax
Methyl Hydroxybenzoate Oral Soution Sodium Tetrachloroaurate Dihydrate for
Sodium Methyl Parahydroxybenzoate, see Sodium Picosulfate Oral Solution, Homoeopathic Preparations, IV-451
Sodium Methyl Hydroxybenzoate III-1104 Sodium Tetradecyl Sulfate Concentrate,
Sodium Molybdate, V-A123 Sodium Picosulfate Powder for Oral II-875
Sodium Molybdate Dihydrate, II-856 Soution, Compound, III-1105 Sodium Tetradecyl Sulfate Injection,
Sodium Molybdate (99Mo) Solution Sodium Picrate Solution, Alkaline, III-1106
(Fission), IV-712 V-A124 Sodium Tetradecyl Sulphate
Sodium 1,2-Naphthoquinone-4- Sodium Polystyrene Sulfonate, II-861, Concentrate, see Sodium Tetradecyl
sulfonate, V-A123 V-S127 Sulfate Concentrate
Sodium Nitrate, V-A123 Sodium Polystyrene Sulphonate see Sodium Tetradecyl Sulphate Injection,
Sodium Nitrite, II-856, V-A123 Sodium Polystyrene Sulfonate see Sodium Tetradecyl Sulfate Injection
Sodium Nitrite Solution, V-A123 Sodium Potassium Tartrate, V-A124 Sodium Tetrahydroborate, V-A125
Sodium Nitrite VS, V-A147 Sodium Potassium Tartrate, see Potassium Sodium Tetrahydroborate Reducing
Sodium Nitroprusside, II-857, V-A123 Sodium ()-Tartrate Solution, V-A125
Sodium Nitroprusside for Injection, Sodium Propionate, II-862 Sodium Tetraphenylborate, V-A125
III-1103 Sodium Propyl Hydroxybenzoate, II-863 Sodium Tetraphenylborate Solution,
Sodium Nitroprusside Infusion, III-1103 Sodium Propyl Parahydroxybenzoat see V-A125
Sodium Nitroprusside Intravenous Sodium Propyl Hydroxybenzoat Sodium Tetraphenylborate VS, V-A147
Infusion, see Sodium Nitroprusside Sodium Pyrosulfite, see Sodium Sodium Thioglycollate, V-A125
Infusion Metabisulfite Sodium Thiosulfate, II-875, V-A125
Sodium Nitroprusside-Carbonate Sodium Pyrophosphate, V-A124 Sodium Thiosulfate, Anhydrous, V-A125
Solution, V-A124 Sodium Rhodizonate, V-A124 Sodium Thiosulfate Injection, III-1106
Sodium Octanoate, see Sodium Caprylate Sodium Salicylate, II-865, V-A124 Sodium Thiosulfate VS, V-A147
Sodium Octanesulfonate, V-A124 Sodium Selenite Pentahydrate, II-866 Sodium Thiosulphate, see Sodium
Sodium Octanesulfonate Monohydrate, Sodium Standard Solution (50 ppm Na), Thiosulfate
V-A124 V-A151 Sodium Thiosulphate Injection, see
Sodium Octanesulphonate Monohydrate, Sodium Standard Solution (200 ppm Sodium Thiosulfate Injection
see Sodium Octanesulfonate Monohydrate Na), V-A151 Sodium Thiosulphate VS, see Sodium
Sodium Octanesulphonate, see Sodium Sodium Standard Solution (1000 ppm Thiosulfate VS
Octanesulfonate Na), V-A151 Sodium Thiosulphate, see Sodium
Sodium Octyl Sulfate, V-A124 Sodium Starch Glycolate (Type A), Thiosulfate
Sodium Octyl Sulphate, see Sodium Octyl II-866 Sodium Tungstate, V-A125
Sulfate Sodium Starch Glycolate (Type B), Sodium Valproate, II-876
Sodium Oxalate, V-A124 II-867 Sodium Valproate Oral Solution,
Sodium Pentanesulfonate, V-A124 Sodium Starch Glycolate (Type C), III-1107
Sodium Pentanesulfonate Monohydrate, II-868 Sodium Valproate Tablets, III-1108
V-A124 Sodium Stearate, II-869 Sodium Valproate Tablets, Gastro-
Sodium Pentanesulfonate Monohydrate Sodium Stearyl Fumarate, II-870 resistant, III-1109
R1, V-A124 Sodium Stibogluconate, II-871 Sodium/calcium acetate buffer solution
Sodium Pentanesulphonate Monohydrate Sodium Stibogluconate Injection, pH 7.0, V-A158
R1, see Sodium Pentanesulfonate III-1106 Sodiums-Lactate Solution, II-851
Monohydrate R1 Sodium Sulfate, II-873, V-A124 Soft Extracts, IV-48
Sodium Pentanesulphonate Sodium Sulfate, Anhydrous, II-868, Soft Soap, II-813
Monohydrate, see Sodium V-A124 Softening Time Determination of
Pentanesulfonate Monohydrate Sodium sulfate, anhydrous R1, V-A124 Lipophilic Suppositories, V-513
Sodium Pentanesulphonate, see Sodium Sodium Sulfate Decahydrate, V-A124 Solid Dosage Forms, Recommendations
Pentanesulfonate Sodium Sulfide, V-A124 on Dissolution Testing of, V-358
Sodium Perborate, II-858 Sodium Sulfide Solution, V-A124 Solid Oral Dosage Forms, Dissolution
Sodium Perborate, Hydrated see Sodium Sodium Sulfide Solution R1, V-A124 Testing of, V-645
Perborate Sodium Sulfite, V-A124 Solids, Determination of Total, V-332
Sodium Perchlorate, V-A124 Sodium Sulfite, Anhydrous, II-869, Solids Including Powders, Wettability of
Sodium Periodate, V-A124 V-A124 Porous, V-536
Sodium Periodate Solution, V-A124 Sodium Sulfite Heptahydrate, II-874 Solids, Pycnometric Density of, V-514
Sodium Periodate VS, V-A147 Sodium Sulphate, Anhydrous, see Sodium Solochrome Dark Blue, V-A125
Sodium Pertechnetate (99mTc) Injection Sulfate, Anhydrous Solochrome Dark Blue Mixture, V-A125
(Fission), IV-714 Sodium Sulphide Solution R1, see Solubility, Definition of Terms Used,
Sodium Pertechnetate (99mTc) Injection Sodium Sulfide Solution R1 I-11, II-11, III-11, IV-11, V-11
(Non-fission), IV-715 Sodium Sulphide Solution, see Sodium Solubility in Alcohol of Essential Oils,
Sodium Phenylbutyrate, II-858 Sulfide Solution V-322
Sodium Phosphate (32P) Injection, Sodium Sulphide, see Sodium Sulfide Solubility, Status of, I-11, II-11, III-11,
IV-716 Sodium Sulphite, see Sodium Sulfite IV-11, V-11
Sodium Phosphate Buffer Solution Sodium Sulphite, Anhydrous, see Sodium Soluble Fluorescein see Fluorescein
pH 8.0, 0.02M, V-A158 Sulphite, Anhydrous Sodium
Sodium Phosphates Enema, III-988 Sodium Sulphite Heptahydrate, see Soluble Paracetamol and Caffeine
Sodium Phosphite, V-A124 Sodium Sulphite Heptahydrate Tablets, III-953
Sodium Phosphite Pentahydrate, V-A124 Sodium Tartrate, V-A125 Soluble Paracetamol Tablets, III-951
page numbers in bold type relate to monograph titles Index V-A857

Soluble Sarcharin, see Saccharin Sodium Spectinomycin Dihydrochloride Standard, International, I-14, II-14,
Soluble Sodium Chloride Tablets, Pentahydrate, II-894 III-14, IV-14, V-14
III-1094 Spectrometry, Mass, V-180 Standard Phosphate Buffer, 0.025M,
Soluble Starch, V-A126 Spectrometry, Nuclear Magnetic V-A156
Soluble Sulfacetamide, see Sulfacetamide Resonance, V-170 Standard Preparations for Biological
Sodium Spectrometry, Raman, V-184 Assays, V-652
Soluble Tablets, III-75 Spectrometry, X-Ray Fluorescence, Standard Solution for the Micro
Solution Calorimetry, Characterisation of V-179 Determination of Water, V-A125
Crystalline Solids by V-541 Spectrophotometry, Absorption, Standard Solutions for Atomic
Solutions, Emulsions and Suspensions, Ultraviolet and Visible, V-169 Spectometry, Elementary, V-A149
Oral, III-57 Spectrophotometry, Atomic, Emission Standard Terms, V-659
Solutions for Haemodialysis, see and Absorption, V-174 Standardised Aloes Dry Extract, IV-55
Haemodialysis Solutions SPF, I-30, II-30, III-30, IV-30, V-30 Standardised Belladonna Leaf Dry
Solutions for Haemodialysis and SPF, Chicken Flocks Free from Extract, IV-92
Haemodiafiltration, see Haemodialysis Specified Pathogens for the Production Standardised Capsicum Tincture, IV-124
and Haemodiafiltration Solutions and Quality Control of Vaccines, Standardised Cascara Dry Extract,
Solvents, I-24, II-24, III-24, IV-24, V-469 IV-130
V-24 Spheroids, Friability of, V-513 Standardised Cinchona Liquid Extract,
Solvents for Pharmacopoeial Tests, I-12, Spike Lavender Oil, IV-240 IV-140
II-12, III-12, IV-12, V-12 Spirapril Hydrochloride Monohydrate, Standardised Frangula Bark Dry Extract,
Solvents, Residual, V-289 II-896 IV-190
Somatostatin, II-878 Spirit, Industrial Methylated, II-248 Standardised Ipecacuanha Liquid
Somatropin, II-879 Spirit (Ketone-free), Industrial Extract, IV-223
Somatropin Bulk Solution, see Somatropin Methylated, II-248 Standardised Ipecacuanha Tincture,
Concentrated Solution Spirit, Rectified, I-900 IV-224
Somatropin Concentrated Solution, Spirits, III-73 Standardised Liquorice Ethanolic Liquid
II-881 Spirits, Industrial Methylated, II-248 Extract, IV-252
Somatropin for Injection, III-1110 Spironolactone, II-898, V-S127 Standardised Opium Dry Extract, IV-297
Somatropin Injection, III-1109 Spironolactone Oral Suspension, Standardised Opium Tincture, IV-298
Sophora Flower, IV-368 III-1113 Standardised Senna Granules, IV-364
Sophora Flower-Bud, IV-369 Spironolactone Tablets, III-1115 Standardised Senna Leaf Dry Extract,
Sorbic Acid, II-883, V-A125 Spongiform Encephalopathy Agents Via IV-366
Sorbitan Laurate, II-884 Human and Veterinary Medicinal Standards, Official, I-4, II-4, III-4, IV-4,
Sorbitan Oleate, II-884 Products, Minimising the Risk of V-4
Sorbitan Palmitate, II-885 Transmitting Animal, V-611 Standards, Primary, V-A141
Sorbitan Sesquioleate, II-885 Spongiform Encephalopathies Animal, Standards, Reference, V-757
Sorbitan Stearate, II-886 Products with Risk of Transmitting Stannated Hydrochloric Acid, V-A73
Sorbitan Trioleate, II-886 Agents of, II-896 Stannous Chloride, V-A125
Sorbitol, II-887, V-A125 Spray-dried Acacia, I-42 Stannous Chloride Dihydrate, II-902
Sorbitol (Crystallising), Liquid, II-886 Spray-dried Liquid Glucose, I-1085 Stannous Chloride Solution, V-A125
Sorbitol (Non-crystallising), Liquid, Sprays, III-60 Stannous Chloride Solution AsT, see
II-887 Nasal, III-60 Tin(II) Chloride Solution AsT
Sorbitol, Partially Dehydrated Liquid Sprays (Liquid Nasal) and Drops (nasal), Stannous Chloride Solution R1, V-A125
II-885 III-59 Stannous Chloride Solution R2, V-A125
Sorbitol Solution (70 per cent) Squalane, II-900, V-A125 Stannous Chloride Solution R1, see
(Crystallising), see Liquid Sorbitol Squill, IV-372 Tin(II) Chloride Solution R1
(Crystallising) Squill, Indian, IV-372 Stannous Chloride Solution R2, see
Sorbitol Solution (70 per cent) (Non- Squill Linctus, Compound, IV-373 Tin(II) Chloride Solution R2
crystallising), see Liquid Sorbitol (Non- Squill Linctus, Opiate, IV-373 Stannous Chloride Solution, see Tin(II)
crystallising) Squill Linctus, Paediatric Opiate, IV-373 Chloride Solution
Sotalol Hydrochloride, II-891 Squill Liquid Extract, IV-372 Stannous Chloride, see Tin(II) Chloride
Sotalol Injection, III-1112 Squill Oral Solution, Opiate, IV-373 Stanolone, V-A125
Sotalol Tablets, III-1113 Squill Oral Solution, Paediatric Opiate, Stanozolol, II-903, V-S128
Soya Oil, Hydrogenated, II-889 IV-373 Staphylococcus aureus Strain V8
Soya Oil, Refined, II-890 Squill Oxymel, IV-373 Protease Type XVII-B, V-A125
Spanish Sage Oil, IV-349 SSI, V-628 Star Anise, IV-67
Spearmint Oil, IV-371 S.S.I. - Statens Serum Institut, address Star Anise Oil, IV-69
Special, V-781 of, I-31, II-31, III-31, IV-31, V-31 Starch, V-A126
Specific Optical Rotation, Determination St. Johns Wort, IV-374 Starch, Cassava, II-916
of, V-244 St Marks Solution, see Compound Glucose, Starch, Hydrolysed, V-A126
Specific Surface Area by Air Sodium Chloride and Sodium Citrate Starch, Hydroxypropyl, II-905
Permeability, V-505 Oral Solution Starch, Hydroxypropyl, Pregelatinised
Specific Surface Area by Gas Adsorption, Stabiliser-free Di-isopropyl Ether, V-A54 II-906
V-515 Stabiliser-free Tetrahydrofuran, V-A131 Starch, Maize II-908
Specific Surface Area By Gas Adsorption Stability of Unlicensed Medicines, Starch, Maize, Pregelatinised see
(2.9.26.) (5.8.), V-701 Storage and, V-784 Pregelatinised Starch
Specificity, V-673 Standard Dichlorophenolindophenol Starch, Pea II-909
Specified Micro-organisms, Tests for, Solution, V-A52 Starch, Potato II-909
V-657 Standard 2,6-Dichlorophenolindophenol Starch, Pregelatinised II-910
Solution, Double-strength, V-A52 Starch, Rice II-911
V-A858 Index

Starch Iodate Paper, V-A126 Sterile Potassium Chloride Concentrate, Strong Methyl Salicylate Ointment,
Starch Iodide Paper, V-A126 III-1004 III-818
Starch Mucilage, V-A126 Sterile Potassium Dihydrogen Phosphate Strong 1-Naphthol Solution, V-A92
Starch, Soluble, V-A126 Concentrate, III-1007 Strong Paediatric Alimemazine Oral
Starch Solution, V-A126 Sterile Products, Methods of Preparation Solution, III-116
Starch Solution, Iodide-free, V-A126 of, V-544 Strong Pholcodine Linctus, III-988
Starch Solution R1, V-A126 Sterile Silver Nitrate Solution, III-1084 Strong Pholcodine Oral Solution see
Starch Solution R2, V-A126 Sterile Single-use Plastic Syringes, V-561 Strong Pholcodine Linctus
Starch Substrate, V-A126 Sterile Sodium Acetate Concentrate, Strong Sodium Hydroxide Solution,
Starch, Tapioca, II-916 III-1089 V-A123
Starch, Wheat, II-912 Sterile Sodium Calcium Edetate Strong Sodium Hypochlorite Solution,
Starches, Hydroxyethyl, II-900 Concentrate, III-1091 III-1101, V-A123
Starflower Oil, Refined, see Refined Sterile Sodium Citrate Solution for Strong-anion-exchange Silica Gel for
Borage Oil Bladder Irrigation, III-1095 Chromatography, V-A118
Stated Potency, I-14, II-14, III-14, Sterile Synthetic Absorbable Braided Strongly Acidic Ion-exchange Resin,
IV-14, V-657, V-14 Sutures, IV-747 V-A76, V-A126
Stavudine, II-917, V-A126 Sterile Synthetic Absorbable Strongly Basic Anion Exchange Resin,
Stearic Acid, II-919, V-A126 Monofilament Sutures, IV-748 V-A28
Stearic Anhydride, V-A126 Sterile Trisodium Edetate Concentrate, Strongly Basic Anion Exchange Resin
Stearoyl Macrogolglycerides, II-920 III-1189 Chromatography, V-A28
Stearyl Alcohol, II-921, V-A126 Sterilisation, Methods of, I-10, II-10, Strontium (89Sr) Chloride Injection,
Sterile Plastic Containers for Human III-10, IV-10, V-544, V-10 IV-717
Blood and Blood Components, V-555 Sterilisation of Parenteral Preparations, Strontium Carbonate, V-A126
Sterile Containers of Plasticised Methods of, III-66 Strontium Chloride, V-A126
Poly(Vinyl Chloride) for Human Sterility, Test for, V-473 Strontium Chloride Hexahydrate,
Blood Containing Anticoagulant Steroids, Identification of, V-198 V-A126
Solution, V-555 Steroids, Tetrazolium Assay of, V-288 Strontium Selective Extraction Resin,
Stephania Tetrandra Root, IV-377 Sterols in Fatty Oils, V-329 V-A126
Sterculia, IV-378 Sticks, III-73 Strontium Standard Solution
Sterculia Granules, IV-378 Sticks, Nasal, III-60 (1.0 per cent Sr), V-A151
Sterculia Gum, see Sterculia Stigmasterol, V-A126 Strontium-85 Spiking Solution, V-A126
Sterile Arginine Hydrochloride Stomata, V-335 Strontium-85 Standard Solution,
Concentrate, III-148 Storage, I-28, II-28, III-28, IV-28, V-28 V-A126
Sterile Catgut, IV-745 Storage and Stability of Unlicensed Styrene, V-A127
Sterile Cetrimide Cutaneous Solution, Medicines, V-784 Styrene-divinylbenzene Copolymer,
III-286 Storage Statements, Status of, I-15, V-A127
Sterile Cetrimide Solution, III-286 II-15, III-15, IV-15, V-15 Subdivision of Tablets, III-73
Sterile Ciclosporin Concentrate, III-311 Stramonium Leaf, IV-379 Subdued Light, Definition of, I-12,
Sterile Clonazepam Concentrate, III-350 Stramonium Prepared, IV-381 II-12, III-12, IV-12, V-197, V-12
Sterile Concentrate, Nizatidine, III-903 Streptokinase Concentrated Solution, Sublingual Tablets and Buccal Tablets,
Sterile Concentrate, Quinine II-922 III-63
Dihydrochloride, III-1048 Streptokinase for Injection, III-1116 Subsidiary Titles, Status of, I-7, II-7,
Sterile Containers of plasticised Streptokinase Injection, III-1115 III-7, IV-7, V-7
poly(vinyl chloride) for Human Blood Streptomycin Injection, III-1116 Substances for Pharmaceutical Use, I-37,
containing Anticoagulant Solution, Streptomycin Sulfate, II-924, V-A126 II-37
V-559 Streptomycin Sulfate for Injection, Sub-visible Particles, Particulate
Sterile Co-trimoxazole Concentrate, III-1117 Contamination, V-393
III-408 Streptomycin Sulphate for Injection, see Sub-visible Particles, Particulate
Sterile Dobutamine Concentrate, III-483 Streptomycin Sulfate for Injection Contamination (2.9.19.) (5.8.), V-701
Sterile Dopamine Concentrate, III-490 Streptomycin Sulphate, see Streptomycin Succinate Buffer Solution pH 4.6,
Sterile Ephedrine Concentrate, III-512 Sulfate V-A158
Sterile Etoposide Concentrate, III-545 Strong Succinic Acid, V-A127
Sterile Isoprenaline Concentrate, III-712 Aminohydroxynaphthalenesulfonic Sucralfate, II-925
Sterile Lidocaine Cutaneous Solution, Acid Solution, V-A24 Sucralose, II-927
III-751 Strong Ammonia Solution, I-154 Sucrose, V-A127
Sterile Lidocaine Solution, III-751 Strong Ammonium Acetate Solution, Sucrose Monopalmitate, II-930
Sterile Lignocaine Solution, see Sterile III-137 Sucrose Stearate, II-931
Lidocaine Solution Strong Cation Exchange Resin (Calcium Sudan Red, V-A127
Sterile Mitoxantrone Concentrate, Form), V-A39 Sudan Red G, V-A127
III-853 Strong cation-exchange Silica Gel for Sudan Red Solution, V-A127
Sterile Non-absorbable Sutures, IV-750 Chromatography, V-A118 Sudan Yellow, V-A127
Sterile Noradrenaline Concentrate, Strong Cetrimide Solution, I-492 Sudan Yellow Solution, V-A127
III-905 Strong Coal Tar Solution, III-1134 Sufentanil, II-933
Sterile Norepinephrine Concentrate, Strong Ginger Tincture, IV-199 Sufentanil Citrate, II-934
III-905 Strong Glutaraldehyde Solution, I-1086 Sugar, Compressible, II-936, V-S33
Sterile Phenoxybenzamine Concentrate, Strong Haloperidol Oral Drops, III-640 Sugar Spheres, II-936
III-979 Strong Haloperidol Oral Solution, Suggested Methods, Status of, I-14,
Sterile Plastic Containers for Human III-640 II-14, III-14, IV-14, V-14
Blood and Blood Components, V-557 Strong Iodine Monochloride Reagent, Sulbactam Sodium, II-937
V-A75 Sulfacetamide Sodium, II-939
page numbers in bold type relate to monograph titles Index V-A859

Sulfacetamide Soluble, see Sulfacetamide Sulfuric Acid VS, V-A147 Sulphur, see Sulfur
Sodium Sulfuric AcidFormaldehyde Reagent, Sulpiride, II-954, V-S129
Sulfadiazine, II-940, V-S128 V-A128 Sulpiride Tablets, III-1123
Sulfadiazine Injection, III-1117 Sulindac, II-952, V-S129 Sultamicillin, II-956
Sulfadoxine, II-942 Sulindac Tablets, III-1122 Sultamicillin Tosilate Dihydrate, II-959
Sulfafurazole, II-943 Sulphamic Acid, see Sulfamic Acid Sumatra Benzoin, IV-96
Sulfaguanidine, II-944 Sulphan Blue, see Sulfan Blue Sumatra Benzoin Tincture, IV-97
Sulfamethizole, II-945 Sulphanilamide, see Sulfanilamide Sumatriptan, II-961, V-S130
Sulfamethoxazole, II-945, V-S128 Sulphanilic Acid Solution, Diazotised, see Sumatriptan Injection, III-1123
Sulfamethoxazole and Trimethoprim Sulfanilic Acid Solution, Diazotised Sumatriptan Nasal Spray, III-1125
Preparations, see Co-trimoxazole Sulphanilic Acid Solution R1, see Sumatriptan Succinate, II-963, V-S130
Preparations Sulfanilic Acid Solution R1 Sumatriptan Tablets, III-1126
Sulfamethoxazole Oral Suspension, Sulphanilic Acid Solution, see Sulfanilic Sunflower Oil, V-A129
Trimethoprim and, see Co-trimoxazole Acid Solution Supercritical Fluid Chromatography,
Oral Suspension Sulphanilic Acid, see Sulfanilic Acid V-216
Sulfamethoxazole Tablets, Dispersible Sulphate Buffer Solution pH 2.0, see Superfine Powder, Definition of, V-501
Trimethoprim and, III-410 Sulfate Buffer Solution pH 2.0 Supplementary Chapters, Contents of
Sulfamethoxazole Tablets, Trimethoprim Sulphate Standard Solution (10 ppm the, V-A631
and, see Co-trimoxazole Tablets SO4) R1, see Sulfate Standard Solution Suppositories, III-69, V-513
Sulfamic Acid, V-A127 (10 ppm SO4) R1 Softening Time Determination,
Sulfan Blue, V-A127 Sulphate Standard Solution (10 ppm V-513
Sulfanilamide, V-A127 SO4), see Sulfate Standard Solution Surgical Spirit, III-1128
Sulfanilic Acid, V-A127, V-A142 (10 ppm SO4) Suspensions, Solutions and Emulsions,
Sulfanilic Acid Solution, V-A127 Sulphate Standard Solution (100 ppm Oral, III-57
Sulfanilic Acid Solution, Diazotised, SO4), see Sulfate Standard Solution Sutures, IV-745
V-A127 (100 ppm SO4) Sutures, Sterile Non-absorbable, see
Sulfanilic Acid Solution R1, V-A127 Sulphated Ash, Determination of, see Sterile Non-absorbable Sutures
Sulfasalazine, II-947, V-S129 Sulfated Ash, Determination of Sutures, Sterile Synthetic Absorbable
Sulfasalazine Tablets, III-1118 Sulphathiazole, see Sulfathiazole Braided, see Sterile Synthetic Absorbable
Sulfasalazine Tablets, Gastro-resistant, Sulphite Standard Solution (1.5 ppm Braided Sutures
III-1120 SO2), see Sulfite Standard Solution Sutures, Sterile Synthetic Absorbable
Sulfate Buffer Solution pH 2.0, V-A158 (1.5 ppm SO2) Monofilament, see Sterile Synthetic
Sulfate Standard Solution (10 ppm SO4), Sulphite Standard Solution (80 ppm Absorbable Monofilament Sutures
V-A152 SO2), see Sulfite Standard Solution Suxamethonium Chloride, II-965
Sulfate Standard Solution (10 ppm SO4) (80 ppm SO2) Suxamethonium Chloride Injection,
R1, V-A152 Sulphomolybdic Reagent R3, see III-1128
Sulfate Standard Solution (100 ppm Sulfomolybdic Reagent R3 Suxibuzone, II-966
SO4), V-A151 Sulphomolybdic Reagent, see Sweet Fennel, IV-185
Sulfated Ash (2.4.14.) (5.8.), V-700 Sulfomolybdic Reagent R2 Sweet Orange Oil, IV-302
Sulfated Ash, Determination of, V-306 Sulphosalicylic Acid, see Sulfosalicylic Acid Swelling Index, V-332
Sulfates, Reactions of, V-269 Sulphur Dioxide, Determination of, see Swertiamarin, V-A129
Sulfathiazole, II-949, V-A127 Sulfur Dioxide, Determination of Symbols, Atomic Weights of Elements,
Sulfinpyrazone, II-950 Sulphur Dioxide R1, see Sulfur Dioxide Names and, V-629
Sulfinpyrazone Tablets, III-1121 R1 Symphytum Officinale Root, Ethanol
Sulfite Standard Solution (1.5 ppm Sulphur Dioxide Solution, see Sulfur Decoction for Homoeopathic
SO2), V-A152 Dioxide Solution Preparations, IV-453
Sulfite Standard Solution (80 ppm SO2), Sulphur Dioxide, see Sulfur Dioxide Symphytum Officinale Root for
V-A152 Sulphur for External Use, see Sulfur for Homoeopathic Preparations, IV-452
Sulfomolybdic Reagent R2, V-A127 External Use Synonyms, Approved, V-598
Sulfomolybdic Reagent R3, V-A127 Sulphuric Acid, Alcoholic Solution of, see Synthetic Air, I-82
Sulfosalicylic Acid, V-A127 Sulfuric Acid, Alcoholic Solution of Synthetic Medicinal Air see Synthetic Air
Sulfur Dioxide, V-A127 Sulphuric Acid, Dilute, see Sulfuric Acid, Synthetic Peptides, Determination of
Sulfur Dioxide, Determination of, V-306 Dilute Acetic Acid in, V-299
Sulfur Dioxide R1, V-A127 Sulphuric Acid, Ethanolic, see Sulfuric Synthetic Retinol Concentrate (Oily
Sulfur Dioxide Solution, V-A127 Acid, Ethanolic Form), II-738
Sulfur for External Use, II-953 Sulphuric Acid, Heavy Metal-free, see Synthetic Retinol Concentrate (Powder
Sulfur for Homoeopathic Preparations, Sulfuric Acid, Heavy Metal-free Form), II-739
IV-451 Sulphuric Acid, 2.5M Alcoholic, see Synthetic Retinol Concentrate,
Sulfur-free Toluene, V-A135 Sulfuric Acid, 2.5m Alcoholic Solubilisate/Emulsion, II-740
Sulfuric Acid, II-954, V-A127 Sulphuric Acid, 0.25M Alcoholic, see Synthetic Vitamin A Concentrate (Oily
Sulfuric Acid, Alcoholic Solution of, Sulfuric Acid, 0.25m Alcoholic Form), see Synthetic Retinol Concentrate
V-A128 Sulphuric Acid, Methanolic, see Sulfuric (Oily Form)
Sulfuric Acid, Dilute, II-954, V-A128 Acid, Methanolic Synthetic Vitamin A Concentrate
Sulfuric Acid, Ethanolic, V-A128 Sulphuric Acid, 5M, see Sulfuric Acid, 5M (Powder Form), see Synthetic Retinol
Sulfuric Acid, Heavy Metal-free, V-A128 Sulphuric Acid, Nitrogen-free, see Concentrate (Powder Form)
Sulfuric Acid, 5M, V-A128 Sulfuric Acid, Nitrogen-free Synthetic Vitamin A Concentrate
Sulfuric Acid, 0.25M Alcoholic, V-A128 Sulphuric Acid VS, see Sulfuric Acid VS (Solubilisate/Emulsion), see Synthetic
Sulfuric Acid, Methanolic, V-A128 Sulphuric AcidFormaldehyde Reagent, Retinol Concentrate, Solubilisate/
Sulfuric Acid, Nitrogen-free, V-A129 see Sulfuric AcidFormaldehyde Reagent Emulsion
Sulfuric acid, nitrogen-free R1, V-A129 Sulphuric Acid, see Sulfuric Acid
V-A860 Index

Synthetic Vitamin A Concentrate Tannic Acid, II-976, V-A129 Temazepam, II-981


(Water-dispersible Form), see Synthetic Tannic Acid Reagent, V-A129 Temazepam Oral Solution, III-1135
Retinol Concentrate, Solubilisate/ Tannins in Herbal Drugs, Determination Temazepam Tablets, III-1136
Emulsion of, V-338 Temperature, I-24, II-24, III-24, IV-24,
Syringes, Sterile Single-use, Plastic, Tanshinone IIA, V-A129 V-24
V-561 Tanshinone IIA CRS, V-A160 Temperature, Expression of, I-6, II-6,
Syrup, III-1129 Tapioca Starch, II-916 III-6, IV-6, V-6
Syrups, III-58 Tapped Density of Powders, Bulk Tenoxicam, II-983
System Suitability, Chromatographic Density and, V-534 Tenoxicam for Injection, III-1136
Tests, V-639 Tar, II-976 Tenoxicam Injection, III-1136
System suitability requirements for Tar, Coal, II-976 Tenoxicam Tablets, III-1138
monographs of the British Tartaric Acid, II-977, V-A129 Terazosin Hydrochloride Dihydrate,
Pharmacopoeia, V-195 Tartrates, Reactions of, V-270 II-984
System Suitability Testing, V-675 Taurodeoxycholic Acid Sodium Salt, Terbinafine Hydrochloride, II-987
V-A129 Terbutaline Sulfate, II-988
Taxifolin, V-A129 Terbutaline Tablets, III-1139
T Td/IPV, see Diphtheria, Tetanus and
Poliomyelitis (Inactivated) Vaccine
Terconazole, II-989
Terfenadine, II-991, V-S131
Table of Physical Characteristics of
(Adsorbed, Reduced Antigen(s) Content) Terfenadine Oral Suspension, III-1140
Radionuclides Mentioned in the
Tea Tree Oil, IV-382 Terfenadine Tablets, III-1141
European Pharmacopoeia (5.7.),
Tears, Artificial, III-669 Terminalia Arjuna Stem Bark, IV-383
IV-656
Technetium (99mTc) Albumin Injection, Terminalia Belerica Fruit, IV-384
Tablets, III-73
IV-718 Terminalia Chebula Fruit, IV-385
Chocolate Basis for, III-76
Technetium (99mTc) Bicisate Injection, Terminology used in Monographs on
Content of active ingredient, III-76
IV-719 Biological Products, V-463
Tablets of the BP, III-76
Technetium (99mTc) Colloidal Rhenium Terms, Definition of, I-5, II-5, III-5,
Tablets and Capsules, Disintegration of,
Sulfide Injection, IV-720 IV-5, V-5
V-346
Technetium (99mTc) Colloidal Sulfur Terpeneless Lemon Oil, IV-246
Tablets and Capsules, Disintegration of
Injection, IV-721 Terpeneless Orange Oil, IV-303
(2.9.1.) (5.8.), V-700
Technetium (99mTc) Colloidal Rhenium g-Terpinene, V-A129
Tablets and Powders for Rectal Solutions
Sulphide Injection, see Technetium Terpinen-4-ol, V-A129
and Suspensions, III-70
(99mTc) Colloidal Rhenium Sulfide Terpineol, II-992, V-A129
Tablets, Buccal, III-63
Injection Terpinolene, V-A129
Tablets, Chewable, III-75
Technetium (99mTc) Colloidal Sulphur tert-Butyl Methyl Ether R1, see 1,1-
Tablets, Coated, III-74
Injection, see Technetium (99mTc) Dimethylethyl Methyl Ether R1
Tablets, Disintegration Test for, V-346
Colloidal Sulfur Injection tert-Butyl Methyl Ether, see 1,1-
Tablets, Dispersible, III-75
Technetium (99mTc) Colloidal Tin Dimethylethyl Methyl Ether
Tablets, Effervescent, III-75
Injection, IV-722 tert-Butylamine, see 1,1-
Tablets for Use in the Mouth, III-75
Technetium (99mTc) Etifenin Injection, Dimethylethylamine
Tablets for Vaginal Solutions and
IV-723 tert-Butylhydroperoxide, V-A36
Suspensions, III-80
Technetium (99mTc) Exametazime Test for Abnormal Toxicity, V-409
Tablets, Gastro-resistant, III-75
Injection, IV-724 Test for Aristolochic Acids in Herbal
Tablets, Modified-release, III-75
Technetium (99mTc) Gluconate Drugs, V-339
Tablets, Orodispersible, III-75
Injection, IV-725 Test for Absence of Mycoplasmas,
Tablets, Resistance to Crushing of,
Technetium (99mTc) Human Albumin V-487
V-513
Injection, see Technetium (99mTc) Test for Bacterial Endotoxins, V-404
Tablets, Soluble, III-75
Albumin Injection Test for Extractable Volume of
Tablets, Subdivision of, III-73
Technetium (99mTc) Macrosalb Parenteral Preparations V-374
Tablets, Sublingual, III-63
Injection, IV-726 Test for Extractable Volume of
Tablets, Uncoated, III-74
Technetium (99mTc) Mebrofenin Parenteral Preparations (2.9.17.)
Tablets, Uncoated, Friability of, V-510
Injection, IV-727 (5.8.), V-701
Tablets, Vaginal, III-80
Technetium (99mTc) Medronate Test for Foreign Oils By Gas
Tadalafil, II-967
Injection, IV-728 Chromatography, V-324
Tagatose, V-A129
Technetium (99mTc) Mertiatide Test for Foreign Oils By Thin-layer
Talc, V-A129
Injection, IV-730 Chromatography, V-323
Talc Dusting Powder, III-1130
Technetium (99mTc) Microspheres Test for Histamine, V-410
Tamoxifen, V-S130
Injection, IV-731 Test for Methanol and 2-propanol
Tamoxifen Citrate, II-972
Technetium (99mTc) Pentetate Injection, (2.9.11.), V-286
Tamoxifen Tablets, III-1130
IV-732 Test for neurovirulence of live virus
Tamper-evident Container, Definition of,
Technetium (99mTc) Sestamibi Injection, vaccine, V-464
I-16, II-16, III-16, IV-16, V-16
IV-733 Test for neurovirulence of poliomyelitis
Tamper-proof Container, Definition of,
Technetium (99mTc) Succimer Injection, vaccine (oral), V-464
I-16, II-16, III-16, IV-16, V-16
IV-734 Test for Pyrogens, V-465
Tampons, Ear, III-44
Technetium (99mTc) Tin Pyrophosphate Test for Specified Micro-organisms,
Tampons, Vaginal, Medicated, III-81
Injection, IV-735 V-700
Tamsulosin Capsules, Prolonged-release,
Technical Changes to Monographs, Test for Sterility, V-475
III-1131
I-xxx Testing of Vaccines, Production and,
Tamsulosin Hydrochloride, II-974
Tecnazene, V-A129 V-463
Tamsulosin Tablets, Prolonged-release,
Teicoplanin, II-977 Testosterone, II-993, V-S131, V-A129
III-1132
Telmisartan, II-979 Testosterone Decanoate, II-995, V-S131
page numbers in bold type relate to monograph titles Index V-A861

Testosterone Enantate, II-996 Tetracycline Tablets, III-1147 Texture Analysis of Semi-solids or Gels,
Testosterone Enantate Injection, n-Tetradecane, V-A130 V-510
III-1142 Tetradecylammonium Bromide, V-A130 Thallium Standard Solution (10 ppm
Testosterone Implants, III-1143 Tetraethylammonium Hydrogen Sulfate, Tl), V-A152
Testosterone Isocaproate, II-998, V-S132 V-A130 Thallium(I) Nitrate, V-A132
Testosterone Propionate, II-999, Tetraethylammonium Hydrogen Thallium(I) Sulfate, V-A132
V-S132, V-A129 Sulphate, see Tetraethylammonium Thallium(I) Sulphate, see Thallium(i)
Testosterone Propionate Injection, Hydrogen Sulfate Sulfate
III-1143 Tetraethylammonium Hydroxide Thallous (201Tl) Chloride Injection,
Tests and Assays, I-12, I-27, II-12, Solution, V-A130 IV-736
II-27, III-12, III-27, IV-12, IV-27, Tetraethylene Pentamine, V-A130 Thallous Sulfate, see Thallium(I) Sulfate
V-12, V-27 Tetraheptylammonium Bromide, V-A131 Thallous Sulphate, see hallous Sulfate
Tetanus Vaccine, (Adsorbed), IV-609 Tetrahexylammonium Hydrogen Sulfate, Thebaine, V-A132
Tetanus Vaccine (adsorbed), Assay of, V-A131 Theobroma Oil, II-1009
V-441 Tetrahydrofuran, V-A131 Theobromine, II-1009, V-A132
Tetanus Antitoxin, IV-523 Tetrahydrofuran for Chromatography, Theophylline, II-1010, V-S132, V-A132
Tetanus Immunoglobulin, IV-502 V-A131 Theophylline-ethylenediamine,
Tetra--Acetyl-Mannose Triflate for Tetrahydrofuran, Stabiliser-free, V-A131 anhydrous see Aminophylline
Radiopharmaceutical Preparations, D-Tetrahydropalmatine Hydrochloride, Theophylline-ethylenediamine Hydrate
IV-667 V-A131 see Aminophylline Hydrate
Tetrabutylammonium Bromide, V-A130 a-Tetralone, V-A131 Theophylline Hydrate, II-1011
Tetrabutylammonium Buffer Solution N,N,N,N-Tetramethyl-p- Theophylline Monohydrate see
pH 7.0, V-A159 phenylenediamine Dihydrochloride, Theophylline Hydrate
Tetrabutylammonium Dihydrogen V-A131 Theophylline Tablets, Prolonged-release,
Orthophosphate, V-A130 Tetramethylammonium Chloride, III-1148
Tetrabutylammonium Dihydrogen V-A131 Thermal Analysis, Determination of,
Phosphate, see Tetrabutylammonium Tetramethylammonium Hydrogen V-253
Dihydrogen Orthophosphate Sulfate, V-A131 Thiamazole, II-1013, V-A132
Tetrabutylammonium Hydrogen Sulfate, Tetramethylammonium Hydroxide Thiamine Hydrochloride, II-1014
V-A130 Pentahydrate, V-A131 Thiamine Injection, III-1148
Tetrabutylammonium Hydrogen Sulfate Tetramethylammonium Hydroxide Thiamine Nitrate, II-1016
R1, V-A130 Solution, V-A131 Thiamine Tablets, III-1149
Tetrabutylammonium Hydrogen Tetramethylammonium Hydroxide Thiamphenicol, II-1017
Sulphate R1, see Tetrabutylammonium Solution, Dilute, V-A131 2-(2-Thienyl)acetic Acid, V-A132
Hydrogen Sulfate R1 Tetramethylammonium Hydroxide, see Thimerosal see Thiomersal
Tetrabutylammonium Hydrogen Tetramethylammonium Hydroxide Thin-layer Chromatography, V-195
Sulphate, see Tetrabutylammonium Pentahydrate Thin-layer Chromatography, Additional
Hydrogen Sulfate Tetramethylbenzidine, V-A131 points for the British Pharmacopoeia,
Tetrabutylammonium Hydroxide, 1,1,3,3-Tetramethylbutylamine, V-A131 V-197
V-A130 Tetramethyldiaminodiphenylmethane Thioacetamide, V-A132
Tetrabutylammonium Hydroxide in 2- Reagent, see 4,4-Methylenebis-N,N- Thioacetamide Reagent, V-A132
Propanol, V-A148 dimethylaniline Reagent Thioacetamide Solution, V-A132
Tetrabutylammonium Hydroxide in Tetramethyldiaminodiphenylmethane, see Thiobarbituric Acid, V-A132
Propan-2-ol VS, V-A148 4,4-Methylenebis-N,N-dimethylaniline Thiobarbituric Acidcitrate Buffer,
Tetrabutylammonium Hydroxide, 0.4M, Tetramethylethylenediamine, V-A131 V-A159
V-A130 Tetramethylsilane, V-A131 Thioctic Acid, II-1018
Tetrabutylammonium Hydroxide Tetrandrine, V-A131 Thiodiethylene Glycol, see Thiodiglycol
Solution, V-A130 1,2,3,4-Tetra-O-acetyl-b-D- Thiodiglycol, V-A132
Tetrabutylammonium Hydroxide glucopyranose, V-A130 Thioglycollic Acid, see Mercaptoacetic
Solution (104 g/L), V-A130 1,3,4,6-Tetra-O-acetyl-b-D- Acid
Tetrabutylammonium Hydroxide mannopyranose, V-A130 Thiomalic acid, V-A132
Solution (400 g/L), V-A130 1,2,3,4-Tetraphenylcyclopenta-1,3-diene, Thiomersal, II-1019, V-A132
Tetrabutylammonium Hydroxide VS, V-A131 Thiopental, V-S133
V-A147 1,2,3,4-Tetraphenylcyclopenta-1,3- Thiopental Injection, III-1150
Tetrabutylammonium Iodide, V-A130 dienone, V-A131 Thiopental Sodium, II-1020
Tetrabutylammonium Iodide VS, Tetraphenylethylene, V-A131 Thiopental Sodium and Sodium
V-A148 Tetrapropylammonium Chloride, Carbonate see Thiopental Sodium
Tetracaine Eye Drops, III-1144 V-A132 Thiopental Sodium for Injection,
Tetracaine Hydrochloride, II-1000 Tetrazepam, II-1006 III-1150
Tetrachloroethane, V-A130 Tetrazolium Assay of Steroids, V-288 Thioridazine, II-1022
Tetrachlorvinphos, V-A130 Tetrazolium Blue, V-A132 Thioridazine (1), V-S133
Tetracosactide, II-1002 Tetrazolium Blue Solution, Alkaline, Thioridazine (2), V-S133
Tetracosactide Injection, III-1144 V-A132 Thioridazine Hydrochloride, II-1023
Tetracosactide Zinc Injection, III-1145 Tetrazolium Bromide, V-A132 Thiotepa, II-1025, V-S134
Tetracos-15-enoic acid methyl ester, Tetrazolium salt, V-A132 Thiotepa for Injection, III-1151
V-A130 Tetryzoline Hydrochloride, II-1008 Thiotepa Injection, III-1151
Tetracycline, II-1003, V-A130 Tet, see Adsorbed Tetanus Vaccine Thiourea, V-A132
Tetracycline Capsules, III-1146 Tet/Ser, see Tetanus Antitoxin THM, V-628
Tetracycline Hydrochloride, II-1005, Texture Analysis, Measurement of, THMP, V-628
V-A130 V-508 Thomson Kudzuvine Root, IV-236
V-A862 Index

Three-lobed Sage Leaf, IV-347 Timolol Tablets, III-1158 TLC Silica Gel F254 Silanised Plate,
Threonine, II-1026, V-A132 Tin, V-A133 V-A134
Threonine, see L-Threonine Tin Liposoluble Standard Solution TLC Silica Gel G Plate, V-A134
Thrombin, V-A132 (1000 ppm Sn), V-A152 TLC Silica Gel GF254 Plate, V-A134
Thrombin, Bovine, V-A132 Tin Standard Solution (0.1 ppm Sn), TLC Silica Gel Plate, V-A134
Thrombin, Human, see Thrombin V-A152 TLC Silica Gel Plate for Aminopolyether
Thrombin Solution, V-A132 Tin Standard Solution (5 ppm Sn), Test, V-A134
Thrombin Solution, Human R1, V-A132 V-A152 TLC Silica Gel Plate for Chiral
Thrombin Solution, Human, see Tinctures, IV-47 Separations, Octadecylsilyl, V-A134
Thrombin Solution Tinctures of the BP, IV-48 TLC Silica Gel Silanised Plate, V-A134
Thromboplastin, V-A133 Tinidazole, II-1042 Tobramycin, II-1050
Thromboplastin Reagent, V-A133 Tin(II) Chloride, V-A133 Tobramycin Injection, III-1163
Thujone, V-A133 Tin(II) Chloride Solution, V-A133 Tocopherol Acetate, all-rac-Alpha- see
Thyme, IV-386 Tin(II) Chloride Solution AsT, V-A133 all-rac-Alpha-Tocopheryl Acetate
Thyme Oil, Thymol Type, IV-388 Tin(II) Chloride Solution R1, V-A133 Tocopherol, all-rac-Alpha- see all-rac-
Thymidine, V-A133 Tin(II) Chloride Solution R2, V-A133 Alpha-Tocopherol
Thymine, V-A133 Tinnevelly Senna Fruit, IV-363 Tocopherol, RRR-Alpha- see RRR-Alpha-
Thymol, II-1027, V-A133 Tinzaparin Sodium, II-1043 Tocopherol
Thymol Blue, V-A133 Tinzaparin Sodium Injection, III-1159 a-Tocopherol, V-A135
Thymol Blue Solution, V-A133 Tioconazole, II-1044, V-S135 Tocopheryl Acetate, RRR-Alpha see
Thymol Type, Thyme Oil, see Thyme Tioconazole Cream, III-1160 RRR-Alpha-Tocopheryl Acetate
Oil, Thymol Type Tioconazole Cutaneous Solution, Tocopheryl Acetate Concentrate
Thymolphthalein, V-A133 III-1161 (Powder Form), Alpha see Alpha-
Thymolphthalein Solution, V-A133 Tioconazole Nail Solution, III-1161 Tocopheryl Acetate Concentrate (Powder
Thymoxamine Hydrochloride, see Tioguanine, II-1045, V-S135 Form)
Moxisylyte Hydrochloride Tioguanine Tablets, III-1162 a-Tocopheryl Acetate, V-A135
Thymoxamine Tablets, see Moxisylyte Tiotropium Bromide Monohydrate, a-Tocopheryl Acetate Concentrate
Tablets II-1046 (Powder Form) see Alpha-Tocopherol
Thyroxine Oral Solution, see Tissue Factor Solution, Human, V-A72 Acetate Concentrate (Powder Form)
Levothyroxine Oral Solution Titan Yellow, V-A133 Tocopheryl Hydrogen Succinate, Alpha
Thyroxine Tablets, see Levothyroxine Titan Yellow Paper, V-A133 see Alpha Tocopherol Hydrogen Succinate
Tablets Titan Yellow Solution, V-A133 Tocopheryl Hydrogen Succinate, RRR-
Tiabendazole, II-1028 Titanium, V-A134 Alpha see RRR-Alpha Tocopherol
Tiabendazole Chewable Tablets, Titanium Dioxide, II-1048, V-A134 Hydrogen Succinate
III-1152 Titanium Ointment, III-1163 Tocopheryl Hydrogen Succinate, RRR-a
Tiabendazole Tablets, see Tiabendazole Titanium Standard Solution (100 ppm see RRR-Alpha Tocopherol Hydrogen
Chewable Tablets Ti), V-A152 Succinate
Tianeptine Sodium, II-1029 Titanium Trichloride Solution, see DL-a-Tocopheryl Hydrogen Succinate see
Tiapride Hydrochloride, II-1030 Titanium(III) Chloride Solution Alpha Tocopherol Hydrogen Succinate
Tiaprofenic Acid, II-1032 Titanium Trichloride, see Titanium(III) Tolazamide, II-1062, V-S135
Tibolone, II-1033 Chloride Tolazamide Tablets, III-1166
Tibolone Tablets, III-1153 Titanium TrichlorideSulfuric Acid Tolbutamide, II-1062, V-S136
Ticarcillin, V-S134 Reagent, see Titanium(III) Chloride Tolbutamide Tablets, III-1166
Ticarcillin and Clavulanic Acid for Sulfuric Acid Reagent Tolfenamic Acid, II-1064
Infusion, III-1155 Titanium TrichlorideSulphuric Acid o-Tolidine, V-A135
Ticarcillin and Clavulanic Acid for Reagent, see Titanium Trichloride o-Tolidine Solution, V-A135
Intravenous Infusion, see Ticarcillin Sulfuric Acid Reagent Tolnaftate, II-1065
and Clavulanic Acid for Infusion, Titanium(III) Chloride, V-A134 Tolu Balsam, IV-390
III-1155 Titanium(III) Chloride Solution, V-A134 Tolu Linctus, Paediatric Compound,
Ticarcillin and Clavulanic Acid Infusion, Titanium(III) Chloride VS, V-A148 IV-392
III-1155 Titanium(III) ChlorideSulfuric Acid Tolu Oral Solution, Paediatric
Ticarcillin and Clavulanic Acid Reagent, V-A134 Compound, IV-392
Intravenous Infusion, see Ticarcillin and Titanium(III) ChlorideSulphuric Acid Tolu Syrup, IV-391
Clavulanic Acid for Infusion Reagent, see Titanium(iii) Chloride Toluene, V-A135
Ticarcillin Sodium, II-1035 Sulfuric Acid Reagent Toluene, Sulfur-free, V-A135
Ticarcillin Sodium and Potassium Titles of Monographs, Changes to, Toluene, Sulphur-free, see Toluene,
Clavulanate Intravenous Infusion, see I-xxxii Sulfur-free
Ticarcillin and Clavulanic Acid Infusion Titles, Official, I-7, II-7, III-7, IV-7, V-7 Toluene-o-sulfonamide, V-A135
Tic/enceph, see Tick-borne Encephalitis Titration, Non-aqueous, V-280 Toluene-o-sulphonamide, see Toluene-o-
Vaccine, Inactivated Titrations, Complexometric, V-281 sulfonamide
Tick-borne Encephalitis Vaccine, Titrimetric Analysis, V-788 Toluene-p-sulfonamide, V-A135
Inactivated, IV-634 TLC Aluminium Oxide G Plate, V-A134 Toluene-p-sulfonic Acid, V-A135
Ticlopidine Hydrochloride, II-1036 TLC Octadecylsilyl Silica Gel F254 Plate, Toluene-p-sulphonamide, see Toluene-p-
Tilidine Hydrochloride Hemihydrate, V-A134 sulfonamide
II-1038 TLC Octadecylsilyl Silica Gel Plate, Toluene-p-sulphonic Acid, see Toluene-p-
Timolol, V-S134 V-A134 sulfonic Acid
Timolol Eye Drops, III-1157 TLC Performance Test Solution, o-Toluenesulfonamide, see Toluene-o-
Timolol Eye Drops, Dorzolamide and, V-A134 sulfonamide
III-492 TLC Silica Gel F254 Plate, V-A134 p-Toluenesulfonamide, see Toluene-p-
Timolol Maleate, II-1039 sulfonamide
page numbers in bold type relate to monograph titles Index V-A863

Toluenesulfonic Acid, see Toluene-p- Tranexamic Acid, II-1074, V-S137 Trichloroethylene, V-A136
sulfonic Acid Tranexamic Acid Injection, III-1171 Trichlorotrifluoroethane, V-A136
Toluenesulfonylurea, V-A135 Tranexamic Acid Mouthwash, III-1172 Tricine, V-A136
o-Toluenesulphonamide, see o- Tranexamic Acid Tablets, III-1173 Triclofos Oral Solution, III-1184
Toluenesulphonamide trans-Cinnamic Acid, V-A44 Triclofos Sodium, II-1093, V-S138
p-Toluenesulphonamide, see p- trans-Cinnamic Aldehyde, V-A44 Tricosane, V-A136
Toluenesulfonamide Transdermal Patches, III-77 Tridocosahexaenoin, V-A136
Toluenesulphonamide, see Transdermal Patches, Dissolution Test Triethanolamine, II-1094, V-A136
Toluenesulfonamide for, V-360 Triethyl Citrate, II-1096
Toluenesulphonic Acid, see Transmitting Animal Spongiform Triethyl Phosphonoformate, V-A136
Toluenesulfonic Acid Encephalopathy Agents Via Human Triethylamine, V-A136
Tolu-flavour Solution, IV-391 and Veterinary Medicinal Products, Triethylamine Hydrogen Carbonate
o-Toluic Acid, V-A135 Minimising the Risk of, V-611 Solution, V-A136
o-Toluidine, V-A135 Transparency, V-669, V-671 Triethylamine R2, V-A136
Toluidine Blue, V-A135 Transparency of Monographs, V-639 Triethylenediamine, V-A136
o-Toluidine Hydrochloride, V-A135 Tranylcypromine Sulfate, II-1075, Triflumuron, V-A137
Topical Powders, III-67 V-S137 Trifluoperazine, V-S139
Topical Powders of the BP, III-68 Tranylcypromine Tablets, III-1174 Trifluoperazine Hydrochloride, II-1097
Topical Semi-Solid Preparations, III-70 Trapidil, II-1076 Trifluoperazine Tablets, III-1184
Topical Semi-solid Preparations of the Trazodone Capsules, III-1174 Trifluoroacetic Acid, V-A137
BP, III-72 Trazodone Hydrochloride, II-1077, Trifluoroacetic Anhydride, V-A137
Tormentil, IV-392 V-S137 3-Trifluoromethylaniline, V-A137
Tormentil Tincture, IV-392 Trazodone Tablets, III-1176 4-Trifluoromethylphenol, V-A137
Tosylarginine Methyl Ester Treated Ethyl Acetate, V-A62 Trifluorothymidine Eye Drops, see
Hydrochloride, V-A135 Treated Formamide, V-A67 Trifluridine Eye Drops
Tosylarginine Methyl Ester Trehalose Dihydrate, II-1079 Trifluorothymidine, see Trifluridine
Hydrochloride Solution, V-A135 Tretinoin, II-1081 Trifluridine, II-1098, V-S139
Tosylchloramide Sodium, II-1068 Tretinoin Cutaneous Solution see Trifluridine Eye Drops, III-1185
Tosyl-lysyl-chloromethane Tretinoin Solution Triflusal, II-1099
Hydrochloride, V-A135 Tretinoin Gel, III-1177 Triglycerol Diisostearate, II-1103
Tosylphenylalanylchloromethane, Tretinoin Solution, III-1178 Trigonelline Hydrochloride, V-A137
V-A136 Triacetin, II-1082, V-A136 Trihexyphenidyl Hydrochloride, II-1103
Total Ash, V-335 Triamcinolone, II-1083, V-A136 Trihexyphenidyl Tablets, III-1186
Total Cholesterol in Oils Rich in Omega- Triamcinolone Acetonide, II-1084, Trimebutine Maleate, II-1104
3-Acids, V-328 V-S138, V-A136 Trimetazidine Hydrochloride, II-1106
Total Ionic Strength Adjustment Buffer, Triamcinolone Acetonide Injection, Trimethadione, II-1107
V-A159 III-1181 Trimethoprim, II-1108, V-S139
Total Ionic Strength Adjustment Buffer Triamcinolone Acetonide Nasal Spray, Trimethoprim and Sulfamethoxazole
R1, V-A159 III-1181 Oral Suspension, see Co-trimoxazole
Total Organic Carbon in Water for Triamcinolone Cream, III-1178 Oral Suspension
Pharmaceutical Use, Determination of, Triamcinolone Dental Paste, III-1180 Trimethoprim and Sulfamethoxazole
V-257 Triamcinolone Hexacetonide, II-1086, Preparations, see Co-trimoxazole
Total Protein, Determination of, V-296 V-S138 Preparations
Total Solids, Determination of, V-332 Triamcinolone Hexacetonide Injection, Trimethoprim and Sulfamethoxazole
Total Viable Aerobic Count, V-657 III-1182 Tablets, Dispersible, see Co-trimoxazole
Toxaphene, V-A136 Triamcinolone Ointment, III-1179 tablets, Dispersible
Toxicodendron Quercifolium for Triamcinolone Oromucosal Paste, Trimethoprim and Sulfamethoxazole
Homoeopathic Preparations, IV-453 III-1180 Tablets, see Co-trimoxazole Tablets
Trachyspermum Ammi, IV-393 Triamcinolone Tablets, III-1180 Trimethoprim Oral Suspension, III-1187
Traditional Chinese Medicine, Names of Triamterene, II-1087 Trimethoprim Tablets, III-1188
Herbal Drugs Used in (5.22.), V-792 Triamterene and Hydrochlorothiazide 1,2,4-Trimethylbenzene, V-A137
Traditional Herbal and Complementary Tablets, III-406 Trimethylchlorosilane, V-A137
Medicines, Crude Drugs; Status of, Triamterene Capsules, III-1183 2,2,4-Trimethylpentane, V-A137
I-17, II-17, III-17, IV-17, V-17 Tribasic Calcium Phosphate, see Calcium Trimethylpentane for chromatography,
Traditional Herbal Medicines, I-xxii, Phosphate V-A137
V-792 Tribenoside, II-1089 Trimethylpentane R1, V-A137
Traditional Herbal Medicines, Tribromophenol, V-A136 Trimethylpentane, see 2,2,4-
Supplementary Chapter VII, V-792 Tributyl Acetylcitrate, II-1090 Trimethylpentane
Tragacanth, II-1068, V-A136 Tributyl Citrate, V-A136 Trimethylsilyl Silica Gel for
Tramadol Capsules, III-1167 Tributyl Orthophosphate, V-A136 Chromatography, V-A118
Tramadol Capsules, Prolonged-release, Tributyl Phosphate, II-1092, V-A136 N-Trimethylsilylimidazole, V-A137
III-1167 Tributylphosphine, V-A136 3-Trimethylsilyl-1-propanesulfonic Acid,
Tramadol Hydrochloride, II-1070, Trichlorethylene, see Trichloroethylene Sodium Salt, V-A137
V-S136 Trichloroacetic Acid, II-1093, V-A136 Trimethylsulfonium Hydroxide, V-A137
Tramadol Tablets, Prolonged-release, Trichloroacetic Acid Cutaneous Trimethylsulphonium Hydroxide, see
III-1168 Solution, see Trichloroacetic Acid Trimethylsulfonium Hydroxide
Tramazoline Hydrochloride Solution Trimipramine Maleate, II-1110, V-S140
Monohydrate, II-1071 Trichloroacetic Acid Solution, III-1183, Trimipramine Tablets, III-1188
Trandolapril, II-1072, V-S136 V-A136 Trinitrin Tablets, see Glyceryl Trinitrate
Trandolapril Capsules, III-1169 1,1,1-Trichloroethane, V-A136 Tablets
V-A864 Index

2,4,6-Trinitrobenzene Sulfonic Acid, Tris(hydroxymethyl)aminomethane Tuberculin Purified Protein Derivative


V-A137 Buffer Solution pH 7.5, V-A160 for Human Use, see Tuberculin Purified
2,4,6-Trinitrobenzenesulphonic Acid, see Tris(hydroxymethyl)aminomethane Protein Derivative
2,4,6-Trinitrobenzenesulfonic Acid EDTA Buffer Solution pH 8.4, see Tubes for Comparative Tests, I-12,
Triolein, V-A137 Tris-EDTA Buffer pH 8.4 II-12, III-12, IV-12, V-270, V-12
Triphenylamine, V-A137 Tris(hydroxymethyl)aminomethane Turmeric Javanese, IV-394
Triphenylethylene, V-A137 sodium chloride buffer solution Turmeric Rhizome, IV-395
Triphenylmethanol, V-A137 pH 7.4, see Tris-chloride Buffer pH 7.4 Turpentine Oil, IV-396
2,3,5-Triphenyltetrazolium Chloride, Tris(hydroxymethyl)aminomethane Turpentine Oil, Pinus Pinaster Type, see
V-A137 Sodium Chloride Buffer Solution Turpentine Oil
Triphenyltetrazolium Chloride Solution, pH 7.4 R1, V-A160 Typhoid (live, oral), see Typhoid (Strain
V-A137 Tris(hydroxymethyl)aminomethane Ty 21a) Vaccine, Live (Oral)
Tripotassium Phosphate Trihydrate, Sodium Chloride Buffer solution Typhoid Polysaccharide Vaccine, IV-636
V-A137 pH 7.4, see tris-chloride buffer pH 7.4 Typhoid (Strain Ty 21a) Vaccine, Live
Triprolidine Hydrochloride, II-1112, Tris(hydroxymethylaminomethane) (Oral), IV-638
V-S140 Solution, see Typhoid Vaccine, IV-638
Triprolidine Tablets, III-1189 Tris(hydroxymethyl)methylamine Typhoid Vaccine, Freeze-dried, IV-638
Tris-acetate Buffer Solution pH 8.5, Solution Typhoid, see Typhoid Polysaccharide
V-A159 Tris(hydroxymethyl)aminomethane- Vaccine
Tris-chloride Buffer pH 7.4, V-A159 EDTA Buffer Solution pH 8.4, Typhoid, see Typhoid Vaccine
Tris-chloride Buffer pH 7.5, V-A159 V-A160 Typhoid, see Typhoid Vaccine, Freeze-dried
Tris-chloride Buffer pH 7.5 R1, V-A159 Tris(hydroxymethylaminomethane), see Tyramine, V-A138
Tris-chloride Buffer pH 8.1, V-A159 Tris(hydroxymethyl)methylamine Tyrosine, II-1123, V-A138
Tris-chloride Buffer pH 8.6, V-A159 Tris(hydroxymethyl)methylamine, Tyrosine, see L-Tyrosine
Tris-chloride Buffer pH 8.8, V-A159 V-A138 Tyrothricin, II-1125
Tris-chloride Buffer Solution, V-A159 Tris(hydroxymethyl)methylamine
Triscyanoethoxypropane, V-A137 Solution, V-A138
1,3,5-Tris(3,5-di-(1,1-dimethylethyl)-4-
hydroxybenzyl)-1H,3H,5H-1,3,5-
Tris(hydroxymethyl)methylamine
Solution, Methanolic, V-A138
U
Ubidecarenone, II-1126
triazine-2,4,6-trione, V-A138 Tris(hydroxymethyl)nitromethane,
Ultraviolet and Visible Absorption
Tris-(2,4-di-(1,1-dimethylethyl)phenyl) V-A138
Spectrophotometry, V-169
Phosphite, V-A138 TriSodium Citrate, see Sodium Citrate
Ultraviolet Light, Definition of, V-197
Tris-EDTA BSA Buffer Solution Trisodium Edetate Infusion, III-1189
Ultraviolet Ray Lamps for Analytical
pH 8.4, V-A159 Trisodium Edetate Intravenous Infusion,
Purposes 2.1.3.), V-197
Tris-EDTA Buffer pH 8.4, V-A159 see Trisodium Edetate Infusion
Umbelliferone, V-A138
Tris-glycine Buffer Solution pH 8.3, Trisodium Orthophosphate, V-A138
Uncoated Tablets, III-74
V-A159 Trisodium Phosphate Dodecahydrate, see
Uncoated Tablets, Friability of, V-510
0.05M Tris-hydrochloride Buffer Solution Trisodium Orthophosphate
Undecanoic Acid, V-A138
pH 7.5, see Tris-chloride Buffer pH 7.5 Tris-sodium Acetate Buffer Solution
Undecenoic Acid, II-1128
R1 pH 7.4, V-A160
Uniformity of Content, V-371
3M Tris-hydrochloride Buffer Solution Tris-sodium Acetate Buffer Solution
Uniformity of Dosage Units, V-372
pH 8.8, see Tris-chloride Buffer pH 8.8 pH 8.0, V-A160
Uniformity of Weight, V-371
1M Tris-hydrochloride Buffer Solution Tris-sodium Acetate-sodium Chloride
Uniformity of Weight (Mass), V-371
pH 8.0, V-A159 Buffer Solution pH 7.4, V-A160
Uniformity of Weight (Mass) of
Tris-hydrochloride Buffer Solution Tris-sodium Acetate-sodium Chloride
Delivered Doses from Multidose
pH 6.8, 1M, V-A159 Buffer Solution pH 8.0, V-A160
Containers, V-371
Tris-hydrochloride Buffer Solution Tritiated (3H) Water Injection, IV-737
Uniformity of Content, V-371
pH 7.5, 0.05M, V-A159 Trometamol, II-1113
Uniformity of Dosage Units, V-372
Tris-hydrochloride buffer solution Tropic Acid, V-A138
Units, International System Of, I-31,
pH 7.5, 1M, V-A159 Tropicamide, II-1114, V-S140
II-31, III-31, IV-31, V-31
Tris-hydrochloride Buffer Solution Tropicamide Eye Drops, III-1190
Units of Activity of Biological
pH 8.0, V-A159 Tropine, V-A138
Preparations, V-653
Tris-hydrochloride Buffer Solution Tropisetron Hydrochloride, II-1115
Units of Biological Activity, Definition
pH 8.3, V-A159 Trospium Chloride, II-1117
of, I-14, II-14, III-14, IV-14, V-14
Tris-hydrochloride Buffer Solution Trospium Chloride Capsules, Prolonged-
Unlicensed Medicines, I-xxiii, V-781
pH 8.8, 1.5M, V-A159 release, III-1190
Unlicensed Medicines, Ethical
Tris-hydrochloride Buffer Solution Trospium Chloride Tablets, III-1192
Considerations, V-781
pH 9.0, 0.05M, V-A160 Troxerutin, II-1118, V-A138
Unlicensed Medicines, General
Tris(hydroxymethyl)aminoethane True Potency, V-657
monograph for, III-78
Solution R1, V-A138 Trypsin, II-1120, V-A138
Unlicensed Medicines, Guidance, V-781
Tris(hydroxymethyl)aminomethane Trypsin for Peptide Mapping, V-A138
Unlicensed Medicines, Labelling of,
Buffer Solution pH 7.5, see Tris- Tryptophan, II-1121, V-A138
III-78, V-782
chloride Buffer pH 7.5 Tuberculin for Human Use, Old, see Old
Unlicensed Medicines, Legal
Tris(hydroxymethyl)aminomethane Tuberculin
Requirements, V-781
Buffer Solution pH 8.1, see Tris- Tuberculin P.P.D., see Tuberculin Purified
Unlicensed Medicines, Monograph
chloride Buffer pH 8.1 Protein Derivative
Selection, V-783
Tris(hydroxymethyl)aminomethane Tuberculin Purified Protein Derivative,
Unlicensed Medicines, Preservative-free,
Buffer Solution pH 8.1, V-A160 IV-646
V-783
Tris(hydroxymethyl)aminomethane
Buffer Solution pH 7.4, V-A160
page numbers in bold type relate to monograph titles Index V-A865

Unlicensed Medicines, Standards for Validation of Analytical Procedures, Vindesine Sulfate, II-1161
Preparation and Manufacture, V-782 V-673 Vindesine Sulfate for Injection, III-1215
Unlicensed Medicines, Status of, I-18, Validation of pharmacopoeial methods, Vinorelbine Tartrate, II-1163
II-18, III-18, IV-18, V-18 I-22, II-22, III-22, IV-22, V-22 Vinpocetine, II-1165
Unsaponifiable Matter, V-320 Valine, II-1141, V-A139 Vinyl Acetate, V-A139
Uracil, V-A138 Valproic Acid, II-1142, V-S141 Vinyl Chloride, V-A139
Urea, II-1128, V-A138 Valsartan, II-1144, V-S141 Vinyl Polymer for Chromatography,
Urea Cream, III-1193 Vanadium Standard Solution (1 g/L V), Octadecyl, V-A139
Urease-active Meal, V-A138 V-A152 Vinyl Polymer for Chromatography,
Uridine, V-A138 Vancomycin Capsules, III-1200 Octadecylsilyl, V-A139
Urofollitropin, II-1129 Vancomycin Eye Drops, III-1201 2-Vinylpyridine, V-A139
Urofollitropin for Injection, III-1194 Vancomycin Hydrochloride, II-1145 1-Vinylpyrrolidin-2-one, V-A139
Urofollitropin Injection, III-1194 Vancomycin Hydrochloride for Infusion, Vinylpyrrolidone Copolymer for
Urokinase, II-1131 III-1202 Chromatography, Divinylbenzene and,
Uronic Acids in Polyssacchride Vaccines, Vancomycin Hydrochloride for Injection, V-A60
V-468 seeVancomycinHydrochlorideforInfusion Viral Safety, V-611
Ursodeoxycholic Acid, II-1132, V-S141 Vancomycin Hydrochloride for Viral Vaccines, Extraneous Agents in,
Ursodeoxycholic Acid Capsules, III-1194 Intravenous Infusion, see Vancomycin V-492
Ursodeoxycholic Acid Oral Suspension, Hydrochloride for Infusion Virgin Almond Oil, I-101
III-1195 Vancomycin Hydrochloride for Oral Virgin Castor Oil, I-430
Ursodeoxycholic Acid Tablets, III-1196 Solution, III-1204 Virgin Linseed Oil, II-114
Ursolic Acid in Polysaccharide Vaccines, Vancomycin Infusion, III-1202 Virgin Olive Oil, II-426
V-A138 Vancomycin Injection, see Vancomycin Virgin Wheat-germ Oil, II-1183
Urtica Dioica for Homoeopathic Infusion Viscometer, V-246
Preparations, IV-455 Vancomycin Intravenous Infusion, see U-tube, V-246
Urtica Urens Herb for Homoeopathic Vancomycin Infusion Viscose Wadding, Absorbent, see
Preparations, IV-456 Vancomycin Oral Solution, III-1204 Absorbent Viscose Wadding
Urushiol i, V-A138 Vanillin, II-1147, V-A139 Viscosity, V-246, V-247
Urushiol ii, V-A138 Vanillin Reagent, V-A139 Capillary viscometer method, V-247
Uva Ursi, see Bearberry Leaf Vanillin Solution, Phosphoric, V-A139 Determination of, V-246
Vardenafil Hydrochloride, Trihydrate, Visible Absorption Spectrophotometry,
II-1148 Ultraviolet and, V-169
V Varicella Immunoglobulin, IV-504
Varicella Immunoglobulin for
Visible Particles, Particulate
Contamination, V-395
Vaccine Strain, Choice of, I-9, II-9,
Intravenous Use, IV-504 Vitamin A, II-1167
III-9, IV-9, V-9
Varicella Vaccine (Live), IV-640 Vitamin A Ester Concentrate, Natural,
Vaccines, IV-524
Var(live), see Varicella Vaccine (Live) II-1168
Vaccines, Adsorbed, Aluminium in,
Vecuronium Bromide, II-1149 Vitamins A, C and D Oral Drops,
V-463
Vegetable Fatty Oils, II-1151 Paediatric, III-1217
Vaccines, Adsorbed, Calcium in, V-464
Vegetable Oil, Hydrogenated, II-1153 Vitamins B and C Injection, III-1219
Vaccines and Immunosera (Antisera),
Venlafaxine Capsules, Prolonged-release, Vitexin, V-A139
Phenol in, V-464
III-1205 Volatile Oil in Drugs, see Essential Oils in
Vaccines for Human Use, Cell
Venlafaxine Hydrochloride, II-1153, Herbal Drugs, Determination of
Substrates for the Production of,
V-S142 Voltametric Titrations, V-281
V-471
Venlafaxine Tablets, III-1206 Volumetric Reagents, V-A141
Vaccines, Production and Testing of,
Venlafaxine Tablets, Prolonged-release, Volumetric Solutions, V-A141, V-A142
V-463
III-1208 Volumetric Solutions, Preparation and
Vaginal Capsules, III-80
Verapamil, V-S142 Standardisation, V-A142
Vaginal Foams, III-81
Verapamil Capsules, Prolonged-release, von Willebrand Factor, IV-504
Vaginal Preparations, III-79
III-1209 von Willebrand Factor, human Assay of,
Vaginal Preparations, Semi-solid, III-81
Verapamil Hydrochloride, II-1154 V-420
Vaginal Solutions and Suspensions,
Verapamil Injection, III-1210 Voriconazole, II-1170
Tablets for, III-80
Verapamil Tablets, III-1211 VS, V-628
Vaginal Solutions, Emulsions and
Verapamil Tablets, Prolonged-release,
Suspensions, III-80
III-1211
Vaginal Tablets, III-80
Vaginal Tampons, Medicated, III-81
Veratric Acid, V-A139
Veratrole, V-A139
W
Valaciclovir Hydrochloride, Hydrated, Warfarin, V-S143
Verbena Herb, IV-402
II-1138 Warfarin Oral Suspension, III-1220
Verbenone, V-A139
Valencene, V-A138 Warfarin Sodium, II-1172
Vigabatrin, II-1157, V-S142
Valerenic Acid, V-A139 Warfarin Sodium Clathrate, II-1174
Vigabatrin Oral Powder, III-1212
Valerian, IV-397 Warfarin Tablets, III-1221
Vigabatrin Tablets, III-1213
Valerian Cut, IV-398 Warnings, I-29, II-29, III-29, IV-29,
Vinblastine Injection, III-1213
Valerian Dry Aqueous Extract, IV-399 V-29
Vinblastine Sulfate, II-1158
Valerian Dry Hydroalcoholic Extract, Washed Flux-calcined Diatomaceous
Vinblastine Sulfate for Injection,
IV-400 Filter-aid, V-A51
III-1213
Valerian Tincture, IV-401 Washes, Nasal, III-60
Vincristine Injection, III-1214
Valeriana, V-609 Water, V-A139
Vincristine Sulfate, II-1159
Valeric Acid, V-A139 Water (15O) Injection, IV-738
Vincristine Sulfate for Injection, III-1214
Water, Ammonia-free, V-A139
Vindesine Injection, III-1215
V-A866 Index

Water, Ammonium-free, see Water, Withanolide A CRS, V-A160 Zinc, Activated, V-A140
Ammonia-free Withanolide B CRS, V-A160 Zinc and Castor Oil Cream, III-1229
Water Bath, Definition of, I-7, II-7, Wool Alcohols, II-1184 Zinc and Castor Oil Ointment, III-1229
III-7, IV-7, V-7 Wool Alcohols Ointment, III-1222 Zinc and Coal Tar Paste, III-1229
Water, Carbon Dioxide-free, V-A139 Wool Fat, II-1185 Zinc and Hexachlorophene Dusting
Water, Determination of, V-307 Working Parties, I-xii Powder, III-642
Water, Determination of, see Water, Wormwood, IV-408 Zinc and Ichthammol Cream, III-1230
Determination of wP, see Pertussis Vaccine (Whole Cell, Zinc and Salicylic Acid Paste, III-1230
Water, Distilled, V-A140 Adsorbed) Zinc and Zinc Salts, Reactions of, V-270
Water, Distilled, Deionised, V-A140 Zinc Chloride, II-1204, V-A141
Water for Chromatography, V-A140 Zinc Chloride Solution, Iodinated,
Water for Diluting Concentrated
Haemodialysis Solutions, III-632
X V-A141
Zinc Chloride VS, V-A148
Xanthan Gum, II-1191
Water for Formulated Preparations, Zinc ChlorideFormic Acid Solution,
Xanthines, Reactions of, V-270
Quality of, I-10, II-10, III-10, IV-10, V-A141
Xanthydrol, V-A140
V-10 Zinc Cream, III-1227
Xanthydrol R1, V-A140
Water for Injections, II-1179, V-A140 Zinc Gluconate, II-1204
Xanthydrol Reagent, V-A140
Water for Preparation of Extracts, Zinc Iodide, V-A141
Xanthydrol Solution, V-A140
II-1182 Zinc Iodide and Starch Solution,
Xenon (133Xe) Injection, IV-738
Water for Use in Manufacturing V-A141
X-Ray Fluorescence Spectrometry,
Parenteral Preparations, III-66 Zinc Ointment, III-1228
V-179
Water in Essential Oils, V-322 Zinc Ointment, Coal Tar and, III-1134
X-ray Powder Diffraction (XRPD),
Water in Medicinal Gases, Zinc Oxide, II-1205, V-A141
Characterisation of Crystalline and
Determination of, V-311 Zinc Paste, Compound, III-1228
Partially Crystalline Solids by, V-526
Water, Nitrate-free, V-A140 Zinc Powder, V-A141
XRPD, Characterisation of Crystalline
Water, Particle-free, V-A140 Zinc Shot, V-A141
and Partially Crystalline Solids by X-
Water, Potable, I-10, II-10, III-10, Zinc Standard Solution (5 mg/mL Zn),
ray Powder Diffraction, V-526
IV-10, V-10 V-A152
Xylene, V-A140
Water R1, V-A139 Zinc Standard Solution (5 ppm Zn),
Xylene Cyanol FF, V-A140
Water, Standard Solution for the Micro V-A152
Xylenol Orange, V-A140
Determination of, V-A152 Zinc Standard Solution (10 ppm Zn),
Xylenol Orange Solution, V-A140
Water-bath, I-24, II-24, III-24, IV-24, V-A152
Xylenol Orange Triturate, V-A140
V-24 Zinc Standard solution (25 ppm Zn),
Xylitol, II-1193
Water-Solid Interactions, V-313 V-A152
Xylometazoline, V-S143
Determination of Sorption- Zinc Standard Solution (100 ppm Zn),
Xylometazoline Hydrochloride, II-1195
Desorption Isotherms and of Water V-A152
Xylometazoline Nasal Drops, III-1223
Activity, V-313 Zinc Stearate, II-1206
Xylose, II-1196, V-A140
Water-soluble Extractive, Determination Zinc Sulfate, V-A141
D-Xylose, see Xylose
of, V-332 Zinc Sulfate Capsules, III-1228
Weak Cationic Resin, V-A39 Zinc Sulfate Eye Drops, III-1228
Weak Copper Sulfate Solution, V-A46 Zinc Sulfate Heptahydrate, II-1207
Weak Ginger Tincture, IV-199 Y Zinc Sulfate Hexahydrate, II-1207
Websites, I-xxv Yarrow, IV-409 Zinc Sulfate Injection, III-1228
Wedelolactone, V-A140 Yel(live), see Yellow Fever Vaccine, Live Zinc Sulfate Lotion, III-1229
Weight per millilitre, Determination of, Yellow Beeswax, I-244 Zinc Sulfate Monohydrate, II-1208
V-245 Yellow Fever Vaccine, Live, IV-641 Zinc Sulfate Tablets, III-1229
Weights and Measures, Expression of, Yellow Mercury(II) Oxide, V-A84 Zinc Sulfate VS, V-A148
I-6, II-6, III-6, IV-6, V-6 Yellow Soft Paraffin, II-502 Zinc Sulphate Capsules, see Zinc Sulfate
Weights, Atomic, I-6, II-6, III-6, IV-6, Yohimbine Hydrochloride, II-1197 Capsules
V-6 Zinc Sulphate Eye Drops, see Zinc Sulfate
Wettability of Porous Solids including Eye Drops
Powders, V-536
Wheat Starch, II-916
Z Zinc Sulphate Injection, see Zinc Sulfate
Injection
(3Z)-3-Butylidene-1,3,4,5-
White Beeswax, I-243 Zinc Sulphate Lotion, see Zinc Sulfate
tetrahydroisobenzofuran-1-oneSee (Z)-
White Cutaneous Emulsion, III-755 Lotion
Ligustilide, V-A80
White Embrocation, III-755 Zinc Sulphate Tablets, see Zinc Sulfate
Zidovudine, II-1199, V-S143
White Horehound, IV-217 Tablets
Zidovudine and Lamivudine Tablets,
White Liniment, III-755 Zinc Sulphate VS,ee Zinc Sulfate VS,
III-1225
White Peony Root, IV-313 V-A148
Zidovudine Capsules, III-1223
White Soft Paraffin, II-502, V-A99 Zinc Sulphate, see Zinc Sulfate
Zidovudine Tablets, III-1224
Whites Tar Paste, III-1229 Zinc Undecenoate, II-1208
Zinc, V-A140, V-A142
Whitfields Ointment, see Compound Zincum Sulfuricum, V-609
Zinc Acetate, II-1201, V-A140
Benzoic Acid Ointment Ziprasidone Hydrochloride
Zinc Acetate Cutaneous Solution,
WHO ISA, V-652 Monohydrate, II-1209
Erythromycin and, see Erythromycin
Wild Pansy, IV-309 Ziprasidone Mesilate Trihydrate, II-1211
and Zinc Acetate Lotion
Wild Thyme, IV-389 Zirconium Standard Solution (1 g/L Zr),
Zinc Acetate Lotion, Erythromycin and,
Willow Bark, IV-404 V-A152
III-526
Willow Bark Dry Extract, IV-406 Zirconyl Chloride, V-A141
Zinc Acetate Solution, V-A140
Withaferin A CRS, V-A160 Zirconyl Nitrate, V-A141
Zinc Acexamate, II-1202
Withania Somnifera Root, IV-407 Zirconyl Nitrate Solution, V-A141
page numbers in bold type relate to monograph titles Index V-A867

(Z)-Ligustilide, V-A80
Z-Ligustilide CRS, V-A160
Zolpidem Tablets, III-1230
Zolpidem Tartrate, II-1213
Zopiclone, II-1215, V-S144
Zopiclone Tablets, III-1232
Zuclopenthixol Acetate, II-1216, V-S144
Zuclopenthixol Acetate Injection,
III-1233
Zuclopenthixol Decanoate, II-1217
Zuclopenthixol Decanoate Injection,
III-1235
Zuclopenthixol Hydrochloride, II-1219,
V-S144
Zuclopenthixol Tablets, III-1235
V-302